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Abstract 
Campylobacter jejuni is the leading causative agent of human bacterial 
gastroenteritis.  Human C. jejuni infection (campylobacteriosis) is frequently 
associated with poultry; through consumption of undercooked products, cross 
contamination from raw meats, or through direct contact with birds or their faecal 
matter, however it is established that poultry is not the sole cause of C. jejuni 
infection in humans. 
This research reveals new information on the MLST ST403 Clonal Complex, a 
previously identified C. jejuni lineage associated with the porcine host.  ST403CC C. 
jejuni have also been linked with other mammalian hosts to a lesser degree, and 
have been implicated in human campylobacteriosis, however to date this clonal 
complex has not been linked to poultry.  The original hypothesis of this research 
predicted that due to sharing a host niche commonly associated with C. coli, the 
porcine ST403CC may show evidence of increased recombination with C. coli, 
however this was not observed.   
Six ST403CC isolates of porcine origin were subjected to phenotype testing and 
whole genome sequencing; these isolates were capable of invasion in vitro, and 
were revealed both to have acquired seemingly lineage specific content, in the form 
of Restriction-Modification (R-M) system associated genes, and to have undergone 
degredation of certain loci.  The ST403CC isolates also exhibited a distinct pattern of 
reduced genomic recombination compared to non-ST403CC C. jejuni, with evidence 
of lineage specific recombination events. 
Both generalist & specialist lineages have previously been revealed in C. jejuni.  The 
research presented here identifies a new specialist lineage which is associated with 
mammalian hosts, and not found in poultry. 
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Chapter One: Introduction 
1.1 History of Campylobacter 
The bacteria we now know as Campylobacter have a complicated history, as 
perspectives have changed with the development of new techniques and 
technologies.  In 2005, Moore et al produced a review which described the history 
of Campylobacter as a group of emerging pathogens; briefly, these organisms were 
first recognised as animal pathogens during the early twentieth century, and later - 
around the 1950s - begun to be occasionally identified from human blood cultures 
and were viewed as occasional opportunistic human pathogens.  However, in later 
years, the development of improved isolation techniques led to the discovery that 
these bacteria in fact represent a substantial cause of human disease; most 
commonly infectious gastroenteritis.  As such there are two important historical 
perspectives when considering Campylobacter; firstly the history of its relation to 
disease, and secondly the history of the nomenclature applied to Campylobacter. 
1.1.1 History of Campylobacter Association with Disease 
Campylobacters were first observed in the early 20th Century, and were initially 
described as ‘Vibrio-like species’ (Debruyne, Gevers & Vandamme in Nachamkin, 
Szymanski & Blaser (Eds), 2008).  These ‘Vibrio-like’ bacteria were first recognised as 
veterinary pathogens; associated with abortion in sheep (McFadyean & Stockman, 
1913 - cited by Vandamme & Goossens, 1992) and cows (Smith, 1918 - cited by 
Vandamme & Goossens, 1992), and were subsequently described as ‘Vibrio fetus’ 
by Smith & Taylor (1919 - cited by Vandamme & Goossens, 1992).  Later, these 
‘Vibrio-likes’ were also linked to diarrhoeal infection in cattle (Smith & Orcutt, 1927; 
Jones, Orcutt & Little, 1931) and were then referred to as Vibrio jejuni.  In 1944 
another ‘Vibrio-like species’ was identified by Doyle in relation to diarrhoea in pigs, 
and later became known as Vibrio coli (Doyle, 1948 - cited in Vandamme & 
Goossens, 1992).  Also during the 1940s, these ‘Vibrio-like species’ began to be 
sporadically isolated from human cases, via body fluid samples, however it was as 
late as the 1970s when Campylobacter  was first successfully isolated from faecal 
samples as described in the review by Butzler (2004). 
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The first significant work on human infection with the ‘Vibrio-like’ later known to be 
Campylobacter jejuni or C. coli was that carried out by King in 1957.  Due to the 
limitations in culture and isolation techniques, these isolates were from blood 
samples but were intellectually linked with diarrhoeal symptoms expressed by the 
patients; at this time culture from stools was unsuccessful, with overgrowth on 
plates due to out-competition by coliforms on growth media.  King (1957) observed 
a distinct group of ‘related Vibrios’ with a higher optimal growth temperature 
(42°C), some biochemical differences, and a distinct diarrhoeal clinical presentation 
compared to previously described animal Vibrio fetus isolates.  The newly observed 
human blood isolates thought to be V. fetus were morphologically indistinguishable 
from their assumed animal counterparts, and showed similar microaerophilic 
growth characteristics, however, the animal isolates grew best between 25-37°C 
with no or very little growth at 42°C whereas the human isolate ‘related vibrios’ 
grew at 37-42°C with optimal growth at 42°C and no or very little growth at 25°C.   
Since then the prevalence and clinical effects of Campylobacter has been 
increasingly studied, particularly due to the development of filtration techniques 
and selective procedures to isolate and culture Campylobacters from stool samples 
by Butzler et al (1973).  These new techniques had a huge impact on the future 
study of human Campylobacter infections, and, for example, led to the work of 
Skirrow (1977), who observed that 7.1% (57) of 803 diarrhoeic patients tested 
positive for C. jejuni or C. coli, with zero observed from 194 non-diarrhoeic control 
individuals.  The highest incidence of Campylobacter was observed in children 
(Skirrow, 1977), and all individuals who tested positive for Campylobacter described 
distinctive symptoms including abdominal pain.  Skirrow (1977) demonstrated the 
link between Campylobacter presence and enteritis with diarrhoea and abdominal 
cramps, and drew attention to Campylobacter as a likely overlooked cause of 
enterocolitis. 
A subsequent study (Skirrow & Benjamin, 1980) also supported the early work of 
King (1957), whereby growth at 25°C provided a clear cut-off between V. fetus and 
the ‘other related Vibrios’ (now identified as C. jejuni/C. coli) and other NARTC 
isolates (nalidixic acid resistant thermophilic Campylobacter isolates), however they 
found that distinguishing between C. jejuni and C. coli was less accurate using 
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temperature and biochemical tests.  Skirrow & Benjamin (1980) also observed 
associations between C. jejuni and cattle and C. coli and pigs, however, poultry 
strains were found to exhibit ‘intermediate’ characteristics, and human isolates 
were observed which represented both groups, but more commonly resembled C. 
jejuni.   
From the 1970s-1980s it was increasingly observed and accepted that the 
previously unculturable Campylobacter isolates in stools were a large cause of 
human gastroenteritis; these were a distinct group from animal pathogens with a 
higher optimal growth temperature despite morphological similarity.  To develop 
the full picture this progression must be paired with the advances in systematics of 
Campylobacter. 
1.1.2 Nomenclature of Campylobacter 
Linked with the general difficulties in culturing and identifying Camyplobacters, 
similar complexity was encountered in the accurate nomenclature for these 
organisms.  As described previously the organism was first known as ‘Vibrio’ in the 
early 20th century; before being expanded and eventually recognised as a new 
genus.  These bacteria were initially described as ‘Vibrio-like’ species around 1910 
with the subsequent addition of species such as V. fetus (Smith & Taylor, 1919 – 
cited in Vandamme & Goossens, 1992), V. jejuni (Smith & Orcutt, 1927; Jones, 
Orcutt & Little, 1931) and V. coli (Doyle, 1948 in Vandamme & Goossens, 1992). 
The genus Campylobacter was introduced in 1963 by Sebald and Véron, (cited in 
Debruyne, Gevers & Vandamme, in Nachamkin, Szymanski & Blaser (Eds), 2008), 
due to the unique characteristics of these isolates, such as their lack of 
fermentation, microaerophily, and low GC content.  Campylobacter initially 
contained two of the previously described ‘related Vibrio’ species; V. fetus and V. 
bubulus, now designated C. fetus  and C. bubulus, with C. fetus as the type species 
and the new genus placed within the family Spirilliaceae (Debruyne, Gevers & 
Vandamme, in Nachamkin, Szymanski & Blaser (Eds), 2008; Sebald & Véron, 1963).  
This was subsequently expanded a decade later by Véron & Chatelain (1973), based 
upon biochemical and serotyping tests combined with assessment of GC content, to 
include the transfer of four ‘Vibrio-like’ species (Vibrio coli, V. jejuni, V. sputorum, V. 
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bubulus) to the genus Campylobacter previously created by Sebald & Véron (1963) 
as the new species C. coli; C. jejuni and C. sputorum (containing subspecies C. 
sputorum sputorum and C. sputorum bubulus), as well as the separation of the 
previously described type species C. fetus into two subspecies; C. fetus fetus and C. 
fetus venerealis.  Numerous revisions of different species have been undertaken 
over the subsequent decades, and in 1991 Vandamme and De Ley introduced the 
family Campylobacteraceae to contain all species of Campylobacter and Arcobacter. 
1.1.2.1 Determining Relatedness & Taxonomy 
Determining the relationships between bacterial species has been a topic of 
consideration since microorganisms first began to be observed and understood.  
The systems for determining these relationships however have been turbulent, with 
frequent changes to classifications being necessary (Ludwig & Klenk, in Garrity (Ed), 
2001).  Initial methods for determining bacterial systematics relied upon observable 
physical characteristics such as morphology, motility and biochemical profiles, and 
in some cases these initial determinants remain relative; however in many cases the 
advent and constant improvement of molecular and genomic methods have altered 
judgements significantly.  Early molecular or genomic methods such as comparing 
G:C nucleotide content, or analysis of cell wall or lipid content frequently provided 
better distinction.  Later (around the 1960s), DNA-DNA hybridisation became the 
process of choice for determining systematic relationships, providing not just 
differentiating information as the earlier methods but also a direct means to 
interpret phylogeny, with the accepted standard being that organisms exhibiting 
greater than 70% hybridisation represent the same species (Ludwig & Klenk, in 
Garrity (Ed), 2001).  Nucleotide sequencing became increasingly valuable, with the 
main example being the use of small subunit rRNA as a measure of relatedness. 
1.1.2.2 Taxonomy of Campylobacter 
In their review of Camyplobacter taxonomy, Vandamme & Goossens (1992) 
described that in the eighth Bergey’s manual (in 1974), Campylobacter was grouped 
with the genus Spirillum into the family Spirillaceae, until in 1984 when the family 
Spirillaceae was discontinued and the orphaned groups including Campylobacter 
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were placed into a collection of unassigned taxa which showed some resemblance 
in physiology or morphology.  Subsequently, in 1987 Romaniuk et al used partial 
rRNA sequencing of six Campylobacter strains and determined that they 
represented a distinct group of eubacteria; as described by Vandamme & Goossens 
(1992) these were later demonstrated to be a subgroup of what is now known as 
the Proteobacteria. 
In the 1980s rRNA cistron similarity became the new vogue for determining 
bacterial classification.  This in part led to the separation in 1989 of the then C. 
pylori and C. mustelae to the novel genus Helicobacter (H. pylori and H. mustelae).  
This marked the beginning of a period of significant study and reorganisation in the 
Campylobacters throughout the 1990s.  This was followed by a large scale DNA-
rRNA hybridisation study by Vandamme et al (1991) – leading to the description of 
what is now known as the epsilon sub-division of Proteobacteria. 
Vandamme et al’s (1991) study of DNA-rRNA hybridisation determined that 
campylobacters and their relatives were a separate phylogenetic branch; rRNA 
superfamily VI.  Several groups already exist within the Eubacteria including the 
Proteobacteria. Already characterised within the Proteobacteria were the alpha, 
beta, gamma and delta subclasses.  Vandamme & De Ley (1991) observed that rRNA 
superfamily VI containing the Campylobacters and related organisms represents a 
separate Proteobacteria subclass, designated the epsilon Proteobacteria.  Based 
upon rRNA-DNA hybdridisation, they proposed that Campylobacter and Arcobacter 
were within the new genera Campylobacteraceae with Helicobacter, Wolinella and 
other related organisms being closely related (superfamily VI) but distinct and 
excluded from the genera.  The epsilon Proteobacteria consists of three clusters; 
cluster one consisting of Bacteroides gracilis; B. ureolyticus; C. coli; C. concisus; C. 
fetus; C. hyointestinalis; C. jejuni; C. lari; C. mucosalis; C. sputorum; C. upsaliensis; 
Wolinella curva; and W. recta.  Cluster two consisting of ‘aerotolerant 
Campylobacter-like organisms’ which were reclassified as the novel genus 
Arcobacter, whilst the third cluster contained C. cinaedi; C. fennelliae; Flexispira 
rappini; Helicobacter mustelae; H. pylori; W. succinogenes and the unnamed 
‘Campylobacter-like-organism-3’ isolate’.   Due to the determination of these 
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clusters they proposed renaming W. curva and W. recta as C. curvus and C. rectus, 
and C. cinaedi and C. fennelliae as Helicobacter cinaedi and H. fennelliae. 
In 1991 Vandamme & De Ley introduced the family Campylobacteraceae, 
comprising the genera Arcobacter and Campylobacter, within the Proteobacteria 
subgroup described previously.  In a subsequent study B. gracilis and B uerolyticus 
were amended to the novel species C. gracilis (Vandamme et al, 1995), with the 
effect that the genus Campylobacter could be described as anything sharing rRNA 
‘cluster one’ homology with the type species C. fetus.  
rRNA studies in the early nineties led to reclassification and improved 
understanding of Campylobacters; the Campylobacter genus species must have 
homology at rRNA hybridization level with the type species, C. fetus (Debruyne, 
Gevers & Vandamme, in Nachamkin, Szymanski & Blaser (Eds), 2008).  At this time 
the genus Arcobacter was introducted, for rRNA ‘cluster two’; whilst two more 
previous ‘campylobacters’ were reassigned as Helicobacters, this time H. cinaedi 
and H. fennelliae.  Vandamme et al (1991) further ‘finessed’ the categories and 
members of Campylobacter and related organisms, introducing genus Arcobacter 
and rearranging some species, as described above.  The genera Campylobacter and 
Arcobacter were assigned to a new family, Campylobacteriaceae; which also 
contains Sulfospurilium, Wolinella and Helicobacter (Vandamme & De Ley, 1991; 
Debruyne, Gevers & Vandamme, in Nachamkin, Szymanski & Blaser (Eds), 2008) 
1.2 The Clinical Significance of Campylobacter 
Species of Campylobacter can be subdivided into two groups which are often 
referred to as the thermophilic and nonthermophilic groups.  In the literature this is  
often used interchangeably with the alternative term thermotolerant 
campylobacters, which is more appropriate as true thermophily is characterised by 
growth/survival at higher temperatures, such as a growth range between 
approximately 20-70°C and an optimum temperature for growth usually in excess of 
50°C (Madigan & Martinko, 2006).   
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Non-thermotolerant Campylobacters grow optimally in the range of 25-37°C, with 
little to no growth observed at 42°C; whereas thermotolerant Campylobacter 
species display optimum growth at 42°C, and strong growth also at 37°C but with 
little to no growth occurring at 25°C (King, 1957; Skirrow & Benjamin, 1980; Butzler, 
2004). 
1.2.1 Human Infections with Campylobacter 
Both non-thermotolerant (C. fetus fetus; C. fetus venerealis) and thermotolerant (C. 
jejuni; C. coli; C. upsaliensis) campylobacters are potential human pathogens 
(Penner, 1988). 
C. fetus fetus causes spontaneous abortion in sheep and cattle, whilst C. fetus 
venerealis causes infective infertility in cattle (Lastovica & Allos, in Nachamkin, 
Szymanski & Blaser (Eds), 2008; Florent, 1959 - cited in Vandamme & Goossens, 
1992). Moore et al (2005) described that C. fetus is a potential but rare cause of 
gastroenteritis in humans, but is more commonly associated with systemic 
infections – typically in patients who are already unwell, as a complication.  Human 
C. fetus infection can include fever and metastatic localisation, and has an 
estimated mortality rate of 15%.  C. fetus fetus can cause diarhhoeal disease in 
humans, which is described by Lastovica & Allos (in Nachamkin, Szymanski & Blaser 
(Eds), 2008) as similar to C. jejuni infection.  Penner (1988) stated that C. fetus fetus 
infections typically include septicaemia and occasionally meningitis occurring in 
patients with illness already presenting.  Human foetal infections can occur but are 
thought to be rare.   
Thermotolerant Campylobacter species, including C. jejuni, C. coli and C. lari, 
commonly cause infectious gastroenteritis in humans.  As described in Butzler’s 
review article (2004), several Campylobacter species are known to cause infective 
diarrhoea in humans (including C. coli, C. concisus, C. fetus fetus, C. hyointestinalis, 
C. jejuni doylei, C. jejuni jejuni, C. lari, C. upsaliensis) however C. jejuni jejuni is by a 
clear margin the most commonly associated Campylobacter with human 
gastroenteritis.  Due to the similarities between infection and characteristics of C. 
jejuni and C. coli, many epidemiological studies do not differentiate between the 
two, either considering both as one group, or including C. jejuni only – and many 
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labs do not routinely carry out speciation between the two (Siemer, Nielsen & On, 
2005). 
1.2.2 Clinical Presentations 
The most common presentation of human Campylobacter infection is a typical 
gastroenteritis illness including diarrhoea, abdominal cramps and fever (Butzler, 
2004) which is often referred to as Campylobacteriosis.  Infection with C. jejuni or C. 
coli causes, normally, an unpleasant but self-limiting diarrhoeal disease which only 
requires treatment in severe or unusual cases.  Symptoms of infection are not 
distinguishable from other common gastroenteral pathogens without the need for 
laboratory confirmation.  Campylobacteriosis typically has an incubation period of 
between two and five days before symptoms are presented, although in some cases 
the incubation period can last as much as ten days (Butzler, 2004; Moore et al, 
2005).  Often, fever, abdominal pain and general malaise begin before the onset of 
diarrhoeal symptoms, which then typically lasts for around forty-eight to seventy-
two hours, after which point the other symptoms may persist longer (Butzler, 
2004).  Stools often contain blood, pus and or mucus due to the inflammation 
caused by the infection. 
Symptoms develop generally between two and three days following the 
consumption of contaminated matter and the majority of cases are self-limiting, 
usually within a week (Moore et al, 2005); however, duration and severity of 
Campylobacter infection can vary greatly, and infection is often associated with 
fever and painful cramps (Zilbauer et al, 2008) and post infection complications can 
occur, and may be severe (Grant, Woodward & Maskell, 2006).  The invasive ability 
of Campylobacter means that bacteraemia (bacteria in blood) is a potential 
complication.  Rarely, C. jejuni infection can lead to bacteraemia; most commonly in 
patients who are already immunocompromised (Butzler, 2004). Other potential but 
uncommon complications of C. jejuni infection include reactive arthiritis, or other 
extra-intestinal infections such as meningitis or osteomyelitis (Butzler, 2004). The 
most serious risk post infection with C. jejuni is the development of autoimmune 
mimicry disease, including GBS (Guillain-Barré Syndrome).  Other infections can be 
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caused if C. jejuni spreads from the site of infection (typically the jejunum, ileum or 
colon) into other regions of the gastrointestinal tract, or extraintestinal spread to 
other organs, even causing bacteraemia in some patients (in rare instances).  
Occasionally C. jejuni infection can lead to serious systemic illness which can end in 
sepsis and death, however these cases are very rare and C. jejuni has very low 
mortality rates (Allos, 2001). 
GBS is the most important potential complication of Campylobacter infection.  GBS 
is a form of flaccid paralysis which is caused by the molecular mimicry of a C. jejuni 
surface antigen of the human GM1 epitope which is expressed on motor neurones; 
the induced anti-GM1 antibody causes autoimmunity leading macrophages to enter 
and destroy the motor nerve axon, creating the flaccid paralysis exhibited in 
sufferers (Yuki, 2001).  GBS incidence is low (estimated at less than 1 per 1000 C. 
jejuni cases), however, with the imminent elimination of poliomyelitis, it is now the 
most frequent cause of acute flaccid paralysis (Allos, 2001; Yuki, 2001).  GBS can be 
associated with specific Penner scheme serotypes, however there is no observed 
link between the severity of the initial C. jejuni infection and the subsequent 
development of GBS (Allos, 2001; Yuki, 2001).   
The symptoms of C. jejuni and C. coli infection are not so distinct that the organism 
can be differentiated from other gastroenteritis causing bacteria in clinical cases 
without microbiological investigation (Butzler, 2004).  In the clinical setting, C. jejuni 
infection is indistinguishable not only from C. coli infection but also those caused by 
other bacterial diarrhoeal pathogens such as Yersinia, Salmonella or Shigella species 
as it typically manifests as a short-term illness with fever cramps and diarrhoea 
(Allos, 2001). 
1.2.3 Treatment & Antimicrobial Resistance in Campylobacter 
Generally campylobacteriosis is self-limiting and symptoms are resolved within two 
weeks, although bacteria may still be shed in faeces for up to eight weeks.  The 
most common treatment required for Campylobacteriosis is simply the provision of 
hydration and electrolytes if necessary to prevent dehydration, however, if a 
patient is immunocompromised or otherwise in ill health, or if symptoms are 
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extreme or persist for over a week, antimicrobial chemotherapy is required (Butzler, 
2004).  Generally the decision to use antibiotics should not be taken unless special 
circumstances require it; such as severe or prolonged illness or for patients who are 
HIV positive, are currently pregnant, or suffer immunocompromising disorders 
(Allos, 2001).  Where possible, antimicrobial treatments are avoided for 
Campylobacter infection, as Campylobacters are known to be naturally resistant to 
some antibiotics and have been demonstrated to acquire resistance to normally 
effective antibiotics under selective pressure.  Additionally antibiotic treatments 
should be avoided where possible not just due to the risk of increasing antimicrobial 
resistance in Campylobacter but also in case of misdiagnosis (E. coli O157:H7 can 
cause a similar bloody diarrhoea, for example) and the risk of increasing 
antimicrobial fitness in other pathogens or in opportunistic commensals (Allos, 
2001). 
Traditionally, fluoroquinolones were commonly used to treat C. jejuni infection 
(Butzler, 2004; Allos, 2001), as they could be used freely without determining the 
specific cause; as a general treatment for bacterial gastroenteritis caused by 
organisms such as Campylobacter, Shigella, Salmonella (Allos, 2001) however this 
has led to an increase in fluoroquinolone resistance in Campylobacters.  An 
additional factor in the prevalence of fluoroquinolone resistance in Campylobacters 
is the use of certain fluoroquinolones in animal husbandry in the UK, USA and 
Europe (Allos, 2001; Butzler, 2004). 
Nachamkin, Ung & Li (2002) reviewed the issue of antibiotic, specifically 
fluoroquinolone, resistance in C. jejuni.  Resistant strains of C. jejuni were first 
identified in the 1980s in Europe, and were linked with the use of fluoroquinolones 
in animal sources.  They also cite research in the USA (Minnesota) showing that 
over a six year period from 1992 to 1998 C. jejuni fluoroquinolone resistance 
expanded from 1.3% to 10.2% (Smith et al, 1999; Nachamkin, Ung & Li, 2002).  Their 
research found that although the presence of erythromycin resistance in tested C. 
jejuni isolates remained relatively consistent across the period between 1982 and 
2001 (around 2-5%) whereas resistance to ciprofloxacin grew from around 10% in 
1996 to approximately 40% in 2001.  Nachamkin, Ung & Li (2002) also found that 
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when MIC (Minimum Inhibitory Concentrations) were taken into consideration, 
although the majority of isolates were inhibited by a low ciprofloxacin 
concentration (≤0.250µg/ml), the resistant isolates had high levels of resistance, 
with MICs in excess of ≥32ug/ml.  Additionally, in their study, foreign travel seemed 
to be associated with acquisition of fluoroquinolone resistant C. jejuni.  In a similar 
study to that by Nachmkin, Ung & Li (2002), Unicomb et al (2003) observed that 
fluoroquinolone resistance, despite being highly prevalent elsewhere, was not a 
significant issue in Australia.  Only twelve of 370 C. jejuni isolates from human cases 
were found to be resistant to fluoroquinolones, and of these ten were 
demonstrated to be associated with foreign travel, although the other two could 
not be assigned, resistance was not observed in the 358 isolates which were locally 
acquired.  They suggest the probable link between the lack of C. jejuni 
fluroquinolone resistance and the lack of use of these in food production animals.  A 
study by Gaunt & Piddock (1996) demonstrated that 4.1% of 2209 isolates taken in 
1991 in the UK were resistant to ciprofloxacin in lab tests, although none of these 
patients had been treated with any quinolones, 33% of them had recently travelled 
abroad.  This suggested that the use of quinolones to treat broiler flocks has created 
a selective pressure for quinolone resistance in Campylobacter.  Smith et al (1999) 
reported a dramatic increase (from 1.3% to 10.2%) in quinolone resistant C. jejuni 
isolates in Minnesota from 1992 to 1998.  They observed that quinolone treatment 
could only be associated with about 15% of resistant cases, and observed that 
although foreign travel was associated with resistant isolates, this explained fewer 
cases as time went on, with 1996-1998 resistance being increasingly associated with 
domestic infections.  They confirmed a link between chicken products and domestic 
infections. 
Erythromycin is now the recommended treatment for C. jejuni infection, where 
necessary (Allos, 2001; Butzler, 2004; others).  Modern macrolides (such as 
clarithromycin and its relatives) have been demonstrated to also represent an 
effective treatment against Campylobacter, however their use is not recommended 
due to the extra cost incurred with no improved success rates over cheaper 
treatments (Nachamkin, Ung & Li, 2002). 
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1.3 The Burden of Campylobacter 
Skirrow (1977) suggested that if the results of the first major study of C. jejuni and 
C. coli in diarrhoeic patients could be extrapolated it was reasonable to suggest that 
Campylobacter may be the biggest single cause of infectious bacterial enterocolitis; 
this has subsequently been demonstrated in modern studies and Campylobacter is 
now accepted as the leading cause of bacterial gastroenteritis worldwide, causing 
more cases than Salmonella spp, Shigella spp or E. coli O157:H7 (Allos, 2001; Moore 
et al, 2005).  According to the HPA (Health Protection Agency), in 2010 there were 
over 62000 reported incidences of Campylobacter infection in England and Wales; 
compared to just more than 9000 recorded cases of Salmonella in the same period.   
In a recent review of the levels of human Campylobacter infections in the UK 
(Strachan & Forbes, 2010) there were 64000 reported cases of Campylobacter 
gastroenteritis in England, Scotland and Wales combined during 2009 (Pollock et al, 
2009, and anonymous HPA reports, 2010 - cited in Strachan & Forbes, 2010), 
however, under-reporting is a significant issue for Campylobacter and for 
gastroenteritis generally, the real figures for this period may be closer to 450000 
(Wheeler et al, 1999; Strachan & Forbes, 2010).  There have been fluctuations in the 
number of confirmed cases reported by the HPA in England & Wales since they 
began screening for Campylobacter, however the general trend across the studied 
time is an increase (from approximately 34 thousand in 1989 to approximately 62 
thousand in 2010).  In a study by Wheeler et al (1999), in England, Campylobacter 
species were the largest bacterial agent of infectious intestinal disease in the 
community and in general practice.  In general, one in five people are affected by 
some kind of infectious intestinal disease every year; of these approximately one in 
six will report to a GP.   
Although Campylobacter infection is not normally serious and does not normally 
require treatment, the sheer number of cases places a considerable burden on the 
workplace and economy through sick days.  According to Strachan & Forbes (2010) 
around 10% of human Campylobacter cases in England, Wales and Scotland require 
hospitalisation.  As stated previously it is also important to remember the large 
degree of un-reported cases meaning the burden is larger than predicted.  Also the 
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expense of the rare complications is still considerable. Outbreaks of Campylobacter 
are uncommon (or at least, identifying them is), with the majority being sporadic 
cases (Janssen et al, 2008).  Where recognised outbreaks do occur they are often 
associated with water or with raw milk products. 
Cases of Campylobacter associated illness can occur at any age, but C. jejuni is 
particularly a cause of morbidity in children and in travellers (particularly holiday 
makers from ‘developed countries’ to less industrialised areas) (Allos, 2001; Crushell 
et al, 2004).  Campylobacter incidence is also more common in rural areas, 
especially in children.  This has been demonstrated in numerous studies, including 
those by: Ethelberg et al (2005) who carried out a longitudinal study over an eleven 
year period in Denmark and observed associations with low population density and 
rural housing and Campylobacter infection, especially in children; Green, Krause & 
Wylie (2006), who observed higher incidence of Campylobacter infection both in 
children, and in rural areas, in a Canadian province with both rural, agricultural and 
urban regions; Strachan et al (2009), who demonstrated that children under five 
years in rural areas in NorthEast Scotland had a higher prevalence of 
campylobacteriosis than those in urban areas; and Strachan et al (2013a) revealed 
that, in Scotland, children in rural areas specifically exhibited increased loads of 
non-chicken associated campylobacteriosis cases in the late spring period. 
1.4 Sources of Campylobacteriosis 
Despite the large volume of human infections, humans are not in fact a natural host 
or reservoir for thermotolerant Campylobacter.  Thermotolerant Campylobacter is 
considered an accidental pathogen of humans and is typically a zoonotic infection – 
transmitted to humans from an animal host.  In this section a brief review is 
prevented of the potential sources for human Campylobacter infection. 
1.4.1 Common Sources of Campylobacter 
The largest recognised source for human campylobacteriosis is poultry, and in 
particular, chickens (Janssen et al, 2008; Moore et al, 2005; Strachan & Forbes, 
2010), with cases attributed to direct handling of poultry, contact or contamination 
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with poultry faeces, handling or preparation of meats, or consumption of 
inadequately cooked poultry products, or of foods which have become cross-
contaminated (Janssen et al, 2008).  A unique example evidencing the link between 
poultry meats and human C. jejuni (C. jejuni/C. coli) infection was created by the 
Dioxin crisis which occurred in Belgium during 1999.  In this instance, contamination 
of livestock foodstuffs with Dioxin led to the removal from sale of all Belgian poultry 
products within Belgium and during this period where poultry was unavailable for 
consumption a 40% drop in documented Campylobacter infections was observed by 
the routine surveillance programme.  The number of cases returned to the ‘normal’ 
level once poultry products returned to the shelves (Vellinga & Van Loock, 2002).   
1.4.2 Campylobacter in Food Production Birds & Animals 
Food production mammals, including cattle, pigs and sheep, are a known source of 
Campylobacter infection although the pervasiveness and human importance of 
these sources is debated in the literature (Moore et al, 2005).  Cattle have been 
thought to have carriage levels anywhere between 0-80% (Atabay & Corry, 1998; 
Moore et al, 2005), sheep around 20% carry Campylobacters (Zweifel, Zychowska & 
Stephan, 2004; Moore et al, 2005), and pigs have accepted high incidence of 
Campylobacter, although this may be associated more with the nature of pig 
carcass processing than a truly higher carrier rate in the gut (Nesbakken et al, 2003; 
Moore et al, 2005).  When Nesbakken et al (2003) investigated carriage of 
Campylobacter spp. in pigs at slaughter in Norway they observed 100% carriage in 
the gastrointestinal tract.  C. coli is more commonly associated with pigs than is C. 
jejuni and pigs tend to carry Campylobacters more than sheep or cattle (Franco, 
1988, cited by Nesbakken et al, 2003).  As described by Nesbakken et al (2003), the 
levels of Campylobacter carriage in pigs varies considerably in literature from as low 
as 2.9% in Poland found by Kwiatek, Wolton & Stern (1990, cited in Nesbakken et al, 
2003) to as much as 95% in Sweden by Svedhem and Kaijser (1981, cited in 
Nesbakken et al, 2003).  Nesbakken et al (2003) found mostly C. coli in pigs by some 
margin, but a few examples of C. jejuni and C. lari were also observed. 
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Pezzotti et al (2003) investigated the occurrence of C. jejuni and C. coli from rectal 
swabs of food animals (broiler chickens, beef cattle and pigs) from farms in North-
East Italy during a period in 2000-2001, observing either C. jejuni and or C. coli in 
82.9% of chickens, 53.9% of cattle and 63.5% of pigs.  They also tested meat, both 
submitted directly to the lab (n=444) or purchased at retail (n=37) observing 
Campylobacter from 81.3% of chicken meat samples, only 1.3% of beef and 10.3% 
of pork.  Furthermore, Pezzotti et al (2003) also investigated the species of the 
Campylobacter isolates found: of the beef cattle with Campylobacter, 22% were C. 
jejuni, 26% were C. coli and the remainder (52%) were ‘other thermophilic species’; 
however in the two retail beef samples which tested positive both (100%) were C. 
jejuni.  In chickens Pezzotti et al (2003) observed 44% C. jejuni and 56% C. coli from 
rectal swabs, with 56% C. jejuni and 44% C. coli from meat.  Whilst in pigs 1.3% of 
Campylobacters recovered by Pezzotti et al (2003) were C. jejuni, 63.5% were C. coli 
and the remaining 35.2% were ‘other thermophilic species’ from rectal swabs; from 
pork meat however 38.9% were C. jejuni and 55.5% were C. coli, with only one 
instance (5.6%) of ‘other’ species.  Pezotti et al (2003) observed an unusually high 
level of C. coli in chicken and cattle compared to other studies; they associated this 
potentially with the high levels of antimicrobial resistance they observed in the C. 
coli isolates, related to routine antimicrobial treatments being used at the farm 
level, and also suggested that the high levels in pork meat could possibly be due to 
cross contamination occurring within butchers shops. 
Siemer, Nielsen & On (2005) considered the epidemiology of C. coli.  They found 
that despite the known prevalence of C. coli in pigs, the majority of human C. coli 
isolates in their study were more closely related to C. coli from poultry sources, and 
suggest that human Campylobacter infection may rarely be linked with pork 
products.  
Atabay & Corry (1998) investigated the prevalence and species of Campylobacters 
from dairy cattle rectal swabs from 136 cattle (42 of which were calves) across 
three farms; they observed around 7% positive for C. jejuni, 11% positive for C. fetus 
fetus, 32% positive for C. hyointestinalis and 21% positive for ‘C. sputorum biovar 
paraureolyticus’. 
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Zweifel, Zychowska & Stephan (2004) studied caecum samples from 653 
slaughtered sheep, of which 17.5% were positive for Campylobacter species, which 
were determined to be comprised of 64.9% C. jejuni and 35.1% C. coli. 
Although poultry is the primary animal source of Campylobacter, it has been 
demonstrated that C. jejuni and C. coli are frequently carried by food production 
mammals.  Calculations of the burden of Campylobacter in food production 
mammals has varied, however it is generally accepted that pigs carry considerable 
loads of Campylobacter, and are particularly associated with C. coli, whilst sheep 
and cattle are generally less commonly associated with Campylobacter infection.  A 
survey of abattoirs carried out by Manning et al (2003) revealed an unusual 
potential association between an MLST clonal complex of C. jejuni isolates and the 
typically C. coli associated porcine host. 
1.4.3 Alternative Sources of Campylobacter 
An MLST survey of over 250 C. jejuni isolates was carried out in 2003 by Manning et 
al, demonstrating that C. jejuni are also recovered from diverse sources including 
giraffes and ostriches as well as environmental samples, whilst Sproston et al (2010) 
later demonstrated that flies and slugs can serve as carriers of C. jejuni and C. coli 
via ruminant faeces, and may represent a potential link in the transfer of C. jejuni 
and C. coli within and between food production mammals, or may be a risk factor 
for human infection through contact with food preparation surfaces. 
Other recognised sources of Campylobacter infection include pets, especially dogs 
and cats.  In one study, Hald & Madsen (1997) investigated the presence of faecal 
shedding of Campylobacters from healthy puppies and kittens (aged 11-17 weeks) 
and found that 29% of the 72 puppies tested positive for Campylobacter; 76% C. 
jejuni, 5% C. coli, 19% C. upsaliensis, whereas of the 42 kittens only 5% (two) were 
positive for Campylobacter, specifically C. upsaliensis in both cases.  Parsons et al 
(2009) also investigated the potential link between dogs and human infection with 
C. jejuni – they found evidence that the same types of C. jejuni (by MLST) could be 
observed in humans and dogs, although this could indicate both are getting it from 
the same source (such as water), or it could be that dogs are transmitting to 
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humans, or even vice-versa, but suggest that it should be acknowledged that this is 
at least a potential route for zoonoses. 
Water is another potential source for Campylobacter infection.  Wilson & Moore 
(1996) 42% of 380 tested shellfish tested positive for Campylobacter spp., with 
seasonal variation observed – 6% tested May-August were positive, compared with 
58% Feb-April and 81% October-January.  Of these, the majority (57%) were 
‘urease-positive thermophilic Campylobacters’ – not commonly associated with 
human infections, the rest being C. lari (24%) or ‘other’ Campylobacter spp (9%) 
with only 8% being C. coli and 2% C. jejuni.  Szewzyk et al (2000) conducted a report 
on the link between waters and microbial infections.  They observed that lake water 
had been implicated as the source for infection of C. jejuni into dairy cattle, and 
stated that Campylobacters have been observed in raw sewage as well as in faecally 
contaminated surface waters.  The involvement of water also goes full circle in 
Stanley, Cunningham & Jones (1998), where dairy cattle were potentially 
responsible for the observation of C. jejuni contaminating groundwater.  Outbreaks 
of Campylobacter from drinking water have also been observed.   
Zoonotic illness is commonly associated with contaminated food but is also linked 
with water and wildlife.  Wilson et al (2008) describe evidence for C. jejuni being a 
waterborne pathogen - the seasonality is similar to that in waterborne illnesses, and 
some studies of phylogeny have suggested that human cases are often caused by 
‘non-livestock’ types; however their study of over 1000 C. jejuni from human 
patients showed that the majority of cases are poultry, then cattle, with only about 
3% of C. jejuni infections caused by water/wildlife sources (Wilson et al, 2008). 
1.5 Prevention Strategies 
As described previously, human infection with Campylobacter, and particularly C. 
jejuni places a considerable burden on healthcare and the economy.  C. jejuni is the 
largest cause of bacterial gastroenteritis in the ‘developed’ nations, so any efforts to 
reduce the impact of these infections could be of great benefit.  Despite the 
recognition in recent times of the prevalence of C. jejuni infection it remains a 
significant issue.  A number of prevention and control strategies have been 
18 
 
introduced or proposed to reduce the occurrence of Campylobacter related illness, 
with varying levels of success; this section provides an overview of the work in this 
area. 
1.5.1 Targets & Techniques for Reducing Campylobacter Infection 
Due to the association between poultry handling and consumption and C. jejuni 
infection the optimal way to reduce incidence of campylobacteriosis would be 
through reducing or eradicating the C. jejuni burden in poultry (Allos, 2001; 
Strachan & Forbes, 2010), however this is almost certainly a futile approach at 
present – even if flocks are cleared, there is ample opportunity for recontamination 
at slaughter house or during packing and distribution.  Therefore other targets for 
reducing or eradicating Campylobacter include the slaughterhouse environment or 
at the latter stages by treating food products and their packaging. 
1.5.1.1 Reducing Campylobacter in Poultry Flocks 
Chicks do not normally hatch already infected with campylobacter – horizontal 
transmission is not a common occurrence – this is why the ‘top-down’ programme 
used to reduce Salmonella in poultry is not of use.  Campylobacter usually enters a 
flock at or after the age of two weeks, and due to the lack of symptoms in the birds 
it can remain undetected unless diagnostic samples are taken (Wassenaar, 2011).  
Water can be a source of infection for the chicks, although acquisition from 
contaminated food stuffs is less common.  Other sources include insects, flies and 
vermin, wild birds or other farm animals, the human handlers and so on.  
Vaccination of chickens has also been largely unsuccessful in Campylobacter – 
despite being a considerable success in Salmonella – this is likely due to the 
variation in Campylobacter, however research has shown there may still be hope for 
an effective vaccination programme, using attenuated Salmonella carrying specific 
Campylobacter proteins, such as Cj0113 (omp18, CjaD) as described by Layton et al 
(2011).  Competitive exclusion of Campylobacter in poultry using pre- or probiotics 
has also been investigated, and although eradication was not achieved it has been 
demonstrated that this may provide a significant reduction in Campylobacter 
burden in poultry flocks (Lin, 2009). 
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Newell et al (2011) considered biosecurity interventions to reduce campylobacter at 
poultry farm flocks. They demonstrated that improved biosecurity can reduce 
Campylobacter colonisation in broiler flocks; however, they acknowledged that this 
would need to be paired with other approaches to have a large impact on reducing 
Campylobacter prevalence at the farm level. 
1.5.1.2 Reducing Campylobacter at the Slaughterhouse 
The above are methods to reduce or eliminate colonisation of the birds themselves.  
The next opportunity would be to reduce the bacterial load at the slaughter-house 
or just prior to slaughter.  Bacteriophage therapy could be applied prior to slaughter 
(Wassenaar, 2011; Connerton, Timms & Connerton, 2011; Lin, 2009) however there 
is a risk of resistance developing and this has not been demonstrated as being 
successful at industrial scale.   
During movement to the slaughter-house and the subsequent slaughter and 
processing of carcasses, each flock is bringing its own bacterial load, and any flocks 
which remained previously uninfected with Campylobacter are likely to acquire it at 
this point through cross contamination; even birds that enter the slaughterhouse 
without Campylobacter are likely to leave as contaminated meat, and transmission 
via the vehicles, workers and poultry crates at the slaughter-house has the potential 
to result in Campylobacter being returned to flocks which were previously clear of 
Campylobacter (Ellerbroek, Lienau & Klein, 2010; Wassenaar, 2011). 
1.5.1.3 Reducing Campylobacter during the Processing & Packaging Stages 
Here we have meat from the slaughterhouse which is contaminated with 
Campylobacter.  A significant issue here is that the environment designed to reduce 
spoilage of meat – reduced oxygen – actually increases the likelihood of 
Campylobacter survival (Wassenaar, 2011).  Even once packaged there is still a risk; 
Patrick et al (2010) demonstrated that children riding in shopping carts were at 
increased risk of campylobacter if raw packaged chicken was in the cart.   
Decontamination of meat and packaging would provide a useful means of reducing 
human Campylobacter infection, however various methods (including forced air 
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chilling, crust freezing, steam treatment, ultrasound, and electrolysed oxidising 
water) have varying levels of both cost and effectiveness and often are not as 
successful as freezing the meat would be (Wassenaar, 2011) although there is 
generally less demand for frozen poultry compared to the fresh meat market. 
Irradiation of food products would be a useful method but is not generally approved 
by the consumers (Allos, 2001).  Other modern methods for treating carcasses and 
packaging include high-intensity light pulses (Haughton et al, 2011) and lactic acid 
washes (Rajkovic et al, 2010).  Rajkovic et al (2010) demonstrated that washing with 
a lactic acid/sodium lactate buffer reduces levels of C. jejuni on chicken carcasses, 
and this was even more effective when combined with subsequent packaging being 
carried out in high oxygen atmosphere.  Additionally, in some countries, hyper-
chlorinated water washes are used to clean carcasses post-harvest; in particular this 
method has had apparent success in New Zealand, however it is not used in Europe 
to legislative restrictions (Newell et al, 2010). 
1.5.1.4 Reducing Campylobacter through Consumer Practices 
The major approach currently in reducing C. jejuni infection is to educate and 
encourage the consumer to take part in good hygiene practices and thorough 
cooking of meat products, especially where poultry is concerned – certainly it 
should not be served pink, thermometers could be used, thorough cleaning of 
cutting surfaces, utensils and hands after handling (Allos, 2001).  Thorough cooking 
is hugely important; the heat will kill any remaining Campylobacters; however the 
biggest risk factor in the home is cross-contamination of other surfaces and food-
stuffs - via chopping boards, utensils, salads and raw foods – (Luber, 2009).   
1.5.2 Successful Interventions for Campylobacter 
Jore et al (2010) reviewed the incidence of Campylobacter across six European 
countries (Denmark, Finland, Iceland, Norway, Sweden and The Netherlands), both 
in human cases and in broiler flocks over a ten year period between 1997 and 2007.  
Each country showed the seasonality of Campylobacter infections, with an increase 
in numbers observed in broilers and in human campylobacteriosis cases reported 
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during summer months, peaking July and August.  Across the time of their study a 
decrease in campylobacteriosis, and broiler carriage was observed in Denmark and 
Sweden (2001-2007), campylobacteriosis cases were also declining in Iceland from 
1999-2007, with broiler carriage falling from 2004-2007. Norway had an increase in 
human cases across the period, and instances in The Netherlands and Finland 
remained relatively consistent across the period of study.  The reduction in Iceland 
is associated with a testing and freezing program which has been implemented 
since 1999; where flocks are tested for Campylobacter presence, and all meat is 
frozen if it tests positive (Lowman et al, 2009 conference poster, cited by Strachan 
& Forbes, 2010). 
Other success has been found reducing Campylobacter in New Zealand (Public 
Health Services report, New Zealand, 2009; Strachan & Forbes, 2010) and in the 
USA (Samuel et al, 2004; Strachan & Forbes, 2010).  Samuel et al (2004) considered 
culture-confirmed cases of campylobacter in the USA during 1996 to 1999.  Overall 
the average Campylobacter incidence observed was 21.9 cases per 100,000 of the 
population, however Samuel et al (2004) observed a reduction each year.  This 
decrease may be potentially associated with improved prevention techniques, 
however it must be noted that Campylobacter infection still remains a significant 
issue, with around 2 million cases per year.  The decrease in numbers observed by 
Samuel et al (2004) did coincide with improved methods in poultry treatment 
(increased water volume in washing and additional disinfection of water) with the 
introduction of “Pathogen Reduction (PR)/Hazard Analysis and Critical Control 
Points (HACCP) systems final rule”, however improved behaviour by food 
production workers and/or the general public could not be ruled out as additional 
factors in the decrease in reported Campylobacter cases.  The numbers and trend 
observed by Samuel et al (2004) appear to be consistent in recent figures; in 2012 
the number of cases per 100,000 were 14.3 as recorded by FoodNet 
(http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6215a2.htm). 
Some countries have successfully caused a reduction in the burden of bacterial 
infectious gastroenteritis (such as The Netherlands), however even these countries 
still face a large incidence of disease (Newell et al, 2010).  The three bacterial agents 
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of food-borne gastroenteritis which receive the most focus are E. coli, Salmonella 
spp. and Campylobacter as they represent the majority of ‘food-poisoning’ cases, 
although in recent years attention is also being focused on other emerging 
pathogens, however despite the consistent research, surveillance and prevention 
strategies over multiple decades these three pathogens remain a significant burden 
(Newell et al, 2010). 
Campylobacter interventions (in the UK) have largely focused on the control of the 
poultry industry – various methods in various countries including at the farm, 
slaughter and processing and packaging, and through addressing at home and in 
industry kitchen hygiene knowledge and standards - as this is known to be a 
significant source for Campylobacter.  As Strachan & Forbes (2010) stated - it is 
important that in the UK we take responsibility for the high burden of 
Campylobacter and acknowledge that effective measures can be introduced with 
investment and commitment, and as Moore et al (2005) stated, the most likely 
route for success in reducing Campylobacter infections should be to apply 
interventions across the food chain; beginning with reducing colonisation of 
animals, improving control during transport, slaughter, dressing and packaging, and 
with improved education of the consumer. 
1.6 Typing, Speciation, & Differentiation in Campylobacter 
This section reviews the current and important earlier methods for typing and 
differentiation in C. jejuni.  As mentioned earlier, in epidemiological studies many 
labs often do not distinguish between C. jejuni and C. coli; this is due to the 
difficulties in quickly and accurately differentiating between the two using standard 
laboratory based tests.   
1.6.1 Biochemical & Serological Typing Methods 
Traditionally, hippurate hydrolysis was used as a discriminatory test to distinguish C. 
jejuni from other thermo-tolerant Campylobacter species, notably C. coli and C. lari 
(Nicholson & Patton, 1995).  The basis for this differentiation was that C. jejuni 
would be hippurate hydrolysis positive whilst C. coli  and C. lari were negative for 
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hippurate hydrolysis; however it has been shown that some C. jejuni strains are 
phenotypically hippurate negative (Caner et al, 2008), although the HipO gene is still 
present.  A further complication in the speciation of C. jejuni are the subspecies; as 
described by Parker et al (2007) the species Campylobacter jejuni is divided into two 
subspecies - C. jejuni jejuni and C. jejuni doylei.  Subspecies doylei isolates are 
hippuricase positive (as are most C. jejuni jejuni) and are commonly distinguished 
from C. jejuni jejuni through their inability to reduce nitrate.  C. jejuni doylei is 
frequently associated with clinical cases, and particularly with blood cultures from 
septicaemia and bacteraemia.  Parker et al (2007) demonstrated that the C. jejuni 
doylei subspecies is phylogenetically distinct, and that it and C. jejuni jejuni most 
likely split from a common ancestor; due either to an ecological barrier preventing 
exchange, or due to some genetic barrier to recombination between the two 
subspecies if they do coexist within the host environment.  Due to the different 
illness typically associated with C. jejuni doylei mistaken identity is not as common 
an issue as between C. jejuni and C. coli. 
Typing techniques are also required as a tool in studying the relatedness of isolates, 
and to reveal sources and routes of transmission.  A significant difficulty in 
understanding Campylobacter is the lack of an agreed typing system – a range of 
biochemical and serotyping methods have been used, but these are not always 
reliable, and it is not uncommon for isolates to return ‘untypeable’ results.   
Serotyping was one of the earliest successful typing techniques; with two 
approaches - firstly Penner & Hennessy (1980) developed a serotyping scheme 
based upon heat-stable antigens using haemagglutination (later revealed to be the 
lipopolysaccharide O-antigen, as reviewed by Penner, 1988); and subsequently Lior 
et al (1982) developed a scheme using heat-labile antigens (using antisera-antibody-
technique). The heat-labile method was easier and generally adopted in clinical labs 
(using coagulation).  Serotyping was a useful tool particularly in the early days of 
Campylobacter research however the large number of untypeable strains became 
an issue as research progressed.  Various other biochemical tests were also used in 
the early period of C. jejuni and C. coli study; including the production of H2S, 
resistance to a group of reagents (‘resistotyping’) and various Carbon source 
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utilisation tests (Penner, 1988).  A bacteriophage typing scheme for C. jejuni and C. 
coli was introduced by Grajewski, Kusek & Gelfand (1985) using fourteen lytic 
phages; creating a profile of susceptibility for each isolate.  This was later updated 
by Sails et al (1998) who created a sixteen phage typing system, including six of the 
original phages from Grajewski, Kusek & Gelfand (1985). 
Each biochemical, phage, or serological based technique, despite usefulness 
suffered some limitations, through variation, poor reliability of reproducibility, 
development of resistance and with the advances in DNA techniques these became 
preferred new methods for study. 
1.6.2 Molecular Typing Techniques 
In 1990, Chang & Taylor used PFGE (Pulsed Field agarose Gel Electrophoresis) to 
establish the size of the Campylobacter genome.  PFGE requires digestion of the 
genome by restriction endonucleases in order to produce a small number of large 
fragments which can then be separated using pulsed field electrophoresis.  
Following on from this, Yan, Chang & Taylor (1991) then considered the potential 
for PFGE as an epidemiological tool for C. jejuni and C. coli, and demonstrated its 
use in not only species differentiation, but also in separating distinct isolates.  This 
led to later studies such as that by Gibson, Lorenz & Owen (1997) who used PFGE to 
create ‘fingerprints’ for heat-stable serotype reference strains, and non-typeable 
strains and demonstrated its use as a method to improve understanding of 
serotypable strains, and determine relatedness of untypeable strains.  In a similar 
study, Fitzgerald, Owen & Stanley (1996) had previously tried to determine 
genotype of heat stable penner reference serotypes and untypeable strains using 
ribotyping – typing based upon the RFLP of the 16S rRNA gene, where it was also 
shown that un-serotypeable isolates were related to serotypable isolates in most 
cases. 
Meinersmann et al (1997) investigated the use of flaA gene sequencing in studying 
the relatedness of C. jejuni isolates.  The flaA gene contains two regions of high 
variability - one between 700-1450bp region, and a short variable region between 
bases 450-600, with conserved regions maintained at both ends of the gene locus 
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(Harrington, Thomson-Carter & Carter, 1997; Meinersmann et al, 1997).  
Meinersmann et al (1997) established that the SVR (Short Variable Region) provided 
discrimination at almost the same level as using the whole flaA gene - they showed 
that flaA SVR typing could be combined with or replace other typing techniques 
such as ribotyping or serotyping.  Harrington, Thomson-Carter & Carter (1997) also 
reviewed the flaA typing method, and observed evidence that recombination occurs 
within the flaA gene. In Campylobacter jejuni the flagellin subunit of the filament for 
flagella is coded by two homologous genes located in tandem but 
promoted/expressed separately - flaA and flaB.  By comparing sequence of flaA in 
eighteen C. jejuni strains they observed that recombination between strains occurs 
within the flaA gene and also observed evidence of recombination between the flaA 
and flaB genes – a mechanism with potential for increased antigenic diversity and to 
protect from loss of the gene (the loss of flaA impairs motility, and it has been 
suggested that recombination from flaB may effectively ‘repair’ the flaA gene).  The 
use of flaA typing is not suitable as a long term assessor of relatedness of C. jejuni 
isolates due to the large amount of recombination that occurs within the gene, 
however it can be highly discriminatory in closely related isolates, particularly when 
applied in combination with other typing strategies (Harrington, Thomson-Carter & 
Carter, 1997; Meinersmann et al, 1997; De Boer et al, 2000).   
De Boer et al (2000) considered the relative merits of flaA typing, PFGE, AFLP and 
automated ribotyping for their discriminatory power and use for epidemiological 
analysis of campylobacters, using fifty poultry Campylobacters.  They found AFLP to 
be more highly discriminatory than PFGE, flaA typing, or automated ribotyping (41, 
38, 31 and 26 types determined, respectively by each method). They also showed 
that combining methods could improve differentiation results in isolates which 
were more closely related.   
As Duim et al (1999) described, various phenotypic methods preceded genotyping 
with varying success – serotyping, phage typing, biotyping which relied on specific 
reagents, and so on – each had varying success in discriminating isolates and tended 
to encounter ‘untypeable’ strains.  As such, genotyping quickly became the more 
desirable method for typing Campylobacter species, and AFLP (Amplified Fragment 
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Length Polymorphism) was one of the more successful ‘early’ methods for 
fingerprinting isolates – previously developed methods included PFGE, flaA typing 
and RFLP, ribotyping however, as described above, each of these also lack either 
discriminatory power (such as flaA typing) or may struggle with reproducible typing 
results.  AFLP selectively amplifies restriction fragments which are cut from the 
target genome; AFLP restriction enzymes digest genomic DNA and then specific 
fragments are amplified by PCR to create bands which produce a ‘fingerprint’ on the 
gel.  Using enzymes HhaI and HindIII with selective primers HindA and HhaA Duim et 
al (1999) were able to obtain 40-50 bands which were well spread across the 
genome and evenly distributed with lengths ranging 50-450bp with acceptable 
levels of reproducibility and good discriminatory power:   AFLP represented another 
successful fingerprinting technique, which readily distinguished distantly related 
isolates, but required combination with other techniques, such as flaA typing, in 
order to differentiate closely related strains.   
1.6.3 MultiLocus Sequence Typing 
MLST (MultiLocus Sequence Typing) is a useful tool for studying closely related 
organisms through the sequencing of essential, and therefore well conserved, 
housekeeping genes.  The MLST scheme for Campylobacter was developed by 
Dingle and colleagues (2001) and compares the sequences of seven loci, which are 
each separated from each other by at least 70kb.  The loci used are as follows: aspA 
(aspartase A); glnA (glutamine synthetase); gltA (citrate synthase); glyA (serine 
hydroxymethyltransferase); pgm (phosphoglucomutase); tkt (transketolase) and 
uncA (ATP synthase α subunit).  Each distinct sequence is given an arbitrary number, 
so each isolate is assigned a seven-digit allelic profile, or Sequence Type (ST).  The 
sequence types are then further grouped into ST-complexes where MLST profiles 
are identical at four or more of the seven loci. 
Dingle et al (2005) created an MLST scheme for C. coli using the same loci as in the 
previously developed MLST scheme for C. jejuni (Dingle et al, 2001), but with new 
primers for the same genes.  They also looked at flaA typing (sequencing the short 
variable region of the flaA gene) and found that it has been shared commonly 
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between C. jejuni and C. coli so it cannot be used to separate species but can be 
useful in distinguishing closely related isolates.  As previously discussed, flaA typing 
alone is not useful for Campylobacter, but it can be used as an additional layer of 
information combined with a typing scheme such as MLST (Dingle et al, 2005.  In 
2008, Dingle et al developed an extended MSLT scheme, improving the 
discriminatory power of their original (Dingle et al, 2001) scheme by adding three 
antigen coding genes; flaA (SVR) flaB (SVR) and porA.   
As described previously, the groupings determined by serotyping, although useful, 
can show very different results to typing based upon genetic analysis, and it has 
been demonstrated that different serotypes can be genetically closely related 
(Taboada et al, 2004).  Genotyping studies such as MLST and PFGE replaced 
phenotypic tests as the ‘gold standard’ techniques for typing in Campylobacter, 
however these too face their limitations, notably in the limited view of considering 
only a small number of genes.  Taboada et al (2004) created a full genome 
microarray using comparative genomic hybridisation (CGH) to investigate genome 
wide conservation. Microarray CGH compares the DNA of 2 strains competitively to 
a full genome on a slide.  The work done on this report combines their fifty-one 
strains with the data gathered in three separate studies, given a total cumulative 
study of ninety-seven strains (Dorrell, 11 strains; Leonard, 16 strains and Pearson, 
18).  CGH/microarray allows study across the entire genome rather than being 
limited to a small number of genes, however it is limited as it can only illustrate 
what the query genome(s) share with the reference genome on the slide.  Later 
microarrays have been created which hold ‘pan arrays’ for a species, for example 
however even these cannot inform on any novel content in the query genome. 
1.7 MLST & Host Adaptation 
Host adaptation has been evidenced in each group of the Campylobacteriales order 
– Campylobacter, Helicobacter and Wolinella (Young, Davis & DiRita, 2007) and 
numerous studies have investigated host association in Campylobacter, particularly 
using MLST and comparative genomic hybridisation (microarray).  Sheppard and 
colleagues (2010) used MLST to investigate host association in C. jejuni and C. coli, 
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and found substantial differences between those isolated from poultry and 
ruminants.  In 2007 McCarthy et al developed an MLST scheme to identify the origin 
of an isolate as cattle, sheep or chicken.  Using microarray techniques it has been 
demonstrated that C. jejuni appears to form two distinct clades; livestock and non-
livestock sources (Champion et al, 2005).  Skirrow & Benjamin (1980) also observed 
associations between C. jejuni and cattle and C. coli and pigs.  Various previous 
studies have linked specific MLST clonal complexes with a specific host, or host 
type, whilst other clonal complexes are associated with isolation from a wide range 
of sources.  
French et al (2005) demonstrated that ST61CC C. jejuni isolates showed an 
association with cattle, and also found ST45CC isolates linked with water and 
wildlife samples, although ST45CC isolates were associated with a range of other 
sources including cattle.  French et al (2005) also considered a specific allele in ST61 
– the founder strain for ST61 has the uncA allele uncA17, and, as they describe, this 
is one of a group of unusual uncA alleles not commonly found in C. jejuni – it was 
suggested that this provides evidence of genetic transfer between C.  jejuni and C. 
coli within the host as this is thought to be originally a C. coli allele.  French et al 
(2005) also identified a range of new isolates with new sequence types which were 
associated with wildlife and water samples and not related to human pathogenic 
isolates.  Manning et al (2003) also showed an association between ST61CC and 
cattle, combined with human isolates; however ST61CC has also been linked with 
sheep (Colles et al, 2003) and therefore is possibly a ruminant adapted isolate – it 
has been associated with human cases and is rarely isolated from poultry (French et 
al, 2005).  Colles et al (2003) observed a possible link between ST45CC and poultry, 
similar to Manning et al (2003); although this has also been associated with 
numerous other host types.  Colles et al (2003) found that both ST61CC and ST42CC 
were over represented in sheep and absent from poultry samples.  In contrast, 
ST21CC doesn’t display host specificity (Colles et al, 2003; Manning et al, 2003).  
Manning et al (2003) identified the ST403 clonal complex as a potential porcine 
adapted group, based upon a survey of 266 C. jejuni isolates from a range of souces. 
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Miller et al (2006) were able to associate specific MLST alleles with host types in C. 
coli.  Miller et al (2006) identified ‘common’ alleles which were present in isolates 
from all four investigated host types (swine, turkey, cattle and chicken) and also 
identified alleles significantly associated with swine, chicken or turkey; they did not 
observed cattle specific alleles.  Swine specific alleles in C. coli included aspA32, 
aspA53, glnA38, glnA153, gltA44, gltA134, glyA81, glyA167, glyA173, pgm118, 
pgm152, and tkt173. 
Host association was also investigated by McCarthy et al (2007), using isolates from 
chickens and from cattle and sheep.  McCarthy et al (2007) did not find successful 
separation based upon MLST or clonal complex, however they demonstrated that 
combining the allelic profiles of isolates provided discrimination; showing that host 
associated markers can be observed in C. jejuni and also demonstrating that C. 
jejuni isolates can share and import genetic content within a shared host.  McCarthy 
et al (2007) found that it was much more difficult to separate cattle and sheep 
isolates from each other than from chicken isolates.  This may be due to cattle and 
sheep isolates sharing a common gene pool, and transmission between these two 
sources.  McCarthy et al (2007) also concluded that source association had a greater 
‘effect’ than time or geographical features. 
Sheppard et al (2010) further demonstrated that the host association of C. jejuni 
isolates over-rides the effect of geographical variation.  Sheppard et al (2011a) 
showed considerable sharing of genetic content between C. jejuni and C. coli, with 
such a large proportion of the movement being from C. jejuni to C. coli they 
suggested that the two species were introgressing such that the species boundary is 
being eroded.  Specifically, introgression was witnessed between C. jejuni and C. coli 
clade 1 – the ‘farm’ associated lineage, with no mosaic alleles observed in clades 2 
and 3.  Sheppard et al (2011b) demonstrated that some lineages can be grouped 
and ascribed to a host type, whilst others may be linked to several hosts and 
therefore not be associated with a specific host associated lineage. 
Host adaptation also occurs in Campylobacter outside of food production animals; 
Griekspoor et al (2013) found that wild bird isolates of C. jejuni were genetically 
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distinct from those from human and food animal isolates.  C. jejuni isolates from 
different wild bird species were also distinct from each other, and Williams et al 
(2010) identified a specialist niche-adapted C. jejuni clone was linked with the bank 
vole (Myodes glareolus). 
Hepworth et al (2011) demonstrated that loss or divergence of certain genes were 
associated with niches, when comparing an isolate (1336, ST841) from the diverse 
water and wildlife lineage of C. jejuni against the host specialist isolate C. jejuni 414 
(ST3704) which is niche adapted to the bank vole.  In other instances, however, 
niche adaptation has also been associated with differential expression: Killiny & 
Almeida (2011) demonstrated in the plant pathogen Xylella fastidiosa that in this 
organism, host specificity is determined by changes in gene regulation. 
It is accepted that the majority of human Campylobacter infections are caused by 
Campylobacter jejuni as demonstrated in case based analysis by Gillespie et al 
(2002). It is also acknowledged that the majority of human C. jejuni cases for which 
a cause can be identified are attributed to chicken as the source be it through 
handling of raw meat, consumption of undercooked meat, or through contact with 
the birds and their faeces, however this does not account for all cases of 
Campylobacteriosis and it is clear that other sources are important.  Campylobacter 
is increasingly becoming considered a ubiquitous organism as it is discovered in 
more and more hosts and sources (Strachan & Forbes, 2010).  Campylobacter jejuni 
and Campylobacter coli have also been found to occur in mammals including food 
production animals such as pigs and cattle as well as in companion animals 
including cats and dogs.  Water has also been recognised as a significant reservoir 
for Campylobacter, including lakes, faecally contaminated surface waters and 
groundwater, as well as drinking water (Szewzyk et al, 2000; Moore et al, 2005. 
Typically, C. jejuni is associated with poultry as the source, whereas C. coli is most 
frequently associated with food production mammals such as cattle and pigs.  
However, although C. jejuni is most commonly associated with poultry (either 
through consumption of poorly cooked food, contact with raw meats, or direct 
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contact with birds/faecal matter); it is accepted that poultry is not the sole source 
of C. jejuni infection in humans.   
1.8 The Current Climate of Campylobacter Research 
The history and description of Campylobacter has been considered, with some focus 
on its relevance to human illness and the sources from which it can cause this.  The 
focus of this work has been and will remain centred on the thermo-tolerant 
Campylobacter species, and particularly on C. jejuni; the most commonly isolated 
bacterial cause of gastroenteritis.  An overview will be provided of the current 
‘climate’ in Campylobacter research; covering recent developments in 
understanding and current accepted knowledge. 
Gaynor & Szymanski (2012) published a review conducted following the 16th CHRO 
meeting (Vancouver 2011) - combining new research discussed at the meeting and 
comparing new developments with the previous 30 years of CHRO research.  New 
areas of research from recent years which were discussed by Gaynor & Szymanski 
(2012) included glycobiology; C. jejuni was the first bacterial species shown to 
possess an N-linked glycosylation pathway - leading to a new frontier in creating 
bacterial glycoconjugate vaccines (work by Brendan Wren); and advancements in 
new or improved animal models for the study of C. jejuni infection, particularly the 
technique of creating ‘humanised’  microbiomes in gnotobiotic mice to investigate 
the role of commensal bacteria in establishment or prevention of C. jejuni 
colonisation. 
In the early to mid-2000s it was discovered that C. jejuni was able to produce 
recombinant glycoproteins (Terra et al, 2012).  The N-linked protein glycosylation 
system observed in C. jejuni was the first instance of this being found in bacteria 
(Linton et al, 2005).  The oligosaccharyltransferase involved (pglB) was subsequently 
expressed in E. coli and used to readily produce glycoconjugates for the 
development of vaccines in a much easier and more efficient way than previously 
possible; and developed even further using PGCT (protein glycan coupling 
technology; Langdon, Cuccui & Wren, 2009, cited by Terra et al, 2012). 
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Bereswill et al (2011) showed that murine microbiota prevents C. jejuni colonisation 
of the mouse model.  Mice with an artificial ‘human’ microbiota, or gnotobiotic 
mice however remained colonised in Bereswill et al’s (2011) experiment for six 
weeks, compared to just two days required to clear C. jejuni in mice with mouse 
microbiota.  The humanised or gnotobiotic mice showed a pro-inflammatory 
immune response and therefore provide a useful model for studying the immune 
regulatory response to C. jejuni infection, as well as providing an additional measure 
for comparing the pathogenicity of individual strains or mutants.   
Previously, research was largely focused upon one strain or one single gene, 
whereas now Campylobacter is now rapidly becoming focused upon whole genome 
sequence and large scale investigations. 
Despite Campylobacter being the largest cause of bacterial gastroenteritis in the 
developed world, and although significant research and advances have been made 
in the last few decades, Campylobacter remains a comparatively poorly understood 
organism, especially when compared to other human intestinal pathogens, such as 
Salmonella and E. coli which have been characterised to a great extent.  Significant 
progress has been made across all aspects of Campylobacter - we now have a much 
greater understanding of sources, transmission and infection than when it was 
considered an emerging pathogen not too distant a time ago; however many 
questions remain in Campylobacter research.  Although it is now generally accepted 
that poultry is a major source of human Campylobacteriosis in ‘developed’ nations, 
there is still much work to be done in controlling this source and preventing 
subsequent infection; additionally even were this to be achieved there remains the 
issue of alternative sources for Campylobacteriosis - as described above there are 
numerous potential reservoirs for Campylobacter each of which may play a varying 
role and may provide cross-talk with other hosts.  Alongside the valuable work 
undertaken elsewhere to investigate means for reducing the burden of 
Campylobacter in poultry there is also a need to investigate other sources and their 
potential importance.   
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In summary, C. jejuni is the most commonly identified thermotolerant 
Campylobacter and is the largest recognised cause of human bacterial 
gastroenteritis.  Its fastidious nature led to difficulties in recognising, describing and 
identifying Campylobacter as an important human pathogen, despite its prevalence.  
It is now established that C. jejuni has a reservoir in many sources including poultry, 
food mammals and water and represents an opportunistic human zoonosis which 
does not require humans as a host but will cause illness when acquired through 
contamination.  Typically human infection with C. jejuni is an unpleasant but not 
serious ‘food-poisoning’ event which is cleared in a number of days-weeks 
characterised by fever, cramps and diarrhoea caused by the invasive behaviour of 
the bacteria within the epithelial cell lining of the intestinal tract; although much 
more serious sequelae can also occur, particularly in ‘at-risk’ groups.  The difficulties 
in recovering and culturing Campylobacters from mixed cultures, coupled with the 
high levels of genomic variation, make the typing and observation of C. jejuni a 
challenging prospect also so studying groups of related and unrelated isolates is an 
important tool in learning more about this variation.  Additionally, host association 
has been observed in Campylobacters and related organisms but more work is 
required to consider the role of hosts or reservoirs as potential melting pots for 
sharing genetic information within and between adapted groups. 
1.9 Background & Aims of the Research 
The research presented in this thesis developed from previous work by Manning et 
al (2003), which used MLST to analyse over 250 C. jejuni isolates from a range of 
veterinary and environmental sources as well as from human clinical cases.  This 
study observed considerable overlap between clinical and veterinary isolates, with 
the majority (eighteen of nineteen) of the observed MLST clonal complexes 
containing both veterinary and clinical isolates.  A single ST complex (the ST403CC) 
was identified however, which contained only veterinary isolates.  Furthermore of 
the isolates within the ST403CC, 89% (sixteen of eighteen) were from pigs.  These 
isolates were recovered from faecal samples taken from animals prior to slaughter 
during a survey of abattoirs conducted in England and Wales during 2000-2001. The 
remaining two ST403CC isolates were recovered from faecal samples taken from 
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cattle at slaughter.  The ST403CC isolates were the only group observed in the study 
by Manning et al (2003) to show a strong association with veterinary only, 
mammalian sources, and were also shown to be hippurate hydrolysis negative in 
laboratory study. The hippurate hydrolysis negative phenotype of the identified 
ST403CC C. jejuni isolates was revealed by Stephen On, and announced by Manning 
et al (2003).  As a result of these two factors, it was suggested that this group of 
isolates may represent a niche adapted clonal group of C. jejuni.  The majority (nine 
of sixteen) were untypeable by the LEP method (Laboratory of Enteric Pathogens 
method; Frost et al, 1998), whilst those that were typeable were: one serotype 22 
(ST270 isolate), one serotype 29 (ST270 isolate), four serotype 23 (one isolate each 
from ST435, ST550, ST552, ST553), and one serotype 35 (ST556).  Of the ST403CC 
pig isolated C. jejuni strains, 4 share a common serotype, two are unique serotypes 
within the group, and 9 were untypeable. 
Of the sixteen porcine ST403CC C. jejuni isolates, six were selected for in depth 
study, each representing a different sequence type within the ST403 clonal compex.  
These isolates are described in Table 1.1. 
 
 
 
Manning et al (2003) reported, following a search of the Campylobacter MLST 
database, that other ST403CC isolates had been observed from food sources and 
Species Isolate ID* Isolate Alias^ 
Sequence 
Type 
MLST 
Clonal 
Complex 
Serotype Source 
C. jejuni PS857 857 270 403 NT◊ Pig 
C. jejuni PS549.1 549.1 403 403 NT◊ Pig 
C. jejuni PS623 623 552 403 NT◊ Pig 
C. jejuni PS304 304 551 403 NT◊ Pig 
C. jejuni PS484 484 435 403 23 Pig 
C .jejuni PS444 444 553 403 23 Pig 
Table 1.1: ST403CC C. jejuni Isolates Included in Study 
Information on the six ST403CC C. jejuni isolates selected for study.  The isolates 
represent different sequence types within the ST403 clonal complex. 
* Isolate ID used in Manning et al (2003) 
^ Isolate alias ID used subsequently throughout the research. 
 ◊ Not typeable  
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from infected humans - particularly from the Dutch Caribbean island Curaçao, 
although some of the specific STs within the complex were unique to pig isolates. 
Manning et al (2003) also cited work by Moore et al (2002), which had previously 
shown that C. jejuni and C. coli from pigs displayed considerable genomic diversity, 
but that the majority of isolates could be assigned to one of four genotypes based 
upon ribotyping and flaA-RFLP.  Moore et al (2002) suggested that the population of 
C. jejuni and C. coli in pigs might consist mostly of a small number of dominant 
types, with a smaller number of variable subtypes.   
The inconsistency in LEP serotype for the sixteen ST403CC pig isolates observed by 
Manning et al (2003) demonstrated the power of MLST over serotyping in this type 
of study as this subgroup would have been entirely overlooked by this method.  It 
was also common for different serotypes to be found in other MLSTCCs and serves 
as evidence also of the fact that closely related isolates can express different 
antigens. 
In March 2011 a search for ST403 complex isolates on the pubmlst.org database 
online (Jolley & Maiden, 2010: http://pubmlst.org/campylobacter/) returned 156 
records in total from a variety of sources including 83 isolates associated with 
human gastroenteritis, 3 unspecified human isolates, 1 asymptomatic human 
carrier and 3 from GBS patients, plus isolates from beef (4), lamb (2), sheep (1) and 
pork (6) meats/offal, 2 from human blood culture (septicaemia), 18 from carrying 
cattle, 2 from dogs, 1 each from ‘farm environment’ and ‘environmental waters’ 
and several (26) from pigs as carriers (10 from Denmark, 16 from UK) a further 3 
unspecified ST-403 complex isolates round out the group.  A large proportion (45) of 
recorded ST-403 complex isolates associated with human gastroenteritis are from 
sporadic cases reported in Curaçao (all of which are sequence type 403 and were 
collected in 2000), plus 6 from Canada; 24 in the UK, 1 in South Africa, 1 in Egypt 
and 6 in the Netherlands. From this information it is clear that the ST-403 complex 
is a wide-spread group, but a tendency for prevalence in humans and pigs seems to 
be apparent.  It also seems particularly interesting that this group has been 
frequently found both in the UK and in Curaçao (Duim et al, 2003; Endtz et al, 
2003), given the markedly different environment and lifestyle between the two.  It 
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was also observed that the ST403CC was not associated with poultry in the 
database, further suggesting that this may represent a niche-adapted group not 
associated with the most common host for C. jejuni. 
These numbers can be compared with a more recent search of the same database 
(18/07/2014) by which point 287 isolates were logged as ST403CC isolates, from a 
total of 29011 isolates (approximately 1%).  Human isolates included still just one 
from blood culture, associated with systemic disease, 159 from human stool – five 
GBS, one carrier, five unspecified (with no additional description provided) 148 
gastroenteritis plus thirteen ‘human unspecified’ isolates, of which seven were 
associated with gastroenteritis, whilst the remaining six were not specified.  The 
remaining 114 non-human isolates break down as fifty-three associated with cattle 
(carriers, meat or milk), three with sheep (animal or meat products), forty with pig 
(carrier, meat or offal), with six associated with dogs, one described as being from a 
‘farm environment’, and eleven with no source description.  Once again this more 
recent search maintains the lack of attribution of ST403CC C. jejuni isolates to 
poultry. 
As described previously, typically C. jejuni is associated with poultry as the source, 
whereas C. coli is most frequently associated with food production mammals such 
as cattle and pigs.  However, although C. jejuni is most commonly associated with 
poultry (either through consumption of poorly cooked food, contact with raw 
meats, or direct contact with birds/faecal matter); it is accepted that poultry is not 
the sole source of C. jejuni infection in humans.   
The major goal of this research is to assess whether these closely related ST-403 
complex porcine C. jejuni isolates may represent a host-adapted group, whilst also 
considering whether pigs may serve as an additional source for Campylobacteriosis.  
This will be achieved through: ‘wet-lab’ assessment of the ST403CC C. jejuni 
isolates, in order to consider the likely virulence potential of the isolates; and via 
whole genome sequence analysis to investigate potential unique features of this 
possibly host adapted group of isolates. 
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As described by Maiden and Dingle (2008, in Nachamkin, Szymanski & Blaser (Eds)), 
in order to truly understand an organism, the large scale population dynamics must 
be combined with comprehensive study focused on a single isolate or group of 
related isolates.  This study aims to do just that; as it combines the established 
knowledge of Campylobacter with physiological and genomic study of this group of 
closely related isolates to inform on the adaptation of C. jejuni. 
 
Over the course of this thesis, a number of different bioinformatics techniques will 
be employed to investigate the genomics of the selected ST403CC C. jejuni isolates.  
Figure 1.1 provides a diagrammatic overview of the main views of the thesis, whilst 
in Table 1.2 brief information is provided regarding the major bioinformatics 
programs which are utilised in this study. 
 
 
Investigating the phenotype 
of ST403CC C. jejuni isolates 
 
Chapter Two 
Producing genome sequence 
for ST403CC C. jejuni isolates 
 
Chapter Three 
Determining the Phylogeny 
of ST403CC C. jejuni isolates 
 
Chapter Three 
Producing genome 
annotation for ST403CC C. 
jejuni isolates 
 
Chapter Four 
Considering the core and 
pan genome of ST403CC C. 
jejuni isolates 
 
Chapter Four 
Identifying genes of 
potential interest in ST403CC 
C. jejuni isolates 
 
Chapter Four 
Considering the role of 
integrated genomic regions 
in ST403CC C. jejuni isolates 
 
Chapter Five 
Considering genetic 
recombination in ST403CC 
C. jejuni isolates 
 
Chapter Six 
Drawing conclusions about 
potential niche adaptation 
in ST403CC C. jejuni isolates 
 
Chapter Seven 
Figure 1.1: Flow of Study 
Illustration of progression of study throughout the thesis. 
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Chapter Method Function Author(s) 
Th
re
e 
VELVET 
Sequence ‘shuffling’ - mixing forward and reverse 
raw FastQ files to produce FastA consensus 
sequence for subsequent improvement and 
analysis 
Zerbino & 
Birney 
(2008) 
ABACAS 
Improves sequence quality by aligning, ordering 
and orientating a contiguated sequence against a 
reference genome 
Assefa et 
al (2009) 
IMAGE Improves draft sequence quality by removing gaps by aligning sequence against a reference genome 
Tsai, Otto 
& 
Berriman 
(2010) 
SRST Determines MLST from genome sequence Inouye et al (2012) 
MUGSY 
Produces multiple genome alignments for 
subsequent analysis including producing 
phylogenetic trees of relatedness 
Angiuoli & 
Salzberg 
(2010) 
Mothur Removes non-alphabetic characters from sequence files 
Schloss et 
al (2009) 
RAxML Produces maximum likelihood phylogenetic trees Rokas (2011) 
FigTree Phylogenetic tree editing software Rambaut (2007) 
BRIG Visualises regions of similarity and divergence between genetic sequences. 
Alikhan et 
al (2011) 
SMALT Produces mapped sequence alignments using a reference sequence 
Ponstigl 
(2009) 
SamTools Assesses SNP variation between aligned sequences Li et al (2009) 
Fo
ur
 
PROKKA Genome annotation using a protein database and BLAST searching 
Seemann 
(2014) 
RATT Transfers annotation from a reference genome to a query genome 
Otto et al 
(2011) 
EDGAR Defines the core and pan genome of a population of sequences 
Blom et al 
(2009) 
Fi
ve
 
PHAST Identifies prophage regions in genome sequences Zhou et al (2011) 
AlienHunter Identifies integrated genomic regions in genome sequences 
Vernikos & 
Parkhill 
(2006) 
Si
x 
Heirarchical 
BAPS Predicts the structure of a population of sequences 
Corander 
et al 
(2012) 
BRATNextGen Identifies recombination events in populations of closely related genome sequences 
Marrtinen 
et al 
(2012) 
Table 1.2: A Summary of the Major Bioinformatics Tools used in the Thesis 
Provides an overview of the main bioinformatics methods used, with reference to the 
authors, and to the chapter in which they are used and described in greater detail. 
39 
 
Chapter Two: Determining the Phenotypic Characteristics of ST403CC 
Campylobacter jejuni Isolates 
2.1 Introduction 
Six Campylobacter jejuni isolates were selected from MLST clonal complex 403.  It 
was hypothesised that these isolates potentially represent a host-adapted clonal 
group of C. jejuni, associated with recovery predominantly from pigs but also from 
cattle.  The isolates were previously un-studied with the exception of being typed 
by MLST and being tested for hippurate hydrolysis, for which they were negative 
(Manning et al, 2003), as such initial phenotypic testing was required in order to 
provide a picture of the general characteristics and behaviour of the isolates.  Due 
to the atypical porcine host of these ST403CC C. jejuni isolates, experiments were 
selected and undertaken in order to investigate the capacity of these veterinary 
isolates to cause disease in humans, in addition to considering whether they exhibit 
any evidence of host adaptation, such as stress resistance or motility, to allow 
survival or possible dominance in porcine or mammalian hosts which may explain 
the bias of isolation of ST403CC from mammalian hosts, and particularly from pigs. 
2.1.1 Host Cell Invasion 
Invasion is one of many routes used by intestinal pathogens to circumvent the host 
immune response.  C. jejuni is known to be intestinally invasive; as has been 
demonstrated using tissue and cell culture methods, patient biopsies, and in animal 
model testing (Moore et al, 2005), and invasive ability is therefore considered an 
important virulence factor in C. jejuni (Hu & Kopecko, in Ketley & Konkel (Eds), 
2008).  Campylobacter is able to survive passage through the stomach, and is 
understood to first adhere to and later invade epithelial cells in the colon, ileum and 
jejunum, by inducing cytoskeletal rearrangement of the host cell (Krause-
Gruszczynska et al, 2007), however the exact full route of invasion taken by 
Campylobacter has not been fully elucidated and does not follow the same pathway 
as model organisms such as Salmonella Typhi or Escherichia coli (Gilbreath et al, 
2011).  Epithelial cell lines have been particularly useful for the study of C. jejuni 
infection in vivo (Young, Davis & DiRita, 2007), including HeLa cells (human cervical 
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carcinoma cell line), INT407 (originally foetal intestinal epithelium, contaminated 
with HeLa, as reviewed by Lacroix, 2008), HEp2 (human epithelial type 2, originally 
human laryngeal carcinoma cells) and the human colonic carcinoma cell line Caco-2. 
In vitro investigation, although informative, has not generally been as successful in 
C. jejuni research due to the lack of an ideal small animal model (Young, Davis & 
DiRita, 2007).  Various animal models have been used, with differing degrees of 
success; ferrets can undergo a similar disease response to C. jejuni as is seen in 
humans, however this is a high cost model, which is not commonly used and as such 
lacks the knock-out techniques available in more well characterised models such as 
mouse (Young, Davis & DiRita, 2007).  The mouse model, which is commonly used in 
the laboratory study of bacterial pathogens, has not been as successful in the study 
of C. jejuni due to the natural colonisation resistance of the mouse against C. jejuni, 
and poor reproducibility found in some studies, as described by Young, Davis & 
DiRita in their review of C. jejuni pathogenesis (2007), although in recent years new 
advancements in techniques have meant that the murine model may be 
increasingly relevant in studying C. jejuni infection and immunology (Bereswill et al,  
2011).  Other animal models include the larvae of Galleria mellonella (Champion et 
al, 2009; Senior et al, 2011) and piglets (Babakhani, Bradley & Jeons, 1993).  Chicken 
colonisation experiments have also commonly been used in C. jejuni research, 
particularly to study the effects of gene knock-outs, however the difference in the 
chicken and human host response and host environment reduce the value of the 
chicken model for predicting pathogenic potential in humans. 
Several methods have been used to investigate the ability of bacteria to internalise 
into host cells, persist and cause disease, including ‘predictive’ tests – those which 
have been associated with particularly virulent isolates – as well as the in vitro and 
in vivo methods described briefly above.  Cell culture models provide a means to 
obtain quantifiable data regarding the invasive capability of a given isolate; Fearnley 
et al (2008), demonstrated that although there is a substantial degree of strain-
strain variation for invasiveness in C. jejuni results for individual strains using the 
gentamicin protection assay are reproducible.  Fearnley et al (2008) also 
demonstrated that C. jejuni isolates could be identified as having low- high- or 
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hyper-invasive phenotype using the gentamicin protection assay with INT407 cells.  
C. jejuni 81116 was used as a low invasive control stain, and formed the basis for 
comparison for attribution to the three classes: a strain which was more than 
twenty-five times more invasive than C. jejuni 81116 was considered hyper invasive; 
any isolate which was ten times more invasive than C. jejuni 81116 was considered 
highly invasive; and any strain less than ten times more invasive than C. jejuni 81116 
would be considered a low invader.  Subsequent studies including that by Javed et 
al (2010) have confirmed these characteristics in the Caco-2 cell line. 
2.1.2 Predictive Tests for Pathogenic Potential 
As described previously, the pathogenic potential of C. jejuni isolates may be tested 
in vitro in cell and tissue culture experiments, and in vivo using whole animal 
models, however in some cases a rapid indication of pathogenic potential can be 
determined using ‘predictive’ methods.  Two such predictive characteristics are 
motility and autoagglutination.   
Motility is important in, but not essential for, host cell invasion by C. jejuni; 
Wassenaar et al (1991) illustrated this through a series of flaA mutant studies.  
Inactivation of flaA leads to an immotile bacterium which is less able to adhere to 
and subsequently invade intestinal epithelial cells experimentally, however these 
non-motile mutants were demonstrated to still be capable of adherence and 
invasion when brought into contact with the host cells via centrifugation.  Further 
studies involving flagellar mutants have shown that the flagellum is unimportant in 
the adherence of Campylobacter to intestinal cells, but is important for 
internalisation (Grant et al, 1993).  Grant et al (1993) demonstrated that aflagellate 
mutants were able to adhere to INT407 cells at levels comparable to the wild type, 
but were significantly less efficient at internalising into INT407 cells.  The 
Campylobacter flagellum does not appear to have a role as a binding mechanism, 
however it has been demonstrated that the flagellar apparatus plays a role in 
secreting virulence proteins which may be involved in invasion (Song et al, 2004; 
Guerry, 2008; Neal-McKinney & Konkel, 2012).  Specifically, in 2004, Song et al 
demonstrated that flagellar apparatus was required for the secretion of FlaC, and 
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that flaC null mutants were impaired for invasion into HEp-2 cells compared to the 
wild type C. jejuni TGH9011; whilst in 2012 Neal-McKinney & Konkel showed that 
the virulence associated protein CiaC required a functional flagellar hook 
mechanism for its secretion, and also highlighted a potential role of CiaC in the 
production of membrane ruffles, an important stage of bacterial internalisation.  
Motility may therefore be considered a useful indicator of virulence potential in 
Campylobacter; as strains with low motility are less likely to successfully colonise 
the human gut, due both to their reduced opportunity of obtaining contact with 
cells in order to adhere, and their reduced capacity for internalisation into the cells 
once adherence occurs. 
Autoagglutination is also a potential indicator for virulence in C. jejuni, as described 
by Misawa & Blaser (2000).  Autoagglutination was shown to be highly associated 
with hydrophobicity, and with adhesion to INT407 cells.  No link was observed 
between autoagglutination and motility, although flagellation was thought to play a 
role in autoagglutination.  As such, autoagglutination may be considered a quick 
test to predict likely pathogenic ability of C. jejuni isolates – a strain with high 
autoagglutination being more likely to successfully adhere to host cells and 
subsequently to invade into the cell. 
For the purposes of this investigation, pathogenic potential was assessed using the 
predictive assays for motility and autoagglutination, and subsequently through 
quantifying the adhesion and invasion efficiency using a standard gentamicin 
protection assay. 
2.1.3 Resistance to Environmental Stressors 
In addition to the invasive potential of a pathogen, the ability of an isolate to 
survive stressful environments may contribute to its ability to colonise the host and 
therefore increase its pathogenic potential (Habib et al, 2010).  Campylobacter is a 
microaerophilic organism and as such is vulnerable to oxygen, however 
Campylobacter must encounter reactive oxygen species (ROS) including superoxide 
radicals (O2·-), hydrogen peroxide (H2O2) and hydroxide radicals (·OH) as a result of 
its own metabolism and during colonisation, both as part of the host immune 
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response and as a result of the metabolism of host microflora (Baillon et al, 1999; 
Palyada et al, 2009).  ROS form a significant hazard for microorganisms as they can 
cause significant cell damage.  Reactive oxygen species affect proteins, nucleic acids 
and lipids.  The lipid membranes of bacterial cells are particularly affected by ROS: 
lipid peroxidation occurs when free radicals attack the polyunsaturated fatty acids 
found in membranes, and significantly affects the properties of the membrane 
itself, and the membrane bound proteins (Cabiscol, Tamarit & Ros, 2000; Palyada et 
al, 2009).  ROS can also damage both the sugars and bases of nucleic acid, resulting 
in breaks in single or double strands, blocking of DNA replication, and loss of 
function through additional cross-links (Cabiscol, Tamarit & Ros, 2000).  Many Gram 
negative bacteria utilise SoxRS and OxyR to regulate their stress response to 
superoxide and peroxide exposure, however these are absent in C. jejuni, which has 
an alternative peroxide sensor known as PerR (van Vliet et al, 1999).  Oxidative 
stressors also play a role in the up-regulation of virulence associated genes (Harvey 
& Leach, 1998). 
Bile, and more specifically the acids within bile, comprise a second environmental 
stress encountered by Campylobacter during the course of colonisation of the 
human host (Fox et al, 2007).  Bile acids are formed in the human liver from 
cholesterol and are present in the intestine (Garrett & Grisham, 2009), providing 
two-fold functions for the human host; aiding in fat digestion, and by acting as a 
detergent with antimicrobial activity through damaging the lipid bilayers of 
bacterial cellular membrane (Raphael et al, 2005; Gunn, 2000).  The two major 
primary bile acids produced in humans are cholic acid and chenodeoxycholic acid, 
which are produced from the liver, and circulated from the gallbladder to the large 
intestine, before being reabsorbed into the blood to return to the beginning of the 
cycle (Masanta et al, 2013).  Within the intestine, commensal bacteria act to 
metabolise any cholic acid and chenodeoxycholic acid left behind into the 
‘secondary’ bile acids deoxycholic acid and lithocholic acid, respectively, with 
deoxycholic acid being the most abundant secondary bile salt (Carey, in Nair & 
Kritchevsky, 1973; Masanta et al, 2013).   
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In addition to the obvious need to survive exposure to bile acids in order to survive 
the human gut, bile acid resistance also has a direct implied link with pathogenicity.  
Deactivation of bile acid resistance processes via mutation of the efflux pump 
CmeABC was demonstrated to increase bile salt sensitivity, and also prevented 
colonisation in the chick model (Lin et al, 2003).  Later it was demonstrated that the 
two component regulator system cbrR-cbrS controls resistance to deoxycholic acid 
(sodium deoxycholate) with cbrR negative mutants exhibiting greatly increased 
sensitivity to deoxycholic acid and also having reduced chick colonisation ability 
(Raphael et al, 2005).   
Chemotaxis plays a significant role in bacterial colonisation of the host (Ketley, 
1997); allowing movement towards nutrients and target organs or surfaces, as well 
as movement away from potentially bactericidal chemicals.  Herrmann & Burman 
(1983) previously showed that E. coli displayed positive chemotaxis towards urine – 
suggesting that this may have a role in its pathogenesis in UTIs (urinary tract 
infections), following this, Hugdahl, Beery & Doyle (1988) demonstrated a similar 
phenomenon for C. jejuni, which displayed positive chemotaxis towards mucin, L-
serine and L-fucose, and negative chemotaxis away from bile acids.  Subsequently, 
Takata, Fujimoto & Amako (1992), using the methods developed by Hugdahl, Beery 
& Doyle (1988), demonstrated that non-chemotactic mutants failed to colonise 
mice.  Resistance to bile acids, and the ability to move away from them are 
therefore important factors in potential C. jejuni virulence – an isolate which is 
unable to move away from high concentrations of bile acids may not survive to 
colonise the host, whilst an isolate which is particularly resistant may be able to 
persist, leading to colonisation. 
Temperature resistance may also play a role in host invasion; C. jejuni does not 
grow at temperatures below 25°C, however it has been demonstrated to survive at 
low temperatures for considerable time (Murphy, Carroll & Jordan, 2006) and 
recover upon consumption by the host.  As with other thermotolerant 
Campylobacter, C. jejuni grows well at 37°C, with an optimum growth temperature 
of 42°C (King, 1957).  In this project, the ST403CC C. jejuni isolates were cultured at 
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37°C and 42°C and displayed normal growth at these temperatures as described 
later in this chapter.   
An isolate which is exceptionally resistant to bile acids and or oxidative stress may 
be able to colonise faster, or more successfully, and may cause increased levels of 
illness both due to the larger exposure and due to the increased invasive potential 
due to up-regulation of virulence genes in the presence of the stressors. 
Resistance to ROS was tested for the ST403CC C. jejuni isolates using hydrogen 
peroxide and pyrogallol, both of which represent oxygen species encountered 
within the host. Hydrogen peroxide comprises the intermediate stage in the 
breakdown of superoxide radicals: NADPH oxidase catalyses the oxidation of 
NADPH to superoxide (NADPH and 2O2 to NADPH + 2O2- + H+); then superoxide 
dismutase catalyses 2H+ + 2O2- to H2O2 and O2 and finally catalase can convert 
2H2O2 to 2H20 and O2..  Hydrogen peroxide conversion from superoxide radicals 
occurs within phagosomes, raising the pH to around 7.8-8, activating antimicrobial 
peptides which break down the engulfed bacterium (Parham, 2009).  Pyrogallol 
(1,2,3-trihydroxybenzene) is a superoxide (O2-) producer; it is oxidised 
spontaneously in air producing O2- and is used to create superoxide stress in 
laboratory experimentation (Champion et al, 2010).  Superoxide and Hydrogen 
peroxide are produced by the human immune system as part of the defence 
response against pathogenic microorganisms (Parham, 2009), and sensitivity to 
both was tested for in the ST403CC C. jejuni isolates. 
The ST403CC C. jejuni isolates were also examined for sensitivity to primary human 
bile acids cholic acid and deoxycholic acid as well as the major secondary bile acid 
chenodeoxycholic acid.   
2.1.4 Summary & Aims 
The overall aim of this chapter was to consider the virulence potential of potentially 
host adapted ST403CC C. jejuni isolates.  This was addressed through predictive 
tests for pathogenicity, assessing the motility and autoagglutination of the isolates, 
as well as through in vivo experiments to establish the invasive capability of the 
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isolates.  Indirect factors affecting the pathogenic potential of the isolates were also 
assessed, considering the sensitivity of the isolates to oxidative stress and bile acids.  
In tandem with the experiments being conducted on the six porcine ST403CC C. 
jejuni isolates, two ‘control’ C. jejuni isolates were also included; the low invasive 
strain C. jejuni 81116 and the high invading strain C. jejuni 11168.  Additionally 
included for comparison were four porcine C. coli isolates; as C. coli is more 
commonly associated with pigs than C. jejuni.  These ‘control’ isolates were included 
as a contrast to the porcine ST403CC C. jejuni isolates.   
The major aims of this chapter were: 
- To investigate the degree of motility across the ST403CC C. jejuni isolates 
and compare to the motility observed for known low and high invasive C. 
jejuni and for porcine C. coli isolates. 
- To observe the level of autoagglutination for the ST403CC C. jejuni isolates, 
compared to those for C. jejuni reference isolates, and porcine C. coli. 
- To determine the adherence and invasive capabilities of ST403CC C. jejuni 
isolates, to investigate whether these isolates have the potential to cause 
disease in humans, to categorise the ST403CC C. jejuni isolates are low- 
high- or hyper- invasive, and to compare against the results observed for 
porcine C. coli strains in the same test.   
o The relationship between motility, autoagglutination and adherence 
and invasion will also be considered. 
- To observe the levels of sensitivity to oxygen stressors and bile acid 
exposure for ST403CC C. jejuni isolates and once again to relate this to the 
reference C. jejuni strains and C. coli from pigs, as well as to consider how 
these sensitivity levels may relate to the ‘direct’ virulence measures. 
- To consider whether, across the phenotypic tests, the ST403CC C. jejuni 
isolates tend to behave in the same way as each other, and whether they 
can be distinguished on the basis of these characteristics as being different 
to the reference C. jejuni strains or sharing characteristics with C. coli 
isolates associated with the same host type.  
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2.2 Methods 
2.2.1 Storage & General Culture Procedures 
All Campylobacter strains were stored at -80°C in Mueller-Hinton broth (Oxoid 
(Thermo Scientific) Item CM0405) containing 20% v/v glycerol (Fisher Scientific Item 
G/0600/17) until required.  Unless otherwise stated, when required, Campylobacter 
strains were cultured from the -80°C stocks onto a blood-free Campylobacter agar 
(MCCDA, Modified Charcoal Cefoperazone Deoxycholate Agar (Oxoid (Thermo 
Scientific) Item CM0739) and incubated microaerobically using anaerobic jars and 
‘CampyGen’ atmosphere generating sachets (Fisher Scientific Item CN025A); 
developing a gas mixture of 5% O2, 10% CO2 and 85% N2,  for 48 hours at 37°C prior 
to use. 
2.2.2 Bacterial Strains included in Phenotypic Study 
To investigate the phenotypic evidence for potential host adaption, the six selected 
ST403CC pig origin C. jejuni isolates were tested alongside two human clinical C. 
jejuni isolates and four porcine C. coli isolates which were selected to provide an 
appropriate basis for comparison, as detailed in Table 2.1. 
The isolates included in the study were each assessed for: motility; 
autoagglutination; adhesion; invasion; and sensitivity to hydrogen peroxide; 
superoxide (pyrogallol); and bile acids cholic acid, deoxycholic acid and 
chenodeoxycholic acid. 
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Species Strain Country of Isolation Host 
Date of 
Isolation 
Sequence 
Type 
Sequence 
Type Complex 
C. jejuni 81116 UK Human 1981 267 283 
C. jejuni 11168 UK Human 1977 43 21 
C. jejuni 857 UK Pig 2000 270 403 
C. jejuni 549.1 UK Pig 1999 403 403 
C. jejuni 623 UK Pig 1999 552 403 
C. jejuni 304 UK Pig 1999 551 403 
C. jejuni 484 UK Pig 1999 435 403 
C. jejuni 444 UK Pig 1999 553 403 
C. coli 99/321 Denmark Pig 1999 ND* ND* 
C. coli 03/121 UK Pig 2003 ND* ND* 
C. coli 03/103 UK Pig 2003 ND* ND* 
C. coli 03/317 UK Pig 2003 ND* ND* 
 
 
 
 
 
 
 
2.2.3 Motility 
Two methods were used to observe motility, firstly the hanging drop method, which 
allows a simple positive or negative result for motility, and secondly an agar plating 
method which allows observation of the degree of swarming motility displayed by 
each isolate. 
- Hanging Drop Method.  Wells were created on glass slides (using petroleum 
jelly to create a barrier) into which was placed a drop of bacterial 
suspension.  The bacterial suspension was created by emulsifying a single 
colony of growth from agar plate into sterile PBS (phosphate buffered saline 
Oxoid (Thermo Scientific) Item BR0053).  Slides were viewed under x400 
magnification in order to observe darting motility. 
- Swarming Motility Method.  A quantifiable method, adapted from Novik, 
Hofreuter & Galán (2010) was used to compare the relative motility of the 
isolates.  Bacterial growth was recovered from the agar plate and suspended 
 
Table 2.1: Isolates Included in Phenotypic Studies 
  C. jejuni isolates 81116 and 11168 were used as control strains due to being amongst the most 
well-characterised C. jejuni strains, both being from human cases and having been defined as low 
and high invasive strains, respectively.  ST403CC C. jejuni isolates were all recovered from pig 
faecal samples during an abattoir survey, and each represent different sequence types within the 
ST403 clonal complex.  C. coli isolates included are from the same host type and same survey 
style, and from around the time frame of recovery of the ST403CC C. jejuni isolates. 
ND* these isolates have not yet been typed by MLST, therefore these details are currently 
unknown. 
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in sterile PBS, bacterial suspensions were subsequently adjusted to an 
optical density of approximately 0.1 at 600nm.  Subsequently 2µl of the 
standardised bacterial suspension was stabbed into the centre of a soft agar 
plate (Mueller-Hinton broth with 0.4% w/v agarose), before being incubated 
for 48 hours at 42°C, following which the diameter of the zone of growth 
was measured to observe the motility displayed by each isolate.  Incubation 
was carried out at 42°C for this assay, due to inconsistent results being 
observed at 37°C during initial runs; in some cases isolates which had been 
demonstrated to be motile under microscopic observation were returning 
negative results for swarming motility.  42°C is the optimal temperature for 
C. jejuni and C. coli and when trialled as a condition for motility provided 
more consistent results in this case, despite 37°C being used in other work 
including Golden & Acheson (2002) and Novik, Hofreuter & Galán (2010). 
2.2.4 Autoagglutination 
Autoagglutination was determined using the method developed by Misawa & Blaser 
(2000): bacteria were grown for 48 hours before being swabbed from the plates and 
suspended in PBS.  The bacterial suspension was adjusted to an optical density of 
1.0 at 600nm (Absorbance at 600nm; A600nm) in 2ml PBS and subsequently 
incubated without agitation at 37°C for 24 hours.  Following incubation, the upper 
layer of the solution was carefully aspirated, and the A600nm was measured again.  
The level of autoagglutination was observed by comparing the starting optical 
density value with the optical density of the upper layer of the bacterial suspension 
following incubation; the principle for autoagglutination is based upon the premise 
that when autoagglutination occurs the resulting ‘clumps’ of bacteria drop to the 
bottom of the solution.  Some settling would occur regardless of autoagglutination, 
but a large change in optical density is caused by autoagglutination (Misawa & 
Blaser, 2000; Golden & Acheson, 2002).  Autoagglutination results were observed as 
the change in optical density between the starting point and the 24 hour point. 
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2.2.5 Adhesion & Invasion 
Adhesion and invasion efficiencies were assessed using a gentamicin protection 
assay with Caco-2 cells.   
Bacteria were grown on blood agar comprised of 20% v/v lyophilised horse blood 
(Fisher Scientific Item SR050C) in Columbia Blood Agar Base (Oxoid (Thermo 
Scientific) Item CM0331) for 48 hours at 37°C before being suspended into PBS to 
be adjusted for introduction to Caco-2 cells.   
Caco-2 cells were maintained in tissue culture flasks, splitting to new cells routinely 
(approximately once per week, as dictated by growth of cells) with media changed 
approximately every three days when cells were not split to new flasks.  Two media 
types of slightly different composition were used to maintain and run assays with 
Caco-2 cells, all media and reagents were pre-warmed prior to use to avoid damage 
to the cells. 
- Growth medium consisted of DMEM (Dulbecco’s Modified Eagle’s 
Medium; Sigma-Aldrich Item D6429), supplemented with 1% v/v non-
essential amino acids (Sigma-Aldrich Item M7145); 20% v/v foetal bovine 
serum (Sigma-Aldrich Item F7524); and 1% penicillin-streptomycin 
antibiotic solution (Sigma-Aldrich Item P0781). 
- Infection medium was prepared in the same way as growth medium, 
with the exception that no antibiotics were added (DMEM, with 10% v/v 
foetal bovine serum, and 1% v/v non-essential amino acids solution 
added. 
When either removing cells to new growth flasks, or to begin gentamicin protection 
assay, growth media was first removed from flask, before twice gently rinsing cells 
with sterile PBS (Dulbecco’s Phosphate Buffer Saline solution; Sigma-Aldrich Item 
D8537) to remove dead cells.  Cells were then disassociated from the flask using 
TrypLE Express (Stable Trypsin-like Enzyme liquid; Fisher Scientific Item 
VX12605028) by adding 5-10ml and incubating for approximately eight minutes 
until cells are in suspension.  Cells were then transferred to a falcon tube and 
centrifuged to form a pellet (5 minutes at 150xG) before being re-suspended into 
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5ml of growth media and counted in order to maintain cells at 2x105 cells/ml in 
25cm3 flask, or 7x105 cells/ml in 75cm3 flask in growth media, or for experimental 
use, seeded to a 24 well plate at 500µl per well with 2x105 cells/ml in infection 
media.  For experimental procedures Caco-2 cells were then grown to semi-
confluency (approximately 80% coverage of well, achieved between 24-48 hours) 
before being ready for assay.  In all cases, Caco-2 cells were incubated at 37C in 5% 
CO2. 
To run the gentamicin protection assay, bacterial cells were recovered from agar 
plates by swabbing, and suspended in PBS, then adjusted to an optical density of 
approximately 0.5 at 600nm before being diluted to provide an infection solution of 
3.5ml with optical density of 0.1 at 600nm.  This equated to a predicted viable count 
of approximately 1x108 cfu/ml (colony forming units per milliletre); actual bacterial 
counts for the inoculum were determined retrospectively using Miles-Misra plate 
counts.  
The standardised, diluted bacterial solution was then applied in 500µl aliquots to 
the Caco-2 cells in 24 well plates, following the removal of cell growth media and 
the cell layers being washed gently three times with PBS to remove any dead cells.  
In each assay, 500µl of bacterial suspension was applied in triplicate to wells on two 
plates – one for assessment of bacterial attachment and one for bacterial invasion 
into the Caco-2 cells.   
The 24 well plates were then incubated for three hours at 37°C with 5% CO2, 
following which the first plate was assessed for bacterial attachment to the cells; 
the infection media was careful aspirated from each well, which were then gently 
washed three times with PBS before being lysed with 1% Triton-X100 (Sigma-Aldrich 
Item T8787) so that bacterial counts could be then determined using Miles-Misra 
plate counts.  At the same three hour time point, the invasion assay plate was also 
aspirated of media and washed with PBS, before being subjected to 500µl of the 
‘infection media’ solution containing 250µg/ml of gentamicin and subsequently 
being incubated for a further two hours under the same conditions in order to kill 
any external bacteria.  Following the additional two hour incubation, cells were 
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washed and lysed and bacterial counts determined as described for the association 
assay. 
Each assay included three replicates of each isolate and assays were performed at 
least in triplicate.  Each assay also included three wells of a no-inoculum blank to 
ensure that results were not confounded by contamination of the intestinal cells or 
the infection media, and three wells of the low invader isolate C. jejuni to confirm 
the reproducibility of the assay.  All bacterial counts using the Miles-Misra 
technique were plated onto MCCDA agar and incubated at 37°C for 48 hours before 
counts were recorded. 
Results were presented as percentage adhesion and percentage invasion; that is, 
the percentage of the original inoculum which was observed to have attached to or 
internalised into the Caco-2 cells.  Percentage adhesion and percentage invasion 
were calculated as follows: 
 
 
 
 
2.2.6 Resistance to Oxidative & Bile Acid Stressors 
Resistance to hydrogen peroxide, and the bile acid stressors cholic acid, deoxycholic 
acid and chenodeoxycholic acid was observed using a disc diffusion assay adapted 
from Baillon et al (1999).  Isolates were recovered from frozen stocks and incubated 
at 37°C for 24 hours before being sub-cultured in duplicate onto fresh MCCDA 
plates and incubated overnight to provide lawns of bacterial growth.  Cultures were 
then re-suspended into Mueller-Hinton broth and adjusted to an optical density at 
600nm of 0.4.  For each assay, 200µl of bacterial suspension was added to 4ml of 
soft Mueller-Hinton agar (Oxoid (Thermo Scientific) Item CM0405; plus 0.4% w/v 
Agarose (Fisher Scientific Item BP1356) which had been cooled to approximately 
35°C to avoid damaging the bacteria.  The mixture was mixed thoroughly before 
% Adhesion = Number of bacteria adhered to cells * 100 
Number of bacteria in inoculum 
+ Where adhered bacteria = total number of bacteria associated with cells – number of bacteria 
invaded into cells 
 
 
% Invasion = Number of bacteria invaded into cells * 100 
Number of bacteria in inoculum 
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being poured over thin layer Mueller-Hinton agar plates and allowed to set.  Sterile 
3mm filter discs were then applied to the surface of the bacteria infused soft agar 
and treated with 3µl each of a range of six concentrations of the stressor; the 
concentration ranges of which are shown below in Table 2.2.  Plates were then 
incubated as previously described and the zones of inhibition around the discs were 
observed after 48 hours.  In each assay isolates were tested in triplicate and for 
each isolate the assays were repeated at least twice. 
 
 
 
Resistance to the superoxide producer pyrogallol was tested using a protocol 
adapted from that of Champion et al (2009).  Isolates were recovered from frozen 
stocks and then sub-cultured as described for the previously described stress 
assays, before being suspended in Mueller-Hinton broth and adjusted to an optical 
density of 0.4 at 600nm.  100µl of the bacterial suspension was then pipetted onto 
a dried Mueller-Hinton agar plate and spread to cover the surface of the plate.  
Once dried, a sterile filter disc was applied in the centre of the plate and inoculated 
with 3µl of 1M pyrogallol.  Zones of inhibition created around the discs were 
observed after 48 hours incubation at 37°C and the assay was repeated at least 
three times for each isolate.  In the assay used by Champion et al (2009), the agar 
was supplemented with catalase (1000 units/ml); this was initially emulated herein, 
however adding the catalase whilst ensuring sterility and complete dispersion 
through the agar was problematic, and parallel tests with and without the addition 
of catalase showed no noticeable variation in results and as such the addition of 
catalase was subsequently abandoned. 
Chemical Concentrations Tested 
Hydrogen Peroxide (%v/v) 1 3 5 10 15 20 
Chenodeoxycholic Acid (mg/ml) 1 3 5 10 15 20 
Deoxycholic Acid (mg/ml) 3 5 10 12 13 15 
Cholic Acid (mg/ml) 0.5 1 2 3 5 10 
Table 2.2: Concentrations of chemicals used for stress assay testing of C. jejuni and C. coli isolates.   
Ranges were selected based upon previously described experiments in literature, so that the 
results for a single representative concentration of each stressor could be presented. 
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2.2.7 Statistical Analyses 
In order to consider the impact of the results produced from these assays, statistical 
testing was applied.  Statistical tests applied were the ANOVA test (one-way, 
unpaired, parametric Analysis of Variance, with multiple comparison testing against 
control values) and standard T-test (unpaired, parametric, two-tailed, with Welch’s 
correction).  These were selected to investigate any differences between the 
porcine origin ST403CC C. jejuni isolates, and non-porcine origin, non-ST403CC C. 
jejuni isolates, and porcine origin C. coli; and to accept or reject the following 
specific null hypotheses: 
- ST403CC C. jejuni isolates do not show evidence of the potential to cause 
disease in humans 
- ST403CC C. jejuni isolates do not exhibit higher pathogenic potential, as 
determined in laboratory tests, than non-ST403CC C. jejuni and C. coli 
isolates 
- ST403CC C. jejuni isolates do not exhibit a distinct phenotypic profile 
compared to non-ST403CC C. jejuni and C. coli 
Analysis using one-way ANOVA compared each category - each isolate, in this case - 
looking for significance in variation between the categories.  Parametric ANOVA 
assumes that the data being tested fits a normal distribution.  This assumption is 
often made when the true distribution of real-world results is not known, in relation 
to the ‘central limit theorem’, whereby random samples under mild conditions tend 
to have normal distribution.  In this instance, distribution was checked for a sample 
of the experiments conducted and normal distribution was observed.  Additionally, 
multiple comparisons were applied to the data as part of the analysis of variance in 
order to establish whether statistically significant variation exists between a 
selected control strain - C. jejuni 81116 - and each of the other individual isolates.  
In contrast, the T-test was used to compare ‘condition a’ vs ‘condition b’ and 
analyse the likelihood that the difference between groups is statistically significant, 
or due simply to chance.  This was used to compare scores for groups of isolates: 
porcine vs non-porcine isolates; porcine vs non-porcine isolates for C. jejuni only; C. 
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coli vs C. jejuni regardless of host.  All statistics presented refer to a confidence 
interval of 95% (P=0.05).   
2.3 Results 
A range of phenotypic tests were applied in order to assess the virulence potential 
of a group of potentially porcine host adapted C. jejuni isolates.  Also included for 
comparison were two human C. jejuni isolates and four porcine C. coli isolates.  
Results are presented below for motility, autoagglutination, adherence to and 
invasion into Caco-2 cells, resistance to hydrogen peroxide and a superoxide 
producer, and resistance to bile acids cholic acid, deoxycholic acid and 
chenodeoxycholic acid.  Unless otherwise stated, values presented are mean values 
calculated from representative scores; experiments were completed at least in 
triplicate, and where considerable variation was observed additional replicates 
were completed to determine more accurate, representative results.  Results are 
presented with error bars using the standard deviation calculated for the mean 
score from the range observed for each isolate individually. 
2.3.1 Motility 
Motility was initially observed qualitatively using the hanging drop method.  All 
isolates displayed motility under microscopic activity, including both reference 
strains and all test isolates.  Subsequently, motility was subjected to a more 
quantitative method of study using swarming motility as described above.  Results 
for swarming motility are presented in Figure 2.1, overleaf.  Control strains C. jejuni 
81116 and 11168 recorded motility diameters of 19mm and 21mm respectively.  
For the test strains, the observed range of score ranged from 3-30mm and showed 
notable variation between isolates.  Overall C. coli showed lower motility (range 3-
11.mm, mean 7.25mm) than the control strains (range 19-21mm, mean 20mm) and 
the ST403CC C. jejuni isolates (range 3-30mm, mean 14.79mm).  The C. coli isolates 
recorded less variation in motility across the selected isolates (3-11.67mm) than 
was observed in C. jejuni (3-30mm), however the C. coli isolates displayed more 
intra-strain variation between tests (the mean standard deviation 2.36, range of 
standard deviation across four isolates 0.0-6.03) compared to C. jejuni ST403CC 
56 
 
isolates (mean standard deviation 1.67, range 0.0-4.0 across six isolates) and the 
reference C. jejuni isolates (zero standard deviation, each isolate replicated exact 
scores across repeat experiments).  No clear trend emerged from the data 
presented in Figure 2.1 to indicate a consistent pattern of motility for ST403CC C. 
jejuni isolates; the ST403CC isolates were demonstrated to be motile but did not 
appear distinct from other C. jejuni or C. coli isolates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One-way ANOVA for swarming motility was found to be statistically significant 
(P<0.001 (to be significant P≤0.05)).  Means vs control analysis revealed significant 
variation between the reference strain control C. jejuni 81116 and C. jejuni 549.1, 
623, 304, plus C. coli 99/321 and 03/121 - all of which recorded significantly lower 
motility, except 304 which displayed higher motility than reference isolate.  T-test 
analysis revealed that, despite appearances (Figure 2.1), variation between groups 
was also statistically significant, for source only (porcine vs non-porcine isolates, 
regardless of species; P<0.0001); for source within C. jejuni isolates (porcine vs non-
Figure 2.1: Swarming Motility of C. jejuni & C. coli Isolates. 
Swarming motility was determined for C. jejuni and C. coli isolates using soft agar stabs.  
Motility was measured as the diameter of the zone of swarming motility in millimetres.  C. 
jejuni control isolates are indicated by green colour and C. coli isolates by blue.  ST403CC C. 
jejuni isolates are indicated by purple colour.  Error bars show standard deviation from the 
mean motility observed; where no error bars are shown the same result was observed across 
repeated experiments. 
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porcine isolates from C. jejuni only; P=0.0361); and for species (C. jejuni vs C. coli, 
regardless of source; P=0.0033).  Considerable strain-strain variation was observed 
for degree of motility, though all tested isolates were motile, and the ST403CC C. 
jejuni isolates displayed, on average, lower motility than typical C. jejuni strains, but 
higher motility than porcine C. coli included in the study. 
2.3.2 Autoagglutination 
Figure 2.2 shows the observed results for autoagglutination, recorded as the change 
in OD600nm after 24 hour incubation without agitation; with a larger change 
indicating a higher level of autoagglutination.  Variation was observed across the 
twelve tested isolates (range 0.26-0.92) with the lowest scores recorded for the 
reference strains C. jejuni 81116 and 11168 (mean scores of 0.26 and 0.35 
respectively).  Autoagglutination scores for the ST403CC C. jejuni isolates ranged 
from 0.36-0.90 (mean change 0.67) whilst scores for the C. coli isolates ranged from 
0.49-0.92 (mean 0.70).  The ST403CC C. jejuni isolate 304 exhibited notable lower 
autoagglutination than the other ‘test’ isolates, recording autoagglutination levels 
more consistent with those of the reference C. jejuni strains. 
One-way ANOVA determined that the variation between samples for 
autoagglutination was statistically significant (P>0.0001) and multiple comparison 
determined that variation from control strain C. jejuni 81116 was statistically 
significant for every included isolate with the exception of C. jejuni isolates 11168 
and 304.  T-test analysis showed significant difference between groups for porcine 
vs non-porcine control isolates, both across both species and for C. jejuni only 
(P<0.0001 for both), but there was no significant difference between C. jejuni and C. 
coli groups (P=0.0820).   
It was demonstrated that the studied ST403CC C. jejuni isolates all exhibited 
autoagglutination, and to a higher degree than the reference C. jejuni isolates. 
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2.3.3 Adherence to and Invasion into Caco-2 Cells 
Figure 2.3, overleaf, shows the adhesion to Caco-2 cell surfaces for C. jejuni and C. 
coli isolates, three hours post infection.  Values are presented as the percentage of 
the inoculum adhered to the cells, calculated from the mean results for two 
representative values. 
As described above, each isolate was tested three times per assay, and each assay 
was repeated at least in triplicate: from this, two representative results were 
selected, then the percentage adherence was calculated for each (from the mean 
inoculum), and the mean of these two values was taken for presentation from this. 
Figure 2.2: Autoagglutination of C. jejuni & C. coli Isolates. 
The level of autoagglutination was observed by comparing the change in optical density 
between the start point of the experiment, and following 24 hours incubation without 
agitation; the values plotted are the mean changes in optical density for each isolate. 
 C. jejuni control isolates are indicated by green colour and C. coli isolates by blue.  
ST403CC C. jejuni isolates are indicated by purple colour.  Error bars show standard 
deviation from the mean motility observed; where no error bars are shown the same 
result was observed across repeated experiments. 
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Substantial strain-strain variation was observed; the range of mean values was 
1.71x106-7.17x106 equating to a range of percentages of initial inoculum of 0.24-
3.33%. 
 
Both the highest and lowest observed percentage adherence were isolates within 
the ST403CC C. jejuni group.  Reference isolates C. jejuni 81116 and 11168 recorded 
adherence percentages of 2.46 and 0.57 respectively, whilst the C. coli isolates had 
an average percentage of inoculum adhered of 1.98% (range 1.56-2.64%) and the 
ST403CC C. jejuni isolates average was 1.44% (range 0.24 to 3.33%).  No obvious 
trend was observed from observation of Figure 2.3, and this was confirmed by 
statistical analyses: one-way ANOVA determined no significant variation between 
strains (P=0.0642), with no significant results from multiple comparison analysis.  
Furthermore no statistically significant variation was observed for adhesion 
between groups by T-test analysis (porcine/non-porcine (P=0.9122); porcine/non-
Figure 2.3: Adherence of C. jejuni & C. coli Isolates to Caco-2 Cells 
Bacterial cells adhered to Caco-2 cells two hours post infection, as 
determined by retrospective bacterial counts and presented as a 
percentage of the initial inoculum for each isolate.   
 C. jejuni control isolates are indicated by green colour and C. coli 
isolates by blue.  ST403CC C. jejuni isolates are indicated by purple 
colour.  Error bars show standard deviation from the mean motility 
observed. 
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porcine C. jejuni (P=0.8312); C. jejuni vs C. coli (P=0.2016)).  Although the statistical 
analysis denies significant variation between strains (range 0.24-3.33, with mean of 
1.63), it is however observable from Figure 2.3, that considerable variation exists 
between strains, and that each of the tested isolates was able to successfully 
adhere to Caco-2 cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 displays retrospective bacterial counts for the number of bacteria 
internalised into Caco-2 cells a total of five hours post infection (three hour 
adhesion phase followed by two hour gentamicin protection phase to remove 
external  bacteria) as a percentage of the initial inoculum.  Figure 2.4a shows the 
results for all twelve isolates; whilst Figure 2.4b shows the same data with the 
exemption of the highly invasive isolate C. jejuni 11168, as the data in part is 
skewed by its presence, and its exclusion in Figure 2.4b allows for greater resolution 
in the remaining eleven datasets.  Considerable variation was observed across the 
Figure 2.4: Internalisation of C. jejuni & C. coli Isolates into Caco-2 Cells 
Bacterial cells internalised into Caco-2 cells five hours post infection, as determined by 
retrospective bacterial counts and presented as a percentage of the initial inoculum for each 
isolate.   
a) includes all twelve isolates tested C. jejuni and C. coli isolates. 
b) excludes the result for C. jejuni 11168 as it is so much more invasive than the others it 
makes viewing the variation between the remaining eleven isolates difficult. 
C. jejuni control isolates are indicated by green colour and C. coli isolates by blue.  ST403CC C. 
jejuni isolates are indicated by purple colour.  Error bars show standard deviation from the 
mean motility observed; where no error bars are shown the same result was observed across 
repeated experiments. 
a b 
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twelve isolates, with reference strains C. jejuni 81116 and 11168 recording 0.04% 
and 0.21% respectively, whilst the ST403CC C. jejuni isolates ranged from 0.001-
0.022% (mean 0.008%) and the C. coli isolates ranged from 0.0004-0.023% with a 
mean of 0.009% of inoculum internalised. 
Invasion data was found to be statistically significant in variation across the group 
by one-way ANOVA (P=<0.0001), although via multiple comparison analysis the only 
strain to differ significantly from the low invasive reference isolate C. jejuni 81116 
was the high invasive reference isolate C. jejuni 11168.  Additionally, invasion 
efficiency was not found to show statistically significant variation between groups: 
by source only (P=0.2118); by source within C. jejuni (P=0.2130); by species 
(P=0.2087).   
Each of the isolates was found to successfully invade Caco-2 cells in vivo.   
Considerable variation was observed between isolates however no association was 
observed between host or species and invasive ability.  ST403CC C. jejuni isolates 
are capable of invasion into Caco-2 cells, with variation observed between strains 
within the group. 
2.3.4 Sensitivity to Oxidative Stress 
The sensitivity of ST403CC C. jejuni isolates, and other C. jejuni and C. coli isolates, 
to oxidative stresses were observed for hydrogen peroxide and superoxide, via the 
superoxide producer pyrogallol. 
2.3.4.1 Sensitivity to Hydrogen Peroxide 
Sensitivity to hydrogen peroxide was observed as zones of inhibition on plates when 
exposed to a range of concentrations.  The concentration which produced the most 
consistent, reproducible results was 3% v/v hydrogen peroxide, and the mean 
diameters of the zones of inhibition for this concentration are presented in Figure 
2.5. 
Some strain-strain variation was observed across the twelve isolates, however no 
clear pattern was observed between the different groups of isolates.  The range 
across the experiment was 18-31.67mm, with reference isolates C. jejuni 81116 and 
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11168 scoring 25mm and 31.67mm respectively.  Zones of inhibition for the 
ST403CC C. jejuni isolates ranged from 23mm to 31.67mm (mean of 25.61mm) 
whilst the C. coli isolates ranged from 18-28mm (mean 23.75mm).  
For the H2O2 assay, statistical analysis found that, by one-way ANOVA, variation 
between strains was statistically significant (P<0.0001), and that some isolates (C. 
jejuni 11168 and 623 and C. coli 03/121) varied significantly from the control strain 
C. jejuni 81116: C. coli 03/121 with a significantly smaller zone of inhibition - being 
more resistant, whilst C. jejuni 11168 and 623 were significantly larger zones - being 
more sensitive.  T-test analysis confirmed that there was no significant difference 
between groups: host origin (P=0.1055); host origin within C. jejuni (P=0.2020); C. 
jejuni vs C. coli (P=0.1073).   
2.3.4.2 Sensitivity to Superoxide 
Sensitivity to superoxide was assessed by observing zones of inhibition created 
when isolates were exposed to the superoxide producer pyrogallol (1M).  Some 
Figure 2.5: Sensitivity to Hydrogen Peroxide of C. jejuni & C. coli Isolates 
H2O2 sensitivity, recorded as zones of inhibition of growth (diameter, mm) using 3% v/v 
Hydrogen Peroxide. 
C. jejuni control isolates are indicated by green colour and C. coli isolates by blue.  ST403CC 
C. jejuni isolates are indicated by purple colour.  Error bars show standard deviation from 
the mean motility observed; where no error bars are shown the same result was observed 
across repeated experiments. 
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variation was observed between isolates, however no distinct pattern of sensitivity 
was observed for species or host type, as depicted in Figure 2.6.  Zones of inhibition 
across the group ranged from 31.80-43.80mm, with diameters of 37.60mm and 
32.40mm for C. jejuni 81116 and 11168.  The range for ST403CC C. jejuni isolate 
sensitivity was larger than non-ST403CC C. jejuni (31.80-43.80mm, mean 37.93mm), 
with ST403CC isolates again representing both the highest and lowest recorded 
scores.  Zones of inhibition for C. coli isolates ranged 32-38.40mm (mean 34.85mm). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The between strain variation observed in the pyrogallol assay was confirmed to be 
significant by statistical analysis (one-way ANOVA, P=0.0001), although the multiple 
comparisons method found no statistically significant variation in any strain 
compared to the control strain C. jejuni 81116.  Additionally there was no significant 
variation between groups: host origin (P=0.2507); host origin within C. jejuni 
(P=0.0899); C. jejuni vs C. coli (P=0.0842).  ST403CC C. jejuni isolates showed similar 
Figure 2.6: Sensitivity to Superoxide of C. jejuni & C. coli Isolates 
Superoxide sensitivity, recorded as zones of inhibition (mm) created when exposed to 
the superoxide producer Pyrogallol (1M). 
C. jejuni control isolates are indicated by green colour and C. coli isolates by blue.  
ST403CC C. jejuni isolates are indicated by purple colour.  Error bars show standard 
deviation from the mean motility observed; where no error bars are shown the same 
result was observed across repeated experiments. 
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superoxide sensitivity to other C. jejuni and C. coli isolates when treated with 
pyrogallol. 
2.3.5 Sensitivity to Bile Acids 
The sensitivity of C. jejuni and C. coli isolates to the major bile acids in humans were 
assessed using disc diffusion methods. 
2.3.5.1 Sensitivity to Cholic Acid 
Sensitivity to cholic acid was assessed by examining zones of inhibition created 
upon exposure to cholic acid.  A range of concentrations were used initially, as 
described in Table 2.2, from the cholic acid assay, the highest concentration used 
(10mg/ml) was selected for presentation, as it provided the most consistent results 
across repeated tests; mean results are shown in Figure 2.7. 
 
Figure 2.7: Sensitivity to Cholic Acid of C. jejuni & C. coli Isolates 
Sensitivity to cholic acid (10mg/ml) as observed by diameter of zones of inhibition 
(mm) observed. 
C. jejuni control isolates are indicated by green colour and C. coli isolates by blue.  
ST403CC C. jejuni isolates are indicated by purple colour.  Error bars show standard 
deviation from the mean motility observed; where no error bars are shown the same 
result was observed across repeated experiments. 
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The control strains recorded similar zones of inhibition (C. jejuni 81116 7.67mm and 
C. jejuni 11168 8.33mm), which were also consistent with the zones observed for 
ST403CC C. jejuni isolates (range 6.67-12mm, mean 8.56mm), whereas the C. coli 
isolates recorded smaller zones of inhibition (6mm-8mm, mean 6.92mm). 
This was confirmed by statistical analysis; one-way ANOVA was statistically 
significant for variation between strains (P<0.0001), and as would be expected, 
multiple comparison of test means against control revealed statistically significant 
variation from C. jejuni 81116 for C. jejuni 304 but not for any other isolate.  T-test 
analysis revealed no significant variation between groups for pig origin vs non-pig 
origin across species (P=0.8134) or between pig origin vs non-pig origin within C. 
jejuni isolates only (P=0.3029), however statistically significant variation (P=0.0023) 
was observed between species (C. jejuni vs C. coli) irrespective of isolate origin. 
With the exception of C. jejuni 304, which was notably more sensitive, the ST403CC 
C. jejuni isolates showed similar levels of cholic acid sensitivity to the C. jejuni 
reference isolates; all of which were less resistant to cholate stress than the C. coli 
isolates. 
2.3.5.2 Sensitivity to Deoxycholic Acid 
As for cholic acid, deoxycholic acid sensitivity was assessed using a range of 
concentrations and measured as the diameter of zones of inhibition.  Figure 2.8 
shows the mean diameters observed using the selected concentration 13mg/ml; 
this concentration was selected as the representative concentration due to the 
reproducibility of results. 
The observed range across all isolates was 6.33-8mm, with reference isolates C. 
jejuni 81116 and 11168 recording zones of inhibition of 6.33mm and 7mm 
respectively.  In comparison the range for the C. jejuni ST403CC isolates was 6.67-
8mm with a mean of 7.45mm, and for the C. coli isolates was 6.67-7mm (mean 
6.86mm).   
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 Results were similar across the twelve isolates, with the smallest diameter (most 
resistant) isolate being C. jejuni 81116.  This observation was supported by 
statistical analysis which confirmed no significant variation between strains via one-
way ANOVA (P=0.4453), with no significant variation from the control strain during 
multiple comparison analysis, as well as no significant variation between groups 
when analysed by T-test (pig origin vs non-pig origin across species (P=0.2771); pig 
origin vs non-pig origin within C. jejuni isolates only (P=0.1375); C. jejuni vs C. coli 
(P=0.1520)).   
2.3.5.3 Sensitivity to Chenodeoxycholic Acid 
Sensitivity to chenodeoxycholic acid was assessed in the same manner as cholic acid 
and deoxycholic acid, and the concentration selected for presentation was 
15mg/ml.  Chenodeoxycholic acid sensitivity results are displayed in Figure 2.9; 
zones of inhibition across the experiment ranged from 5.33-9mm, with diameters of 
6mm for C. jejuni 81116 and 6.33mm for C. jejuni 11168, compared with a range of 
5.33-7.33 (mean 6.28mm) for the ST403CC C. jejuni isolates, and 5.67-9.00mm 
(mean 7.17mm) for the C. coli isolates.  Once again for chenodeoxycholic acid 
 
Figure 2.8: Sensitivity to Deoxycholic Acid of C. jejuni & C. coli Isolates 
Sensitivity to deoxycholic acid (13mg/ml) as observed by diameter of zones of 
inhibition (mm) observed. 
C. jejuni control isolates are indicated by green colour and C. coli isolates by blue.  
ST403CC C. jejuni isolates are indicated by purple colour.  Error bars show standard 
deviation from the mean motility observed; where no error bars are shown the same 
result was observed across repeated experiments. 
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minimal variation was observed across the isolates.  Statistical analysis determined 
that variation between the strains was statistically significant (P<0.0001), however 
multiple comparison test against the control strain revealed that only most sensitive 
isolate C. coli 03/317 varied from the control strain C. jejuni 81116 statistically 
significantly.  T-test analysis did not determine any significant variation between 
groups (pig origin vs non-pig origin across species (P=0.1146); pig origin vs non-pig 
origin within C. jejuni isolates only (P=0.7075); C. jejuni vs C. coli (P=0.0652)).   
Overall, for the bile salt acid assays, variation was less than for other assays, 
however the difference across the group was statistically significant (95% C.I.) for 
both chenodeoxycholic acid and cholic acid.  Species appeared to have an effect 
only for the cholate assay, and porcine vs non-porcine origin did not appear 
important in differences in bile acid sensitivity.  In each of the three bile acid tests, 
the ST403CC C. jejuni group demonstrated some variation between isolates, but 
recorded sensitivity levels similar to other C. jejuni and C. coli isolates. 
Figure 2.9: Sensitivity to Chenodeoxycholic Acid of C. jejuni & C. coli Isolates 
Sensitivity to chenodeoxycholic acid (15mg/ml) as observed by diameter of zones of 
inhibition (mm) observed. 
C. jejuni control isolates are indicated by green colour and C. coli isolates by blue.  
ST403CC C. jejuni isolates are indicated by purple colour.  Error bars show standard 
deviation from the mean motility observed; where no error bars are shown the same 
result was observed across repeated experiments. 
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2.3.6 Summary of Experiments Characterising ST403CC C. jejuni Isolates 
Figure 2.10 provides an overview of the phenotyping results as a ‘heat-map’.  The 
colour gradient indicates the virulence potential of the isolate; for each experiment, 
a darker colour signifies the more virulent phenotype (such as high invasion or 
motility, or low sensitivity to a stressor), whereas a paler colour indicates a less 
virulent phenotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Considerable variation in virulence potential was found across the group of isolates 
and range of tests included.  Neither the ST403CC C. jejuni nor the other C. jejuni or 
C. coli formed a distinct pattern of behaviour, however it was observed that the 
Isolate 
Test 
1 2 3 4 5 6 7 8 9 
C. jejuni 81116          
C. jejuni 11168          
C. jejuni 857          
C. jejuni 549.1          
C. jejuni 623          
C. jejuni 304          
C. jejuni 484          
C. jejuni 444          
C. coli 99/321          
C. coli 03/121          
C. coli 03/103          
C. coli 03/317          
 
 
 
 
 
 
1. Motility 
2. Autoagglutination 
3. Percentage of Inoculum Adhered 
4. Percentage of Inoculum Invaded 
5. Sensitivity to Hydrogen Peroxide 
6. Sensitivity to Superoxide 
7. Sensitivity to Cholic Acid 
8. Sensitivity to Deoxycholic Acid 
9. Sensitivity to Chenodeoxycholic Acid 
Figure 2.10: Overview of Phenotyping Results 
Overview of phenotyping results, darker colour indicates ‘higher’ virulence 
potential (low sensitivity to stressors, high adherence and invasion, high motility or 
autoagglutination) Tests are indicated as described below: 
 Low virulence 
 
 
 
 
High virulence 
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ST403CC C. jejuni isolates showed similar virulence potential to other C. jejuni and C. 
coli isolates. 
2.4 Discussion 
Phenotypic assays were used to assess the potential capacity for human disease of a 
group of C. jejuni isolates which were suspected as being adapted to the porcine 
host.  The isolates were part of the MLST 403 clonal complex, and were unstudied 
prior to this study with the exception of being typed by MLST and having been 
shown to be hippurate negative (Manning et al, 2003).  This chapter set out to 
investigate the phenotype and pathogenic potential of the ST403CC C. jejuni isolates 
in order to determine whether these isolates may theoretically be capable of 
causing illness in humans, and whether this potentially host adapted group of 
isolates exhibited a distinct phenotypic profile when compared to other C. jejuni 
and C. coli isolates.  Phenotypic characterisation demonstrated that the ST403CC 
isolates did not have a specific phenotypic profile compared to other C. jejuni and C. 
coli isolates, however they have the potential to cause disease in humans. 
2.4.1 Motility 
Motility results for the reference strain C. jejuni 81116 were lower than in 
previously published work (Fearnley et al, 2008), however the results were 
consistent across repeated tests.  This was observed despite the similarities 
between methodologies (stabbing inoculum into Mueller-Hinton with 0.4% agar, 
and incubating for 48 hours are 42°C); with diameters of motility between 5-5.8cm 
in contrast to the mean of 1.9cm observed here.  Differences which may serve to 
explain this variation include the different media for prior culture (bacteria were 
grown at 42°C on BASA plates (Blood agar containing Skirrow’s selective antibiotics 
in Fearnley et al 2008  for 24 hours then transferred to brain heart infusion broth 
supplemented with yeast extract for 20 hours - in contrast to recovery for 48 hours 
at 37°C on MCCDA plates) and a possible difference in concentration of the bacterial 
suspension; they adjusted theirs to a consistent optical density but did not state 
what; it may be that they were using a higher initial inoculum than was described 
here (optical density of approximately 0.1 at 600nm).  These different culture 
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techniques may have led their isolates to express virulence associated genes and 
therefore behave differently in the assay compared to the version used here.  
Another potential factor would be the increasing lab adaptation of isolate C. jejuni 
81116 leading to a reduction in motility, although passage was minimal in an 
attempt to avoid this risk.  Fearnley et al (2008) found no significant differences in 
motility between low and hyper invasive isolates.   
All of the tested isolates exhibited motility, and considerable variation was observed 
between the twelve studied isolates.  The ST403CC C. jejuni isolates displayed on 
average lower motility than the human C. jejuni isolates, and higher motility than 
the porcine C. coli isolates.  Aroori, Cogan & Humphrey (2013) investigated the 
effect of temperature on motility and invasion in Campylobacter species; they 
observed that C. coli isolates were less motile at 37°C than at 42°C; it is possible 
therefore that the low motility observed for C. coli was linked to this temperature 
effect, and that the lower motility of ST403CC isolates indicates a similarity in 
behaviour with C. coli isolates. 
2.4.2 Autoagglutination 
Considerable variation in autoagglutination was observed across the twelve C. jejuni 
and C. coli isolates.  Interestingly, ST403CC C. jejuni isolate 304, which was the most 
motile of the strains, showed the lowest degree of autoagglutination of the test 
strains, being notably closer to the reference strains (reference strains 0.26 and 
0.92, C. jejuni 304 0.36, remaining ST403CC isolates 0.61-0.90).  This may infer a 
possible trend of inverse relationship between motility and autoagglutination, of 
which there is some further evidence amongst the dataset; of the six highest 
observed motility scores (C. jejuni strains 304, 857, 11168, 81116, 484 and 444), five 
are also amongst the lowest autoagglutination scores (81116, 11168, 304, 03/121, 
444, 857) although there are also two clear exceptions amongst these groups – C. 
jejuni 484 recorded the fourth highest motility score, yet was also the second 
highest autoagglutination score, whilst C. coli 03/121 recorded the third lowest 
autoagglutination score whilst also having recorded the equal lowest motility score 
of the twelve included strains.  Misawa & Blaser (2000) used mutant studies of C. 
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jejuni 81116 to investigate motility and autoagglutination and found that motility 
itself may not be essential for autoagglutination – a flagellated but non motile flaA 
variant retained autoagglutination close to that of the wild-type strain, whilst an 
aflagellate variant did not display autoagglutination.  This was expanded upon by 
Golden & Acheson (2002) who showed that flaA is not the only determinant in 
autoagglutination levels – presence of flaA is necessary for autoagglutination but 
alone is not sufficient.  Golden & Acheson (2002) showed that motility and 
autoagglutination (and subsequent invasion ability) are related, but that motility 
does not predict autoagglutination, or vice versa. 
2.4.3 Adherence to & Invasion into Caco-2 Cells 
Variation in invasion efficiency across the twelve isolates was statistically significant, 
although the only isolate which was significantly different from the low invader 
control strain C. jejuni 81116 was the high invader control strain C. jejuni 11168.  
This corroborates the work of Fearnley et al (2008) which first distinguished the 
categories of low- high- and hyper- invasive C. jejuni isolates.  In the categories 
defined by Fearnley et al (2008), high invasive strains including C. jejuni 11168 
exhibit 10 times higher invasive efficiency than the low invasive type strain C. jejuni 
81116.  By extension of this it was established that the ST403CC C. jejuni isolates, 
which all demonstrated invasive capabilities in the Caco-2 model, would all be 
considered low-invasive strains.  The same description may also be applied to the 
four C. coli isolates, however it may be risky to extrapolate from an original study 
based solely upon C. jejuni isolates to apply to another albeit closely related species.  
It is however reasonable to state that both the tested C. coli and ST403CC C. jejuni 
isolates displayed a similar range of invasive capability, and it can therefore 
tentatively be suggested that, based upon these data, the porcine ST403CC C. jejuni 
isolates exhibit a similar level of potential for causing illness as do the porcine C. coli 
isolates. 
Strain-strain variation is very common in ‘wet-lab’ tests of Campylobacter, and 
adhesion and invasion assays are no exception to this; however, the invasion 
efficiency results observed in this study were comparable to results observed in the 
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literature.  For instance, Fearnley et al (2008) observed that the majority of the 
isolates they investigated showed an invasion efficiency percentage of between 
0.0006 and 0.3% of the inoculum being internalised (into INT407 cells); this range 
included their result for the low invader control isolate C. jejuni 81116 which was 
used in this study and recorded an invasion efficiency of 0.04%, both this and all the 
included experimental isolates fit within the low invader efficiency range observed 
by Fearnley et al (2008). 
Multiplicity of infection (MOI) may be considered an important factor in the 
gentamicin protection assay, and a range of MOIs have been utilised in the 
literature: Hu & Kopecko (1999) used a range of MOI for C. jejuni 81-176 and 
determined that an MOI of 0.2 was most efficient for internalisation percentage, 
with MOIs in the range 0.2-200 providing a steady increase in raw numbers of 
internalised bacteria in INT407 cells.  In 1994, Russell & Blake found an MOI of ratio 
1000:1 to be suitable when studying C. jejuni 81-176 invasion in Caco-2 cells, whilst 
in 2010 Javed et al utilised an MOI of 100 when using C. jejuni strains 11168, wild-
type and mutant strains of hyper invasive isolate 01/51 and the flaA/flaB mutants of 
81116.  C. jejuni invasion in cell culture has been demonstrated to occur at a 
considerable range of MOIs: maximal efficiency for invasion occurs around 100-
200:1, with an increase in the number of bacterial cells internalised but not in the 
percentage efficiency of invasion observed after this point.  The most important 
factor is consistency to allow comparison between repeat tests and different 
isolates, initial runs to test the assay conditions and procedure were successful and 
were deemed to have an approximate MOI of 1000:1 following retrospective 
bacterial counts; as such an MOI of approximately 1000:1 was subsequently used 
for all tested strains; estimated by adjusting optical density to a standardised 
amount, and confirmed using retrospective counts. 
Definite links were not observed between the ‘predictor’ tests and efficiency in 
adhesion or invasion.  Although the most motile isolate (C. jejuni 304) was also the 
top isolate in the adhesion assay, of the other top five motility isolates, only one 
other (81116) was in the top six isolates for adhesion efficiency, whilst others (C. 
jejuni 11168, 857) were low efficiency adherence isolates.  Likewise although one 
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isolate was a high scorer in both autoagglutination and adhesion efficiency (C. coli 
03/317), the highest adhesion isolate (C. jejuni 304) was the third lowest scorer in 
the autoagglutination assay.  Similar variation was observed between motility and 
invasion efficiency; three of the top six motility isolates were also in the top four for 
invasion efficiency (C. jejuni isolates 304, 11168 and 484), however the second 
highest motility isolate (C. jejuni 857) was also second lowest for invasion efficiency.  
Similar patterns were observed between autoagglutination and invasion efficiency; 
the second most efficient invasion isolate (C. coli 03/317) was also the highest 
scorer in the autoagglutination assay, however the highest invading isolate (C. jejuni 
11168) was the second lowest scoring isolate in the autoagglutination assay.  
Additionally, adhesion efficiency did not appear to have a direct relationship with 
subsequent invasion efficiency; although some isolates, such as C. jejuni 304 and C. 
coli 03/317, were efficient at both adhesion and invasion, and others were mid-
range for both, other isolates were poor in adhesion efficiency, yet amongst the 
most efficient invaders included in the study; most notably, the lowest adherence 
efficiency observed was that of C. jejuni 11168, the highly invasive control isolate, 
which was the most efficient invader studied by a considerable margin. 
ST403CC C. jejuni isolates were demonstrated to be capable of adherence to and 
invasion into Caco-2 cells, as such they likely possess the capacity to cause 
gastrointestinal disease in humans.  Considerable variation was observed across the 
six ST403CC isolates in efficiency for both adhesion and invasion, however it is 
common for variation to be observed in C. jejuni.   
2.4.4 Sensitivity to Hydrogen Peroxide & Superoxide Stress 
Baillon et al (1999) used agar pour plates and applied 6mm discs loaded with 3µl of 
3% H2O2 and observed a ‘zone of killing’ for C. jejuni 81116 of 20mm, compared to 
the 25mm observed in this study, using a similar technique; applying 3µl of 3% H2O2 
using 3mm discs in soft agar pour plates.  This apparent increase in sensitivity may 
potentially be attributed to continuing lab adaptation of the C. jejuni 81116 isolate; 
although passage is kept to a minimum this isolate has been used in laboratory 
culture and study for over thirty years. 
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The ST403CC C. jejuni isolates 304 and 623 once again formed the outlier scores 
within the ST403CC group, with 304 being the second most resistant overall (lowest 
being C. coli 03/121), whilst 623 was the second most sensitive isolate after C. jejuni 
11168. 
No apparent link was observed between resistance to hydrogen peroxide and 
resistance to superoxide; some isolates were amongst the most sensitive to both (C. 
jejuni 623) and others resistant to both (C. coli 03/121) but others were amongst 
the most sensitive to one and most resistant to the other (C. jejuni 11168 and 
549.1).  There is possibly some relationship between adhesion efficiency and 
hydrogen peroxide resistance; the three most efficient adherers (C. jejuni 304, C. 
coli 03/317, C. jejuni 81116) were also amongst the most resistant to hydrogen 
peroxide stress, likewise poor adherence isolates such as C. jejuni 11168 and 623 
were also the most sensitive to hydrogen peroxide exposure – although the picture 
was not complete as there were isolates which contradict this pattern, and this 
does not expand to include superoxide resistance, or invasion efficiency.  A link 
between adhesion efficiency and hydrogen peroxide sensitivity would make sense 
as isolates which are more able to survive the H2O2 stress would potentially have a 
better opportunity to adhere to the cells, both in vitro and in vivo.  Harvey & Leach 
(1998) proposed that oxidative stress can increase the invasive potential of 
Campylobacter isolates; a link was not observed between survival of oxidative stress 
and increased invasion in these experiments however as only one high-invasive 
strain and a majority of low invasive isolates were tested it may be likely that this 
trend wasn’t observed due to the lack of additional high or hyper invasive strains.  
Grant & Park (1995) observed katA presence in Campylobacter and its function as a 
potential oxidative stress defence system.  Catalase is common to thermo-tolerant 
Campylobacters (Day et al, 2000), and it is known to play a role in surviving 
oxidative stress in the environment, as well as protecting against oxidative burst 
(hydrogen peroxide) in macrophage (Grant & Park, 1995).  Grant & Park (1995) 
demonstrated that deactivation of the katA gene resulted in an oxidative stress 
sensitive isolate. 
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Direct testing for catalase activity was not carried out, as C. jejuni and C. coli are 
known to be catalase positive (Penner, 1988) although some examples of catalase 
negative or weak C. jejuni have been observed, these were recategorised as C. 
upsaliensis.  Had any isolates failed to survive at all in the hydrogen peroxide assay 
then catalase testing would have been applied along with PCR confirmation of katA 
presence to confirm the results. 
2.4.5 Bile Acid Sensitivity 
Overall the variation between isolates appeared less than for other assays, however 
the variation across the group was nevertheless statistically significant (95% C.I.) for 
both cholic acid and chenodeoxycholic acid.  Species appeared to have an effect 
only for the cholic acid assay, and host origin (porcine vs non-porcine) did not 
appear significant in bile salt sensitivity.  C. coli isolates were significantly more 
resistant to cholic acid stress than C. jejuni isolates, but this was not reflected in the 
deoxycholic or chenodeoxycholic acid assays.  This may seem slightly unexpected as 
the major bile acids in pigs are hyocholic acid, chenodeoxycholic acid, and 
hyodeoxycholic acid (Elliott, in Danielsson & Sjövall, 1985). 
C. jejuni 304 was notably sensitive across the three bile acid assays, being the most 
sensitive of all twelve isolates to cholic acid, the joint most sensitive to deoxycholic 
acid, and third most sensitive, after C. coli isolates 03/103 and 03/317, to 
chenodeoxycholic acid.  C. jejuni isolate 623 however was the equal most resistant 
isolate to both chenodeoxycholic acid and deoxycholic acid; although it recorded 
the third most sensitive result for cholic acid however the variation across the range 
of cholic acid results – with the exception of 304 – is small (range of just 6-8.33mm). 
Exposure to bile acids is known to have regulatory effects on C. jejuni.  Malik-Kale, 
Parker & Konkel (2008) described that exposure to sodium deoxycholate 
(deoxycholic acid) induced the expression of virulence genes (ciaB, cmeABC, dccR, 
tlyA) and increased invasive potential in INT407 cells, without affecting the motility 
or adherence for C. jejuni F38011.  Fox et al (2007) found that culturing C. jejuni 
with above ‘natural’ bile concentrations (up to 5% ox bile w/v in brain heart infusion 
broth) induces a stress response involving GroEL GaIU and bacterioferritin.  
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Hugdahl, Beery & Doyle (1988) observed negative chemotaxis from cholic acid and 
deoxycholic acid, and positive chemotaxis towards bile (both bovine and hog), 
demonstrating that although bile is a chemoattractant for C. jejuni, its individual 
components act as chemorepellants. 
Raphael et al (2005) used growth measurements using optical density observation 
following the addition of various antimicrobial reagents in 96 well plate growth 
assay.  Using this method, they observed MIC concentrations of 12.5mg/ml for 
deoxycholic acid, 10mg/ml for chenodeoxycholic acid, and 3.125mg/ml for cholic 
acid for C. jejuni human disease isolate F38011.  Raphael et al (2005) demonstrated 
that inactivation of Cj0643 (which they designated cbrR – Campylobacter bile 
resistance regulator) prevents growth at 1% wt/vol deoxycholic acid, and inhibits 
growth in other bile acids, but does not affects sensitivity to antibiotics and other 
stressors, and causes decreased ability to colonised in the chicken model.  This 
further supports the belief that bile resistance is important in host colonisation, and 
demonstrates that the response regulator cbrR modulates bile acid resistance in C. 
jejuni.  The ranges of stressor concentrations used in this study were guided by the 
results of the study by Raphael et al (2005), and the single concentrations selected 
for inclusion in results and discussion (10mg/ml cholic acid; 13mg/ml deoxycholic 
acid; 15mg/ml chenodeoxycholic acid) reflected the patterns observed across the 
range, with the least intra-strain variation.   
Varying degrees of sensitivity to bile acids were observed across the twelve 
included isolates, and across the ST403CC C. jejuni isolates.  What was observed 
however is that these isolates can survive bile acid stresses, as they must if 
colonising the human or porcine host. 
2.4.6 Summary & Overall Discussion of Phenotype 
Gripp et al (2011) attempted to investigate host-specificity by using ST21 isolates 
from a variety of sources.  As they stated, it had been frequently shown that closely 
related strains (MLST) can be found in a variety of sources, but that the limitation of 
MLST considering only conserved house-keeping genes might be overlooking 
important information about virulence or host specific genes.  Gripp et al (2011) 
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observed considerable phenotypic diversity within the single ST however this was 
general variation between isolates and did not correlate with source.  Gripp et al 
(2011) also completed genome sequences of five of the ST21 isolates and 
determined that the dominant STs which are found across a variety of sources have 
a ‘generalist’ phenotype which enables them to colonise humans and a range of 
domestic animals, however they also acknowledged that this does not rule out 
specialism in other C. jejuni.  Examples of specific niche adaptation include the bank 
vole host adapted C. jejuni MLST3704 including isolate 414 which was distinct in 
both phenotype and accessory genome (Hepworth et al, 2011). 
There is currently little understanding of why Campylobacter causes such different 
response in chickens and humans (Young, Davis & DiRita, 2007), and this 
phenomenon is also important with regards to Campylobacters in pigs, as piglets 
have been used as a model of human infection, despite the fact that some C. jejuni 
and C. coli strains are isolated from pigs which were not expressing symptoms. 
In conclusion the ST403CC C. jejuni isolates from food production pigs, representing 
a potential example of C. jejuni niche adaptation, did not exhibit a notably different 
phenotypic profile during this series of wet-lab experiments, however they behaved 
similarly to both human C. jejuni isolates and porcine C. coli isolates, with 
considerable variation between the strains, and with results suggesting their likely 
ability to cause pathogenesis in humans.  This indicates that these ST403CC C. jejuni 
isolates are capable of causing gastrointestinal illness, as were the ST403CC C. jejuni 
isolates observed by Duim et al (2003) in Curaçao.  Whilst these results indicate that 
the tested ST403CC C. jejuni isolates are potentially capable of causing disease in 
humans this is an extrapolated conclusion.  Additionally this does not inform on the 
potential for disease of these isolates in other host species; the isolates have been 
demonstrated to be capable of invasion using a human colonic cell line, and may or 
may not be capable of invasion in other host cell types.  It is unlikely that these 
isolates are a common cause of illness in the porcine or bovine host, as they were 
recovered from an abattoir and not from suspected cases of disease.  C. jejuni may 
rarely cause illness in other host species (poultry, cattle, pigs) but generally is a 
harmless coloniser in these hosts; it is therefore unlikely that ST403CC C. jejuni 
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isolates would cause disease in the host, although this may occur as an 
opportunistic infection, for example if an individual is otherwise 
immunocompromised.   
Null  hypotheses were outlined previously - in relation to these, based upon the 
results observed in this chapter, we can reject the first null hypothesis ‘ST403CC C. 
jejuni isolates do not show evidence of the potential to cause disease in humans’; 
however we must accept the following two null hypotheses: ‘ST403CC C. jejuni 
isolates do not exhibit higher pathogenic potential, as determined in laboratory 
tests, than non-ST403CC C. jejuni and C. coli isolates’ and ‘ST403CC C. jejuni isolates 
do not exhibit a distinct phenotypic profile compared to non-ST403CC C. jejuni and 
C. coli’. 
It was demonstrated that the ST403CC C. jejuni isolates from pigs, previously 
identified as a potentially host adapted group and being unusual hippurate negative 
strains (Manning et al, 2003) behaved similarly to more ‘typical’ C. jejuni isolates in 
virulence and stress tests.  Lack of distinction by these tests however cannot rule 
out evidence for adaptation in the genome of these isolates, it could be that host 
associated genes have been acquired which simply were not important in these 
tests.  The subsequent chapters will focus upon acquiring and investigating the 
genome sequences of these six ST403CC C. jejuni isolates, beginning by confirming 
their phylogeny within known C. jejuni isolates. 
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Chapter Three: Investigating the Whole Genome Phylogeny of ST403CC 
Campylobacter jejuni isolates 
3.1 Introduction 
It was previously established that the selected ST403CC C. jejuni strains are closely 
related in terms of MLST, representing different Sequence Types within a Clonal 
Complex (Chapter One; Manning et al, 2003) and has now been demonstrated that 
they have the capacity to cause disease in humans (Chapter Two).  The next 
significant objective was to determine how closely related the ST403CC C. jejuni 
isolates are at the whole genome level, where they fit within the Campylobacter 
phylogeny, and to begin investigating any genetic evidence of adaptation. 
3.1.1 Methods for Investigating Phylogeny 
Numerous methods exist to study the relatedness of bacterial isolates and 
introduced briefly below are some of the most important tools used in the study of 
Campylobacter; MLST, genomic hybridisation and microarray analyses, and whole 
genome sequence ‘phylogenomics’. 
3.1.1.1 MultiLocus Sequence Typing 
As introduced in previous chapters, MultiLocus Sequence Typing (MLST) is a useful 
method for typing and studying the population structure of Campylobacter, as it is 
based upon the genetic sequence of seven ‘house-keeping’ genes across the 
genome (Dingle et al, 2001).  MLST is informative as these genes are slowly 
changing, essential genes which cannot be deactivated or lost entirely and is 
particularly valuable as a starting point when investigating new isolates.  MLST is 
also an important measure as it is readily shareable and allows rapid comparison 
between laboratories.  MLST is limited however in that it only considers the seven 
genes in the scheme and cannot inform on any grander characteristics of an isolate. 
As the efficiency of whole genome sequencing increases, and resulting costs 
decrease, bacterial research has reached an age where it is frequently more feasible 
to conduct whole genome sequencing than to use traditional MLST (Larsen et al, 
2012; Inouye et al, 2012).  As such an increasing number of researchers are using 
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and developing tools to glean MLST information from short-read sequences (Inouye 
et al, 2012).  In some instances the MLST genes are identified from genomes which 
have already been produced to a draft quality level; that is the initial short-read 
sequences have been assembled and annotated to a sufficient level that the 
appropriate loci can be selected and typed, and may be concatenated to provide 
short segments of sequence representing the complete MLST profile of the isolate; 
such as that described in papers by McCarthy et al (2007) and Sheppard et al (2009) 
which are both described with more detail below.  Other researchers have 
developed means to assess the MLST of newly sequenced isolates without the need 
for the ‘completion’ of the genome; Inouye et al (2012) developed a software tool 
which uses raw short-read sequence data to determine the sequence type with a 
high degree of accuracy, shortly after Larsen et al (2012) produced a browser based 
platform with similar capabilities.   
MLST provides useful indications of relatedness between isolates (Dingle et al, 
2001), however as it is limited to seven genes it cannot inform on other genetic 
characteristics of isolates. 
3.1.1.2 Hybridisation Techniques 
Hybridisation techniques have provided another important tool in assessing 
similarity and likely relatedness between bacterial isolates (Leonard et al, 2003).  
Comparative genomic hybridisation (CGH) allows direct comparison of a query 
isolate to a reference isolate at the full genome level, without the need for 
sequencing the query isolate, by observing hybridisation to fragments of sequence 
from the reference genome (Leonard et al, 2003; Luo, Lin & Xu in Xu (Ed), 2010).  
DNA microarrays can be produced based upon a full genome, displaying every open 
reading frame in a given isolate for comparative genomic hybridisation; providing 
detailed information on the genetic content of a query isolate by identifying ORFs 
common to both isolates, and ORFs which are present in the reference isolate but 
absent from the query strain (Taboada et al, 2004). 
The use of DNA microarrays formed an important stage in the development of 
knowledge about genetic variation in Campylobacter.  Following the sequencing and 
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annotation of the first C. jejuni genome (NCTC11168) in 2000 by Parkhill et al, 
microarray provided a framework for comparison of isolates.  Dorrell et al (2001) 
developed a whole genome DNA microarray for the newly sequenced C. jejuni 
NCTC11168, allowing hybridisation experiments to inform on the presence or 
absence of each coding sequence in a query isolate. 
Microarray analysis provided a tool which could give much more information than 
PFGE and RAPD, which were the main typing tools preceding its introduction 
(Leonard et al, 2003).  However, microarray study was and is limited by the content 
on the slide – a C. jejuni 11168 microarray can assess only the similarity of a single 
strain to the genome content of C. jejuni 11168, whilst a pan genome array, 
although with much wider scope is still limited to what is present on the array.  
Leonard et al (2003) demonstrated that a DNA microarray can uncover both highly 
conserved or divergent regions between isolates or groups of isolates, however, 
microarray analysis cannot inform on genetic information present in the 
experimental isolate which is not found on the array, so any additional genetic 
content is overlooked.  This limitation could be addressed using methods such as 
suppression subtractive hybridisation (SSH), wherein the DNA of a pair of strains are 
digested before being subjected to hybridisation leaving behind DNA present only in 
the test strain for subsequent analysis, revealing additional genetic content of that 
isolate (Winstanley, 2002); this process is valuable in determining variation between 
closely related isolates, however once again this technique is limited to one ‘test’ 
strain and one ‘driver’ (reference) strain.  As described below, whole genome 
sequencing is now more commonly used to investigate variation in genomic 
content.    
During the early 2000s, microarray analysis was more cost effective than full 
genome sequencing, however with the development of second generation 
sequencing techniques and the advent of high-throughput low cost methods it is 
now typically more appropriate to use whole genome sequencing methods to 
answer the questions previously addressed by DNA based hybridisation techniques 
(Croucher & Thomson, 2010). 
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3.1.1.3 Whole Genome Alignment 
Sequence data is the most valuable and most commonly used basis for 
phylogenetics.  Whole genome sequence based phylogeny, or phylogenomics, is 
increasingly being recognised as an important measure of relatedness between 
bacterial isolates (Luo, Lin & Xu in Xu (Ed), 2010). 
Phylogenetic analysis can be attributed to the so called ‘first fact’ of biological 
sequence analysis, attributed to Dan Gusfield of the Unviersity of California in 1997 
(as cited by Mushegian, 2007): outlining the concept that similarity between 
sequences often implies similarity in structure or function, and also, crucially, that 
high sequence similarity often suggests an evolutionary link. 
Numerous approaches and techniques exist within whole genome studies of 
relatedness, including investigation of core and pan genomes, core genome 
alignment and maximum likelihood trees, comparative genome searching and 
alignment such as BLAST (Basic Local Alignment Search Tool; Altschul et al, 1990) 
and BRIG (BLAST Ring Image Generator; Alikhan et al, 2011), and analysis of single 
nucleotide polymorphisms (SNPs). 
The core, accessory, and pan genome of a species are effectively the essential, non-
essential, and total portions of the genome content of a bacterial species (Tettelin 
et al, 2005).  The core genome is the shared genomic content, including essential 
and conserved genes, whilst the accessory genome is the additional content present 
in some or individual isolates, and the pan genome is the term for the total content 
of both core and accessory genome (Tettelin et al, 2005).  These elements can also 
be studied at higher levels such as genera, or across smaller defined groups.   
Whole genome phylogeny can be inferred from global alignment of sequences.  
Sequence alignment determines the evolutionary relationship of sequences based 
upon homology (Dewey & Pachter, 2006).  From multiple whole genome sequence 
alignments, phylogenetic trees can be produced as a visualisation of evolutionary 
relationships.  Phylogenetic trees show the evolutionary relationships of individuals; 
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the divergence of the closest common relative, rather than the overall similarity of 
the sequences (Rokas, 2011). 
Comparative searching and alignment methods can be used to specifically 
investigate whether a particular gene or sequence region is found in other genome 
sequences.  BLAST (Basic Local Alignment Search Tool, Altschul et al, 1990) 
searching can be carried out using the web-based repository of published 
sequences, or using a local database created with specific sequences of interest, 
and produces a score of similarity for query sequence against a database; allowing 
specific inferences on sequence homology.  Various methods exist for visualising 
these comparisons, such as ACT (Artemis Comparison Tool, Carver et al, 2005; 
Carver et al, 2012) which uses Artemis sequence viewer (Rutherford et al, 2000) to 
provide visual results of ‘A vs B’ BLAST comparisons for pairs of sequences, and 
BRIG (BLAST Ring Image Generator, Alikhan et al, 2011) which produces circular 
diagrams of BLAST results for multiple query sequences against a reference 
sequence. 
The detection of Single Nucleotide Polymorphisms (SNPs) is a useful tool for 
identifying variation in sequences.  This method compares two sequences and 
identifies single nucleotide variations between a reference sequence and the query 
sequence.  This approach can be used to consider evolution or variation in specific 
genes, or can provide an approximation of relatedness between isolates; a higher 
number of SNPs suggesting more divergence.  SMALT (Ponstigl, 2010 – currently not 
published as a journal article, program and manual available 
at https://www.sanger.ac.uk/resources/software/smalt/) maps query sequencing 
reads against a reference sequence; the output of which can subsequently be 
assessed for the presence of SNPs using SAMtools (Li et al, 2009). 
The species concept is problematic in bacteriology, and the degree of similarity 
within accepted species boundaries varies significantly depending on the levels of 
diversity and recombination observed in different bacterial species and genera 
(Hanage, Fraser & Spratt, 2005).  In a study of species phylogeny using the sequence 
of MLST alleles in Neisseria, Hanage, Fraser & Spratt (2005), it was observed that in 
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such a highly recombinogenic species, there can exist ‘fuzzy’ species boundaries, 
wherein intermediary isolates may be located in between two existing accepted 
species.  Further to this, in 2012, Corander et al demonstrated that the ‘fuzzy 
species’ within Neisseria demonstrate elevated rates of recombination between 
species. 
Comparative genomics is the use of whole genome sequencing to study differences 
between isolates, between species, and larger scales.  It can inform on adaptation, 
virulence and phenotype (Wren, 2000). 
3.1.2 Campylobacter Phylogeny 
Comparative genomic hybridisation has been utilised to investigate population 
structure in Campylobacter, and can provide data which is informative of what is 
present or absent in an experimental strain in relation to the clusters on the 
microarray slide.  The microarray for comparative hybridisation may be based upon 
the genome of a single isolate, or a ‘pan-genome’ array with sequence data from a 
representative group of isolates, and may be used for determining genomic 
content, or for investigation gene expression (transcriptomics) (Luo, Lin & Xu, in Xu 
(Ed), 2010).   
Champion et al (2005) used DNA microarray analysis based upon the genome 
sequence of C. jejuni NCTC11168 to demonstrate that C. jejuni forms two distinct 
clades, associated with livestock and non-livestock sources.  Within this study 
Champion et al (2005) also observed a set of genes which were associated with 
isolates from the livestock clade, including a cluster of genes associated with the 
flagellin glycosylation locus. 
In 2009, Lefébure & Stanhope created a phylogenetic tree based upon the core 
genome alignment of seventeen Campylobacter sequences; ten C. jejuni genomes, 
plus one each representing C. coli, C. concisus, C. curvus, C. fetus, C. hominis, C. lari 
and C. upsaliensis.  It was observed that the genome based phylogeny distinctly 
separared the two major groups of Campylobacter; the thermo-tolerant and non-
thermotolerant clades.  Within the thermo-tolerant group, C. lari was shown to be 
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the most ancestral genome, with C. coli and C. jejuni the most recently evolved 
species.  Figure 3.1 shows the maximum likelihood tree produced by Lefébure & 
Stanhope (2009) for illustration of the relationships of Campylobacter as 
determined by their investigation. 
 
Figure 3.2, overleaf, was produced using MUGSY (Angiuoli & Salzberg, 2010), RAxML 
(Rokas, 2011), and FigTree (Rambaut, 2007) based upon concatenated MLST 
sequence data taken from the PubMLST database (Jolley & Maiden, 
2010; http://pubmlst.org/campylobacter/) and reveals that various ST403CC C. 
Figure 3.1: Maximum likelihood Campylobacter Phylogenetic Species Tree.  Taken from 
Lefébure & Stanhope (2009).   
The phylogenetic tree produced by Lefébure & Stanhope (2009) shows clear separation 
between thermotolerant and non-thermotolerant isolates.  Branch labels indicate 
percentage of gene tree support (below branches) and number of genes determined to be 
under positive selection (above) as determined in the original study. 
This tree was produced based upon an alignment of the core genome after discarding 
recombinant genes with homogeneous phylogenetic signal.  The resulting 511 genes 
created the tree above through nonparametric bootstrapping to give maximum likelihood 
tree shown above.  
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jejuni isolates group together within this basis of comparison and are distinct from 
other Clonal Complexes; this is similar for most other included MLST Clonal 
Compexes (including ST42CC and ST354CC), whereas other Clonal Complex isolates 
group together with isolates from other Clonal Complexes (such as the ST21 and 
ST206 Clonal Complexes).  Other Clonal Complexes, notably the host generalist 
ST61CC displayed visibily distinct groupings based upon concatenated MLST 
sequence data. 
ST403CC 
ST42CC 
ST45CC 
ST177CC 
ST1332CC 
ST48CC 
ST61CC 
ST1034CC 
ST354CC 
ST257CC 
ST353CC 
ST574CC 
ST206CC 
ST21CC 
ST283CC 
ST362CC 
STntCC*   
*Clonal Complex not determined 
 
Figure 3.2: MLST Phylogenetic Tree for C. jejuni Isolates 
Phylogeny tree based upon sequence alignment of ninety C. jejuni isolates concatenated MLST 
sequences. 
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Species boundaries in eukaryotes are often clearly defined and demonstrated, 
however the distinguishing of species in the study of bacteria is a considerably more 
controversial area, particularly with the recent developments in 16S rRNA and 
whole genome sequencing approaches (Lan & Reeves, 2000; Sheppard et al, 2008).  
The issue of the bacterial species concept and flow has been particularly relevant in 
modern studies of thermo-tolerant Campylobacter.  In 2008, Sheppard et al 
reported that C. jejuni and C. coli, due to a ‘recent’ change in gene flow are 
converging progressively and ‘despeciating’; already they share 86.5% nucleotide 
similarity, a proportion similar to that between E. coli and Salmonella; which are 
closely related species sharing a large common gene pool, but with the 
maintenance of distinct species boundaries, and are thought to have diverged 
around 120 million years ago (Gordienko, Kazanov & Gelfand, 2013).   
In contrast, Caro-Quintero et al (2009) reanalysed the same MLST data used by 
Sheppard et al (2008) and concluded that although recombination is indeed 
occurring between species, it was not at a rate to suggest species convergence, and 
asserted that a clear boundary was maintained between C. jejuni and C. coli.  In fact, 
Caro-Quintero et al (2009) finish that the convergence of any two bacterial species 
has yet to be proven.  In addition, Lefébure et al (2010) sequenced 42 C. coli and 43 
C. jejuni isolates using Illumina GAII and concluded that the pan genomes of these 
species are finite, and that the two species have similar pan genome sizes, although 
the core genome of C. coli is larger than the core genome of C. jejuni.  Lefébure et al 
(2010) also observed that each species had a set of species specific core genes, and 
they concluded that C. coli and C. jejuni were ‘sympatric’ – they share the same 
hosts and environments but do not ‘interbreed’.  Lefébure et al (2010) consider this 
evidence of species specific genes and low observed levels of horizontal gene 
transfer to directly contradict the conclusions drawn by Sheppard et al (2008); they 
suggest that the two cannot be converging (‘despeciating’) due to the maintenance 
of these boundaries.  Both Caro-Quintero et al (2009) and Lefébure et al (2010) 
propose that the study by Sheppard et al (2008) was limited by the use of MLST, 
focusing on only seven house-keeping genes.  However more recent work by 
Sheppard et al (2011) expanded upon the original study using a ‘word searching’ 
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method and whole genome sequences and confirmed the results originally 
presented by Sheppard et al (2008). 
3.1.3 Phylogenetics & Host Adaptation 
MLST does not provide explicit information on the grander characteristics of an 
isolate, however considerable evidence has shown that certain STs or ST complexes 
can be associated with specific hosts or host types.  Research which has used MLST 
to study the origin of isolates and population structure includes McCarthy et al 
(2007) and Sheppard et al (2009): in each case these used concatenated sequence 
from the seven MLST alleles as an ‘ST genotype’ for analysis.  McCarthy et al (2007) 
included isolates from cattle (n=245), sheep (n=159) and chicken (n=309), and using 
STRUCTURE – a clustering method for inference of population structure (Pritchard, 
Stephens & Donnelly, 2000) – were able to predict the source of isolates.  McCarthy 
et al (2007) found that predictions made using STRUCTURE based upon the ‘MLST 
genotype’ were able to predict isolates as being chicken or bovid more accurately 
than using just MLST or MLSTCC profile data.  The method also showed some 
success at distinguishing between sheep and cow isolates, but with less accuracy.  
Sheppard et al (2009) analysed a large dataset (n=9093) using both STRUCTURE and 
an asymmetric island model using the concatenated sequence of the MLST alleles, 
and demonstrated that the majority of clinical isolates for both C. jejuni and C. coli 
were attributed by both methods to chicken origins, with lower numbers associated 
with ruminants, and fewer isolates for other sources such as wild bird, 
‘environment’, swine and turkey. 
Existing literature has shown that some sequence types or complexes can be 
associated with specific hosts, or host types, including the pig association previously 
observed for the ST403CC C. jejuni isolates (Manning et al, 2003).  For example, in 
addition to attributing sources of human clinical isolates, Sheppard et al (2009) also 
observed that strains isolated from farmed poultry and ruminants were 
substantially different; and even greater variation was found between farmed 
chickens and wild birds at the same site.  Also observed were associations between 
ST61 with cattle, and ST257 with chickens. 
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3.1.4 Aims  
It was previously observed that the isolates selected for this research (six ST403CC 
C. jejuni isolates) were closely related through MLST, sharing four or more identical 
alleles with the clonal complex sequence type ST403.  This chapter aimed to 
investigate how closely related the six ST403CC C. jejuni isolates are, based upon 
whole genome sequence rather than solely upon the seven MLST genes.  This 
chapter also investigated how the ST403CC C. jejuni isolates fit within other C. jejuni 
and C. coli isolates. 
Whole genome alignment has become a critical tool in understanding diversity and 
evolution in bacteria (Angiuoli & Salzberg, 2010) and this project utilised this 
modern approach to improve understanding of evolution and population diversity 
in Campylobacter. 
The specific aims of this chapter were as follows: 
- To produce high quality genomic DNA for sequencing for six ST403CC C. 
jejuni isolates, and four C. coli isolates. 
- To acquire genome sequence data for the ten isolates, courtesy of the 
University of Exeter. 
- To utilise in silico MLST methods to confirm MLST results for the six ST403CC 
C. jejuni isolates, and to determine MLST for the four C. coli isolates. 
- To determine the phylogeny of the ST403CC C. jejuni isolates amongst a 
range of reference C. jejuni and C. coli sequences. 
3.2 Methods 
In order to address the phylogeny of the ST403CC C. jejuni isolates, quality draft 
genomes were required. 
3.2.1 Obtaining Genomic DNA 
The initial step in the process was to produce genomic DNA for sequencing.  
Genomic DNA was extracted using a traditional phenol-chloroform extraction 
process.   
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Bacteria were recovered from frozen stocks (-80°C storage in Mueller-Hinton broth 
(Oxoid (Thermo Scientific) Item CM0405) containing 20% v/v glycerol (Fisher 
Scientific Item G/0600/17)) on MCCDA plates (Oxoid (Thermo Scientific) Item 
CM0739) for 48 hours at 37°C, with an appropriate gas environment produced using 
CampyGen sachets (Fisher Scientific Item CN025A; developing a gas mixture of 
5%O2, 10%CO2 and 85% N2)  in gas jars.  Bacterial growth was then swabbed from 
plates and suspended into 1ml sterile PBS, mixed thoroughly to break down any 
clumps and create a homogenised suspension.   
Bacterial cells were then harvested by centrifugation at 4000xg for ten minutes, and 
resuspended into a lysis solution (2ml TE buffer (Tris-EDTA buffer; Sigma-Aldrich 
Item 93283) with 150µl of 10% SDS (Sodium Dodecyl Sulphate; Sigma-Aldrich Item 
L3771) and 150µl of 20mg/ml proteinase K (Sigma Aldrich Item P6556) and mixed 
thoroughly by inversion and then incubated for sixty minutes at 65°C.  The resulting 
lysate solution was subsequently separated through a series of centrifugation steps.  
To the lysate solution was added 2ml of phenol-chloroform-isoamyl alcohol 
(25:24:1; Sigma-Aldrich Item P2069) and the solution was mixed carefully by 
inversion five times before being transferred to a Phase-Lock tube (5Prime Phase-
Lock Gel Light 15ml tubes, SLS Item 2302840) and centrifuged for ten minutes at 
1500xg.  The upper layer of supernatant was then carefully removed and 
transferred into 2ml of phenol-chloroform-isoamyl alcohol, mixed by inversion 
three times, then transferred to a new phase-lock tube and again centrifuged for 
ten minutes at 1500xg.  The previous step was repeated a second time so that the 
suspension had competed three Phase-Lock separation steps, after which the upper 
layer of the supernatant was again carefully removed, and then transferred into a 
fresh tube containing 3ml of room temperature 100% ethanol, and precipitated by 
gentle inversion.  The DNA was then removed using a sterile hook and swirled in ice 
cold 70% ethanol before being left to dry for up to thirty minutes and subsequently 
dissolved without vigorous mixing in sterile nuclease free water (Ambion Item 
AM9938: an initial volume of 200µl of water was added, however where necessary 
this was increased up to a maximum of 500µl in order to fully dissolve the DNA). 
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Quality and concentration were checked using a microvolume spectrophotometer 
(NanoDrop 2000) with samples accepted if they had a 260/280 of 1.8 and 260/230 
of 2.0-2.2.  Genomic DNA samples were assessed for fragmentation using gel 
electrophoresis: a 0.5% agarose gel was produced (TAE buffer (Tris-Acetate-EDTA; 
Fisher Scientific Item ELR-328-010v)) with 0.5% w/v agarose (Fisher Scientific Item 
BPE1356) with 1% SybrSafe (Life Technologies Item S33102) added prior to pouring.  
3µl of sample was mixed with 2µl of loading dye (Biolabs blue loading dye Item 
B70215) and loaded into wells.  The gel was run for 25 minutes at 95v, using 5µl of 
Norgen HighRanger Plus 100bp ladder (EurolabSupplier Item NO-12015-5), 
subsequently visualised at 200ms exposure. 
If the sample passed quality checks it was subsequently diluted as required to a 
concentration of approximately 10µg in 100µl and stored at -20°C before being 
submitted for sequencing. 
3.2.2 Sequencing Genomic DNA – Performed by The University of Exeter 
Once suitable genomic DNA was prepared, sequencing was kindly carried out at The 
University of Exeter, using an Illumina HiSeq 2000 machine, creating 36bp paired-
end reads, which provided high quality short-reads of sequence, in FastQ format.  
Briefly, the stages of Illumina sequencing are as follows; firstly, a DNA library is 
prepared – DNA is fragmented into small pieces and the sheared ends are repaired 
and adenylated before adapter oligos are joined to each end of the fragments.  
Once the fragment library is complete, clusters are generated – the DNA fragments 
are applied to a flow cell which holds a lawn of oligonucleotide primers which bind 
to the adaptors on the fragments.  Enzyme and nucleotides are then added to begin 
‘bridge amplification’, leading to both ends of the fragment being attached to the 
flow cell, and double stranded.  The double stranded fragments are then denatured 
to leave large numbers of single stranded templates available for binding; 
amplification leads to the formation of dense clusters of dsDNA.  Base-by-base 
sequencing then takes place using fluorescently labelled reversibly terminated 
nucleotides which bind competitively (to provide higher accuracy than ‘one-at-a-
time’ nucleotide exposure).  Laser excitation is used to identify which base is added 
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(once again aiding the accuracy of the sequence data, as the cyclic nature of the 
sequencing reduced the likelihood of homopolymeric tracts confounding the 
results); this process results in large numbers of accurately sequenced short-reads. 
Once sequence data was complete, the information was provided by the University 
of Exeter, for subsequent assembly and analysis to be carried out by the author. 
3.2.3 Assembly of Genomic Sequences 
Upon receipt of the raw genomic sequence data, genomes were assembled to 
provide draft quality genome sequences for subsequent analysis.  Both forward and 
reverse raw FastQ files were trimmed to 16 million lines, if necessary, before being 
‘shuffled’ to provide a consensus sequence for assembly using VELVET (Zerbino & 
Birney, 2008), with the settings; 31kmer, exp_cov 75 cov_cutoff 8 which were 
adjusted where necessary (exp_cov 35, 50; cov_cutoff 4, 5, 6) in order to provide 
average contig lengths of tens of thousands of basepairs.  Subsequently the genome 
sequence was improved using ABACAS (Assefa et al, 2009) and IMAGE (Tsai, Otto & 
Berriman, 2010) using C. jejuni RM1221 and C. coli RM2228 as reference isolates for 
each species. 
3.2.4 Confirming MLST in silico 
The newly acquired sequence data were used to confirm the MLST findings for the 
ST403CC C. jejuni isolates described by Manning et al (2003), and to establish the 
MLSTs of the four C. coli isolates.  Sequence Types were determined in silico for the 
ten sequenced strains, using the PubMLST Campylobacter database (available 
via http://pubmlst.org/campylobacter/), and using Short Read Sequence Typing 
(SRST, Inouye et al, 2012).  The PubMLST database inferred the sequence type and 
clonal complex of each sequence, achieved by uploading the FastA sequence file for 
each genome to the sequence query page.  The pubMLST query was used to query 
the MLST database, producing output describing the allele version of each loci, 
including length and position, as well as informing the resulting Sequence Type and 
Clonal Complex.  SRST was used as an additional confirmation method.  SRST is a 
software tool built to assess MLST from short-read sequencing data (Inouye et al, 
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2012).  There were two processes required in SRST analysis; firstly a database was 
created using all known alleles for each locus (as available from PubMLST, 
downloaded March 2013).   
A locally stored database of MLST alleles was created in Ubuntu Linux, using the 
definitions from the pubMLST database (Jolley & Maiden, 
2010: http://pubmlst.org/campylobacter/) and created using BLAST (Altschul et al, 
1990; Madden, 2002; Camacho et al, 2008). 
The database was then subsequently queried using nucleotide BLAST (Altschul et al, 
1990; Madden, 2002; Camacho et al, 2008) for matches for each isolate using the 
raw FastQ sequence files, producing output files describing matching alleles and 
resulting Sequence Types and Clonal Complexes.  SRST also requires model flanking 
regions for each allele, which were provided from C. jejuni 81116. 
3.2.5 Core Genome Alignment & Phylogenetic Trees 
Phylogenetic analysis is the inference of evolutionary relationships, the output of 
which is typically displayed as a phylogenetic tree.  Phylogenetic trees portray the 
evolutionary relationships between genetic sequences, in contrast to determining 
sequence similarity (Rokas, 2011).  Phylogenetic trees may be rooted or unrooted: 
rooted phylogenetic trees include a root at the earliest common ancestor, 
displaying the direction of evolution; whereas unrooted trees demonstrate distance 
between sequences but not the direction of evolutionary progress (Rokas, 2011). 
Phylogenetic trees were created using 33 Campylobacter genomes, including the 
newly sequenced six porcine C. jejuni and four porcine C. coli, and a variety of 
publicly available genomes (Table 3.1).  FastA file sequences were aligned using 
MUGSY (Angiuoli & Salzberg, 2010) to rapidly produce multiple genome alignments 
without the need for a reference genome.  MUGSY is a tool which incorporates four 
steps and utilises some pre-existing programs within a simple user friendly process, 
combining: Nucmer pairwise alignment (Kurtz et al, 2004); construction of 
alignment graphs and subsequent refinement (Rausch et al, 2008; Doring et al, 
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2008); detection of local colinear blocks (LCBs) and calculation of alignment for LCBs 
(SeqAn::TCoffee, Rausch et al, 2008), within a single wrapper script. 
Following completion of MUGSY alignment, the resulting output file was then post-
processed to convert the multiple alignment file (.maf) into a single concatenated 
FastA (.fa) file, which was stripped of non-alphabetic characters (‘-‘; ‘.’ Schloss et al, 
2009), before being converted to an appropriate file type - phylip (.phy) - for tree 
generation using Randomised Accelerated Maximum Likelihood software (RAxML, 
Rokas, 2011). 
RAxML produces a ‘most likely’ phylogeny by encompassing different search 
strategies in turn; first by building a starting tree by iteratively selecting random 
sequences from the query set and determining location.  This random selection 
means that the outcome can be different between repeats on the same sample, 
therefore the option (-x) in the software was used to dictate the start point for each 
analysis to minimise the effect of the random selection between trees of the same 
sequences (-x 12345). 
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Strain ID 
Species 
Country of 
Isolation 
Host 
Date of 
Isolation 
Sequence 
Type 
Sequence 
Type Complex 
1336 C. jejuni jejuni - Water - 841* ~ 
414 C. jejuni jejuni UK Water Vole 2000 3704 ~ 
81-176 C. jejuni jejuni USA Milk 1981 604* 42* 
S3 C. jejuni jejuni UK Sheep 1999 632 42 
IA3902 C. jejuni jejuni USA Sheep 2006 8 21 
269.97 C. jejuni doylei South Africa Human 1997 1845 ~ 
ICDCCJ07001 C. jejuni jejuni China Human 2007 2993 362 
81116 C. jejuni jejuni UK Human 1981 267 283 
M1 C. jejuni jejuni UK Human 1999 137 45 
11168 C. jejuni jejuni UK Human 1977 43 21 
01/10 C. jejuni jejuni UK Human - 104* 21* 
01/51 C. jejuni jejuni UK Human - 19* 21* 
RM1221 C. jejuni jejuni USA Chicken 1997 354 354 
857 C. jejuni jejuni UK Pig 2000 270 403 
549.1 C. jejuni jejuni UK Pig 1999 403 403 
623 C. jejuni jejuni UK Pig 1999 552 403 
304 C. jejuni jejuni UK Pig 1999 551 403 
484 C. jejuni jejuni UK Pig 1999 435 403 
444 C. jejuni jejuni UK Pig 1999 553 403 
RM2228 C. coli USA Chicken 1998 1063 828 
JV20 C. coli - Human - 860* 828* 
111-3 C. coli USA Pig 2001 1467* 828* 
132-6 C. coli USA Pig 2001 3861* ~ 
151-9 C. coli USA Pig 2001 1102* ~ 
59-2 C. coli USA Pig 2000 890* 828* 
67-8 C. coli USA Pig 2000 1061* 828* 
7—1 C. coli USA Pig 2001 3860* ~ 
84-2 C. coli USA Pig 2000 113* 828* 
90-3 C. coli USA Pig 2001 3862* ~ 
99/321 C. coli Denmark Pig 1999 1153* 828* 
03/121 C. coli UK Pig 2003 887* 828* 
03/103 C. coli UK Pig 2003 2732* 828* 
03/317 C. coli UK Pig 2003 1145* 828* 
 
 
 
 
Additionally, during RAxML, the trees are subjected to ‘Lazy Subtree 
Rearrangement’ (LSR), whereby subtrees are removed and reinserted at every 
possible point on the tree to find the most likely correct position; LSR is applied to 
the original starting tree and to each best tree determined, until no better tree can 
 
Table 3.1: Isolates included in Phylogenetic Analysis 
Details of isolates whose genome sequences were used for phylogenetic analysis. 
*determined in silico in lieu of formal MLST data. 
- data not available or unclear. 
~ Sequence type either not able to be assigned to a current MLST complex, or may represent a 
novel clonal complex. 
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be determined.  RAxML was run through 100 bootstrap repetitions, with a defined 
random seed, using the GTRGAMMA model for determining rate of nucleotide 
heterogeneity.  Following the RAxML process, best trees were subsequently 
visualised and edited for presentation using FigTree software (Rambaut, 
2007: http://tree.bio.ed.ac.uk/software/figtree/). 
 
3.2.6 BLAST Ring Image Generator (BRIG) 
In order to visualise regions which were consistent across the C. jejuni ST403CC 
isolates, or additional in the ST403CC isolates compared to reference C. jejuni the 
BLAST Ring Image Generator (BRIG; Alikhan et al, 2011) was used.  BRIG uses BLAST 
searches and CGView (Stothard & Wishart, 2005) to produce images demonstrating 
similarity between a reference sequence and query sequences as a series of 
concentric rings.  BRIG was used to create a series of images; comparing the pig C. 
jejuni against each other, against the pig C. coli and against human and chicken C. 
jejuni; comparing pig C. coli against each other, against the pig C. jejuni, and against 
human and chicken C. coli. 
BRIG was run using the Graphical User Interface (GUI), using the default BLAST 
settings in each case, the first two rings (working from the centre outwards) 
represent the G:C content and G:C Skew, respectively.  Each subsequent ring 
represents the genome of an isolate, as indicated by the colour coded legend 
included in the output image.  In each output image, three gradients of colour may 
be seen per ring; the darkest shade represents 100% similarity with the lighter 
shade indicating the highest cut off value, and the lightest shade the lower cut-off 
value, whilst white space indicates highly disparate or missing regions. Cut-off 
values used were 90% and 70% for same species comparisons, and 70% and 50% for 
across species comparisons. 
3.2.7 Single Nucleotide Polymorphisms (SNPs) 
An additional method used to investigate the relatedness of the ST403CC C. jejuni 
isolates to each other, and to other C. jejuni isolates was a measure of Single 
Nucelotide Polymorphisms (SNPs) using SMALT (Ponstigl, 
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2010; https://www.sanger.ac.uk/resources/software/smalt/) and SAMtools (Li et al, 
2009).  SMALT (Ponsitgl, 2009) produces alignments of a query sequence (paired 
fastQ) against a reference sequence (fastA) by producing a hash table for the 
reference sequence and subsequently mapping the query reads against it.   
SMALT was run in Linux using using a word length (-k) of 17, and a sampling step 
size (-s; the distance between successive words) of 2 so that every second word was 
hashed (the default –s is the same as the –k).  A higher value for –s reduces the 
memory demand on the machine; given the power of the machine and size of 
genome the –s was reduced to 2 for greater detail. 
SamTools (Li et al, 2009) was used to assess SNP variation between the reference 
and query sequence based upon the mapping produced using SMALT.  SamTools 
was run in Linux. 
3.3 Results 
The relatedness of a group of potentially host-adapted C. jejuni isolates was 
investigated by a range of genome sequence based means.  The isolates were 
previously demonstrated to represent different STs within an MLST Clonal Complex 
(Manning et al, 2003), and were earlier shown to be potentially human pathogenic 
strains (Chapter 2).  Genomic DNA was prepared, and subsequently sequenced at 
The University of Exeter, and sequence data was considered in a variety of manners.  
3.3.1 Genomic DNA Extraction 
Genomic DNA was extracted from each isolate to provide DNA of suitable quality 
and concentration for sequencing.  Quality control was carried out quantifiably 
using spectrophotometry, and qualitatively by running through an agarose gel.  
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Figure 3.3 shows the resulting samples which were subsequently submitted for 
sequencing.  Each of these samples were within acceptable ranges for quality and 
diluted to a suitable concentration of approximately 10µg or more per 100µl of 
buffer.  The bands shown in Figure 3.3 illustrate varying strengths of solution, but all 
were within acceptable boundaries.  Additionally some shearing can be seen in 
some lanes (particularly lane 9, C. jejuni 304), however due to the high 
concentration and otherwise good quality these were deemed acceptable for 
submission.  The faint bands visible at the bottom of the gel are RNA left over from 
the extraction process.  This could have been prevented by RNAase treatment 
during the extraction process; however, its presence does not affect the subsequent 
sequencing process. 
 
  1      2      3      4      5     6      7      8      9     10   11   12 
Figure 3.3: Genomic DNA Extracts 
The above agarose gel image shows DNA extracts submitted for sequencing. 
It was produced using a 0.5% agarose gel with Norgen HighRanger Plus 100bp 
ladder, ran for 25 minutes at 95v, and visualised at 200ms exposure.   
Lane 1 Norgen HighRanger Plus 100bp ladder  
Lane 2 C. coli 03/103 
Lane 3 C. coli 03/317 
Lane 4 C. jejuni 549.1 
Lane 5 C. jejuni 857 
Lane 6 C. jejuni 444 
Lane 7 C. coli 03/121 
Lane 8 C. jejuni 484 
Lane 9 C. jejuni 304 
Lane 10 C. coli 99/321 
Lane 11 C. jejuni 623 
Lane 12 Norgen HighRanger Plus 100bp ladder  
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3.3.2 MLST 
MultiLocus Sequence Types were recorded, where available, from the pubMLST 
database, and were also observed for each newly sequenced isolate using whole 
genome sequence based techniques.  Sequence types were determined using SRST 
(Inouye et al, 2012) from the raw FastQ sequence data, and also using the pubMLST 
database, based upon the assembled FastA sequences. 
As shown in Table 3.2, some discrepancies were observed between the original 
MLST done for the ST403CC C. jejuni isolates, and the subsequent in silico results, 
however agreement was consistent for all isolates across the two in silico methods.  
Of the six C. jejuni ST403CC isolates, four (857, 549.1, 623, 484) were consistent 
across all three methods, while C. jejuni 304 varied at four loci between the original 
MLST results and the two in silico measures, and 444 had one discrepancy between 
the MLST result and in silico methods.  Figure 3.4 shows visual representation of the 
nucleotide variation between the predicted alleles. 
As described in Table 3.2, the MLST profile of C. jejuni 304 differed at four loci 
between the previously carried out MLST (Manning et al, 2003), and the newly 
observed in silico techniques.  The four divergent loci were glnA, gltA, glyA and tkt.  
The allele determined for glnA by MLST (allele 27) differed from the allele 
determined by genome sequence based methods (allele 54) by a single base 
variation, an A-G substitution at position 139.  The differing alleles for gltA (25 and 
59) vary by two A-G substitutions at positions 12 and 348.  More variation existed 
between the divergent alleles for glyA (alleles 19 and 4), with a total of 8 
differences spread across the length of the locus, whilst the fourth allele variation, 
tkt, was a single base change at position 28, a substitution between T (allele 22) and 
C (allele 5).  As a result of these differences, C. jejuni 304 was designated as 
Sequence Type 2676 by in silico methods, as opposed to ST551 as was initially 
described; however, both of these STs remain within the ST403 Clonal Complex. 
The second isolate with variation in observed MLST results was C. jejuni 444, which 
differed only at one loci; tkt, and showed the same discrepancy as C. jejuni 304 at 
this locus – a single base change at location 28 (T-C substitution) leading to 
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designation as allele 5 instead of allele 22 as described by MLST.  This single 
nucleotide difference for C. jejuni 444 means that it would be a novel ST, rather 
than part of ST553, although once again it would remain part of the ST403CC.   
Strain Method aspA glnA gltA glyA pgm tkt uncA ST ST-Complex 
857 
MLST 10 27 43 19 6 18 7 270 403 
in silico 10 27 43 19 6 18 7 270 403 
SRST 10 27 43 19 6 18 7 270 403 
549.1 
MLST 10 27 16 19 10 5 7 403 403 
in silico 10 27 16 19 10 5 7 403 403 
SRST 10 27 16 19 10 5 7 403 403 
623 
MLST 10 27 59 4 10 5 7 552 403 
in silico 10 27 59 4 10 5 7 552 403 
SRST 10 27 59 4 10 5 7 552 403 
304 
MLST 10 27 25 4 10 22 7 551 403 
in silico 10 54 59 19 10 5 7 2676 403 
SRST 10 54 59 19 10 5 7 2676 403 
484 
MLST 10 27 43 19 10 5 7 435 403 
in silico 10 27 43 19 10 5 7 435 403 
SRST 10 27 43 19 10 5 7 435 403 
444 
MLST 10 27 16 4 6 22 7 553 403 
in silico 10 27 16 4 6 5 7 ND** 403 
SRST 10 27 16 4 6 5 7 6601*** 403 
99/321 
MLST ~ ~ ~ ~ ~ ~ ~ ~ ~ 
in silico 33 39 30 82 118 35 17 1153 828 
SRST 33 39 30 82 118 35 17 1153 828 
03/121 
MLST ~ ~ ~ ~ ~ ~ ~ ~ ~ 
in silico 33 38 30 82 104 85 68 887 828 
SRST 33 38 30 82 104 85 68 887 828 
03/317 
MLST ~ ~ ~ ~ ~ ~ ~ ~ ~ 
in silico 33 39 30 82 104 44 17 1145 828 
SRST 33 39 30 82 104 44 17 1145 828 
03/103 
MLST ~ ~ ~ ~ ~ ~ ~ ~ ~ 
in silico 53 38 30 82 104 43 36 5345 828 
SRST 53 38 30 82 104 43 36 5345 828 
 
 
 
 
Figure 3.4 shows the relevant segments of alignments where discrepancies occurred 
between Sequence Typing methods. MLST results for the four C. coli isolates were 
entirely consistent between the web-based PubMLST and the SRST (Inouye et al, 
Table 3.2: MLST Results for Newly Sequenced C. jejuni & C. coli Isolates 
Results for MLST by traditional MLST sequencing, in silico determination using pubMLST and 
using the SRST software. 
~ Test not completed. 
 Discrepancy observed between MLST and in silico methods. 
**ND - Sequence type not defined by test method. 
*** Novel sequence type by test method. 
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2012) attribution methods.  Each of the four isolates was attributed to a different, 
pre-existing Sequence Type, however all four were within the ST828 Clonal 
Complex.  Additionally, all four C. coli isolates shared the same alleles at gltA (30) 
and glyA (82). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.3 Core Genome Alignment & Phylogenetic Trees 
Figure 3.5 shows the resulting output from the MUGSY (Angiuoli & Salzberg, 2010) 
and RAxML (Rokas, 2011) pipeline, following visualisation using FigTree (Rambaut, 
2007) and after additional annotation, for the thirty three included genomes.  Each 
Figure 3.4: Alignments for Discrepant MLST Alleles 
In each image, the top row represents the allele determined by the original MLST, and the bottom 
row represents the discrepant allele observed by in silico methods. 
a) glnA top line allele 27, bottom line allele 54.  A-G substitution at position 139. 
b) gltA top row allele 25, bottom row allele 59.  A-G substitutions at positions 12 and 348. 
c) glyA top row allele four, bottom row allele 19.  Eight substitutions in total; T-C at position 114, 
A-G position 120; A-G position 129; C-T at position 136; T-A at position 138; in second image, A-G 
substitution at position 202; third image shows the T-C substitution at position 309; fourth image 
shows the G-C substitution at position 390. 
d) tkt top row allele 22, bottom row allele five.  One T-C substitution at position 28. 
c 
d 
b 
a 
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genome was labelled at the end of the branch, and colour coded according to 
source.  The scale bar segment visible in Figure 3.5 illustrates the length of branch 
representing an amount of genetic change of 0.04; the units of this measure of 
genetic change are the number of nucleotide changers per site (number of 
substitutions ÷ length of sequence). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The phylogeny tree (Figure 3.5) shows a clear species divide between C. jejuni and 
C. coli isolates.  The phylogeny of C. coli isolates, although limited by the small range 
of dates (1998-2003), countries (Denmark, UK, USA) and sources (human, chicken, 
pig), did not appear to be affected by these factors, with observed grouping not 
reflecting country or date of isolation, or source.  A possible exception to this was 
observed in that the closest relative to the chicken isolate RM2228 was the human 
microbiome project isolate JV20 (AEER01000000), however, the nearest ancestor to 
these two isolates was 99/321, the Danish porcine isolate.   
Figure 3.5: Phylogenetic Tree for C. jejuni & C. coli Isolates 
Phylogeny tree based upon core genome alignment of thirty-three C. coli and C. jejuni whole 
genome sequences. 
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The phylogeny of C. jejuni isolates did not show a clear association of source, date 
or location, with the exception of the ST403CC C. jejuni isolates, which were shown 
to be closely related to each other, and formed a distinct cluster within C. jejuni 
phylogeny.  The same techniques were used to produce a second phylogeny tree, 
using just the C. jejuni genomes in order to provide a clearer image of the 
relatedness of the nineteen C. jejuni isolates (Figure 3.6).  The most distant isolate 
was C. jejuni 414, the bank vole niche specialist, followed by C. jejuni doylei 269.97 
and the wild bird isolate 1336.  The ST403CC C. jejuni isolates were closely grouped 
together within the phylogeny tree.  C. jejuni 857 was revealed to be the most 
ancestral of the sequenced ST403CC isolates, with the remainder branching off from 
it, the most distant of which being 484 and 549.1.  The ST403CC C. jejuni isolates 
were seen to represent a distinct clonal group within the C. jejuni genomes.  Also 
included in Figure 3.6 is MLST information for the C. jejuni isolates (as previously 
described in Table 3.1), Clonal Complex was used where one has been described, 
for those which have not been assigned a clonal complex, the ST was used.  In 
general, the location and date of isolation did not affect phylogeny, with distant 
isolates such as 81176 (USA, 1981) and ICDCCJ07001 (China, 2007) being closely 
related.  Clonal Complex however did concur with whole genome phylogeny, as 
evidenced both by the grouping together of the ST403CC porcine isolates, and also 
by the grouping of ST21CC isolates, over a range of dates, and being from both UK 
and USA and from both human and sheep isolates. 
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3.3.4 BLAST Ring Image Generator (BRIG) 
BRIG (Alikhan et al, 2011) was used to provide a first look at the variation between 
the ST403CC C. jejuni isolates and specific reference isolates, and across the 
ST403CC isolates.  As described above, BRIG produces circular diagrams illustrating 
BLAST search matches between a reference sequence and query sequences, 
indicating similarity and discrepancy between the reference and each query 
sequence. 
BRIG was used to show the similarities between reference genome C. jejuni 81116, 
a well-studied historical human isolate, and the ST403CC C. jejuni isolates (Figure 
3.7).  Several regions were observed at which all six of the ST403CC C. jejuni isolates 
were highly divergent from the genome of C. jejuni 81116, including some 
particularly large regions around 50kb, 270-290kb, 650kb, 1080-110kb, 1250-
1270kb, 1340-1370kb, 1470kb, 1505kb and 1600kb approximately.  Interestingly, 
around 990-1010kb some regions of discrepancy were observed between C. jejuni 
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Figure 3.6: Phylogenetic Tree for C. jejuni Isolates 
Maximum likelihood tree based upon core genome alignment for nineteen C. jejuni isolates. 
MLST Clonal Complex was labelled alongside the isolate name and host legend 
* Sequencce Type labelled as Clonal Complex not confirmed. 
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81116 and only some of the ST403CC isolates, particularly one clear region which 
was discrepant in 857, 623 and 444.  However, other than this region, the highly 
divergent regions between C. jejuni 81116 and the ST403CC isolates were consistent 
across the group – little evidence was revealed by this method of individual 
ST403CC isolates differing from the reference genome where the remaining 
ST403CC isolates did not. 
 
 
 
 
 
 
 
 
 
106 
 
  
Figure 3.7: BRIG Output for C. jejuni 81116 as Reference Genome against ST403CC C. jejuni 
Isolates 
Image created with BLAST Ring Image Generator using the human C. jejuni isolate 81116 as 
a backbone for comparison against 6 pig C. jejuni sequences (inside to out 857, 549.1, 623, 
304, 484, 444).  Solid colour indicates 100% similarity, with the fainter colours indicating 
90% and 70% identity; areas which are colourless suggest zero similarity. 
Highly divergent regions between the six ST403CC isolates and the reference genome 81116 
were observed at several  points, including a substantial region around 50kb, smaller 
regions around 160kb and 240kb, several segments around 270-90kb, another region 
around 470kb, and others around 520kb, 535kb, 635kb and 650kb.  There were several 
small regions around 720kb, 750kb, 770kb, 800kb, 815kb, 885kb and 920kb.  Some 
inconsistent regions of variation were present at around 990-1010kb.  Another larger region 
of discrepancy was observed around 1080-1100kb and another at 1250-1270kb, followed by 
a smaller region around 1280kb and another larger region around 1340-1370kb.  Two more 
small regions of discrepancy were observed around 1440kb, followed by a group around 
1470-1480kb and a larger solid region of discrepancy around 1505kb and some small 
regions around 1550kb and 1580kb.  Another large region was observed around 1600kb, 
and some final small regions of variation were observed around 1620kb. 
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A similar comparison was also carried out with another well-known isolate; C. jejuni 
11168 (another historical human isolate from the UK), as shown in Figure 3.8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: BRIG Output for C. jejuni 11168 as Reference Genome against ST403CC C. jejuni 
Isolates 
Image created with BLAST Ring Image Generator using the human C. jejuni isolate 11168 as 
a backbone for comparison against 6 pig C. jejuni sequences (inside to out 857, 549.1, 623, 
304, 484, 444).  Solid colour indicates 100% similarity, with the fainter colours indicating 
90% and 70% identity; areas which are colourless suggest zero similarity. 
Highly divergent regions between the six ST403CC isolates and the reference genome 81116 
were observed at several  points, including around 10kb, 60kb, 80kb, 125kb, 140kb, 150kb, a 
larger region around 170-180kb, 240kb, 260kb, 380kb.  Another larger region of discrepancy 
was observed between 440-460kb, with other regions around 520kb, 530kb, 590kb, 620kb, 
630kb, and a group around 690-710kb.  Smaller regions were observed around 740kb, 
760kb, 810kb, 900kb, followed by a region around 970-990kb, another small divergent area 
around 1055kb, and another larger region between 1070-1080kb.  A region of small 
divergent segments was observed around 1220-1280kb, followed by another large region 
around 1350-1380, a large region around 1480-1500kb, small region around 1560kb and 
two large regions around 1580-1605kb and 1630-1640kb. 
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Once again, several regions were observed where all six ST403CC isolates were 
noticeably and consistently divergent from the reference genome C. jejuni 11168, 
including large regions at approximately 170-180kb, 440-460kb, 1070-1080kb and 
1480-1500kb.  There also remained little evidence of individual ST403CC isolates 
being highly divergent from the reference genome, with the exception of a region in 
C. jejuni 444 around 1520kb which was highly conserved amongst the other isolates. 
In addition, each of the ST403CC C. jejuni isolates were used for reference 
comparison against the other ST403CC isolates, as shown in Figure 3.9.  This 
overview demonstrated that, despite the close phylogenetic relationship of the 
ST403CC C. jejuni isolates, evidence of strain-strain variation existed across the 
genomes, although large amounts of 90-100% identity were also observed.  Few 
instances were observed where five of the six strains differed significantly from the 
reference genome; when C. jejuni 623 was used as the reference genome two 
examples were observed.  At approximately 1420kb, 623 shared high similarity with 
857 but showed high divergence in 304, 484, 444 and 549.1, whilst at approximately 
1680kb, high similarity existed between 623 and 444, with high divergence in the 
other ST403CC isolates.  Other instances of this were observed when C. jejuni 304 
was used as the reference genome, including at approximately 340kb where high 
similarity was shared with 549.1 and high divergence from the others, and 1450kb 
where the region was conserved in 857, and distinct in the other isolates.  
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Figure 3.9: BRIG Outputs Comparing ST403CC C. jejuni Isolates 
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3.3.5 Single Nucleotide Polymorphisms 
SMALT (Ponstigl, 2010) and SAMtools (Li et al, 2009) were used to assess the 
number of SNPs between isolates.  SNP analysis gave an overview of the total 
number of single nucleotide changes between two isolates, as a measure of 
variation between isolates. 
Reference Strain Query Strain No. of SNPs 
C. jejuni 81116 C. jejuni 484 1110 
C. jejuni 857 C. jejuni 484 372 
C. jejuni 549.1 C. jejuni 484 256 
C. jejuni 623 C. jejuni 484 2831* 
C. jejuni 304 C. jejuni 484 662 
C. jejuni 444 C. jejuni 484 413 
C. jejuni 81116 C. jejuni 623 9846 
C. jejuni 857 C. jejuni 623 2341 
C. jejuni 549.1 C. jejuni 623 2736 
C. jejuni 304 C. jejuni 623 2651 
C. jejuni 484 C. jejuni 623 2831 
C. jejuni 444 C. jejuni 623 1734 
C. jejuni 81116 C. jejuni 857 1166 
C. jejuni 81116 C. jejuni 01/51 1459 
C. jejuni 81116 C. coli 03/317 52080 
C. coli 99/321 C. coli 03/317 2374 
C. coli 03/121 C. coli 03/317 1791 
C. coli 03/103 C. coli 03/317 3745 
 
SNPs were determined from C. jejuni 81116 for the closest relative amongst the 
ST403CC C. jejuni isolates (857), one of the most distant (484) and one from the 
middle branch (623), as well as for a C. coli isolate (03/317), and a hyper invasive C. 
jejuni isolate (01/51).  The number of SNPs observed between the low invasive, 
human isolate C. jejuni 81116 and ST403CC C. jejuni 857 (1166) was comparable to 
Table 3.3: SNP Results 
The table shows the number of single nucleotide polymorphisms 
calculated between the reference genome and query genome in 
each case. *623ref484 is approximate – it is taken from the result 
for 484ref623.  As part of the investigation I looked at differences 
caused by switching reference and query, and found that for 857 vs 
484 the variation was 26 calls (372 vs 398) so although it is likely the 
actual number is different, it is unlikely to vary by more than 
approximately 7-10% so the number still provides a useful indicator 
of disparity between strains. 
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the number of SNPs between 81116 and the hyper invasive isolate 01/51 (1459), as 
well as being consistent with the number between 81116 and the more distant 
ST403CC isolate 484 (1110), however a much higher SNP difference was observed 
between 81116 and 623.  The number of SNPs between reference C. jejuni genome 
81116 and a representative C. coli sequence was also calculated for comparison, 
and, expectedly was much larger even than was observed for C. jejuni 623.  SNPs 
across porcine C. coli isolates were also assessed and were observed at a similar 
level to those between C. jejuni 623 and the other ST403CC isolates. 
SNP comparisons were also completed against the raw FastQ sequence of both the 
distant isolate 484 and the intermediary isolate 623 for each of the ST403CC 
isolates.  C. jejuni 623 was considerably more SNPs away from the other ST403CC 
isolates, than was observed for C. jejuni 484.  Fewer SNPs exist between the closely 
related 623 and 444 than between 623 and other isolates.  SNP analysis of C. jejuni 
484 suggested that the ST403CC isolates were closely related.  It may be suggested 
that 623 (and 444) may have additional genetic content leading to this larger 
variation from the rest of the isolates.   
SNP analysis was also run comparing the 623 FastA reference file against the 623 
FastQ query sequences in order to assess the accuracy of the method – 127 SNPs 
were observed between the two, this appears to indicate inaccuracy in the data, 
however 127 bases across a genome size of 1.8mb is a relatively low error rate, and 
if factored into the other SNP results would not significantly alter the interpretation. 
3.4 Discussion 
This chapter set out to produce genomic sequence data for six potentially porcine 
host adapted ST403CC C. jejuni isolates, and to perform initial analysis of the 
evolutionary relationship of these isolates to other non-ST403CC C. jejuni and C. coli 
isolates - these aims were achieved as described above, and discussion is included 
below.  Genomic DNA extracts were produced, and were submitted for sequencing 
by the University of Exeter.  Genome sequences were produced by the University of 
Exeter and subsequently returned to the researcher for assembly and analysis.   
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Whole genome sequence based methods were used to assess the relatedness of 
ST403CC C. jejuni isolates to each other, and to other C. jejuni and C. coli isolates.  
The ST403CC C. jejuni isolates had previously been shown to be related by MLST 
(Manning et al, 2003), and were previously demonstrated (Chapter Two) to be 
capable of potentially causing disease in humans.  Phylogenetic studies 
demonstrated that the ST403CC C. jejuni isolates were closely related at the whole 
genome level, as well as based solely upon the seven MLST genes, and indicated 
some regions where ST403CC C. jejuni isolates were uniformly different from 
human C. jejuni isolates.  Phylogenetic investigations also determined that variation 
was observed between the ST403CC isolates, between individual strains and 
potential ‘sub-groups’ within the ST403CC isolates. 
3.4.1 Sequencing & Assembly 
The sequencing approach used produces high quality short-read sequences, which 
are accurate but rely upon being ‘put together’ correctly.  The assembly process 
used in this project was implemented to provide genomes which were assembled, 
arranged and adjusted to reduce gaps, although base error checking was not carried 
out, the sequences were completed to a greater degree than much of what is 
publicly available, as it is common to publish raw short-read sequences; whereas 
these sequences have been assembled and been treated to improve quality of 
sequence data.   
3.4.2 MLST 
MLST was carried out using two in silico methods using whole genome sequence 
data.  This served as a ‘second opinion’ for the ST403CC C. jejuni isolates, to confirm 
that they had be correctly identified and ensure inferences were accurate; and also 
as an ‘indicator’ method for the newly sequenced C. coli isolates which had not 
previously been studied by traditional MLST.   
The results observed for the ST403CC C. jejuni isolates were consistent across the 
two sequence based methods, however they were in disagreement with the original 
typing data in some instances, as described previously.  C. jejuni 304 had differing 
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alleles between the original MLST and the sequenced based methods at four loci, 
which were attributed to a total of twelve substitutions, whilst C. jejuni 444 was 
different by just one nucleotide in one loci.   
Considering the discrepant alleles – 444 was determined to be a novel ST by the in 
silico methods, whereas C. jejuni 304 would be altered from ST551 to ST2676.  A 
search for ST2676 on the PubMLST database (29/07/14) gave only one match for 
this ST – a UK (Aberdeen) cattle isolate (C. jejuni 611) from 2006, submitted by Sam 
Sheppard. 
As the C. coli isolates had not previously been typed by traditional MLST, the typing 
done in silico is the only data available for them; however, given the high degree of 
agreement between the in silico methods and traditional MLST data for the C. jejuni 
isolates this may be presumed to be representative.  Additionally, the accuracy of 
these methods has been cited (Inouye et al, 2012) so a degree of confidence can be 
placed in these results.  Each of the C. coli isolates was placed within a currently 
described Sequence Type, with at least one entry in PubMLST.  C. coli 99/321 was 
determined as ST1153 – currently (29/07/14) there are four entries for ST1153 on 
PubMLST, all representing pig isolates; three from the USA in 2003 and one from 
Germany in 2007: two of which were included in the paper on generalist lineages by 
Gripp et al (2011), and another from Miller et al (2006) in which it was associated 
with swine in both recorded ST1153 isolates.  C. coli 03/121 was identified as being 
part of ST887, for which there were ten recorded isolates in the PubMLST database; 
one associated with chicken meat or offal (UK, no date), one associated with human 
stool sample from gastroenteritis (UK, 2007), one recoded simply as ‘other animal’ 
(UK) and seven from pigs (three UK, 2004; one USA no date; three Germany (one in 
2007 and two in 2008)).  C. coli 03/317 was found to be in ST1145, which had eight 
isolates on PubMLST: two USA pig isolates (no date), a pig isolate from The 
Netherlands (2004), four UK human gastroenteritis stool sample isolates (one 2004 
and three from 2011) and a ‘human unspecified’ isolate (Switzerland, 2009).  Lastly, 
C. coli 03/103 was identified as an ST5345 isolate, a ST which had only one recorded 
isolate on PubMLST, a UK isolate lacking other information.  All four of the C. coli 
isolates were deemed to be part of the ST828 Clonal Complex.  This is unsurprising 
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as the ST828CC is known to be one of the most prevalent clonal complexes within C. 
coli, constituting a large part of the ‘clade one’ livestock and human isolates as 
described by Sheppard et al (2010). 
As described by Inouye et al (2012), the main previous alternative to acquiring MLST 
data from whole genome sequences was web-based (Larsen et al, 2012), requiring 
sequences to be uploaded and relying upon a database which is updated once 
monthly from the PubMLST databases, whereas with SRST the user builds their own 
databases prior to use and so can be updated when required and as fresh as 
possible when being used.  Comparing the results of using the PubMLST website to 
assess the MLST of a genome with that of SRST, both methods were equally 
successful, however SRST does not require completion of assembled genomes prior 
to analysis so it can provide this information much more quickly and with the same 
degree of accuracy, however once the genome is completed it is easier to use the 
browser based PubMLST service. 
It was confirmed that the ST403CC porcine isolates were closely related by MLST, 
although some discrepancies in typing were observed.  MLSTs were also 
determined for the newly sequenced C. coli isolates. 
3.4.3 Phylogenetic Trees of Relatedness 
Trees visualising the phylogeny of C. jejuni and C. coli isolates were produced based 
upon whole genome sequence alignment.  Genome sequence data for thirty three 
isolates (nineteen C. jejuni and fourteen C. coli) were included and an alignment 
was produced based upon the shared information between the isolates, and 
variation within it – core genome alignment.  This was interpreted as a tree by 
predicting the distance of each genome from the other isolates.   
As described above, phylogenetic grouping did not seem to be largely affected by 
country or date of isolation, and although some grouping by host type was 
observed, this was not clear cut – some, but not all, human isolates grouped 
together, and often grouped with or near to isolates from other sources such as 
sheep or chicken.  MLST Clonal Complex was reflected by whole genome phylogeny 
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in the cases of ST403CC and ST21CC, however the two ST42CC isolates were not 
closely related.   
Miller et al (2006) investigated host associated alleles in C. coli from food animals, 
including 488 isolates from cattle, chickens, pigs and turkeys from USA locations 
over a six year period.  Miller et al (2006) revealed host associated MLST alleles and 
ST profiles in C. coli, and also identified ‘common’ MLST alleles at each locus which 
were found across all four sources.  Considering the C. coli isolates newly sequenced 
in this work, three had ‘common aspA allele 33’, however 03/103 has the swine 
associated aspA53 allele.  Two of the isolates had common allele glnA39, whilst two 
had swine associated glnA38 (strains 03/121 and 03/103 had glnA38, of which 95% 
of examples were observed in swine by Miller et al (2006)).  All four strains had gltA 
30, a ‘common’ allele, and all four also had common allele glyA 82.  For pgm three 
of the four isolates had allele 104, a ‘common’ allele, one (99/321) had swine 
associated allele 118 (97% in swine, one instance (3%) of it in chicken).  Regarding 
tkt, 99/321 had the swine associated allele tkt35 (94% swine, 1% cattle, 5% 
chicken); 03/103 had the ‘common’ allele tkt43; 03/317 had swine associated allele 
tkt44 (93% swine, 4% chicken, 4% turkey); and the 03/121 allele tkt85 showed a 
‘mild’ swine association (72% swine, 22% chicken, 6% cattle). Finally for uncA; two 
isolates shared the uncA17 ‘common allele’; uncA36 swine associated allele in 
03/103 (96% swine, 3% chicken, 1% turkey); and uncA68 swine associated allele was 
found in 03/121 (95% swine, 3% cattle, 3% chicken).  Miller et al (2006) state that 
some host-associated alleles have been found in C. jejuni however these are much 
less common than in C. coli and typically associated with avian hosts; examples 
include gltA22, glyA48, pgm17, uncA23, each of which are absent from the six 
ST403CC swine isolates. 
Sheppard et al (2010) showed that the effect of host association over-rides 
geographic association in Campylobacter, based upon MLST ‘genotypes’.  Gripp et al 
(2011) ST21 C. jejuni isolates were demonstrated to have phage related genes and 
high levels of recombination, and therefore high levels of genomic diversity (based 
upon whole genome sequence analysis), however for this ST no features were 
identified which linked with host type (in terms of genetic information or chicken 
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colonisation) and Gripp et al (2011) therefore concluded that ST21 is characterised 
by diversity and flexibility allowing a generalist lifestyle, as opposed to the 
specialism seen in other species and in other STs/isolates of C. jejuni. 
A strong link between MLST and host association has been described (Sheppard et 
al, 2010) although some STs do not show this pattern and rather exhibit a generalist 
genotype (Gripp et al, 2011).  The work here appears to support the findings of 
Sheppard et al (2010) at the whole genome level; although some isolates do group 
with isolates from different sources, certainly geographical and temporal 
associations seem less important.  The results from whole genome phylogeny also 
concur with the conclusions of Gripp et al (2011); the ST21 isolates were 
demonstrated to be closely related at the whole genome level, despite host source. 
3.4.4 Variation Indicated by BRIG 
BRIG is a simple comparison tool used for quick overviews and to give indication of 
differences and similarities between one reference strain and one or more query 
isolates.  In this project BRIG was used as an early stage test to visualise the 
variation between well characterised C. jejuni isolates and the newly sequenced 
ST403CC C. jejuni isolates, and to check for homology within the ST403CC C. jejuni 
group. 
 
Region (approx. kb) Predicted content 
40-50 putative membrane proteins, hypothetical proteins 
270-290 transferases 
650 hypothetical proteins, putative phage repressor protein C8J_0649 
1080-1100 LOS genes including waaC and waaF 
1250-1270 LOS/LPS genes including neuA and neuB, flagella genes flaA and flaB 
1340-1379 Capsule region (kpsS, kpsF, kpsD, kpsE, kpsT, kpsM) 
1470 R/M modification subunit rloB 
1505 Putative transporter proteins 
1600 Ribosomal proteins 
Table 3.4: Contents of Variable Regions Identified by BRIG 
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As described above, comparisons between the ST403CC C. jejuni isolates revealed 
large degrees of highly conserved sequence, but also demonstrated that 
considerable strain-strain variation was present between the closely related 
isolates.  This fits with the literature as C. jejuni isolates are known to be highly 
variable even when closely related.  At this stage conclusions could not yet be 
drawn about the content of the variable regions between the isolates due to the 
lack of annotation of genes present; this will be addressed in later chapters.  It is 
likely that at least some of this variation, as for the two reference isolates, may be 
linked to known variable regions such as the capsule and LOS regions, however 
there remains a possibility that these regions may be shared by ST403CC C. jejuni 
isolates. 
BRIG images demonstrated that ST403CC C. jejuni isolates share highly similar 
sequence with reference C. jejuni isolates but also display considerable and in some 
cases consistent variation.  Some of these regions of variation appear to be linked to 
known variable regions, whilst others are not well understood from this method of 
analysis.  Likewise ST403CC c. jejuni isolates demonstrate high similarity with each 
other based upon BRIG investigation, however variation between isolates was also 
observed, the content of which are considered later. 
3.4.5 SNPs 
SNP analysis revealed an overview of the extent of variation between C. jejuni and 
C. coli sequences.  Larger numbers of SNPs were observed between the ST403CC 
623 genome and the other ST403CC C. jejuni isolates, than across the rest of the 
ST403CC group.  This may indicate that C. jejuni 623 has undergone considerable 
horizontal genetic transfer not present in the other ST403CC isolates.   
Determination of SNPs has proved useful in rapid determination of common clonal 
complexes in C. jejuni and C. coli.  In 2004, Best et al, determined three SNPS in two 
MLST alleles which were common across the ST21 Clonal Complex, and were able to 
use PCR amplification, hybridisation to reference probe, and analysis of the 
subsequent melting point temperature to rapidly determine whether isolates 
formed part of the ST21CC.  Best et al (2007) further expanded this to provide a 
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scheme which could rapidly identify isolates directly from faecal samples as being 
part of the six most common Clonal Complexes (ST21CC, ST45CC, ST48CC, ST61CC, 
ST206CC, ST257CC) as accurately as by carrying out full MultiLocus Sequence Typing 
in a fraction of the time.  However, this SNP based method was of course limited in 
that it could only ascribe an isolate to one of these six Clonal Complexes, without 
determining the actual Sequence Type of the isolate, or recognising novel STs. 
SNP comparisons are a useful tool for reducing the large volumes of data of full 
genome sequences into a smaller, informative dataset (Méric et al, 2014), 
determining the number of SNPs between two sequences of interest, or in closer 
detail to illustrate the location of SNPs in coding sequence.  SNP analysis may be of 
less value in Campylobacter due to the high sequence variability in these genomes, 
being at risk not only of identifying SNPs caused by sequencing error rather than 
true SNPs, but also with the risk of being skewed by high volumes of closely packed 
SNPs caused by divergent regions acquired by HGT in the reference sequence which 
are absent or highly divergent in the query sequence.  Another issue caused by the 
reference based nature of SNP comparison is that it is unable to identify additional 
genetic content in the query sequence.  The method for determining the presence 
of SNPs used here assessed the number of SNPs across the whole length of 
reference and query genome, so values are affected by additional/lost accessory 
genome content.  An alternative method would have been to use the core genome 
alignment to analyse SNPs however the method used required raw FastQ sequence 
rather than multiple alignment sequence data, additionally although this would 
have allowed consideration of the SNPs present in the shared portion of the 
genomes, it would not provide as true an indication of the variance between the 
isolates.  SNP analysis suggested that considerable variation, potentially due to 
horizontal gene transfer, may exist between the ST403CC C. jejuni isolates.  At this 
stage it cannot be predicted what this sequence variation may be, however the 
content of the genomes will be considered in later chapters, following the 
annotation of the ST403CC C. jejuni genome sequences in Chapter Four.   
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3.4.6 Summary & Conclusions 
ST403CC C. jejuni isolates were demonstrated to be closely related not only by 
MLST, but also at the whole genome level.  Regions of variation were identified 
where ST403CC C. jejuni isolates varied from well-studied human C. jejuni isolates, 
and variation was also observed across the ST403CC C. jejuni group.  It was shown 
that the ST403CC C. jejuni isolates represented a distinct group within C. jejuni but 
are not a ‘fuzzy’ intermediary group between C. jejuni and C. coli species.  Fuzzy 
species have been shown to exist, particularly in Neisseria (Hanage, Fraser & Spratt, 
2005; Corander et al, 2012) however evidence of this phenomenon was not 
observed for the ST403CC C. jejuni isolates, which do not appear to represent an 
intermediary group with increased recombination with both C. jejuni and C. coli.   
The results observed in this chapter further supported the idea that these ST403CC 
C. jejuni isolates may be an adapted group of isolates based upon whole genome 
phylogeny, and suggested that they may be lacking or highly variant in some regions 
compared to other C. jejuni genomes.  This chapter also provided genome 
sequences which will be utilised throughout the rest of the thesis.  Having 
confirmed initial sequence based tests, the next chapter considers the annotation of 
the genomes and more thorough investigation of the genome content and 
variation. 
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Chapter Four: Genome Annotation & Investigating Genome Content of  
ST403 Clonal Complex C. jejuni Isolates 
4.1 Introduction 
 Six ST403CC C. jejuni isolates were identified as potentially host adapted isolates 
(Manning et al, 2003), and have been demonstrated to be closely related at the 
whole genome level (Chapter Three), and exhibit pathogenic potential in vivo 
(Chapter Two).  Initial genome comparison investigation indicated that certain 
regions observed in the ST403CC C. jejuni isolates were consistently different from 
other, well studied, C. jejuni genomes.  It was observed that some of these regions 
may represent known variable regions including LOS and capsule, however it was 
not feasible to draw detailed conclusions on the content of these regions, the 
likelihood that the same divergent event was conserved across the group, or the 
possible implications this variance may have on the isolates.   
The aim of the current chapter therefore was to follow on from the phylogenetic 
studies of Chapter Three, via the completion of annotation of the ST403CC C. jejuni 
isolate genomes, and subsequent analysis of these in comparison to reference 
genomes.  A number of specific goals are approached in this chapter: annotation of 
newly sequenced ST403CC C. jejuni isolates; to ascertain the core and pan genome 
of the ST403CC C. jejuni isolates within the context of a library of included genome 
sequences; to consider the presence and potential function of specific genes of 
interest which may be related to the regions of variation identified previously 
(Chapter Three), or which may be revealed by pan genome analysis and inform on 
potential adaptation in ST403CC C. jejuni isolates. 
4.1.1 Genome Annotation 
Acquisition of genome sequence allows for useful comparisons of relatedness in 
isolates, as demonstrated in Chapter Three.  However in order to better understand 
the genotype of an isolate, the identification and annotation of coding regions is an 
important step.  In the early days of bacterial genome sequencing, producing 
complete sequences was costly and time consuming enough that manual 
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annotation of genomes, or manual curation of automated annotations was 
practical, however with the boom of next generation sequencing techniques this is 
not typically fast enough to match the production of new sequences (Richardson & 
Watson, 2012).  The caveat with fully automated annotation however is that it can 
lead to the propagation of problematic annotations which are inaccurate or lacking 
consistency (Richardson & Watson, 2012).  An additional issue with this is 
transferring annotation from one sequence to a newly sequenced relative, leading 
to the omission or poor annotation of additional genomic content in newly 
sequenced isolates (Richardson & Watson, 2012). 
Annotation transfer can be a useful tool in rapidly applying annotation to newly 
sequenced genomes, although it relies on the quality of the reference genome 
annotation, and can overlook additional genome content (Otto et al, 2011; 
Richardson & Watson, 2012).  Otto et al (2011) developed a tool (RATT; Rapid 
Annotation Transfer Tool) to rapidly annotate new genome sequences based upon a 
reference genome, at a level which is more accurate than existing automated 
annotation processes.  
The quality of a transferred annotation relies on the quality of the reference 
annotation being utilised (Otto et al, 2011; Richardson & Watson, 2012).  Various 
methods exist to create annotated genomes, including approaches such as PROKKA 
(Prokaryotic Annotation tool) (Seemann, 2014) which combines numerous existing 
processes to produce rapid, reliable annotation of bacterial genome sequences. 
4.1.2 Sequence Similarity 
Assessing the similarity to pre-existing sequences often provides the first step in 
studying new nucleotide or amino acid sequence (Madden, 2013).  Traditionally, the 
major method for determining sequence similarity was DNA-DNA hybridisation – 
comparing two genomes using direct hybridisation (Luo, Lin & Xu, in Xu (Ed), 2010).  
The advance of genome sequencing provided a key opportunity to develop 
computer-based multiple genome similarity comparisons.  Similarity searches are 
highly valuable in investigating nucleotide or protein sequences, indicating function 
and relatedness of the sequence, based upon the ‘first fact’ of biomolecular 
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sequence analysis as described by Gusfield (Gusfield, 1997, in Mushegian, 2007); 
the concept that a high degree of similarity between sequences implies substantial 
structural or functional similarity, and additionally the idea that sequence similarity 
often also indicates an evolutionary relationship, however it is also important to 
remember that this link does not work in reverse; proteins may share functional or 
structural similarity despite having dissimilar sequence and being evolutionarily 
distinct (Gusfield, 1997 in Mushegian, 2007; Madden, 2013).    
BLAST (Basic Local Alignment Search Tool) was first introduced by Altschul et al in 
1990 and further improved by Altschul et al (1997), whilst BLAST+ effectively 
superseded previous versions in 2009 (Camacho et al, 2009) and is currently the 
predominant method in determining sequence similarity (Madden, 2013).  BLAST 
uses heuristic searching (also referred to as informed searching) as opposed to an 
uninformed search strategy; uninformed searches simply differentiate between 
states, whereas a heuristic search strategy is provided with additional information 
in order to predict which state is more ‘favourable’ (Russell & Norvig, 2013); this 
strategy is faster and more computationally efficient as it can discard lower scoring 
results part way through a search if a better scoring match has already been 
determined.  Heuristic searching is commonly used in biological sequence analysis 
as it is not generally computationally possible to use other, potentially more 
accurate methods such as the dynamic programming algorithm, which produces a 
highly accurate alignment of two sequences but is highly demanding (Altschul et al, 
1990).  BLAST uses informed searching with well-defined mutation scores which 
allow a faster and less computationally demanding calculation of results which are 
highly similar to those that would be produced via dynamic programming 
algorithms (Altschul et al, 1990).  BLAST combines this informed search strategy 
with a calculated ‘E value’ predicting the likely accuracy of the result determined by 
approximating how many matches would occur at the given score by chance.  
Additionally, BLAST executes ‘local’ alignments which, rather than requiring the 
alignment of the whole sequence (global alignment), is suited to finding 
conserved/functional domains within proteins/CDS.  As a result, BLAST identifies 
small regions (‘words’) with high similarity and then ‘extends’ along the sequence to 
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identify the boundaries of the region of homology (Altschul et al, 1990).  In contrast, 
global searching attempts to align the entire lengths of the sequences (Madden, 
2013).  BLAST therefore is uniquely able to identify conserved regions and domains 
or motifs compared to global search methods. 
 As described by Madden (2013) there now exist numerous versions of BLAST, each 
based upon the same principle but optimised for different sequence types or for 
speed in sequences known to be closely related.  The BLAST versions include 
nucleotide query against nucleotide database (blastn, megablast), protein query 
against protein database (blastp, DELTA-BLAST, PSI-BLAST, PHI-BLAST), translated 
nucleotide query against protein database (blastx), protein query against translated 
nucleotide database (tblastn) or translated nucleotide query against translated 
nucleotide database (tblastx).  As well as the various types of BLAST query there are 
numerous ways to utilise BLAST, primarily based upon either using the web-based 
tool using the online databases at NCBI, or using stand-alone BLAST on an individual 
machine, which can either utilise the NCBI databases or create custom locally stored 
datasets. 
This chapter utilises BLAST based similarity searching to confirm previous 
phenotyping results (Chapter Two; Manning et al, 2003), to inform of the presence 
or absence of specific genes associated with virulence, and to investigate any coding 
sequences of interest revealed through pan genome content analysis. 
4.1.3 Hippurate Hydrolysis 
As described previously (Chapter One; Chapter Two), hippurate hydrolysis was 
commonly used as a discriminatory test to distinguish C. jejuni from the other 
thermo-tolerant Campylobacter species (Nicholson & Patton, 1995).  Differentiation 
was based upon the expectation that C. jejuni isolates would be positive for 
hippurate hydrolysis, whilst C. coli and C. lari would be negative for hippurate 
hydrolysis.  However, it has more recently been established that some C. jejuni 
strains are phenotypically hippurate negative, although the HipO gene is retained, 
as determined by PCR (Amri et al, 2007; Caner et al, 2008). 
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Previous work (Stephen On, cited by Manning et al, 2003) demonstrated that the 
ST403CC C. jejuni isolates used in this research were phenotypically negative for 
hippurate hydrolysis.  In this chapter it will be investigated whether this negative 
result is associated with a lack of the HipO gene, as is observed in C. coli, or confirm 
the presence of the HipO gene despite the negative phenotype, as described 
elsewhere (Amri et al, 2007; Caner et al, 2008). 
4.1.4 Surface Polysaccharides & Capsule in C. jejuni 
It was initially thought that C. jejuni produced only LOS (lipooligosaccharide); LPS 
(lipopolysaccharide) lacking O-antigen repeats and with low molecular weight 
(Logan & Trust, 1984).  However, it was later found that around one-third of C. 
jejuni reference strains for serotyping were also able to produce O-antigen; a high 
molecular weight LPS molecule (Preston & Penner, 1987).  Following on from this, 
as a consequence of the genome sequencing of NCTC11168 (Parkhill et al, 2000) it 
was discovered that C. jejuni possessed a number of genes with homology to 
capsule polysaccharide biosynthesis proteins in other bacteria, despite the fact that 
capsule had never been detected in laboratory culture or study of C. jejuni.  This led 
to the conclusion that the previously assumed O-antigen polysaccharide was in fact 
capsular polysaccharide (Karlyshev et al, 2000).  Following this discovery, Bacon et 
al (2001) demonstrated the role of capsule in virulence of C. jejuni 81-176 by 
revealing that, when compared to wild type, a kpsM mutant, rendered unable to 
produce the high molecular weight glycan, was significantly impaired in both 
adherence and invasion in vitro using INT407 cells and was also impaired in the 
animal model (ferret).   The mutant was also rendered untypeable using HS23 and 
HS36 antisera - effectively confirming Karlyshev et al’s conclusions (2000).  In 2001, 
Karlyshev, McCrossan & Wren were able to visualise capsule in an isolate associated 
with Guillain-Barré syndrome (C. jejuni G1), and for a gastroenteritis associated 
isolate (C. jejuni X) but were not able to demonstrate capsule production in the 
sequenced gastroenteritis isolate C. jejuni 11168, despite the presence of the 
appropriate gene cluster.  Capsule is thought to be potentially synthesised by the 
majority of C. jejuni isolates (Karlyshev, McCrossan & Wren, 2001) and has a role in 
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evading the host immune response, and has been demonstrated to be specifically 
involved with serum resistance (Keo et al, 2011). 
BLAST similarity searching will be used in this chapter to confirm the presence of 
capsule biosynthesis genes.  As the ST403CC C. jejuni isolates represent a potentially 
pig adapted group it is of interest to determine whether they have the potential 
ability to produce capsule, given its role in surviving the human host response; it has 
been demonstrated that these isolates have the potential to internalise into human 
colonic cells and therefore cause disease, however if they are lacking means to 
survive within the host this colonisation may be unlikely to occur. 
4.1.5 Virulence Associated Genes in Campylobacter jejuni 
Numerous virulence associated genes have been identified in C. jejuni, some of 
which show evidence of source bias (Datta, Niwa & Itoh, 2003).  The most well 
recognised virulence genes in C. jejuni are cadF, cdtA, cdtB, cdtC, ciaB, dnaJ, flaA, 
iamB, pldA, racR, virB11 and wlaN, each playing a variety of roles.  These include 
genes associated with adherence and colonisation: flaA involved in motility and 
colonisation (Nuijten et al, 2000), cadF and dnaJ mutations in which have been 
shown to have a significant effect on colonising ability (dnaJ is involved in response 
to environmental stress encountered within the host, whilst cadF is suspected to 
have a role in binding to host cells (Ziprin et al, 2001) and racR which is involved in 
temperature response during chicken colonisation (Brás et al, 1999).  Genes 
associated with invasion ability; ciaB and pldA mutants are poor invaders (Konkel et 
al, 1999; Ziprin et al, 2001) and virB11 has been shown to confer an advantage in 
invasion in vitro and in pathogenicity in the ferret model (Bacon et al, 2000).  The 
genes required to produce cytolethal distending toxin; cdtA,B and C (Purdy et al, 
2000), and finally a gene which has been linked to GBS - wlaN (Linton et al, 2000). 
The presence of these virulence associated genes in the ST403CC C. jejuni isolates 
will be assessed in order to relate to the literature, with particular reference to host 
association as described by Datta, Niwa & Itoh (2003). 
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4.1.6 Defining the Core & Pan Genome 
Typically, in Eukaryote genomics, the genome of a single individual provides the 
substantial majority of the genetic information for its species (Lan & Reeves, 2000).  
In Prokaryotes, and particularly in bacteria however, the situation is tremendously 
different.  Bacteria undergo constant, considerable, intraspecies genomic exchange 
and modification (Lan & Reeves, 2000), ranging from the acquisition or loss of 
plasmids and/or lysogenic phages and the presence or absence of gene groups such 
as pathogenicity islands (PAIs), to variation in possession of single genes 
(particularly those associated with metabolism) and to smaller changes including 
variation of gene coding sequence, or in copy number, all the way down to single 
nucleotide polymorphisms (SNPs).  As such, a single isolate is unlikely to inform 
upon the genome of a species; unless perhaps in the case of a species with highly 
reduced genetic recombination such as Mycoplasma spp., which represents a 
substantially restricted genome.  Liu et al (2012) observed a core genome of just 
196 genes based upon 20 Mycoplasma genomes representing 17 different species 
from a range of highly divergent hosts.  To establish a bacterial ‘species genome’ 
would therefore typically require numerous diverse individuals to be sequenced 
before a moderately confident assessment could be drawn.  The species genome 
may also be referred to as the pan genome (Medini et al, 2005) and may be loosely 
defined in this context as ‘all genes found in a species’, or more generally as ‘the 
collection of genes which are present in all known genomes of a defined group of 
organisms’ (Lapierre & Gogarten, 2009), however even when numerous isolates 
have been sequenced for a species, it remains common for new genes to be found 
in each additional strain sequenced.  At the time of writing, Lan & Reeves (2000) 
stated that it had been demonstrated that up to 20% of one strain’s DNA might be 
missing from another individual of the same species, and mathematical predictions 
(Medini et al, 2005; Tettelin et al, 2005) suggest that further new genes will 
continue to be revealed even with up to hundreds of individual sequences for a 
species.  However, the concept of the pan genome increasing to ‘infinity’ with 
additional new genes identified with each additional sequenced isolate is likely a 
weakness of the mathematical prediction model, as suggested by Snipen, Almøy & 
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Ussery (2009), although it remains unrealistic to expect that the pan genome of a 
species can be fully ascribed.  The concept of characterising a bacterial species’ full 
genome content is therefore rather like chasing the edge of an ever expanding 
universe, as there will always be additional unsequenced examples of a species; 
however, each additional genome sequenced can be used to expand our knowledge 
of the species’ pan genome.   
Lan & Reeves (2000) explained that the pan genome should be considered as two 
elements: firstly, the ‘core’ set of genes found in most, or all, sequenced individuals; 
these include those that determine the characteristic properties of that species, 
including the genes essential for function & survival.  It is worth noting that this is 
not the same as the ‘minimal’ geneset defined by Hutchinson et al (1999) which 
described the minimum essential genome for laboratory growth of Mycoplasma 
genitalium.  And secondly, the ‘auxiliary genes’ (also commonly referred to as the 
accessory, or dispensable genome), those which may be present in one or a group 
of individuals and are not essential for the species (Lan & Reeves, 2000), but may, 
for example, convey an advantage to certain isolates in a given environment or host 
(Lefébure & Stanhope, 2009).   
4.1.7 Core & Pan Genome in Campylobacter 
The recent advances in sequencing and annotating multiple isolates within a species 
has created a new opportunity to study the progression of adaptation through 
assessing differences in the core genome of bacterial species and sub-species 
groups (Lefébure & Stanhope, 2009) and expanded the understanding of the pan 
genome (Lapierre & Gogarten, 2009).  In 2009 more than 18 genomes were 
available for Campylobacter, representing eight different species (Duong & Konkel), 
compared to just one in 2000 (Parkhill et al, 2000), and four C. jejuni genomes in 
2007 (Pearson et al, 2007).  Today these numbers are exponentially higher, with 
around 352 of identified individual isolates across 27 species, including 173 C. jejuni 
and 98 C. coli available publicly as nucleotide sequences, with varying levels of 
‘completeness’ (based upon a search of ncbi taxonomy 
browser: http://tinyurl.com/mcplzjd  in May 2014). 
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Various attempts to characterise the core and pan genome of C. jejuni have been 
made, with differing results: for a sample of five genomes, Snipen, Almøy & Ussery 
(2009) observed a C. jejuni core genome of 847 and pan genome of 3221 CDS; 
whilst in 2010 Friis et al estimated C. jejuni pan and core genome using the 13 
‘complete’ genomes available at the time, consisting 2427 and 1295, respectively; in 
2011 Biggs et al recorded a C. jejuni core genome of 1001 across 13 genomes; and 
in 2014, Méric et al estimated pan and core genome across two C. coli and five C. 
jejuni  of 3933 and 1035 respectively, they subsequently expanded their study to a 
total of 130 C. jejuni genomes with a core genome of 947 and pan genome of 3648 
CDS. 
Previous pan and core genome based research has obtained varying degrees of 
success in investigating host adaptation in Campylobacter.  In 2010, Lefébure et al 
were unable to ascertain a link between specific genes and host species in C. jejuni 
but did find some evidence of host type associated genes in C. coli, whereas in 2005 
Champion et al were able to identify distinct livestock and non-livestock clades of C. 
jejuni, including a cluster of livestock associated genes potentially associated with 
flagella glycosylation. 
Host adaptation typically involves the gain of additional genes which confer a 
survival advantage in the given host (Dale & Park, 2004; Bliven & Maurelli, 2012), or 
the loss or decay of genes which are no longer necessary in the new environment 
(Bliven & Maurelli, 2012).  Gene loss events are typically associated with pathogenic 
bacteria, an example being the minimalistic genome of obligate intracellular 
pathogens such as Yersinia pestis (Bliven & Maurelli, 2012).  Assessment of the pan 
genome of a group of isolates allows comparative analysis of the accessory genome 
which may reveal these markers of adaptation. 
An assessment of the pan and core genome will be produced using a total of 33 
isolates, as detailed in Chapter Three (Table 3.1; Appendix 9.1) in order to identify 
genes which may have been gained or lost in the ST403CC C. jejuni isolates as a 
result of host adaptation. 
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4.1.8 Determining the Core & Pan Genome 
The basis for determining which genes are shared across a group of genomes relies 
traditionally upon BLAST (Altschul et al, 1990) or FASTA (Lipman & Pearson, 1985; 
Pearson & Lipman, 1988) program based searching procedures, which require one-
by-one searching of each individual CDS against a database to determine its 
prevalence against a custom built database such as the collective available genomes 
for a species in order to construct banks of core or accessory genes across the 
group.  Scripts were developed to automate the input of each CDS for querying 
however this remained a limited and inefficient method which was particularly 
affected by the low number of genomes within a species which were historically 
available (Tettelin et al, 2005; Pearson, in Misener & Krawetz (Eds), 2000).  Also, in 
the earlier years of expanding genomic sequencing, the general trend in genome 
analysis tools previously had been designed with the main goal of comparing 
between species rather than within species - such as GeConT, xBASE and others, as 
reviewed by Blom et al (2009).  Therefore the modern boom in multiple isolates 
within species created a need for different analysis tools.  The primary manner in 
which the problem of within species comparisons was addressed was through the 
creation of databases, notably the Microbial Genome Database (MBGD; Uchiyama, 
2003) and the Comprehensive Microbial Resource (CMR; Davidsen et al, 2010; no 
longer active), however these each have limitations in their capabilities.  As a result, 
Blom et al (2009) introduced EDGAR (Efficient Database frameworks for 
Comparative Genome Analysis using BLAST Score Ratios), a browser based solution 
to provide both CDS orthology information, and analysis of pan, core and accessory 
genome as well as phylogenomics.   
EDGAR calculates core genome via an iterative pairwise comparison of the set of 
genomes.  A single genome must be chosen as the reference (A), with ‘any’ number 
allowed for comparison (B, C, D and so on).  Every gene in genome A which does not 
have an orthologue in genome B is removed from the data set.  The remaining set is 
then iteratively compared against genomes C, D and so on, until a remaining group 
of coding sequences is created with orthologues present in all genomes across the 
group.  EDGAR identifies orthologues using Bi-directional Best Hits (BBHs) – to 
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identify genes with conserved function – via BLAST (blastp with blosum62 similarity 
matrix). Rather than using absolute BLAST scores, EDGAR relies on BLAST Score 
Ratio Values (SRVs) – comparing BLAST bit score to maximum bit score (maximum 
score resulting from aligning the gene against itself). To discriminate orthologous 
genes from nonspecific hits, a sliding LSW – lowest scoring window – is used to 
identify the SRV with the lowest hit count within the LSW: this filters out low quality 
BLAST hits.  An SQL (Structured Query Language; a form of programming language 
for storing and interacting with relational databases) database stores the BBH 
BLAST information for the all-against-all comparison of the genomes. 
The calculation of the pan genome is similar; every gene in genome B that is not in 
genome A is added to the dataset, and this runs iteratively across the group of 
genomes producing a total database of all coding sequences present in the group. 
As with any genome comparison technique EDGAR has some potential for error, 
however it is comparable to other techniques and based upon methods which have 
been demonstrated to be amongst the most effective: the use of BBHs and BLAST 
SRVs have been demonstrated to be effective and appropriate measures (Altenhoff 
& Dessimoz 2009; Lerat, Daubin & Moran, 2003).  Due to its use of BBHs, EDGAR 
can overlook instances where a target genome has multiple copies of an 
orthologous gene - the additional copies will be identified as separate matches, and 
requires some manual curation to assess these duplicated matches and condense 
these to a single CDS match in the core or pan genome.  Additionally, the use of 
BLAST SRVs can be less effective in highly divergent genera such as Corynebacterium 
(Blom et al, 2009); however EDGAR remains a suitable method for investigation in 
organisms such as Campylobacter.  Also, a very small degree of bias (<1; Blom et al, 
2009), and the size of the resulting calculated core or pan genome, can occur 
depending on the reference genome selected; in the work conducted here the 
largest resulting outputs were used in each case. 
EDGAR was used to produce predicted core and pan genome tables for the 33 
included C. jejuni and C. coli genomes (Table 3.1; Appendix 9.1) which will be 
investigated for evidence of increased homology between the porcine ST403CC C. 
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jejuni isolates and the porcine C. coli isolates, as well as for any additional or lost C. 
jejuni associated genes in the ST403CC C. jejuni isolates. 
4.1.9 Aims 
The first goal of this chapter is to produce annotated genomes for the newly 
sequenced, potentially pig host adapted ST403CC C. jejuni isolates in order to study 
genome content.  In this chapter, local database BLAST is used to assess the 
presence of the HipO gene, virulence genes and capsule genes in the ST403CC C. 
jejuni isolates.  This chapter will also produce information on the core and pan 
genome of the group of included C. jejuni and C. coli genomes, which will be 
assessed to identify genes gained or lost in ST403CC C. jejuni isolates.  Additional 
means including BLAST similarity searching will also be applied to CDS of interest 
which may be revealed by accessory genome analysis. 
As has been briefly described here, various approaches have been taken to address 
the question of the core and pan genome of C. jejuni and to use these groups to 
inform on adaptation of isolates, however due to the nature of the question, and 
the reliance upon the genomes included in analysis different results for the size of 
the core and pan genome have been reported.  Nonetheless investigating the pan 
and core genome of species and groups within species provide a useful tool to 
potentially identify host, environmental or pathogenic associated genes.  This 
chapter attempts to utilise study of the core and pan genome in order to assess the 
genome content of the six newly sequenced ST403CC C. jejuni isolates and identify 
any genes gained or missing in this group compared to reference non-ST403CC C. 
jejuni and C. coli isolates. 
This chapter attempts to investigate evidence for potential host adaptation in C. 
jejuni ST403CC isolates.  As mentioned above, host adaptation can be characterised 
by gene gain or loss; consideration of the core and pan genome of the group of 
isolates is used to assess the presence of additional genes in ST403CC C. jejuni 
isolates, and investigate any genes which have been lost by the ST403CC isolates.  
Specifically, the major goal for this chapter was to assess evidence for loss of 
‘poultry associated’ CDS and gain of potential ‘porcine’ or ‘mammalian associated’ 
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CDS.  This chapter also sets out to consider whether the ST403CC C. jejuni isolates, 
being recovered from a host typically associated with C. coli, show any evidence for 
increased homology with C. coli isolates compared to that found in ‘typical’ C. jejuni 
isolates. 
4.2 Methods 
In order to assess the shared and variant coding genome content in ST403CC C. 
jejuni isolates compared to other C. jejuni and C. coli isolates, firstly annotated 
genomes were required and subsequently the establishment of the core and pan 
genome for included isolates was necessary. 
4.2.1 Annotation 
Genome sequences were produced as described in Chapter Three, and were 
subsequently annotated as follows.  One C. jejuni ST403CC isolate (C. jejuni 857) and 
one C. coli isolate (C. coli 03/121) were selected for primary detailed annotation.  C. 
jejuni 857 is the probable most ‘ancestral’ of the sequenced ST403CC C. jejuni 
isolates, as it is closest relative to non-ST403CC isolates by whole genome 
phylogeny (Chapter Three), whilst C. coli 03/121 was selected as it effectively sits in 
the ‘middle ground’ of the C. coli isolates, also due to the higher clonality in C. coli it 
was less of a concern to pick a ‘representative’ from the four isolates.  Annotation 
was carried out using PROKKA (Seemann, 2014) for the two selected isolates, and 
subsequently transferred to the remaining isolates using RATT (Rapid Annotation 
Transfer Tool; Otto et al, 2011), a tool which takes a query and reference genome, 
and finds all matches for CDS on the reference genome in the query genome, 
applying the annotation for each.  PROKKA annotates assembled genomes without 
relying on a single reference genome, rather it utilises a database of numerous 
reference genomes, and is therefore able to find most likely annotation for each 
CDS individually, and requires little subsequent manual completion. 
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4.2.2 BLAST Sequence Similarity Searching 
Both web-based NCBI BLAST searches and BLAST searches based upon locally 
produced databases were used to investigate the probable function and prevalence 
of specific coding sequences. 
4.2.2.1 Web-Based BLAST Sequence Similarity Searching 
Web-based NCBI BLAST searches were run directly from Artemis sequence viewer 
(Rutherford et al, 2000) using the ‘run’ option.  The primary method used was 
BLASTp, although BLASTn searches were also included.  Results were obtained in 
the browser output, and the top three scoring matches were recorded for 
interpretation.  Artemis viewer (Rutherford et al, 2000) was also used to investigate 
the neighbouring regions of CDS. 
4.2.2.2 Local Database BLAST Sequence Similarity Searching 
CDS of interest were queried against locally built genome databases.  In order to 
achieve this, the CDS of interest was selected whilst viewing in Artemis (Rutherford 
et al, 2000) and extracted as FastA sequence which was then used to search for 
matches in the database.  Custom nucleotide databases were created using a locally 
installed version of BLAST (Camacho et al, 2008; 2013), through creating a FastA file 
containing all of the required genomes; in this case 34 included genomes, the 14 C. 
coli, 13 C. jejuni, 6 ST403CC C. jejuni, and the additional historical ST403CC C. jejuni 
isolate ATCC33560.  BLASTn was employed as the primary search method, where no 
matches were found tBLASTx was conducted subsequently. 
Output from local database BLAST searching was obtained as a plain text file, 
exported to table format, providing details on which isolates recorded matches, the 
BLAST similarity score and the E value for each. 
4.2.3 Hippurate Hydrolysis Gene HipO 
The presence or absence of the HipO gene was queried against the 34 genome local 
database, using the HipO gene from C. jejuni NCTC11168 (Cj0985c coding sequence 
at loci c919903-918406, genome accession AL111168) as the query sequence.  
134 
 
Matches were compared to the score observed for the ‘self-hit’ – the BLAST score 
recorded for the C. jejuni 11168 HipO gene against the C. jejuni 11168 genome. 
4.2.4 Capsule Production Genes 
The presence of a capsule region was investigated using C. jejuni 11168 as the 
reference sequence. The capsule region was queried against the local database 
using seven individual coding sequences (kpsC, kpsD, kpsE, kpsF, kpsM, kpsS, kpsT).  
Once again the resulting scores were compared to the ‘self-match’ score for the 
reference sequence provided. 
4.2.5 Virulence Associated Genes 
The presence of virulence associated genes were also investigated using local 
database BLAST similarity searching.  Virulence genes used were all taken from the 
genome sequence of C. jejuni 11168 with the exception of virB11, which was taken 
from the C. jejuni 81-176 pVir plasmid (Bacon et al, 2000: accession; chromosome 
CP000538,; plasmid pVir AF226280). 
4.2.6 Investigating the Core & Pan Genome 
The core and pan genome sizes and content were determined, and subsequently 
analysed to identify coding sequences of interest. 
4.2.6.1 Determining the Core & Pan Genome 
Following the annotation process, EDGAR (Blom et al, 2009) was used to assess the 
core and pan genome for the 33 included isolates (Chapter 3, Table 3.1; Appendix 
9.1).   
The pan genome was determined for the 33 included genomes, using each genome 
in turn as the reference, in order to establish the largest possible pan genome, 
being determined at 5329 CDS (reference genome C. coli 03/103).  Core genome of 
591 CDS (reference genome C. jejuni 81116). 
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4.2.6.2 Filtering the Pan Genome 
The resulting pan genome outputs were then subjected to a ‘post-processing 
pipeline’ in order to identify CDS of potential interest for comparative analysis.   
The resulting table of CDS was subsequently filtered to remove essential and 
species specific coding sequences, as illustrated in Figure 4.1. Firstly the core genes 
across the group were removed - those with orthologues present in 100% of the 33 
included genomes; secondly, in order to focus on the ST403CC isolates as a group, 
all CDS were removed which were not either 100% present or 100% absent across 
the six ST403CC C. jejuni genomes; finally, in order to slim down further to potential 
genes of interest, the remaining 1220 CDS were further filtered by removing CDS 
present in 100% of the ST403CC isolates and equal to or greater than 80% of the 
reference genomes and those absent from 100% of ST403CC isolates and present in 
equal to or less than 20% of the reference genomes.   
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 Figure 4.1: Flow Chart Illustrating the Filtering Process for CDS following EDGAR 
Pan genome determined by 
EDGAR 
 
5329 CDS 
Removed core genome CDS, CDS with varied presence in 
ST403CC C. jejuni isolates, and CDS which were either highly 
common (present in 100% of ST403CC C. jejuni isolates and 90% 
or greater of the reference genomes) or rare (present in 0% of 
ST403CC isolates and 10% or less of reference genomes) 
 
1220 CDS 
Increased cut off levels to remove more common and rare CDS 
(CDS present in 100% of ST403CC C. jejuni isolates and 80% or 
greater of the reference genome and CDS present in 0% of 
ST403CC isolates and 20% or less of reference genomes) 
 
673 CDS 
 
Split into categories for 
analysis 
CDS absent in ST403CC C. 
jejuni isolates and present 
in 20-80% of reference 
genomes 
 
417 CDS 
CDS present in ST403CC 
C. jejuni isolates and 
absent in 100% of 
reference genomes 
 
26 CDS 
CDS present in 100% 
ST403CC C. jejuni isolates 
and present in 20-80% of 
reference genomes 
 
230 CDS 
CDS confirmed using EDGAR comparative viewer and 
duplicated CDS removed and filtered out C. jejuni specific CDS 
(present in 80% of C. jejuni and 0% of C. coli genomes) and C. 
coli specific CDS (present in 80% of C. coli and 0% of C. coli 
genomes) 
 
473 CDS 
CDS absent in ST403CC C. 
jejuni isolates and present 
in 20-80% of reference 
genomes 
 
271 CDS 
CDS present in ST403CC 
C. jejuni isolates and 
absent in 100% of 
reference genomes 
 
11 CDS 
CDS present in 100% 
ST403CC C. jejuni isolates 
and present in 20-80% of 
reference genomes 
 
191 CDS 
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4.3 Results 
In order to assess the genome content of a group of potentially host adapted, 
closely related ST403CC C. jejuni isolates, annotated genomes were produced using 
genome sequences produced as described in Chapter Three.  The ST403CC C. jejuni 
isolates had previously been demonstrated to be potentially capable of causing 
human illness (Chapter Two), and were shown to be closely related based upon 
MLST (Manning et al, 2003) and whole genome sequence based phylogeny (Chapter 
Three).  Annotated genomes were produced, and the core and pan genome of the 
included isolates was determined and investigated. 
4.3.1 Annotation 
Annotated genomes were produced for the newly sequenced six C. jejuni ST403CC 
and four C. coli isolates.  A single genome for C. jejuni (857) and C. coli (03/121) 
were annotated using PROKKA (Seemann, 2014) and transferred onto the remaining 
C. jejuni and C. coli sequences respectively, using RATT (Otto et al, 2011).   
4.3.2 Presence of the HipO Gene 
Figure 4.2 shows the percentage presence of the HipO gene for all C. jejuni isolates, 
all C. coli isolates, and for ST403CC C. jejuni isolates, as determined by local BLASTn 
query.  As described previously, the ST403CC C. jejuni isolates were previously 
identified as phenotypically negative for hippurate hydrolysis (Manning et al, 2003), 
however, significant matches with C. jejuni 11168 HipO were observed in all 
included C. jejuni isolates, including the ST403CC C. jejuni isolates.  No homology 
was observed in any of the C. coli isolates.  The ‘self-match’ score for C. jejuni 11168 
was 2767, with a mean across remaining the remaining 19 C. jejuni genomes of 
2600 (with a range of 2025-2678), and for the ST403CC C. jejuni isolates the mean 
observed score was 2642 (with a range of 2628-2645), indicating high conservation 
of the gene across the included C. jejuni isolates, including the phenotypically 
negative ST403CC isolates. 
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4.3.3 Capsule Gene Presence 
Figure 4.3 combines the results concerning the prevalence of the capsule genes 
following local database BLAST searches.  Individual percentages were as follows: 
kpsC matches were present in 100% of C. jejuni isolates and 14% of C. coli isolates; 
kpsD matches were present in 100% of included isolates; kpsE matches were 
observed in 100% of C. jejuni isolates and 86% of the C. coli isolates; kpsF had 
homologues in 100% of C. jejuni isolates, and 71% of C. coli isolates; kpsM was 
present in 70% of C. jejuni isolates, including 100% of the ST403CC C. jejuni isolates, 
and 7% of C. coli isolates; kpsS had significant matches in all of the included isolates, 
from both species; and kpsT had matches in 100% of C. jejuni isolates and 14% of C. 
coli isolates.   
Figure 4.2: Presence of the HipO Gene in C. jejuni & C. coli Isolates 
Green colour indicates all C. jejuni isolates combined (ST403CC and non-
ST403CC).  ST403CC C. jejuni isolates are indicated by purple colour, C. coli is 
indicated by blue bar, however none is visible due to the zero observed 
presence of the HipO gene in this group. 
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4.3.4 Presence of Virulence Genes 
Figure 4.4 provides an overview of the presence of virulence genes across the 34 
genomes.  Five of the eleven virulence associated genes (cadF; ciaB; dnaJ; iamB and 
racR) were found to have homologues in 100% of C. jejuni isolates and none of the 
C. coli isolates.  Four more had no orthologues in C. coli, and were present in 100% 
of the ST403CC C. jejuni isolates but did not have complete prevalence across all C. 
jejuni genomes included (cdtA and cdtB were present in 80% of C. jejuni isolates, 
whilst cdtC homologues were found in 85% of the C. jejuni isolates and pldA had 
homologues in 90% of the included C. jejuni genomes).  Finally, two of the 
investigated virulence associated genes did not have homologues in the ST403CC C. 
jejuni isolates, these CDS also had varied prevalence across the rest of the genomes; 
flaA was found in 30% of C. jejuni and 7% of C. coli, whilst wlaN was present in just 
10% of the included C. jejuni isolates, and had no homology in C. coli. 
 Figure 4.3: Presence of Capsule Associated Genes in C. jejuni & C. coli Isolates 
Green colour is combined C. jejuni (ST403CC and non-ST403CC).  ST403CC C. jejuni isolates 
are indicated by purple colour and C. coli isolates by blue.   
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4.3.5 Core & Pan Genome Analysis 
The pan genome was determined for the 33 included genomes, using each genome 
in turn as the reference, in order to establish the largest possible pan genome, 
being determined at 5329 CDS (reference genome C. coli 03/103).  The core genome 
for the 33 included isolates was 591 CDS (reference genome C. jejuni 81116). 
The core and pan genome for the ST403CC C. jejuni isolates alone were 1444-1450 
CDS (using C. jejuni 444 and 623 as reference sequences, respectively) and 2216-
2220 (using C. jejuni 623 and 857 as references, respectively).  The pan genome for 
all included C. jejuni isolates was 3887 CDS (with C. jejuni 1336 as the reference 
genome) and the core genome for C. jejuni isolates was found to contain between 
883 CDS (based upon C. jejuni 1336) and 966 CDS (based upon C. jejuni 304). 
 
Figure 4.4: Presence of Virulence Associated Genes in C. jejuni & C. coli Isolates 
Green colour indicates combined C. jejuni (ST403CC and non-ST403CC).  ST403CC C. jejuni 
isolates are indicated by purple colour and C. coli isolates by blue.   
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4.3.5.1 Investigating Pan Genome Content 
As described above, EDGAR (Blom et al, 2012) analysis was used to determine the 
pan genome for the 33 isolates, and the contents of the pan genome were 
investigated to identify potentially relevant CDS differentially found in ST403CC C. 
jejuni genomes compared to the reference group.  This genome content analysis 
revealed a total of 379 CDS of interest, which were separated into three categories: 
CDS which were present in 20-80% of reference genomes and absent from 100% C. 
jejuni ST403CC isolates; CDS present in 20-80% of reference genomes and present in 
100% C. jejuni ST403CC isolates; CDS absent from 100% of reference genomes and 
present in 100% C. jejuni ST403CC isolates - each of which contained a range of 
different potentially functional proteins, and the contents of which are discussed in 
greater detail below. 
Figure 4.5 provides an overview of the remaining CDS following EDGAR analysis and 
subsequent filtering.  The majority of the CDS remaining after the filtering steps 
were those present in a mixture of the reference genomes and absent from the 
ST403CC C. jejuni isolates, with fewer CDS present in all of the ST403CC isolates and 
a variety of the reference genomes, and a much smaller proportion found only in 
the ST403CC C. jejuni isolates and lacking from the rest of the included genomes. 
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The first of the three categories, referred to as the ‘Absent’ category, consists of 
258 CDS which were found to have orthologues in 20-80% of the included reference 
genomes, but had no observed orthologues in the six ST403CC C. jejuni isolates.  
This was further sub-categorised by reference genome species; 69 of the CDS had 
orthologues in C. coli references only, ten had orthologues only in C. jejuni, and the 
remaining 179 CDS with no orthologues in ST403CC C. jejuni isolates had 
orthologues in a mixture of C. jejuni and C. coli reference genomes (Appendix 9.3.1).   
 
 
Figure 4.5: CDS of Interest Identified Following EDGAR Analysis 
From the pan genome of 5329 CDS, after filtering steps, 379 CDS of interest 
remain, as represented in the pie charts: 258 CDS ‘absent’ from ST403CC C. jejuni 
isolates; 110 CDS present in ST403CC C. jejuni isolates and between 20 and 80% of 
reference genomes; and 11 CDS present ‘exclusively’ in the ST403CC C. jejuni 
isolates based upon the 33 included genomes. 
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The predicted functions of the CDS in the absent group are represented in Figure 
4.6. The majority of the CDS which were present in 20-80% of the reference 
genomes and lacking homologues in the ST403CC C. jejuni isolates were 
hypothetical proteins for which function has not been determined, and the second 
largest proportion were also proteins of unknown function or other ‘miscellaneous’ 
proteins.  However a number of functional proteins were found to be lacking or 
highly divergent in the ST403CC C. jejuni isolates, including cell membrane 
associated proteins, metabolism and biosynthesis associated proteins, and coding 
sequences associated with prophages, and the conjugal transfer of plasmids. 
 
The functional assignment of the ST403CC ‘absent’ CDS are considered in relation to 
the three sub-categories; CDS in C. jejuni isolates only, CDS in C. coli isolates only, 
and CDS in a combination of C. jejuni and C. coli isolates, in Figure 4.7. 
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Figure 4.6: Distribution of Protein Function in CDS ‘Absent’ in ST403CC C. jejuni Isolates 
& with Homologues in Reference Genomes 
CDS which were absent in 100% of the ST403CC C. jejuni isolates and with homologues 
present in between 20% and 80% of the reference genomes. 
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Figure 4.7a 
Distribution of protein function in CDS absent in 100% of the ST403CC C. jejuni 
isolates and with homologues present in between 20% and 80% of C. jejuni only 
reference genomes. 
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Figure 4.7b 
Distribution of protein function in CDS absent in 100% of the ST403CC C. jejuni isolates and 
with homologues present in between 20% and 80% of C. coli only reference genomes. 
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Figure 4.7c 
Distribution of protein function in CDS absent in 100% of the ST403CC C. jejuni isolates 
and with homologues present in between 20% and 80% of a mixture of C. jejuni and C. coli 
reference genomes. 
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The majority of the C. jejuni associated CDS lacking homologues in the ST403CC C. 
jejuni isolates were hypothetical or miscellaneous proteins, however also observed 
were two cell membrane associated proteins, and one gene associated with 
chemotaxis signalling (Figure 4.7a). 
A considerable proportion of the C. coli associated CDS lacking homologues in the 
ST403CC C. jejuni isolates were also proteins without known predicted function.  
There was considerable evidence of plasmid acquisition (conjugal transfer) content 
and DNA replication and repair proteins which were linked with C. coli genomes and 
lacking in ST403CC C. jejuni (Figure 4.7b). 
Those CDS present in a mixture of the reference C. jejuni and C. coli genomes 
lacking homologues in ST403CC C. jejuni isolates were also dominated by proteins of 
unknown or hypothetical status, although also observed were genes associated 
with cell membrane, metabolism, biosynthesis, transport and prophage content 
(Figure 4.7c). 
As stated above, the second major category resulting from EDGAR analysis was that 
containing CDS with orthologues present in 20-80% of reference genomes and 
present in 100% C. jejuni ST403CC isolates (n=110).  This was separated into three 
sub-categories, similarly to the ‘Absent’ group: CDS with orthologues in C. coli only 
(n=3); CDS with orthologues in C. jejuni only (n=47); CDS with orthologues in a 
mixture of both species (n=60).  A summary of the predicted function of these CDS 
is provided in Figure 4.8. 
The functional content of the ‘non-exclusive’ ST403CC CDS are separated by 
category (C. jejuni associated; C. coli associated; shared with C. jejuni and C. coli) in 
Figure 4.9. 
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As depicted in Figure 4.9a, the majority of CDS which were present in ST403CC C. 
jejuni isolates and with homologues in 20-80% of included C. jejuni isolates were 
proteins associated with the cell membrane.  A considerable proportion were also 
associated with transport, although there were also the same number of 
hypothetical proteins.  Additionally, five of the forty-seven CDS in this category 
were associated with metabolism and biosynthesis. 
The three CDS shared between the ST403CC C. jejuni isolates and C. coli isolates 
only were all hypothetical proteins (Figure 4.9b). 
A range of functions were predicted within the CDS which were shared between the 
ST403CC C. jejuni isolates and a combination of reference C. jejuni and C. coli 
genomes.  The majority again were hypothetical or unknown proteins, however a 
considerable number (eleven of sixty) were predicted surface polysaccharides, and 
smaller proportions represented transport proteins and cell membrane associated 
CDS (Figure 4.9c). 
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Figure 4.8 
Distribution of protein function in CDS present in 100% of the ST403CC C. jejuni isolates and 
with homologues present in between 20% and 80% of the reference genomes. 
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Distribution of protein function in CDS present in 100% of the ST403CC C. jejuni isolates and 
with homologues present in between 20% and 80% of C. jejuni only reference genomes. 
3 
Hypothetical Proteins
Figure 4.9b 
Distribution of protein function in CDS present in 100% of the ST403CC C. jejuni isolates and 
with homologues present in between 20% and 80% of C. coli only reference genomes. 
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Figure 4.9c 
Distribution of protein function in CDS present in 100% of the ST403CC C. jejuni isolates and 
with homologues present in between 20% and 80% of a mixture of C. jejuni and C. coli 
reference genomes. 
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The third group, referred to as the ‘exclusive’ group, were CDS which were present 
in 100% of the ST403CC C. jejuni isolates and with homologues not found across the 
reference C. jejuni and C. coli genomes.  This group consisted of seven (64%) 
hypothetical proteins, and four (36%) restriction/modification system associated 
proteins (Figure 4.10). 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1 shows the breakdown of the numbers of CDS of interest by group and by 
species.  The majority of the CDS present in reference genomes and not found in 
the ST403CC C. jejuni isolates had homologues in both C. jejuni and C. coli genomes, 
with a smaller proportion only having homologues observed in C. coli isolates and 
just 4% of the ST403CC ‘absent’ CDS found only in reference C. jejuni isolates.  Of 
those CDS which were found to be present in all included ST403CC C. jejuni isolates 
and also in a number of the reference genomes, the majority again had homologues 
in both C. jejuni and C. coli isolates, although the margin was smaller in this 
instance, with slightly fewer CDS having orthologues only in C. jejuni and a much 
smaller number having orthologues only in C. coli (3%).   
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Figure 4.10: Protein Function in CDS Present in ST403CC C. jejuni & without 
Homologues in Reference Genomes 
Protein distribution in CDS present in 100% of the ST403CC C. jejuni isolates and 
without homologues in the reference genomes. 
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Further analysis of the ST403CC absent group identified some CDS which were 
present in the majority of the included C. jejuni isolates and lacked homologues in 
ST403CC C. jejuni isolates, including a putative integral membrane protein and a 
protein hydrolase, present in each of the included C. jejuni genomes with the 
exception of one of the human isolates; the C. jejuni doylei isolate 269.97.   
The present non-exclusive group did not reveal any CDS with apparent links to host 
type; some CDS showed some bias towards being in human C. jejuni isolates, others 
with predominantly porcine origin in C. coli isolates, however this may be attributed 
simply to the bias induced by the high numbers of isolates from these sources. 
4.3.6 ST403CC C. jejuni Associated Coding Sequences 
As described above a small number of CDS were identified which were common to 
the six ST403CC C. jejuni isolates, but lacked homology across any of the other 
genomes included in the pan genome analysis.  The presence of these genes which 
were ‘exclusive’ to the ST403CC C. jejuni isolates by EDGAR analysis were subjected 
to further consideration; both to confirm their ‘exclusivity’ in the locally constructed 
database, and to consider the potential implications of these CDS, including further 
investigation of their potential role and studying the neighbouring regions for 
additional information. 
 
Category of CDS 
Orthologues 
in C. coli 
Orthologues in 
C. jejuni 
Orthologues in 
both species 
Total 
ST403CC Absent 69 10 179 258 
ST403CC Present Non-
Exclusive 
3 47 60 110 
ST403CC ‘Exclusive’ - - - 11 
 
Table 4.1: Overview of CDS Identified following EDGAR Analysis 
A total of 379 coding sequences of potential interest remained after filtering the content of 
the pan genome.  These CDS were subdivided into three categories as shown above. 
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4.3.6.1 Predicting Function of ST403CC C. jejuni Associated CDS 
Following the identification of ST403CC ‘exclusive’ CDS via EDGAR analysis, web-
based NCBI BLAST was utilised to assess the true ‘exclusivity’ and prevalence of 
these CDS outside the included 33 genomes, and to further investigate their 
potential functions. 
Table 4.2 gives details of the CDS which were found across the ST403CC C. jejuni 
isolates that did not record homologues in the reference genomes via EDGAR 
analysis.  In order to attempt to determine potential function of the hypothetical 
proteins, and to assess the ‘exclusivity’ of these CDS across a larger platform, the 
eleven CDS were investigated using BLAST searching as described above. 
BLAST querying confirmed the likely functions of the predicted proteins, however 
no additional functional predictions were made for the seven hypothetical proteins, 
with the exception that one of three matches for hypothetical protein CJ857_01361 
was associated with a possible metabolic enzyme.  Matches were observed for all 
eleven of the ST403CC ‘exclusive’ CDS as determined by EDGAR based analysis, 
demonstrating that homologues do exist in a larger database. 
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CDS 
Predicted 
Function 
(PROKKA) 
Blastp Hits 
Percentage 
Coverage 
Percentage 
Identity 
Description Isolate 
CJ857_00074 
Hypothetical 
protein 
Hypothetical protein 
C. jejuni 
ATCC33560 
100 99 
CJ857_00075 
Hypothetical 
protein 
Hypothetical protein 
C. jejuni 
ATCC33560 
78 99 
CJ857_00839 
Hypothetical 
protein 
Hypothetical protein C. coli K3 100 95 
Partial hypothetical protein 
C. jejuni 
ATCC33560 
88 99 
CJ857_00896 
R.HinP1 
restriction 
endonuclease 
Hypothetical protein 
C. jejuni 
ATCC33560 
100 100 
Hypothetical protein 
H. cinaedi ATCC 
BAA-847 
96 74 
Type II R-M system restriction 
endonuclease 
H. cinaedi 
PAGU611 
95 74 
CJ857_00897 
Modification 
methylase 
Hhal 
DNA methyltransferase 
C. jejuni 
ATCC33560 
100 99 
CJ857_01361 
Hypothetical 
protein 
Hypothetical protein C. jejuni 2008-979 100 100 
2-amino-4-hydroxy-6-
hydroxymethyldihydropteridine 
pyrophosphokinase 
C. jejuni CG8421 100 99 
Hypothetical protein 
C. jejuni LMG 
23263 
100 97 
CJ857_01649 
Hypothetical 
protein 
Hypothetical protein 
C. jejuni 
LMG23223 
100 99 
C. jejuni 
LMG23210 
100 99 
C. jejuni 1997-10 100 99 
C. jejuni 2008-979 100 99 
CJ857_01723 
Hypothetical 
protein 
Hypothetical protein C. coli LMG23336 100 100 
CJ857_01724 
R.Pab1 
restriction 
endonuclease 
Hypothetical protein 
C. coli H56 100 100 
C. coli LMG23336 100 99 
CJ857_01734 
Hypothetical 
protein 
Hypothetical protein C. jejuni 129-258 100 100 
CJ857_01735 
Recombination 
protein F 
Putative ATPase 
 
C. jejuni  129-258 100 100 
 
 
 
Table 4.2: CDS Present in ST403CC C. jejuni Isolates without Homologues in Reference 
Genomes 
This table describes the BLASTp NCBI search results for the eleven CDS which were only 
found amongst ST403CC C. jejuni isolates following EDGAR analysis. 
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4.3.6.2 Further Investigation of ST403CC C. jejuni Associated CDS 
Following on from web-based BLAST searching, the ST403CC C. jejuni isolate 
‘exclusive’ CDS as determined by EDGAR analysis were also further investigated 
using local database BLAST, and consideration of the surrounding coding regions.  
Local BLAST queries were used as described previously, using the sequences 
extracted from C. jejuni 857 for database queries against the 34 genome local 
database; including the 33 genomes included in pan genome analysis, and the 
additional ancestral ST403CC isolate C. jejuni ATCC33560, as well as an additional 
local database containing additional C. coli genomes.  Local database BLAST 
searching confirmed presence in 100% of ST403CC isolates and zero of reference 
isolates for CJ857_00074, CJ857_00075, CJ857_00839, CJ857_00896, CJ857_00897, 
CJ857_01734 and CJ857_01735.  CJ857_00839 did record some low scoring or high 
error matches in other isolates in the database (Appendix 9.4.1), however these 
were not considered to be significant matches.  CJ857_01361 recorded several low 
scoring matches which were not significant, however in addition to the ST403CC C. 
jejuni isolates, an additional significant match was observed in C. jejuni 01/51.  The 
three remaining EDGAR ‘exclusive’ CDS (CJ857_01649, CJ857_01723 and 
CJ857_01724) each showed significant matches in C. coli 03/317 in addition to the 
C. jejuni ST403CC isolates.  Both CJ857_01723 and CJ857_01724 showed further 
significant matches when queried against the C. coli database in C. coli H56 and 
LMG23336 (Appendix 9.4.2). 
Investigation using Artemis (Rutherford et al, 2000) was used in order to give 
further consideration to the size and position of the CDS, including the possibility of 
the CDS being pseudogenes; rather than being truly ‘exclusive’ CDS, these may 
represent C. jejuni genes which have become ‘pseudogenised’ – function and part 
of the coding sequence may be lost or degraded to the extent that it no longer 
appears related to the original CDS as seen in other isolates. 
Figure 4.11 illustrates the region on the C. jejuni 857 genome containing 
CJ857_00074 and CJ857_00075.  The first point to notice is the potential that 
CJ857_00074 and CJ857_00075 may have previously been a single coding sequence, 
indicated by the shortness of CJ857_00074, and the observable stop codons in all 
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three reading frames.  In the C. jejuni 857 genome the pair of CDS are located in 
between proB and fmt, which as Figure 4.11b shows, were observed to be 
neighbouring CDS in C. jejuni 11168.  In both genomes proB (Glutamate 5-kinase; 
Cj0097; 11168) is 756bp in length, so there was no evidence of this being 
fragmented; similarly fmt (methionyl-tRNA formyltransferase; Cj0098; 11168) has 
the same length (918bp) in 11168 and 857 genomes and therefore was not 
considered to be degraded.  BLASTx searching of the region recorded low scoring 
partial matches in hypothetical proteins in the genome of C. jejuni ATCC33560. 
a 
Figure 4.11: Visualisation of ST403CC Associated CDS CJ857_00074 & CJ857_00075 
in C. jejuni Isolate 857 
a) Artemis viewer screen for C. jejuni 857 showing the region around 
CJ857_00074 and CJ857_00075. 
b) Artemis viewer screen for the C. jejuni 11168 proB region. 
b 
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It was deemed to be probable that CJ857_00074 and CJ857_00075 are 
pseudogenes. They do not appear to be products of the degradation of 
neighbouring genes proB or fmt however, and it remains unclear whether this is 
frameshift based, genuine stop codon insertion mutation, or sequencing error. 
Figure 4.12, overleaf, shows the region of C. jejuni 857 containing the ‘exclusive’ 
CDS CJ857_000839, which is one of a number of consecutive short CDS (120-246bp) 
found upstream of xerD_2 - an additional second copy of xer_D , which is 
downstream of intA in C. jejuni 857.  IntA is a potential prophage intergrase, and 
may suggest that this region was acquired as part of a prophage. 
Both CJ857_00896 and CJ857_00897 (hhaIM) can be seen in Figure 4.13.  In C. jejuni 
11168, thiH and thiG are direct neighbours on the chromosome.  These two CDS 
may represent an insertion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13: Visualisation of ST403CC Associated CDS CJ857_00896 & 
CJ857_00897 hhaIM in C. jejuni 857 
Artemis viewer image for the region of C. jejuni 857 containing both 
CJ857_00896  and CJ857_00897 (hhaIM). 
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Figure 4.12: Visualisation of ST403CC Associated CDS CJ857_00839 in C. jejuni 857 
Artemis viewer output for the C. jejuni 857 CJ857_00839 region, including the second copy 
or XerD, plus output for the first copy of XerD in C. jejuni 857, and the related region in C. 
jejuni 11168. 
a) CJ857_00839 region in C. jejuni 857 
b) C. jejuni 857 region containing xerD_1 
c) xerD region in C. jejuni 11168 genome 
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As shown in Figure 4.14, the ST403CC C. jejuni ‘exclusive’ CDS CJ857_01361 
neighbours purM (Phosphoribosylformylglycinamidine cyclo-ligase) and dcuD_4 in 
C. jejuni 857.  The purM sequence was the same size in the genomes of both C. 
jejuni 857 and 11168, and the region was similar upstream to in 11168 (purM, coaE, 
dapF), however the downstream area was different.  In C. jejuni 857, dcuD copies 
1,2 and 3 are neighbouring and in fact are probably one pseudogeneised copy of 
dcuD, however dcuD_4 was located remote from these, it was also truncated  
 
 
 
 
 
Figure 4.14: Visualisation of ST403CC Associated CDS CJ857_01361 in C. jejuni 857 
Artemis viewer output for the C. jejuni 857 region containing CJ857_01361, and showing the 
location of the neighbouring CDS purM in 11168. 
a) C. jejuni 857 genome region containing CJ857_01361 
b) C. jejuni 11168 region containing purM 
 
a 
b 
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(555bp) compared to the full dcuD (UniProtKB:P45428; 1368bp; Putative cryptic C4-
dicarboxylate transporter) and is quite possibly pseudogeneised with CJ857_01360.  
Interestingly the CDS neighbouring purM in C. jejuni 11168 (Cj1528) was also 
described as a putative C4-dicarboxylate anaerobic carrier pseudogene - therefore it 
may be likely that all three (dcuD_4, CJ857_01360, CJ857_01361) are an equivalent 
pseudogene in ST403CC C. jejuni. 
Figure 4.15 shows the region of C. jejuni 857 containing ‘exclusive’ CDS 
CJ857_01649.  This region contained numerous hypothetical CDS, many of which 
were small and likely to be degraded fragments.  The nearest downstream 
neighbours are fcl and rfbC; these two CDS are also close to each other in C. jejuni 
11168 however the upstream region is the capsule region, which is not the case in 
C. jejuni 857.  CJ857_01649 may be a ‘true’ hypothetical protein (861bp) however it 
is directly downstream of 01650 (1542bp) so it is possible the two were once one, 
or that they are jointly expressed. 
Figure 4.16 shows the region of the C. jejuni 857 genome region containing 
CJ857_01723 and CJ857_01724.  In C. jejuni 857 the ‘exclusive’ hypothetical protein 
CJ857_01723 had two neighbouring hypothetical proteins, and lies upstream of 
carB and downstream of tal.  C. jejuni 11168 had a single hypothetical coding region 
Figure 4.15: Visualisation of ST403CC Associated CDS CJ857_01649 in C. jejuni 857 
Artemis viewer output for the C. jejuni 857 region containing the ‘exclusive’ CDS 
CJ857_01649. 
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in between carB and tal.   For both genomes, both carB and tal were found to be 
the same length.  It appears possible that CJ857_01723 (hypothetical protein, 
1068bp), CJ857_01724 (restriction endonuclease, 714bp), and CJ857_01725 
(hypothetical protein, 423bp) may represent a pseudogenised gene as they are 
direct neighbours in different reading frames. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17 shows the Artemis view containing CJ857_01734 and CJ857_01735 and 
the downstream neighbours lpxB (1095bp), greA (486bp). Both of these CDS are 
present and neighbouring in 11168, with same lengths as observed in C. jejuni 857. 
Upstream of lpxB in 11168 is peb3 (periplasmic protein), glpT (putative glycerol-3-
b 
a 
 
Figure 4.16: Visualisation of ST403CC Associated CDS CJ857_01723 & CJ857_01724 in C. 
jejuni 857 
Artemis view showing the C. jejuni 857 CDS CJ857_01723 and CJ857_01724, neighbouring 
carB, and the carB region as found in C. jejuni 11168. 
a) In C. jejuni 857 showing CJ857_01723 and CJ857_01724 with neighbour carB. 
b) In C. jejuni 11168 the carB region similar but has only one hypothetical protein, in 
different reading frame 
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phosphate transporter) pseudogene.   The glpT pseudogene is also present in C. 
jejuni 857, upstream near surE.  
 
 
 
It was also noted (Figure 4.17) that the next neighbour gene in C. jejuni 11168 was 
surE. This is also upstream in 857, however more potential CDS exist in between, 
including CJ857_01736, which is not an ST403CC ‘exclusive’ CDS, but is a putative 
methyltransferase, and CJ857_01737 which is a type III restriction-modification 
system enzyme.  CJ857_01734 may be a pseudogene or hypothetical protein; the 
function is not determined, and it marks the beginning of an apparent inserted 
region in C. jejuni 857 compared to C. jejuni 11168. 
a 
b 
Figure 4.17: Visualisation of ST403CC Associated CDS CJ857_01734 & CJ857_01735 in C. jejuni 
857 
Artemis output for the region containing CJ857_01734 and CJ857_01735 in C. jejuni 857, and 
region relating to neighbouring CDS in C. jejuni 11168. 
a) CJ857_01734 in ST403CC C. jejuni 857 upstream of greA and lpxB 
b) Region in C. jejuni 11168 greA and lpxB next to peb3 protein. 
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4.4 Discussion 
The work undertaken in this chapter provided well annotated genomes for the 
newly sequenced C. jejuni ST403CC isolates, and used them to assess the core and 
pan genome of the selected group of isolates, in order to establish CDS potentially 
involved in host adaptation of the ST403CC group.  In general terms, the apparent 
association of ST403CC C. jejuni isolates with the porcine host, and the uncommon 
lack of hippurate hydrolysis in phenotypic testing (Manning et al, 2003) had been 
thought to indicate potential host adaptation in this clonal group; it might be logical 
to predict therefore that evidence of host adaptation could be evidenced in part by 
the loss of ‘poultry associated’ CDS, the sharing of genes with porcine or mammal 
associated isolates, or increased sharing of CDS typically found in C. coli.   
The results produced in this chapter have determined the presence of specific genes 
of interest in the ST403CC C. jejuni isolates, and provided further insight into the 
prevalence of ST403CC ‘exclusive’ CDS as elucidated from pan genome analysis.  
This section will consider the implications of the determined gene presence, whilst 
considering the potential roles of the variation observed. 
4.4.1 Annotation  
RATT (Otto et al, 2011) provides rapid annotation for newly sequenced genomes,  
however it relies on the presence and quality of a pre-existing reference genome 
annotation; if there is no currently annotated closely related genome, RATT cannot 
successfully be used, and RATT is limited by the quality of the existing annotation, 
and by the content of the annotated reference genome; any mistakes in the 
reference annotation will be propagated to the new sequences, and any additional 
coding content will not be annotated.  RATT, therefore, is a useful tool for rapidly 
providing an ‘approximate’ annotation, but requires extra work to ‘complete’ the 
annotation. 
PROKKA (Seemann, 2014), unlike RATT (Otto et al, 2011), has the benefit of not 
requiring a reference genome; instead PROKKA uses a range of tools to identify 
coding regions and subsequently query those regions against a database to 
determine most probable annotations.  PROKKA has the benefit of not being limited 
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to a single reference genome, and therefore can produce improved accuracy of 
annotation, however due to the nature of automated annotation using databases 
post annotation ‘sense-checking’ may be required if an annotation seems unlikely.  
PROKKA also encounters the same potential pitfall as RATT in relying on the 
accuracy of existing annotations, however due to the inclusion of large protein 
databases this effect is minimised. 
Both RATT (Otto et al, 2011) and PROKKA (Seemann, 2014) provide rapid and 
accurate annotations, which may not be as accurate as full manual annotation of a 
genome but are highly useful, and significantly less time and labour intensive. 
As described by Richardson & Watson (2012) the rapid production of genome 
sequences has meant that manual annotation of genomes simply cannot keep pace 
with the production of new information, and automated annotation therefore has 
become hugely important.  Various inconsistencies in annotation cause problems in 
automated annotation, including inconsistent annotation of homologous proteins, 
and even spelling mistakes in some annotations, as well as instances where the 
same gene names have been assigned to different sequences with different product 
(Richardson & Watson, 2012).  Hypothetical proteins remain a significant burden in 
annotation databases, and a limitation of transferring and automating annotation is 
that these hypothetical proteins remain and propagate without function being 
determined (Richardson & Watson, 2012).  As described by Richardson & Watson 
(2012) the most useful approach at current is to apply an automated method, and 
include manual curation to improve accuracy; this is the method that was applied 
here, wherein genes in regions of interest were manually investigated to attempt to 
confirm likely products. 
4.4.2 Presence of the HipO Gene in ST403CC Campylobacter jejuni 
As described, HipO presence was confirmed for all included C. jejuni isolates, 
including the six ST403CC C. jejuni isolates which were previously characterised as 
phenotypically negative for hippurate reduction.  It can therefore be concluded that 
these are new examples of HipO positive, hippurate reduction negative (gene 
positive, phenotype negative) isolates, as have been described previously (Caner et 
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al, 2008).  The HipO gene from C. jejuni 11168 was selected as the gene for 
comparison as this is one of the most well studied C. jejuni isolates, this was also 
deemed an appropriate reference due to the modular search methods employed by 
BLAST, as described above.  The use of this HipO gene was confirmed to be suitable 
by the results obtained - as expected matches scoring high similarity with the ‘self-
match’ score were observed across the C. jejuni isolates, with no significant matches 
observed across the C. coli isolates.   
The hippuricase gene was initially sequenced from C. jejuni TGH9011 due to its 
strong positive hippurate hydrolysis reaction, and was determined to consist of 
1152 nucleotides, coding for 383 amino acids (Hani & Chan, 1995).  Brief analysis 
revealed that the hipO gene was of equal length in the original sequenced isolate (C. 
jejuni TGH9011), the well characterised hippurate hydrolysis positive isolates 
NCTC11168 and 81116, and the phenotypically hippuricase negative ST403CC C. 
jejuni isolates.  There was no evidence of truncation or variation in the hipO coding 
sequence between known hippurate hydrolysis positive isolates and the hippurate 
hydrolysis negative ST403CC C. jejuni isolates.  The gene appears to remain 
potentially functional in these isolates.   
It is thought that hippurate negative C. jejuni isolates are relatively uncommon 
(Totten et al, 1987), so it remains an interesting characteristic to be shared across 
the group.  Inaccurate phenotype testing can be an issue in determining the 
hippurate hydrolysis status of an isolate, although false negative results are less 
frequent than false positives (Amri et al, 2007).  It could therefore be argued that 
false-negative results were observed for the tested ST403CC isolates, however this 
is unlikely as it was consistent across all isolates, and were carried out by a 
reputable lab with appropriate control measures (Manning et al, 2003).  The results 
recorded for hipO and hippurate hydrolysis for ST403CC C. jejuni isolates also serves 
as additional evidence that for speciation, PCR based methods are more valuable 
than phenotypic testing in this instance, as is often seen in the literature (Denis et 
al, 1999; Wainø et al, 2003; Caner et al, 2008). 
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4.4.3 Capsule Synthesis Gene Presence in ST403CC Campylobacter jejuni 
The capsule has been demonstrated to play a role in colonisation and invasion into 
host cells in C. jejuni 81-176 (Bacon et al, 2001); therefore it is interesting to 
consider capsule homology in ST403CC C. jejuni isolates.  A previous study by 
Karlyshev et al (2000) first identified the seven capsule associated CDS in C. jejuni, 
including three (kpsM; kpsS; kpsC) which were conserved across all the included 
isolates (nine strains including 11168 and 81116).  For the twenty C. jejuni isolates 
included in this study, homologues were observed for six of the seven capsule 
genes, whilst kpsM was present in only 70% of C. jejuni isolates, but was found in all 
ST403CC C. jejuni genomes.  Considerably lower capsule gene prevalence was 
observed for the C. coli isolates; providing another example where the ST403CC C. 
jejuni isolates have much more in common with ‘normal’ C. jejuni isolates.   Only 
structural genes were used in this research, further investigation would be required 
to identify the specific Penner serotype of the isolates; as cited previously, it was 
determined that both ST403CC C. jejuni isolates 484 and 444 were HS:23 serotype 
whilst the remaining four sequenced isolates were deemed non typeable (Manning 
et al, 2003; Frost et al, 1998).  These results suggest that these ST403CC isolates are 
all potentially capable of producing capsule but cannot inform upon serotype.   
4.4.4 Presence of Virulence Associated Genes in ST403CC Campylobacter jejuni 
Monteville et al (2003) investigated the role of cadF (Campylobacter adhesion to 
fibronectin) in the process of invasion, stating that cadF has been repeatedly 
exhibited to be conserved among C. jejuni and C. coli (Konkel et al, 1999; Amri et al, 
2007; Datta et al, 2003; Rozynek et al, 2005; Nayak, Stewart & Nawaz, 2005).  It is 
surprising therefore to find two isolates which do not appear to have cadF 
homologues, however it may be that it is degraded in these porcine associated C. 
coli isolates, or that they are divergent enough that they did not score BLAST 
matches; invasion assays have not been completed on these isolates so it is also 
possible that they are non-pathogenic strains.  It could also be a fault in sequencing 
or assembly in these two genomes. 
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cdtA,B,C were present in most (89%) of the studied C. jejuni, with no matches in the 
C. coli isolates included in the database.  The two C. jejuni isolates lacking cdtABC 
were C. jejuni doylei 269.97 and C. jejuni jejuni IA3902.  These two are potentially 
‘divergent’ strains, although the lack in 269.97 is surprising as it is a human 
pathogenic isolate.  This coincides with previous study be Rozynek et al (2005), who 
observed cdtA,B,C presence in almost all of their tested C. jejuni isolates, and in less 
than 6% of included C. coli isolates in work by.  Also, Datta, Niwa & Itoh (2003) 
found 100% prevalence of cdtABC in their PCR study on 111 C. jejuni isolates from 
various sources. 
The virulence associated genes ciaB and dnaJ were observed as being present in 
100% of the included C. jejuni isolates and absent from all included C. coli.  This 
correlates with research by Datta, Niwa & Itoh (2003) who observed high levels of 
prevalence of ciaB in C. jejuni with little variation by source (100% of poultry meat 
isolates, 100% of broiler faeces isolates, 98% of human clinical isolates, 85% of 
bovine faeces isolates) and for dnaJ (98% in human clinical samples, 91% poultry 
meat samples, 100% broiler faeces samples, 100% bovine faeces samples).  Both 
iamb and racR were also found in all tested C. jejuni isolates and none of the 
included C. coli strains, whereas Datta, Niwa & Itoh (2003), found that racR was less 
prevalent than many of the virulence genes they studied (98% in human clinical 
isolates, 91% of poultry meat isolates, 86% of broiler faecal isolates, 77% of bovine 
faecal isolates).  Due to the nature of short read sequencing as used in this project, 
and the subsequent necessity of reference based assembly, the issue of potential 
mis-assembly should be considered particularly in the case of a potential false-
positive result for gene presence.  Brás et al (1999) originally identified the RacR-
RacS type two component regulatory system in C. jejuni 81116 and determined that 
mutation of racR reduced colonisation ability in the chicken model.  The reference 
used for genome assembly of the ST403CC isolates was C. jejuni RM1221; which was 
found (as were all C. jejuni in this study) to be positive for racR by BLAST searching.  
The annotated genome of RM1221 (accession CP000025.1) contains identified racR 
- which is the same length and orientation as in 81116 (accession CP000814.1). 
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The possibility that the 100% coverage of racR observed in the included C. jejuni 
isolates was due to mis-assembly or sequence inaccuracy was considered however 
the presence of racR in ST403CC C. jejuni isolates is unlikely to be due to the 
sequence assembly against RM1221 as it is present at the same length not as a 
short CDS fragment or pseudogene giving a false positive result.  Additionally, racR 
was observed in all included C. jejuni isolates which were independently assembled 
and annotated by various laboratory groups; therefore the likelihood of each of 
these positive results being false seems slim.  Additionally, the source group with 
the lowest prevalence of racR in Datta, Niwa & Itoh’s (2003) study was bovine faecal 
associated isolates, of which the only included isolate in this study was ATCC33560.  
This isolate was positive for racR according to BLAST searching; however this does 
not contradict the fact that other bovine isolates may be negative for racR.  Finally, 
the average contig lengths for the ST403CC C. jejuni sequences before alignment 
against the C. jejuni RM1221 reference genome were in the thousands of base pairs 
so it unlikely that a short fragment was accidentally aligned with the racR CDS. 
In Datta, Niwa & Itoh’s study (2003) flaA was found to be present across 100% of C. 
jejuni isolates included in their study regardless of source, however here presence 
was determined for only 30% of C. jejuni and 7% of C. coli isolates, with no 
homologues observed in ST403CC C. jejuni isolates.  Flagella are not essential for 
colonisation, however mutant studies have shown that mutants without flaA are 
impaired in colonisation compared to wild type strains (Wassenaar et al, 1993).  
Despite this, ‘normal’ levels of motility were previously observed for the ST403CC C. 
jejuni isolates (Chapter Two); it is probable that this apparent absence is in fact due 
to low homology resulting in BLAST similarity not being observed.  The flaA gene is 
known to have highly variable regions, with highly conserved end regions (Chapter 
One; Harrington, Thomson-Carter & Carter, 1997; Meinersmann et al, 1997), it is 
possible that the variation was such that the conserved signature was not detected 
by this method. 
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Using ACT (Artemis Comparison Tool; Carver et al, 2005), Figure 4.18 was produced 
visualising the differences in sequence between the flaA region in C. jejuni 11168 
and ST403CC C. jejuni isolate 857.  Figure 4.18 indicates that the ends of the flaA 
region in C. jejuni 11168 have high similarity with the flaA region in C. jejuni 857, 
however it is clear that the highly variable middle region appears to be missing from 
the ST403CC isolate - this may indicate that the flaA gene has been degraded in C. 
jejuni 857; however this may also potentially be due to mis-assembly during 
reference based assembly of the short-read genome sequence, as previously 
discussed regarding racR.  Investigation of the flaA region in C. jejuni 857 using 
Artemis (Rutherford et al, 2000) revealed that the larger flaA CDS area expected 
appears pseudogenised due to stop codons in the area, leading to the tagged flaA 
coding sequence being shorter (1718bp in 11168, 312bp in 857) as shown in ACT 
Figure 4.18.  As well as the expected neighbouring flaB coding region, C. jejuni 857 
Figure 4.18: Artemis Comparison Tool View of flaA in C. jejuni 11168 & 857. 
The Artemis Comparison Tool (ACT; Carver et al, 2005) output showing the flaA coding region 
in C. jejuni 11168 (top) against the flaA coding region in ST403CC C. jejuni isolate 857. 
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also contained a duplicate predicted flaA region in a different location on the 
chromosome, which is longer (2253bp) and may explain the motile phenotype 
observed in Chapter Two.  As described by Meinersmann & Hiett (2000) flaA is 
found as part of a duplicate region with flaB which allows flagellation alongside 
antigenic phase variation .   
Datta, Niwa & Itoh (2003) observed had high prevalence of pldA in C. jejuni isolates 
included (human clinical isolates 91%, poultry meat and broiler faeces isolates 
100%, bovine faeces 85%), as was found here. 
Finally, wlaN was observed in just 10% of included C. jejuni isolates, with no 
homology in ST403CC strains, and no homology in C. coli strains.  This is consistent 
with literature, as wlaN was also one of the least common virulence genes as tested 
by Datta, Niwa & Itoh (2003) with the highest amount being in the human clinical 
isolates (25%), followed by poultry meat isolates (24%), then bovine faecal samples 
(8%) and broiler faeces (5%).  Linton et al characterised wlaN in 2000, and observed 
it in three of the six isolates included in their study.  It may be concluded that wlaN 
was absent from the database of isolates, with the exception of the ‘self-hit’ in C. 
jejuni 11168 and the high scoring match (1677) in C. jejuni 01/51; a known hyper 
invasive isolate (Javed et al, 2010), despite being absent from the other included 
hyper invasive isolate (C. jejuni 01/51). 
4.4.5 Coding Sequences Variably Present in ST403CC and Non-ST403CC 
Campylobacter Genomes 
The CDS which were determined to be missing from the C. jejuni ST403CC genomes 
may indicate loss of genes no longer required by ST403CC isolates which are 
typically needed by C. jejuni, or by Campylobacters associated with specific host 
types.  It was observed that CDS lacking in ST403CC isolates frequently had 
homologues in both reference C. jejuni and C. coli genomes and represented a 
range of protein functions, particularly membrane associated proteins, transporters 
and potential metabolic proteins.  This may suggest differential metabolic processes 
being used in the ST403CC C. jejuni isolates, however a clear pattern was not 
observed to support the idea that poultry host associated metabolic processes were 
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lost in the potentially porcine adapted ST403CC C. jejuni isolates; the ST403CC 
absent CDS were spread across reference genomes across the different sources and 
host types. 
CDS present in ST403CC and also found in reference genomes may inform upon 
what remains common between these ‘unusual’ isolates and C. jejuni from various 
sources, they may also provide useful information on similarity between the 
ST403CC isolates and references from the porcine or mammalian host, and 
particularly demonstrate commonality between ST403CC C. jejuni isolates and C. 
coli genomes.  The CDS shared between ST403CC C. jejuni and non-ST403CC C. jejuni 
did not exhibit bias towards host source, and were typically spread across a variety 
of diverse origins.  Three CDS were observed which, by EDGAR analysis, were 
present in all ST403CC C. jejuni isolates, with homologues only in C. coli, two of 
which were in only 43% of included C. coli isolates, and were not restricted to a 
single source, and one present in 100% of C. coli genomes.  The presence of these 
hypothetical proteins indicates some similarity between ST403CC C. jejuni and C. 
coli isolates; however it does not confirm increased sharing between ST403CC C. 
jejuni and C. coli as a result of surviving in the typically C. coli associated porcine 
host.  The ‘present non-exclusive’ CDS group did not reveal any CDS with apparent 
links to host type; some CDS showed some bias towards being in human C. jejuni 
isolates, others with predominantly porcine origin in C. coli isolates, however this 
may be attributed simply to the bias induced by the high numbers of isolates from 
these sources.   
The C. jejuni ST403CC ‘exclusive’ CDS; found in all of the ST403CC isolates but 
lacking homologues in the rest of the included genomes may inform of genes gained 
by ST403CC isolates which may potentially aid in, or be related to, host adaptation, 
or may serve as genetic markers for this group of isolates.  BLAST searches carried 
out on the ‘exclusive’ CDS were unable to assign additional functional information 
on the hypothetical proteins, but confirmed the likelihood of the restriction 
modification genes.  Homology for the various CDS was determined in eight C. jejuni 
strains, three C. coli strains, one C. upsaliensis and two H. cinaedi isolates, the 
majority of which had homology with only one or two of the CDS in question, and 
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ranging from a number of sources (human clinical isolates, including a GBS 
associated C. upsaliensis isolate and a H. cinaedi strain associated with bacteraemia, 
chicken meat and faeces, and bovine faeces), however one isolate - C. jejuni 
ATCC33560 - had significant homology with five of the eleven CDS, including two of 
the restriction/modification enzymes.  Further investigation revealed that this 
isolate was in fact also an ST403CC isolate; a newly available sequence for a 
historical strain isolated from bovine faeces in Belgium prior to 1970, which was 
found to be closely related to the porcine source C. jejuni ST403CC isolates at the 
whole genome level, despite the differences in host, time and location.   
These ‘exclusive’ CDS represent only a minimal proportion of the pan genome for 
the 33 isolates, and consisting largely of hypothetical proteins appear relatively 
uninformative, however the evaluation of the role of these CDS leads to two 
potentially important conclusions: the studied ST403CC C. jejuni isolates have each 
acquired a set of restriction modification associated enzymes, which do not have 
homologous genes present in included EDGAR genomes, and following BLAST 
analysis have few high scoring matches in the NCBI database; and the identification 
of a temporally and geographically distinct C. jejuni ST403CC isolate sharing some of 
these ‘exclusive’ CDS. 
4.4.6 Coding Sequences Associated with ST403CC Campylobacter jejuni 
Although it appears unexpected that additional homologues to the ST403CC C. 
jejuni ‘exclusive’ CDS were observed following local database BLAST queries, this 
can be explained by considering the methodology implemented by EDGAR; 
specifically, it iteratively judges each annotated CDS region, recording each CDS 
with significant homology to it.  As stated previously, EDGAR relies upon the tagged, 
annotated CDS, whereas standard BLAST searching as applied in this chapter studies 
homology in raw sequence data, and is not affected by annotation as it uses raw 
fasta format sequence data.  Therefore the additional homologues can be described 
as CDS not annotated in the genbank files used for EDGAR analysis.  This is 
evidenced as the additional homologues were observed in genomes with 
transferred annotations; the annotation applied to C. jejuni 01/51 was transferred 
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from the annotation of C. jejuni 01/10, and the homologue to CJ857_01361 was not 
annotated as it is not present in C. jejuni 01/10.  By the same principle, the 
annotation used to C. coli 03/317 was transferred from the annotated genome of C. 
coli 03/121 - again the CDS (CJ857_01649; CJ857_01723; CJ857_01724) which are 
present on C. coli 03/317 genome were not found in the annotated C. coli 03/121. 
The more detailed analysis carried out here on the ST403CC ‘exclusive’ CDS 
following EDGAR analysis revealed that several of these are potential pseudogenes, 
lacking function, possible evidence of genomic degradation; for example it was 
determined that CJ857_01361 may represent a pseudogenised dicarboxylate 
transporter.  However, there are challenges in ascribing CDS or pseudogenes; given 
the numerous definitions and debate around bacterial pseudogenes it can be 
difficult to assign pseudogenes (Karro et al, 2007), this is particularly difficult for 
hypothetical proteins with unknown function - typically a gene has become a 
pseudogene if it is altered such that it is no longer a functional protein, however this 
can be harder to recognise when the function is unknown – particularly, for 
example, if two short hypothetical proteins are commonly found neighbouring to 
each other, do they represent two parts of a common pseudogene, or are they two 
separate unknown hypothetical proteins? 
Analysis of the ST403CC ‘exclusive’ CDS and their neighbouring regions also 
revealed the possibility that the ST403CC isolates may have gained prophage DNA 
at some stage; as indicated by the presence of intA - a prophage integrase - in the 
region containing CJ857_00839, and also through the region surrounding the 
CJ857_01734 and CJ857_01735 CDS which contains a number of short potential 
coding regions.  This information bears further examination, and the following 
chapter (Chapter Five) will attempt to uncover whether phage may play a role in 
what makes ST403CC C. jejuni isolates different from other C. jejuni. 
The observation of these ST403CC C. jejuni ‘exclusive’ CDS and their possible roles 
as restriction endonucleases, modification methylase and recombination protein 
also warrants further consideration.  The results of this and the previous chapter 
provide evidence that the ST403CC C. jejuni isolates are not undergoing increased 
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genetic exchange with C. coli, however the presence of these specific ‘exclusive’ 
CDS may provide a new explanation for this; CJ857_00896, CJ857_00897, 
CJ857_01724 and CJ857_01735 are homologues of genes associated with 
restriction/modification systems. R/M systems are known to play a role in reducing 
genomic inflow, specifically, they ‘protect’ the genome by preventing the 
integration of new sequence information (Wilson, 1991).  This will be investigated 
subsequently (Chapter Six). 
4.4.7 Summary & Overall Discussion 
Gripp et al (2011) combined virulence studies and genome analysis and were unable 
to find genes related to specific hosts, or demonstrate fixed host adaptation.  
Therefore they concluded that some C. jejuni isolates, and specifically those within 
Sequence Type 21 exhibited the behaviour of a generalist rather than a specialist, 
that is, the variation in host isolates was thought to be linked to variations in 
expression rather than to the loss or gain of coding regions.  It is possible that this 
phenomenon is also occurring in these ST403CC C. jejuni isolates; they may not have 
explicitly altered genome content in order to specialise to the porcine or 
mammalian host, rather they may be capable of generalist survival in a potentially 
non-optimal host. 
The information provided by pan genome analysis has provided new information on 
the genes specific to, and shared by, the ST403CC C. jejuni isolates, however it must 
be acknowledged that the pan genome concept does have its limitations.  It is 
important to consider the fact that, by its nature, the calculated pan genome is 
always dependent on the sample of genomes included; restricted by the number 
and origin of isolates included.  As such, the work presented here is limited by the 
range of reference and target genomes included, however the selected genomes 
were included to represent range of hosts and sources, including well-characterised 
isolates, as well as some automated pipeline output sequences where these 
represented the best available sequences for the host type in question.  It is 
important to acknowledge the potential limitations of the database used, however 
Méric et al (2014), in their work developing new approaches to the problem of the 
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pan genome found that a relatively small number of genomes were able to 
represent a significant portion of the total sample: They estimated a C. jejuni pan 
genome based upon 130 isolates at 3648 CDS, having identified 99% of this total 
using their initial comparison of just 75 C. jejuni genomes, similarly in C. coli the pan 
genome was estimated as 3520 CDS for 62 genomes, 99% of which was established 
by the comparison of just 40 genomes.  It is therefore reasonable to expect that 
although it cannot provide a complete picture, the selection of genomes included 
can provide some useful insight into the characteristics of the query isolates.  In 
order to address the limitations of the pan genome references included, BLASTp 
searching was implemented to consider the prevalence of the ‘exlcusive’ CDS in the 
public NCBI database.  Significant scoring matches were found for each of the 
eleven CDS, however several of these were not in Campylobacter, and each only 
had a small number of matches.  They were CDS with few homologues even across 
the much larger database so considering them ‘exclusive’ or rather ‘associated’ was 
a reasonable step.  BLASTp search results for the eleven ‘exclusive’ CDS confirmed 
the likely function of the four restriction/modification/recombination proteins, 
however the method was unable to provide functional information for the seven 
hypothetical proteins.   
It has also been suggested that the approach of viewing the genome in terms of 
accessory and core genes may be too simple to demonstrate the full picture of how 
genes are shared across a population.  For example, for a sample of five genomes, 
Snipen, Almøy & Ussery (2009) observed a C. jejuni core genome of 847 and pan 
genome of 3221 CDS, whilst their mixture model based predictions estimated a 
likely 470 and 6587 CDS respectively.  Using their multiple component model they 
found that most of their included species had an optimal model with 3 components, 
whilst the remainder had even more; this could indicate that the standard split of 
core and dispensable genes is limited as none of the mixture models were most 
effective with just two components, however it is suggested that this implied 
weakness may be due to skewed data: if several of the included individuals are 
‘related’ in some way; such as pathogenic potential or epidemiology than this may 
create an extra sub-group indicating genes shared across this sub-population. 
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In addition to the caveats surrounding the pan genome concept, there are also 
some limitations to each method used to calculate the pan or core genome.  In this 
instance, EDGAR is reliable in accurately predicting homologues and provides a 
useful picture of the pan or core genome, however it is limited by its requirement 
for annotated genomes meaning that un-annotated genomes cannot be included 
for study, and that the pan genome determined is also restricted by the 
completeness and accuracy of the annotations included, as it runs its iterative 
searching process based on tagged coding regions, and therefore does not consider 
additional non coding sequence. 
In order to support the theory that the ST403CC isolates undergo increased genetic 
exchange with C. coli, it may be expected that a number of CDS would be found to 
be common between the ST403CC isolates and the C. coli reference genomes.  It 
may also be predicted that the ST403CC isolates may share less information with 
the non-porcine C. jejuni isolates.  However, the EDGAR based genome content 
analysis failed to identify significant sharing of homologous CDS between ST403CC 
isolates and C. coli, and few ST403CC absent CDS which are C. jejuni specific.   
In the ST403CC C. jejuni genomes, there is not a clear pattern of the gain of 
mammalian host associated genes, or loss of poultry host associated genes.  
Additionally, the ST403CC C. jejuni isolates do not exhibit a large number of 
homologues shared with C. coli isolates.   
In summary, this chapter has provided estimated core and pan genome information 
for thirty-three C. jejuni and C. coli isolates; this allowed investigation into CDS 
which were absent from, shared in, or exclusive to ST403CC C. jejuni isolates within 
the context of the included genomes.  It was revealed that ST403CC C. jejuni 
isolates, despite sharing a host commonly associated with C. coli isolates, do not 
exhibit evidence of increased C. coli associated content; however the analysis did 
reveal a small number of ST403CC C. jejuni isolates which may play a role in 
recombination of this group of isolates, as well as raising the question of the role of 
potential prophage content in ST403CC C. jejuni isolates. 
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Chapter Five: Prevalence & Influence of  
Integrated Genomic Regions in the ST403CC Campylobacter jejuni Chromosome 
5.1 Introduction 
The uptake of new genomic content from external sources is a key event in 
evolution and adaptation of bacterial strains.  Genetic acquisition occurs by a 
number of means, including horizontal gene transfer between bacterial isolates, 
uptake of phage DNA and integration of plasmids.  The information transferred can 
range from short sequences and individual coding sequences, up to large regions 
such as genomic islands and in some cases can confer a fitness advantage to the 
bacteria.  This chapter uses genome sequence based analysis to investigate the 
imported genetic content of the ST403CC C. jejuni isolates in order to investigate 
the role of ‘foreign’ DNA in these strains. 
The identification of a possible phage integrase gene in ST403CC C. jejuni 857 in the 
neighbouring region of a possible ST403CC group associated CDS highlighted the 
potential role that phage acquisition may have played in separating the ST4303CC 
group from other C. jejuni genomes.  This chapter therefore will focus on phage and 
other foreign DNA in the ST403CC C. jejuni isolates; beginning with assessing the 
prevalence of the integrase identified in C. jejuni 857, and considering the overall 
potential phage or other integrated genomic regions in the ST403CC C. jejuni 
genomes. 
5.1.1 Mechanisms of Horizontal Genetic Transfer 
As mentioned previously, the forms of integrated genetic elements vary in size, type 
and origin.  There exist three major mechanisms for horizontal exchange of DNA in 
bacteria; conjugation, natural transformation and transduction.  Conjugation is the 
direct, active exchange of DNA from a donor to a recipient cell.  Conjugation is 
typically associated with plasmid DNA but also occurs with non-plasmid regions 
known as Integrating Conjugative Elements (ICEs).  Transformation occurs in certain 
bacteria which are able to uptake and integrate external DNA from their 
surrounding environment.  Transduction is the process by which non-viral DNA is 
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shared via viral particles (Burrus & Waldor, 2004; Dale & Park, 2004).  Examples of 
transferrable elements include insertion sequences, transposons, genomic islands 
(GIs), bacteriophages and plasmids (Vernikos & Parkhill, 2006; Hacker & Kaper, 
2000; Dale & Park, 2004).  Insertion sequences (IS) are the most basic mobile 
genetic element; containing a transposase - for the movement of the element, and 
with inverted repeats at either end (one of the targets for identifying inserted 
regions). ISs are usually approximately 1300-1500bp in length but can be longer or 
shorter, and may be present as numerous copies on a genome; for example E. coli 
can hold six copies of IS1 (768bp) as well as numerous copies of other IS elements 
(Dale & Park, 2004).  Insertion sequences can have deleterious effects on genes but 
do not contain additional coding sequence, whereas transposons are essentially IS 
elements which also contain additional genetic content, such as metabolic or 
resistance genes (Dale & Park, 2004).  Genomic islands (GIs) are large elements 
(typically 5-500kbp in length; Langille, Hsiao & Brinkman, 2008), which are 
transferred through HGT, and harbour a group of functionally linked genes, whilst 
pathogenicity islands (PAIs) are a GIs which confer virulence associated genes 
(Vernikos & Parkhill, 2006). 
It is well established that pathogenicity factors can be carried and shared via mobile 
genetic elements, including bacteriophage (once internalised into a bacterium it 
may then be shared to other bacteria via HGT) , transposons, plasmids and more 
recently identified PAIs (Hacker & Kaper, 2000).   
5.1.2 Bacteriophages & Prophages 
Due to the identification of a potential phage gene in ST403CC C. jejuni isolate 857, 
consideration will be given to the prevalence of the intA gene specifically, and to 
establish the presence and influence of phage DNA in the ST403CC C. jejuni isolates.  
In order to consider the role of phage content, these must first be considered in 
further detail. 
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5.1.2.1 Bacteriophages 
Viruses exist which infect all kinds of living cells; bacteriophages, also referred to as 
phages, are virus particles which infect bacterial cells (Dale & Park, 2004).  
Bacteriophages are similar to other viruses, being comprised of a protein coat 
encasing either DNA or RNA sequence, and replicating within a host cell (Dale & 
Park, 2004).  Bacteriophages can be separated into two major groups – lytic phages 
and temperate phages (Zhou et al, 2011).  Temperate phages may also be referred 
to as latent phages or lysogenic phages.   
The main process of the viral life cycle involves lysis of the host cell.  The virus 
particle first attaches to and enters the cell, then following entry, the production of 
‘early’ genes begins, utilising the host’s enzymes; next the viral nucleic acids are 
copied repeatedly at maximal speed and eventually the ‘late’ genes are expressed – 
those involved in producing new phage particles, before finally the progeny phages 
are built and released through the lysis of the host cell (Birge, 1994; Dale & Park, 
2004).  This typical progression of viral infection can also be described as the lytic 
cycle, and is the most common outcome of bacteriophage infection, however the 
temperate phages are able to enter a lysogenic phase within the host cell, at which 
time the viral DNA is preserved as a prophage – the viral nucleotide sequence is 
integrated into the DNA sequence of the host cell and is replicated at the same rate 
as the host cell (rather than at the unrestricted rate seen during lytic growth) and is 
passed onto each bacterial daughter cell as part of the bacterial chromosome, thus 
being maintained within the bacterial strain (Birge, 1994; Campbell, in Neidhardt et 
al (Eds), 1996; Dale & Park, 2004). 
5.1.2.2 Prophages: Integrated Bacteriophages 
A phage which has been integrated into the host genome is referred to as a 
prophage, whilst a prophage which has been inactivated and is no longer capable of 
entering the lytic infectious cycle is known as a cryptic prophage (Birge, 1994; 
Campbell, in Neidhardt et al (Eds), 1996; Casjens, 2003).  Once a temperate phage 
has become a prophage within a host cell, the prophage is able to preserve its own 
presence within the host DNA by producing a protein repressor in order to prevent 
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the transcription of the phage ‘late’ genes, including the structural proteins.  When 
the lysogenic phase has been entered, the lytic cycle does not resume unless 
triggered by some outside factor (Birge, 1994; Campbell, in Neidhardt et al (Eds), 
1996), as a result prophages can persist within the bacterial genome for significant 
periods of time.  Whilst they are behaving as part of the host sequence however, 
prophage genes can be lost in the same way as any other coding sequence – they 
are subject to the same mutation, degradation and recombination pressures as any 
other part of the host DNA (Birge, 1994).  Cryptic prophages can still play a 
significant role in the host bacteria as they may still harbour functional bacterial 
genes (Zhou et al, 2011). 
5.1.3 Identifying Prophages & other HGT Elements 
Traditionally, identifying prophages relied upon inducing lysis by damaging the 
bacterial host cell; however this was experimentally demanding, and limited to 
prophages which remain fully intact and functional, also not all prophages can be 
induced by the same conditions (Zhou et al, 2011, Campbell, in Neidhardt et al 
(Eds), 1996).  With the advance of sequencing techniques, genomic methods were 
developed to circumvent the restrictions of laboratory identification of prophages; 
typically these methods involved the examination of known potential attachment 
sites, or the identification of atypical nucleotide content which may represent 
prophage DNA, however each of these approaches also suffer weaknesses, due to 
the fact that prophages do not always use consistent integration sites, and may not 
always indicate abnormal sequence.  In order to investigate possible prophage 
content without encountering these difficulties, this project makes use of PHAST 
(PHAge Search Tool; Zhou et al, 2011), which attempts to address these previous 
limitations and provides rapid results at a degree of accuracy comparable or 
superior to other current methods (Zhou et al, 2011). 
As described previously however, prophages are just one means by which ‘foreign’ 
DNA may be internalised into the bacterial genome.  Alienhunter (Vernikos & 
Parkhill, 2006) uses IVOM (Interpolated Variable Order Motifs) methods to 
investigate integrated DNA, with particular focus on genomic islands.  Many genes 
178 
 
acquired through horizontal transfer HGT have negative effects and will cause 
bacteria to be lost from the population, some can appear neutral, conferring no 
advantage or disadvantage therefore not coming under selective pressure, the 
persistence of these depends largely on luck. Finally there are those HGT events 
that confer an advantage to the recipient isolate, or those which are able to elicit 
their own maintenance and propagation – these can be shared quickly across a 
population (Thomas & Nielsen, 2005). 
Transferrable elements, particularly GIs, often have clear motifs, such as direct 
repeats or inverted repeats, and various methods exist to identify these regions and 
predict ‘foreign’ regions of genomic content.  Vernikos & Parkhill (2006) developed 
a modern approach which does not reply upon high quality annotation already 
being completed for a genome, and utilises new techniques to improve the 
prediction of ‘alien’ sequence. 
5.1.4 Bacteriophages in Campylobacter  
Having described briefly the general characteristics of integrated genomic DNA it is 
now important to consider integrated DNA in Campylobacter as described in the 
literature.  The majority of known Campylobacter bacteriophages are lytic phages 
(Sails et al, 1998), however it has long been established that Campylobacter may 
also harbour lysogenic phage.  In 1968 Firehammer & Border demonstrated an 
inducible lysogenic prophage from a cattle origin ‘Vibrio fetus’ (now classified as 
Campylobacter fetus, as described in Clark & Ng, 2008). 
Campylobacters regularly encounter lytic bacteriophages during colonisation of the 
avian intestinal system.  Scott et al (2007) investigated phage survival and the 
response to phage ‘attack’ and demonstrated that C. jejuni isolates which colonised 
chickens represented a distinct phage resistant type which undergo genomic 
rearrangements in response to phage.  These isolates undergo intra-genomic 
inversions in sections of sequence between integrated Mu-like phage sequences 
within their chromosomes, causing the inversion of large segments of the genome.  
These modified isolates then exhibit a clear phenotype; they are resistant to phage 
infection, are poor colonisers of the chicken gut, and produce infectious virions of 
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the phage CampMu.  Scott et al (2007) also demonstrated that this was a reversible 
event, with the original phage sensitive type being restored by passage through the 
chicken gut. 
Bacteriophages have also been considered as potential therapeutic agents for 
Campylobacter infection in the face of rising antimicrobial resistance (Connerton, 
Timms & Connerton, 2011) and form the basis of a typing system (Sails et al, 2008).   
The presence of temperate phage in Campylobacter was not well established until 
the availability of genome sequence data in recent years revealed that prophages 
were present in some but not all strains (Fouts et al, 2005; Connerton, Timms & 
Connerton, 2011).  The Myoviridae are the most common group of bacteriophages 
found in Campylobacter, these can be split into four groups; three groups of lytic 
virions (described by Sails et al, 1998 in typing scheme) and the latent group 
(Connerton, Timms & Connerton, 2011). 
In recent years various studies have investigated the presence and content of 
integrated elements in Campylobacter genomes, including notable works by Fouts 
et al (2005), Parker et al (2006) and Clark & Ng (2008).   
Fouts et al (2005) investigated the genome content of four Campylobacter isolates 
from different species (C. coli strain RM2228; C. jejuni RM1221; C. lari strain 
RM2100 and C. upsaliensis strain RM3195) with a focus on identifying the major 
sequence differences between them.   Amongst their discoveries was the 
recognition of four integrated elements within the genome of C. jejuni RM1221, 
termed CJIE (Campylobacter jejuni Integrated Elements) 1-4, the content of which 
was described in detail (Fouts et al, 2005; Parker et al, 2006). CJIE1 was found to be 
a Mu-like prophage region, designated CMLP1 (Camyplobacter Mu-like phage one).  
CJIE2 may represent either a cryptic prophage, or a non prophage genomic island, 
as it did not display any recognised capsid, scaffold or portal phage proteins.  CJIE3 
likely represents a genomic island or possibly an integrated plasmid region as it 
does not contain any prophage proteins.  CJIE4 contained potential phage related 
proteins including methylases, endonucleases and repressor proteins, however the 
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region lacked most prophage structural proteins.  CJIE4 also showed some 
homology with C. lari RM2100 prophage element. 
Parker et al (2006) followed on from the work conducted by Fouts et al in 2005, 
investigating the prevalence of the C. jejuni RM1221 CJIE regions across a group of 
67 C. jejuni and 12 C. coli isolates using PCR, as well as a DNA microarray based 
upon both C. jejuni 11168 and RM1221 sequences.  Parker et al (2006) 
demonstrated that, of their study group, 27% of C. jejuni isolates contained two or 
more RM1221 CJIEs and 55% of C. jejuni isolates contained at least one RM1221 
CJIE-like region.  Additionally, 58% of the included C. coli were positive (by PCR) for 
one of the four RM1221 CJIEs – always either CJIE1 or CJIE3.  Additionally they 
showed that in all C. jejuni isolates containing CJIE/CMLP1, it occupied a different 
chromosomal location; demonstrating that this phage (and potentially others) can 
be located at varying sites, adding to the potential for resulting variation. 
Clark & Ng (2008) used southern blotting techniques to investigate the prevalence 
of the seven individual prophage genes present in C. jejuni RM1221 CMLP1; 
demonstrating that within their population of 35 C. jejuni isolates 77% with one or 
more gene, and 43% with five or more, leading them to conclude that CMLP1 
(CJIE1) represents an individual example within a family of phages which exist 
within C. jejuni. 
Barton et al (2007) conducted a study based upon the Mu-like phage described by 
Fouts et al (2005) investigating via PFGE the content of C. jejuni isolates from a 
water-borne outbreak, and demonstrated that the difference in PFGE patterns for 
four water-borne outbreak isolates was caused by the differential presence of 
phages and showed that prophages may have a role in adaptive C. jejuni biology in 
addition to natural transformation. 
5.1.5 Aims 
Integrated genomic DNA from bacterial and viral sources has been demonstrated to 
play a role in adaptation and variation in bacteria, and is known to occur within C. 
jejuni.  Data revealed in Chapter Four indicated the possible presence of prophage 
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DNA within the ST403CC C. jejuni isolates.  As such the goal of this chapter is to 
utilise sequence based techniques to investigate the prevalence and potential 
influence of prophages or other integrated genomic elements in the evolutionary 
separation of the ST403CC C. jejuni isolates from other C. jejuni. 
5.2 Methods 
In this chapter a range of sequence based methods are combined to investigate the 
presence of ‘foreign’ DNA content within the genomes of potentially host adapted 
ST403CC C. jejuni isolates. 
This process will consider the presence and content of any integrated phage 
sequence, and investigate other inserted elements such as IS, transposons or 
genomic islands. 
5.2.1 Investigating the intA Gene 
The predicted prophage integrase gene intA was observed in C. jejuni 857 during 
investigation of regions surrounding ST403CC ‘exclusive’ genes - CDS identified 
during pan genome analysis which were common to all six included ST403CC C. 
jejuni isolates and with homologues not present within the included C. jejuni and C. 
coli reference genomes.  Firstly, in order to determine the prevalence of intA across 
the six ST403CC C. jejuni genomes, and to investigate the content of the 
neighbouring sequences, regions were examined using Artemis viewer (Rutherford 
et al, 2000) as described previously.  The annotated genomes were searched using 
the ‘go to’ feature built into Artemis (Goto Feature with Gene Name) to quickly 
locate intA, and the surrounding area viewed for other CDS of potential relevance.  
This was done using annotations transferred from the PROKKA annotation 
(Seemann, 2014; using RATT; Otto et al, 2011) of ST403CC C. jejuni isolate 857, in 
order to maintain the same CDS tags and annotation.  
Local database similarity searches were carried also carried out, using BLASTn, as 
introduced in Chapter Four (Altschul et al, 1990).  Local BLAST database searches 
were conducted using nucleotide BLAST, and the intA sequence was used as taken 
from C. jejuni strain 857 and queried against the 34 genome local database 
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containing genome sequence for the 33 genomes included in phylogenetic and pan 
genome analysis (Table 3.1; Appendix 9.1), as well as the additional historical 
ST403CC C. jejuni isolate ATCC33560. 
5.2.2 Identifying Prophage Content 
To investigate prophage content in the ST403CC C. jejuni isolates, PHAST (Zhou et al, 
2011) was run using the browser based service 
at http://phast.wishartlab.com/index.html submitting each sequence individually. 
5.2.2.1 Improved Annotation for PHAST Analysis 
Each of the six ST403CC C. jejuni genomes was annotated using PROKKA (Seemann, 
2014) to produce the genbank format annotated files used for PHAST investigation.   
5.2.2.2 PHAST Analysis of Prophage Content 
To investigate the consistency of the method, both ‘raw’ FastA and annotated 
genbank format files were used and received consistent results; subsequently, 
results obtained using the genbank format files were used for analysis and 
discussion in order to relate to the annotated genomes.  For C. jejuni isolate 
ATCC33560 files were used by submitting the unannotated genome via genbank 
accession 380625642. 
5.2.3 Identifying Integrated Genomic Content using AlienHunter  
Alienhunter (Vernikos & Parkhill, 2006) was run with command line using fasta files, 
and the output was read into the annotated genome sequence in Artemis 
(Rutherford et al, 2000). 
5.3 Results 
The determined foreign DNA content for C. jejuni ST403CC isolates is described in 
this section, beginning with a summary of the intA related content using Artemis 
(Rutherford et al, 2000) and local database BLAST searches (Altschul et al, 1990) and 
followed by detailed information provided by PHAST (Zhou et al, 2011) and 
AlienHunter (Vernikos & Parkhill, 2006) analysis. 
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5.3.1 Prevalence of intA 
As described previously, the presence of intA detected in ST403CC C. jejuni isolate 
857 in Chapter Four lead to interest in prophage regions in ST403CC genomes.  The 
first step taken was to confirm whether intA homologues existed in all sequenced 
ST403CC C. jejuni isolates, and to investigate the surrounding regions in the 
genomes for additional prophage associated content, as well as considering the 
prevalence of this gene amongst non-ST403CC C. jejuni or C. coli genomes. 
As shown in Table 5.1, a homologue of C. jejuni 857 intA gene was observed in each 
included ST403CC C. jejuni isolate.  The intA coding sequence was found to be a 
consistent length (627bp, 208aa) in the six newly sequenced ST403CC C. jejuni 
isolates, however some variation was observed in its location and the neighbouring 
CDS.  In C. jejuni strain 857, intA is located between CJ857_00834 (downstream) and 
xerD_2 (upstream).  This same organisation is also observed in 549.1, 623, 304 and 
444 (although the neighbouring region is more heavily pseudogenised in 444).  The 
same pattern is not observed for strain 484 however, where intA is found at a 
distinct and distant site.  
In the case of C. jejuni 484, CJ857_00839 (an ST403CC ‘exclusive’ gene as described 
in Chapter Four) and xerD_2 are still found located close to each other, and intA is 
still a direct neighbour of CJ857_00834, however it is also linked to possible 
pseudogene CJ857_01602 on the complementary strand (Figure 5.1).  CJ857_01602 
is also in the region in C. jejuni 444 however it is upstream of intA in this case and 
remains frameshift pseudogeneised but with CJ857_00839 overlapping.  
It was noted that in each case the region surrounding intA tended to be made up of 
hypothetical proteins likely to be pseudogenes or fragments, including one of the 
previously identified ‘ST403CC exclusive’ CDS, however no additional prophage 
linked CDS were observed.   
In Figure 5.1 additional potential ORFs can be seen - these were not annotated due 
to the transference of annotation from C. jejuni 857 to C. jejuni 484 which simply 
transferred the initial annotation, and cannot ascribe new ORFs; however, NCBI 
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nucleotide BLAST searches were carried out and these ORFs would only represent 
additional hypothetical protein regions, and therefore do not significantly affect the 
investigation. 
 
 
 
 
 
 
 
 Nucleotide BLAST queries were run against the local databases to investigate 
whether intA was specific to the ST403CC C. jejuni isolates (full output for local 
database BLAST queries are included in Appendix 9.4).   
Isolate Size (bp) Location 
Downstream 
Neighbour 
Upstream 
Neighbour 
C. jejuni 857 627 774069..774695 CJ857_00834 xerD_2 
C. jejuni 549.1 627 581511..582137 CJ857_00834 xerD_2 
C. jejuni 623 627 731890..732516 CJ857_00834 xerD_2 
C. jejuni 304 627 1061331..1061957 CJ857_00834 xerD_2 
C. jejuni 484 627 805772..806398 CJ857_00834 CJ857_01602 
C. jejuni 444 627 776779..777405 CJ857_00834 xerD_2 
 Table 5.1: Presence of the intA Gene in ST403CC C. jejuni Isolates 
Comparing the sequence length, location and neighbouring CDS of the predicted intA gene in 
ST403CC C. jejuni isolates 
a 
Figure 5.1: The intA Gene in ST403CC C. jejuni Isolates 857 & 484 
intA coding sequence in a) 857 and b) 484.  Other ST403CC C. jejuni isolates also possess intA 
homologue in highly similar location and configuration as 857. 
 b 
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The ‘self-match’ score for C. jejuni 857 intA gene (1158) was closely matched by all 
other ST403CC isolates (range 1153-1158, mean 1156). Additional matches were 
observed however, one in C. jejuni 1336 (score 957) and in C. coli 67-8 (score 1079), 
2685 (score 1024), 80352 (score 1079), LMG9860 (score 1068; range 1024-1079, 
mean 1063).  The presence of intA was shown to be common to all sequenced 
ST403CC C. jejuni isolates, but also occurs in other non-ST403CC C. jejuni and in C. 
coli.  These isolates represent diverse host types; C. jejuni 1336 is a wildlife 
associated isolate (French et al, 2005) whilst C. coli 67-8 is porcine, C. coli 2685 is 
from turkey, C. coli 80352 is from chicken, and C. coli LMG9860 is a human isolate 
(Lefébure et al, 2010). 
Although the intA gene did not appear to be associated with additional phage DNA 
in ST403CC C. jejuni isolates, it was still considered worth-while to conduct analysis 
of possible prophage content in the ST403CC isolate genomes.  First using PHAST to 
look for specifically for the presence of prophage and subsequently using 
AlienHunter to confirm results from PHAST and consider other kinds of foreign DNA 
including integrated elements and plasmid associated content. 
5.3.2 PHAST Analysis & Prophage Content 
PHAST provided overview images for each isolate; showing a circular genome 
diagram indicating the presence, location and status of prophage content (Figure 
5.2).  As Figure 5.2 shows, at least one prophage region was predicted for each of 
the porcine origin ST403CC isolates, however no prophage region was identified in 
the historical, bovine ST403CC isolate ATCC33560.  As shown in the legend, PHAST 
indicates the possible status of a prophage region as intact (red colour), incomplete 
(grey) or questionable (green); each of the ST403CC porcine C. jejuni isolates 
contained at least one potential intact prophage region, whilst some strains 
contained additional intact or incomplete prophage regions. 
Considering each isolate individually, C. jejuni 857 had only one phage region, which 
was determined to be an intact region of approximately 8kbp, whereas C. jejuni 
strain 549.1 contained three prophage regions; regions one (28118bp) and three 
(6792bp) were designated as intact prophage, whilst region two (18799) was 
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considered incomplete.  Strain 623 was found to carry two intact predicted phage 
regions, measuring approximately 31 and 5kbp.   
  
  
  
 
a 
 
Figure 5.2：Overview of Prophage Content in 
ST403CC C. jejuni Isolates as Determined by PHAST 
PHAST output images showing circular genome with 
identified prophage regions. 
a. C. jejuni 857 
b. C. jejuni 549.1 
c. C. jejuni 623 
d. C. jejuni 304 
e. C. jejuni 484 
f. C. jejuni 444 
g. C. jejuni ATCC33560 
b 
c d 
e f 
g 
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Strain 304 contained three observed phage regions of approximately 13, 42 and 
5kbp in length respectively, the first of which was incomplete, with the remaining 
two being considered intact.  Strain 484 had two phage regions, both intact, at sizes 
of 49 and 19kbp respectively.  Finally, strain 444 contained only one predicted 
phage region, with a length of around 5kbp and predicted to be an intact prophage 
region. 
In summary, two of the porcine ST403CC C. jejuni isolates (857 and 444) were 
thought to have only one (intact) prophage region, two (623 and 484) were 
observed as having two (intact) prophage regions, whilst the final two strains (549.1 
and 304) each contained three predicted prophage regions; two intact and one 
incomplete.   
The circular genome diagrams produced by PHAST provided a useful overview of 
the potential phage content of ST403CC C. jejuni isolates; below these regions are 
discussed in greater detail. 
As stated previously, each of the porcine ST403CC C. jejuni isolates contained at 
least one intact prophage region; further investigation showed that this 
represented a common prophage: with matching sequence in Enterobacteriaceae 
phage F1 sensu lato, a group IV RNA phage (Figure 5.3).  The PHAST predicted F1 
prophage regions range from 5389-19215 bp in length, with between 6 and 12 
predicted coding sequences.  The length is skewed somewhat by strain 484 - which 
registered a distant phage attachment site as part of the same phage region - if this 
were discarded from consideration the predicted phage region would be 
approximately 9kbp.  Table 5.2 summarises the size and predicted content of the 
type Enterobacteriaceae F1 phage compared to that F1 prophage region predicted 
in each ST403CC isolate. 
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Figure 5.3a: Content of Common Prophage Region in ST403CC C. jejuni Isolates 
PHAST regions identified by similarity with Enterobacteriaceae phage F1 sensu lato for 
isolates a) C. jejuni 857, b) C. jejuni 549.1, c) C. jejuni 623 
a 
b 
c 
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Figure 5.3b: Content of Common Prophage Region in ST403CC C. jejuni Isolates 
PHAST regions identified by similarity with Enterobacteriaceae phage F1 sensu lato for 
isolates a) C. jejuni 304, b)C. jejuni 484, c) C. jejuni 444 
a 
b 
c 
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The reference genome for Enterobacteriaceae phage F1 sensu lato is 4276bp in 
length, with three coding regions - a maturation protein, a phase-variable coat 
protein, and the replication protein (Inokuchi et al, 1988), whereas the ST403CC 
regions were tagged with considerably more potential coding regions.  The coding 
content is described in further detail later in the section. 
Figures 5.3a and 5.3b provide detailed PHAST output on the Enterobacteriaceae F1 
phage region identified in each of the porcine ST403CC C. jejuni isolates.  The 
majority of the coding regions tagged by PHAST in the Enterobacteriaceae phage F1 
were categorised as ‘other phage like protein’, some of these have more detailed 
descriptions in the comprehensive PHAST output, however in order to give a more 
detailed picture of the regions, PROKKA annotations were combined in the analysis 
of the region. 
Sequence F1 sensu lato 857 549.1 623 304 484 444 
Length (bp) 4276 7963 6792 5389 5464 19215 5458 
#CDS 3 8 9 6 7 12 7 
 
 
 
 
The identified Enterobacteriaceae prophage F1 region observed in the porcine 
ST403CC C. jejuni isolates contained between 6 (strain 623) and 12 (strain 484) CDS 
according to PHAST study (mean number of CDS; 8).  Considering the PROKKA 
annotation of these regions, the number of CDS observed remained consistent for 
strains 857, 549.1, 623, 304 and 444, however the region described by PHAST in 
strain 484 contained a number of additional predicted coding regions within the 
large empty space observed by PHAST, where PHAST identified 12 potential 
prophage coding regions, PROKKA identified a total of 24 potential coding regions, 
including xerD_2, two flagellin proteins, glycosyltransferase family two protein, 
carbon starvation protein A and general stress protein A, guanylate kinase gmk, 
 
Table 5.2: Prophage Region Common to ST403CC C. jejuni Isolates 
Comparing the sequence length and content of the predicted phage region shared by the 
ST403CC C. jejuni isolates against the original phage identified as a potential match. 
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twin arginine translocase protein A, arginine tRNA ligase, and two spermidine 
export proteins mdtI and mdtJ, as well as 8 hypothetical proteins. 
Considerable similarity was observed for the F1 prophage region across the isolates; 
homologues of ‘bacteriophage scaffolding protein D’, ‘microvirus J protein’, ‘capsid 
protein (F protein)’, ‘major spike protein (G protein)’ and ‘microvirus H protein 
(pilot protein)’ were found in all six of the ST403CC isolates.  Additionally 
‘bacteriophage replication gene A protein GPA’ was found in five of the six porcine 
ST403CC isolates, lacking a homologue only in C. jejuni 484.  Additional content 
included hypothetical proteins in C. jejuni strains 857, 549.1 and 484, a ‘phosphate 
import ATP-binding protein pstB’ in strain 549.1 and numerous additional isolates 
were observed in strain 484 as described above. 
Whereas ST403CC C. jejuni strains 857 and 444 contained only the 
Enterobacteriaceae phage F1, the remaining four isolates contained either two or 
three prophages in total.  Two prophages were identified which were each shared 
by two of the ST403CC porcine C. jejuni isolates.  The first of these was 
Enterobacteriaceae prophage Fels_2. 
Enterobacteriaceae phage Fels_2 matching regions were identified in C. jejuni 549.1 
and 623, as shown in Figure 5.4 with lengths of 28118bp and 31087bp and with 44 
and 49 coding sequences respectively identified by PHAST; the 44 coding sequences 
are identical between the two, with 623 having an additional five coding sequences 
at the upstream end of the phage region, each of which are considered hypothetical 
proteins by PHAST.   
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The second prophage which was determined to be common to two of the six 
porcine ST403CC C. jejuni isolates was the prophage Haemophilus phage SuMu.  
PHAST analysis identified regions matching Haemophilus phage SuMu in both C. 
jejuni 549.1 and 484, as shown in Figure 5.5.  The region is approximately 18kbp in 
a 
b 
Figure 5.4: Content of Prophage Region Observed in ST403CC C. jejuni Isolates 549.1 & 623 
Regions identified as related to Enterobacteriaceae prophage Fels_2 in C. jejuni strains a) 
549.1 and b)623. 
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549.1 and 49kbp in 484, with the regions having 15 and 58 coding sequences, 
respectively.  
 
a 
b 
 
Figure 5.5: Content of Prophage Region Observed in ST403CC C. jejuni Isolates 549.1 & 484 
Prophage region SuMu matches in a)549.1 and b)484. 
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PHAST tagged 58 CDS for the 484 version of SuMu, whereas PROKKA annotation of 
the same area tagged 72 CDS.  Two of the PHAST CDS (CDS one and fifty eight, the 
Att proteins) do not have corresponding annotation in PROKKA annotation, 
however the PROKKA annotation has 16 additional CDS not tagged by PHAST at the 
downstream end (between where the Att ‘should be’ and the second PHAST CDS 
(PLP) which corresponds to CJ484_00217).  Ten PHAST CDS are shared between the 
549.1 and 484 SuMu prophage regions; CDS one to ten in 549.1 match CDS 49-58 in 
484.  Additionally, the main ‘body’ of the SuMu prophage region in 484 is strikingly 
similar to the Fels_2 region previously described; PHAST CDS 1-46 of strain 623 
Fels_2 region correspond (by prokka annotation) to CDS 2-47 of SuMu in strain 484.   
Finally there were also two phage types which were observed only in one of the 
ST403CC isolates, both of which were observed within strain 304.  These included 
Mannheimia phage phiMHaA1 (Figure 5.6) and Synechococcus phage S-SKS1 (Figure 
5.7). 
In ST403CC C. jejuni isolate 304 the first additional prophage matched with 
Mannheimia phage phiMHaA1, and was 13493bp in length, with 16 coding 
sequences described by both PHAST and PROKKA. 
Figure 5.6: Content of First Prophage Region Observed in ST403CC C. jejuni Isolate 304 
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The second prophage region associated only with ST403CC C. jejuni isolate 304 
recorded similarity with Synechoccus phage S-SKSI, is 42706bp in length and has 64 
coding sequences identified by both PHAST and PROKKA.  In PHAST analysis the S-
SKSI region was found to be bookended by a pair of Att proteins, however these 
were not identified by PROKKA, in fact they lay within larger CDS by this means of 
annotation (a hypothetical protein at PHAST CDS one and a putative transcriptional 
regulatory protein at CDS 64).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.3 provides an overview of the predicted prophage content recorded in 
ST403CC C. jejuni isolates, as predicted by PHAST (Zhou et al, 2011). 
 
 
 
Figure 5.7: Content of Second Prophage Region Observed in ST403CC C. jejuni Isolate 304 
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Strain #CDS Region Length 
Phage 
Similarity 
GC 
Percentage 
Genome GC 
Percentage Phage State 
857 8 7963 Enterobacteria FI sensu lato 38.36% 30.06 Intact 
549.1 
44 28118 Enterobacteria Fels 2 30.67% 
30.08 
Intact 
13 18799 Haemophilus SuMu 30.45% Incomplete 
9 6792 Enterobacteria FI sensu lato 41.45% Intact 
623 
49 31087 Enterobacteria Fels 2 29.97% 
30.02 
Intact 
6 5389 Enterobacteria FI sensu lato 44.57% Intact 
304 
16 13493 Mannheimia phiMHaA1 28.33% 
29.97 
Incomplete 
62 42693 Synechococcus S-SKS1 29.84% Intact 
7 5464 Enterobacteria FI sensu lato 44.66% Intact 
484 
56 49181 Haemophilus SuMu 29.46% 
30.23 
Intact 
10 19203 Enterobacteria FI sensu lato 32.72% Intact 
444 7 5458 Enterobacteria FI sensu lato 44.61% 30.01 Intact 
ATCC33560 0 0 0 0 - None 
 
 
 
5.3.3 Integrated Genomic Content & AlienHunter 
Having considered results from initial impressions using Artemis and BLAST, and 
following the more detailed, prophage focused, approach of PHAST the final 
method employed was AlienHunter, which as stated previously looks for all sections 
of nucleotide sequence of potentially ‘outside’ sources, this would include prophage 
but also genomic islands and other inserted regions.  Results from AlienHunter are 
summarised in Table 5.4. 
As previously described, AlienHunter (Vernikos & Parkhill, 2006) produces output 
which can be read into Artemis (Rutherford et al, 2000) over annotated sequence 
files, to aid further investigation into location and content of potential ‘foreign’ 
regions. 
Table 5.3: Summary of Prophage Regions Identified by PHAST Analysis in ST403CC C. jejuni 
Isolates 
Displaying the number, size, status and content of each predicted prophage region in investigated 
ST403CC C. jejuni isolates. 
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Isolate Number of AlienHunter Regions 
C. jejuni 857 81 
C. jejuni 549.1 82 
C. jejuni 623 64 
C. jejuni 304 81 
C. jejuni 484 64 
C. jejuni 444 45 
C. jejuni ATCC33560 66 
 
 
 
 
Visual AlienHunter results were colour coded from white through pink to red, with 
darker regions (red) representing higher scores indicating more divergent regions 
and paler colours indicating lower divergence, higher similarity to the host genome. 
As shown in Figure 5.8, overleaf, AlienHunter found a considerable number of 
potential inserted regions across each of the ST403CC C. jejuni isolates including 
ATCC33560 (range 45-82, mean 69). 
5.3.4 Relating PHAST & AlienHunter Prophage Results 
In order to relate the results of AlienHunter with those from PHAST, in this section 
the overlap between PHAST and AH described regions are investigated.  Firstly 
considering C. jejuni ST403CC isolate 857 as stated previously contained one 
identified prophage region, with homology to Enterobacteria phage F1, located 
between 1537380 and 1545342 on the chromosome.  This region maps almost 
exactly with an identified ‘alien’ region from AH results; AH region 61, existing at 
bases 1537500 to 1550000.   
 
 
 
Table 5.4: Integrated Regions in ST403CC C. jejuni Isolates Predicted by Alien Hunter Analysis 
Displayed are the number of predicted ‘alien’ regions determined by the AlienHunter 
software in each of the studied ST403CC C. jejuni isolates. 
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Figure 5.8: Integrated Regions Predicted by 
AlienHunter Analysis of ST403CC C. jejuni Isolates 
AlienHunter output images showing circular 
genome with identified integrated regions. 
a. C. jejuni 857 
b. C. jejuni 549.1 
c. C. jejuni 623 
d. C. jejuni 304 
e. C. jejuni 484 
f. C. jejuni 444 
g. C. jejuni ATCC33560 
 
a b 
c d 
e f 
g 
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Strain 549.1 also demonstrated some agreement between PHAST and AlienHunter; 
the F1 phage region (1631853..1638644bp) is contained within AlienHunter region 
76 (1627500..1642500), whilst both the Fels_2 and SuMu regions were found to be 
associated with AH region 71; Fels_2 (1444573..1472690) displayed partial overlap 
with AH region 71, whilst SuMu (1474716..1493526) was contained within the AH71 
region (1465000..1532500).  For strain 623 however no such association was 
observed, for both F1 (1588403..1593791) and Fels_2 (106664..137750) no 
corresponding region was observed by AlienHunter investigation.  Strain 304 had 
mixed results; as with 623 there was no corresponding AH region for 304’s F1 region 
(1579279..1584742), however both the Mannheimia phage region 
(906613..920105) and Synechococcus region (1422807..1465512) were associated 
with AlienHunter regions; the Mannheimia phage contained AH region 40 
(907500..912500) whilst the Synechococcus region contained both AH region 64 
(1432500..1437500 ) and region 65 (1440000..1450000).  Isolate 484 recorded 
Alienhunter region matches for both PHAST prophage regions; F1 
(1656603..1675817) contained region AH 62 (1662500..1667500) and SuMu region 
contained AH 8 (210000..215000).  Finally, strain 444 also contained agreement 
between PHAST and AlienHunter, with its F1 prophage region (1783373..1788830) 
contained within Alienhunter region 45 (1777500..1800282).  It was also noted that 
intA was not located within the AlienHunter identified ‘foreign’ regions. 
5.3.5 Summary of Results 
In summary, the phage associated gene intA was confirmed present in each of 
theST403CC C. jejuni isolates, however it was also found in one other C. jejuni 
isolate included in the study, and four C. coli isolates.  The location of intA showed 
some variation in location and surrounding CDS within the ST40CC C. jejuni isolates, 
however it was commonly associated with a second copy of xerD_2 and 
CJ857_00839.   
Potential prophage regions were observed in each of the porcine ST403CC C. jejuni 
isolates, however no prophage regions were observed in bovine ST403CC C. jejuni 
isolate ATCC33560.  Each of the six ST403CC isolates shared one common called 
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region, with some strains having just this one region and others containing upto 
three potential prophage regions; further consideration of the origin and impact of 
these regions is discussed below.  
Additional predicted integrated regions were identified by study with AlienHunter, 
which showed some agreement with PHAST prophage results, but did not indicate 
the presence of an integrated region containing the intA homologue. 
5.4 Discussion 
It was established in this chapter that ST403CC C. jejuni isolates contain predicted 
integrated genomic regions, including but not limited to potential prophage regions.  
The contents of these regions were described, however further discussion is 
required to establish potential implications of these regions and their contents in 
order to draw conclusions.  
5.4.1 Prevalence of intA  
The intA homologue observed in ST403CC C. jejuni strain 857 led to the 
investigation of the possibility of prophage content within the ST403CC C. jejuni 
isolates.  The gene intA is a prophage integrase, also referred to as intX or slpA, 
described by Blattner et al (1997) in their annotation of the genome sequence of E. 
coli strain K12, located on the prophage CP4-57 (as described by first observed by 
Kirby, Trempy & Gottesman (1994) who identified CP4-57 (cryptic P4-like prophage 
at minute 57).  A potential homologue of intA (CJ857_00835) was present in each 
(porcine) ST403CC isolate (local blast also confirmed presence in ATCC33560), 
although the region surrounding it varied between strains (for C. jejuni 857, 623, 
549.1, 304 and 444 intA was between CJ857_00834 and xerD_2, whilst in 484 it was 
at a divergent region, and still neighboured with CJ857_00834, though xerD_2 and 
rest of region were still at the ‘normal’ location as in the other five).  In each case 
the CDS near intA are largely hypothetical, and probably represent pseudogenes.  
Local database BLAST searches showed that intA homologues were present in one 
of the thirteen included non-ST403CC C. jejuni isolates, and four of forty-eight C. coli 
genomes.  The presence of intA was not associated only with ST403CC C. jejuni 
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isolates, and was also not associated with a specific host type, with the intA positive 
strains coming from a variety of sources; C. jejuni 1336 was first isolated by French 
et al (2005) during a UK MLST study investigating association of specific sequence 
types with certain environments, and was subsequently investigated further by 
Hepworth et al (2011) using comparative genomic hybridisation, and genome 
sequencing, and was described as a representative isolate from a group of water 
and wildlife isolates; whereas C. coli isolates 67-8, 2685, 80352 and LMG9860 were 
each sequenced as part of a large sequencing project by Lefébure et al (2010) 
investigating the genome dynamics of C. coli and C. jejuni, each representing 
different source types (swine, turkey, chicken, human). 
The neighbouring region surrounding intA consisted largely of short potential 
coding sequences, mostly described as hypothetical proteins and also including in 
each case a second copy of xerD, a tyrosine recombinase.  In five of the six porcine 
ST403CC isolates, the neighbouring region also contained one of the ‘ST403CC 
exclusive EDGAR CDS’ as described in Chapter Four, however this, as most of the 
CDS in the region are very short regions which may represent degraded genes. 
Results observed using both PHAST and AlienHunter demonstrated that the 
potentially prophage associated gene intA observed in ST403CC C. jejuni isolates 
was not located within a predicted integrated prophage region.  There may be 
several reasons for this seemingly surprising result; firstly, genome annotation was 
carried out using PROKKA (Seemann, 2014), which uses a large database to find the 
most likely matches for each CDS, however it does not ‘sense check’ observed 
matches, so the process can give occasionally produce some inaccurate answers.  
An NCBI BLASTp query for CJ857_00835 intA recorded matches for 30S ribosomal 
protein S15 in various C. jejuni and C. coli genomes (100% coverage, 99% identity).  
Secondly, the assembly of the short read sequence data may have placed the gene 
in an inaccurate location; assembly was carried out using a reference to build 
against so each area is lined up against that, this can mean that additional or 
divergent areas can be tagged on towards the ‘end’ of the genome, however it is 
unlikely that a single CDS would be put in the ‘wrong’ place.  Thirdly, is the 
possibility that the intA homologue in fact be within a prophage region which was 
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overlooked by both PHAST and AlienHunter, however this is considered highly 
unlikely, as it would be very surprising for a genuine prophage region to be missed 
by both methods.  Finally it may be possible that this intA coding sequence was 
genuinely an integration protein for a prophage, which was under neutral or 
negative selection pressure and was degraded so as to be unrecognisable to the 
detection methods utilised.   
5.4.2 PHAST Prophage Content 
Although the potential prophage gene intA did not appear to be associated with 
integrated prophage regions in ST403CC C. jejuni isolates, as described earlier, 
potential prophage content was observed for each of the six porcine ST403CC C. 
jejuni isolates.  Two strains had only one potential prophage region, two had two 
and two had three.   
Potential prophage regions were initially determined for each of the six porcine 
ST403CC C. jejuni isolates with a single common predicted prophage shared across 
the six strains.  However, during subsequent analysis and following an update to the 
PHAST database the evidence indicated that the shared predicted prophage region 
tagged by PHAST analysis as a potential relative of Enterobacteria phage F1 was in 
fact potentially associated with phage phix174.  Carrying out repeat PHAST runs 
using the recently updated viral database gives matches previously identified as the 
‘f1 region’ being designated ‘phix174’ regions.  This indicates that rather than being 
a group specific prophage this may be a remnant of phix174 control spikes from the 
Illumina sequence run.  This phage is commonly used as a control during Illumina 
sequencing procedures, such as those used in this project.  Although efforts can be 
made to strip remnants of phiX174 data from the sequence, and targeted reference 
based assembly makes an extra step to help remove these sequences, fragments 
can be left behind in the final sequence.  It was therefore considered likely that this 
potential common region is remnant phix174 sequence from the Illumina 
sequencing procedure.  Enterobacteria phage F1 is a relative of phiX174, both being 
from the family Microvirus, there remains some possibility that this region may 
represent a novel phage associated with porcine ST403CC C. jejuni isolates however 
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this is highly unlikely due to the similarity to the phiX174 phage, given knowledge of 
the Illumina sequencing process, and the different type of prophage normally 
observed in Campylobacter. 
This potentially problematic revelation however does not cause significant changes 
to the overall results or conclusions regarding prophage content in ST403CC C. jejuni 
isolates, as the potential F1/phiX174 region contains only phage associated CDS and 
would have no effect on the ‘behaviour’ of the isolates. Additionally the prophage 
region would not have served as a marker for ST403CC isolates as it was not 
observed in the non-porcine ST403CC C. jejuni isolate.  Also it is established that the 
issue of contaminating phiX174 sequence is highly prevalent in published sequence 
data. 
PHAST analysis initially identified potential prophage regions in each of the six 
porcine C. jejuni ST403CC isolates, however as described above further analysis 
revealed that the shared prophage region is most likely a remnant from the 
sequencing procedure.  This leaves the remaining results wherein two isolates 
contain two potential prophage regions, two contain one potential prophage 
region, and two have no prophage content.  As such it can be said that as in other 
Campylobacter isolates, prophage content may have a role in determining individual 
characteristics however it does not provide a mechanism for specialism or host 
adaptation in ST403CC C. jejuni isolates.   
The initial prophages Enterobacteria phage Fels_2, Haemophilus phage SuMu, 
Mannheimia phage phiMHaA1, Synechococcus phage S-SKS1 each belong within the 
order Caudovirales, an order of single stranded DNA viruses containing three 
families; Myoviridae, Siphoviridae, and Podoviridae.  Repeated PHAST runs using the 
updated database were carried out during the analysis of phiX174 content, from 
which the same regions were determined as being prophage but recorded new 
higher scoring matches; each of the prophage regions had homology with 
Campylobacter phages NCTC12673 or CP30A.  Phage CP30A is not currently 
published in literature but was sequenced by Connerton, Siringan & Cummings in 
2012 as part of a study into recombination and diversity of bacteriophages in 
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Campylobacter from chickens, whilst phage NCTC12673 is one of the virulent 
‘typing’ bacteriophage as described in Sails et al (1998), as this is a type III virulent 
Campylobacter phage it is not likely that this phage is integrated into the genome of 
the ST403CC C. jejuni isolates, rather it serves as confirmation that these are 
Caudovirales bacteriophages, probably of the family Myoviridae. 
PHAST searches against a phage database, and although it is the most up to date 
and comprehensive phage database currently available this is still somewhat of a 
limitation; it cannot find additional prophage content which has not already been 
described and added to the database, and when it does describe a match it can only 
provide the most similar relative which it currently has.  This means that although a 
prophage match was described as ‘Mannheimia phiMHaA1’ for example, this does 
not confirm the presence of this phage, rather it serves as an indicator of homology 
with this phage.  It may be more beneficial to consider the order or family of phage 
observed rather than the individual phages described. 
The ‘real’ prophages were all of order Caudovirales (old matches and new matches) 
so it is acceptable to state that four of six porcine ST403CC contained one or two 
potential Caudovirales order prophages.  This is ‘acceptable’ as these are known to 
be the most common Campylobacter lysogens (Connerton, Timms & Connerton, 
2011; Sails et al, 1998).  Additionally this relates to the observed overlaps and 
similarity between the different phage regions observed; as described previously 
regions of the ‘SuMu’ phage were almost identical to regions of the ‘Fels_2’ phage 
in other isolates, and so on, again this implies homology and relatedness of 
prophage regions. 
To provide comparisons for PHAST reliability, control runs were carried out for C. 
jejuni isolates 11168 and RM1221; these showed concurrence with literature such 
as Fouts et al (2005) in that zero prophage regions were observed for 11168 and 
four regions were observed for RM1221, however only three of the four RM1221 
integrated regions are thought to be prophage related so this highlights some 
weakness in PHAST. 
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5.4.3 AlienHunter Integrated Genomic Content 
Having considered the information from PHAST analysis the final dataset to 
consider was that produced from AlienHunter (Vernikos & Parkhill, 2006) analysis.  
AlienHunter searches for integrated genomic elements and recorded considerable 
numbers of predicted integrated regions across the ST403CC C. jejuni genomes (45-
82 regions).  Due to the lack of published data using AlienHunter for studying 
Campylobacter comparisons were provided using C. jejuni RM1221 (52 regions), 
11168 (24 regions) and 81116 (29 regions); the number of regions predicted by 
AlienHunter for ST403CC isolates (45-82) were comparable to, albeit higher than, 
those for well-known C. jejuni isolates RM1221, 11168 and 81116. 
Considering the association between PHAST and Alienhunter results, as expected, 
most phage regions identified by PHAST were also recognised by AlienHunter, along 
with a number of additional non-prophage integrated regions.  As PHAST searches 
only for prophages with matches in its database, any novel prophages which might 
be overlooked by PHAST might well be picked up by AlienHunter, plus the presence 
of other types of integrated regions including insertion sequences and genomic 
islands.  It was noted that some prophage regions predicted by PHAST were not 
identified as integrated regions by Alienhunter.  As AlienHunter searches for specific 
patterns and for divergence from the host genome whereas PHAST directly 
compares sequence to a database of virus sequences, AlienHunter can overlook 
integrated regions which have prophage homology if they do not appear 
significantly distinct from the host chromosome.  This can occur when an integrated 
region has been within the host sequence for an extended period of time, as it can 
begin to look more like that host genome, and degradation may disrupt target 
sequences so that they can no longer be recognised (Vernikos & Parkhill, 2006; 
Lawrence & Ochman, 1997).   
In order to provide perspective for the observed results data from the literature 
must be considered.  When the AlienHunter software was first developed and 
published it was used on Salmonella Typhi genomes, and was able to accurately 
predict all of the known genomic islands and integrated prophages, as well as some 
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previously unidentified island regions – it was successful, and more accurate than 
previous methods.  They observed 17 Salmonella pathogenicity islands (three of 
which were newly discovered by this method), and five bacteriophages; these 
numbers of integrated regions were considerably lower than the numbers observed 
here in ST403CC C. jejuni, however C. jejuni is known to be highly competent and 
readily undertake the uptake of DNA from the environment through natural 
transformation (Gaasbeek et al, 2009), whereas Salmonella is not naturally 
competent (Ferguson, Heinemann & Kennedy, 2002) therefore it is logical to 
encounter considerably more integrated regions in these isolates. 
5.4.4 Integrated Genomic Content in Campylobacter 
As described previously, the major work published regarding C. jejuni integrated 
genomic regions focuses on comparisons between and against isolates 11168 and 
RM1221; such as that by Parker et al (2006) which investigated the prevalence of 
integrated elements and genomic diversity across a total of 79 C. jejuni and C. coli 
isolates, however they compared solely against the four integrated elements found 
in C. jejuni RM1221 , so provided no information on other additional integrated 
genomic regions, however they were able to demonstrate that integrated regions 
with some homology to RM1221 integrated elements were common across C. jejuni 
and C. coli, and not distinct to a single isolate or group of isolates.  Parker et al 
(2006) demonstrated that genes carried by lysogenic bacteriophages play a role in 
genomic diversity in Campylobacters. 
Other studies on the effects of integrated regions in C. jejuni have also been based 
upon the integrated elements in C. jejuni RM1221, including work which suggested 
strains carrying CJIE1 may be slightly more virulent in vitro than those without (Clark 
et al, 2012) and studies considering the impact of integrated elements on further 
genomic variation.  It has been established that the uptake of exogenous DNA 
(transformation) is a method used by some bacterial species to increase genetic 
diversity.  C. jejuni is naturally competent for transformation, however it has been 
demonstrated that some strains lack this ability (Gaasbeek et al, 2009).  In 2009, 
Gaasbeek et al demonstrated using knockout and complementation that the gene 
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dns, a periplasmic DNase found in CJIE1, inhibits natural transformation in C. jejuni, 
and also identified other CDS contained within CJIE which were associated with 
non-naturally competent C. jejuni strains.  Further to this, in 2010 Gaasbeek et al 
demonstrated similar roles for DNases encoded on CJIE2 and CJIE4.  This is of 
interest as a homologue of dns was observed within prophage regions of the four 
ST403CC C. jejuni isolates carrying predicted prophages, suggesting that these 
isolates may lack natural competence.  It is possible that secreted DNAase enzymes 
are protecting the ST403CC C. jejuni isolates from the uptake of integrated genomic 
regions.  A standard test to confirm the action of deoxyribonulease activity could be 
carried out using DNAse agar (such as Sigma Aldrich item number D2560), however 
the production of DNAase would not prevent all uptake of new genetic information.   
5.4.5 General Discussion & Conclusions 
Some general conclusions can be drawn from this chapter. Firstly, it was observed 
that the apparent presence of intA did not appear to show any association with 
Campylobacter species, multilocus sequence type, or host source.  Despite being 
described as a prophage integrase, the intA homologue observed in ST403CC C. 
jejuni isolates was not found to be located near a prophage or other integrated 
region.  As stated previously (section 5.4.1), it is most likely that this CDS was 
annotated inaccurately due to the limitations of annotation relying on the accuracy 
of previous annotations, and may in fact be a 30S ribosomal protein, however there 
remains a slight possibility that this region represents a historical cryptic prophage.   
Although the presence of intA (CJ857_00835) was not an indicator of integrated 
genomic content, considerable potential integrated regions were observed across 
the ST403CC C. jejuni genomes.  Foreign DNA was found to be present in ST403CC C. 
jejuni isolates, and like other strains, may play a role in adaptation and evolution, 
however no evidence was observed of prophage regions being implicated in 
specialisation of the ST403CC group. 
Analysis of prophage content demonstrated that ST403CC C. jejuni isolates may, but 
do not always, contain Caudovirales prophages.  These are the most common form 
of integrated phages observed in Campylobacters and as such suggest that in this 
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respect, the ST403CC C. jejuni isolates reflect the published data for non-ST403CC 
isolates.  ST403CC C. jejuni are capable of gaining and losing prophage similarly to 
other C. jejuni isolates and may gain some advantage individually as with any other 
strain, however they do not share a common prophage which indicates niche 
adaptation.  It may be stated that whatever pressure led to this group appearing 
distinct by MLST and whole genome core phylogeny, was not linked to prophages or 
genomic islands.  Relating prophage and integrated genomic content to whole 
genome based core phylogeny; no significant links were observed, there was no 
association between branch/ancestry of the ST403CC isolates and the number or 
‘type’ of phage, nor the number of AlienHunter regions. 
The overall conclusion regarding the prevalence and influence of integrated regions 
on the genomes of ST403CC C. jejuni isolates therefore is that although they may 
contain integrated content, there is no evidence of a specific adaptive event, adding 
further evidence that these isolates are generalist strains, rather than being 
specifically host adapted.  This chapter has suggested that the integration of 
‘foreign’ DNA may potentially play a role in the adaptation of ST403CC C. jejuni 
isolates, as it may in other non-ST403CC C. jejuni isolates; however the results 
observed provided no evidence for specific integrated content leading to 
specialisation in these isolates.  It has also raised the possibility that some ST403CC 
isolates may be non-naturally competent isolates, which may have an impact in 
their ability to share genomic information and may go some way to explain their 
apparent isolation at the whole genome phylogeny level.  The next stage in the 
project will partly carry on this idea of reduced genomic exchange in ST403CC C. 
jejuni isolates, by returning to the outcomes of previous chapters and considering 
the role and effect of potential new restriction modification systems in ST403CC C. 
jejuni strains. 
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Chapter Six: Recombination Events in ST403CC Campylobacter jejuni Isolates 
6.1 Introduction 
Previous work identified a group of isolates which were closely related by MLST, 
and were thought to potentially represent a host-adapted group of C. jejuni isolates 
(Manning et al, 2003).  Work presented in this thesis has demonstrated that a 
selection of these isolates are potentially pathogenic (Chapter Two) and are closely 
related at the whole genome level (Chapter Three).  Investigations were carried out 
to attempt to discover evidence for host adaptation based upon genome content.  
Despite the feature of the porcine host being more commonly associated with C. 
coli, the ST403CC C. jejuni did not show evidence of higher sharing of genome 
content with C. coli compared to C. jejuni isolates from more typical sources such as 
chicken and human infections.  Identified during analysis of genome content were a 
group of potential restriction/modification system enzymes associated with 
ST403CC isolates which did not have homologues across the included C. jejuni and 
C. coli reference genomes.  Given the role of r/m systems and the apparent lack of 
sharing with C. coli determined by investigating whole genes; this chapter will 
consider the rate of (homologous) recombination within ST403CC C. jejuni isolates 
compared to other C. coli and C. jejuni isolates. 
6.1.1 Uptake of Genetic Content 
Three means exist which allow bacteria to acquire and assimilate new genetic 
content: transduction, conjugation, and transformation (Gilbreath et al, 2011).  
Transduction and conjugation both rely on an ‘infectious’ donor providing DNA to 
the recipient cell, the donor being phage or plasmid, respectively (Redfield, 2001), 
whereas transformation is the integration of loose genetic content available in the 
environment (Krüger & Stingl, 2011) which results in exchanges of sequence 
content within a localised environment (Feil & Spratt, 2001) due to the recipient cell 
acquiring parts of the DNA of other cells within a closed space which have been 
broken open.   
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6.1.2 Homologous Recombination 
Homologous recombination plays a significant role in bacterial adaptation, with the 
gain of new DNA providing one of the major forces driving bacterial evolution (Feil 
& Spratt, 2001; Gilbreath et al, 2011; Tang et al, 2009; Krüger & Stingl, 2011) and is 
particularly significant in species which experience selection pressures due to 
exposure to antimicrobials or the need to evade the host immune system (Feil et al, 
2000; Suerbaum et al, 2001).  Neutral variations often occur via recombination 
(Spratt & Maiden, 1999; Feil et al, 2000); that is, variation in sequence within 
conserved genes such as those necessary for essential metabolic processes, as such, 
MLST scheme ‘housekeeping’ genes are a useful target for recombination studies 
and have been the basis for numerous studies. 
6.1.3 Recombination in Campylobacter 
The extent to which recombination occurs in C. jejuni is debated (Fearnhead et al, 
2005; Suerbaum et al, 2001; Wilson et al, 2009; Yu et al, 2012), but is considered to 
be between 2-8 times more than the levels of point mutation.  Wilson et al, 2009 
estimated that recombination was occurring at twice the rate of mutation (2.67 
times more), but that despite this the changes are subjected to a ‘purifying 
selection’ which ‘purges 60% of novel variation’.  Yu et al (2012) observed much 
higher proportion of recombination than mutation (between 2.97 and 8.91 times), 
although both papers use MLST sequences for recombination analysis, Yu et al 
(2012) studied only single locus variants (SLVs - MLSTs which share six out of seven 
alleles).  Fearnhead and colleagues (2005) however estimated that recombination 
was occurring at a similar rate to mutation using MLST data for farm and wildlife 
isolates of C. jejuni using an approximate likelihood model.  They also concluded 
that small recombination fragments are much more likely than rare instances of 
complete genes being transferred by recombination.  Suerbaum et al (2001) also 
studied MLST alleles, but used the HOMOPLASY method (as described by Maynard 
Smith & Smith, 1998), and concluded that C. jejuni frequently undergoes 
intraspecies recombination - with homoplasy ratios between 0.36 and 0.48 for five 
assessed fragments (where 0 signifies entirely clonal and 1 signifies free 
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recombination).  Each of these examples uses MLST allele sequence data as the 
basis for recombination analysis, however here it was possible to use whole 
genome sequence to investigate recombination frequency in potentially host 
adapted ST403CC C. jejuni isolates. 
6.1.4 Methods for Revealing Recombination 
BAPS (Bayesian Analysis of Population Structure) is a statistical method for 
predicting structure of a given population of sequences, first introduced by 
Corander, Waldmann & Sillanpää (2003) and subsequently revised (Corander et al, 
2008) to have improved computational efficiency and allow for analysis of larger 
datasets, and again to allow more complex analysis including MLST classification 
(Cheng et al, 2011).  Observing recombination and population structure is 
particularly challenging for genomes which undergo large amount of Horizontal 
Gene Transfer.  The most recent advance in the BAPS software is hierarchical BAPS, 
which uncovers nested populations structures from multiple sequence alignments 
(Cheng et al, 2013).  BRATNextGen (Bayesian Recombination Tracker) (Marttinen et 
al, 2008) is part of the BAPS software package, which determines recombination 
events for large datasets of heterogeneous populations within closely related 
sequences.   
Recent publications to make use of BAPS and BRAT include De Been et al’s study of 
Enterococcus faecium (2013), McNally et al’s work with E. coli (2013), Tang et al’s 
2009 Neisseria study and Willems et al’s Enterococcus faecium paper (2012).  As an 
example, De Been et al (2013) used BRATNextGen as described by Marttinen et al 
(2012) to investigate the role of recombination in the evolution of Enterococcus 
faecium.  The Enterococci are gut commensal organisms, but have played an 
increasing role in opportunistic disease in recent decades.  Initially opportunistic 
Enterococcus infection was mostly associated with E. faecalis, but in the last twenty 
years E. faecium cases have increased in prevalence and is now considered as 
important as E. faecalis; this rise in E. faecium infection is associated with its ability 
to readily acquire new genetic elements, particular antibiotic resistance genes.  
BRAT analysis revealed that recombination was playing a significant role in the 
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evolution of E. faecium; specifically they observed an increase in recombination 
within an important hospital associated sub population compared to commensal 
isolates, but also saw that ‘modern’ clinical isolates show a reduction in 
recombination.  This concurs with McNally et al (2013) and Willems et al (2012) in 
the idea that new clinical strains can arise through acquisition of advantageous 
genes, and subsequently become a more clonal group with less recombination as a 
result of new characteristics. 
6.1.5 Aims 
The aims of this chapter were  
- To investigate the level of recombination in ST403CC C. jejuni isolates 
compared to that in other C. jejuni and C. coli isolates. 
- To determine whether recombination events are shared between ST403CC 
C. jejuni from pigs, and C. coli porcine isolates: although Chapter Four didn’t 
identify significant sharing between C. coli isolates and the porcine ST403CC 
C. jejuni isolates based upon coding regions/whole genes it was of interest 
whether homologous recombination events may exist which represent a 
marker for host adaptation and admixture with the typical porcine occupier, 
C. coli. 
- To consider recombination rates in ST403CC C. jejuni isolates in relation to 
the whole genome phylogeny determined in Chapter Three, and also to 
consider the content of any observed recombinant regions, with reference 
to the integrated sequence elements revealed in Chapter Five. 
In this chapter, frequency of recombination events and genetic admixture is 
determined for whole genome sequences of ST403CC C. jejuni isolates using BAPS 
6.2 software package, and compared to non ST403CC C. jejuni and C. coli strains, as 
described in previous chapters.   
6.2 Methods 
The recombinant status of ST403CC C. jejuni isolates was determined, and 
compared to other C. jejuni and C. coli isolates, using the isolates previously 
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described for use in genetic analysis (Table 3.1; Appendix 9.1), and the additional 
ST403CC isolate ATCC33560. 
6.2.1 Revealing Recombination 
Recombination events and genetic admixture were investigated to reveal concealed 
population structure not exposed by other methods.  
6.2.1.1 Core Genome Alignment for Recombination Analysis 
Core genome alignment was produced for thirty-four C. jejuni and C. coli isolates, 
using Mugsy (Angiuoli & Salzberg, 2010) as described previously (Chapter Three).  
6.2.1.2 Heirarchical BAPS Completed by Jukka Corander & Colleagues at The 
University of Helsinki 
Hierarchical BAPS was used with settings as described in Corander et al (2012) to 
create clustering results for multiple sequence alignment. 
6.2.1.3 BRATNextGen Analysis Completed by Jukka Corander & Colleagues at The 
University of Helsinki 
BRATNextGen was used with default settings as put forward by Marttinen and 
colleagues (2012) to estimate recombination events based on evolutionary lineage 
clusters determined using Bayesian analysis. 
6.2.1.4 Phylogenetic Tree Based upon the Non-Recombinant Core Genome 
Completed by Jukka Corander & Colleagues at The University of Helsinki 
A phylogenetic tree was produced, showing the relatedness of isolates based upon 
the remaining core genome alignment upon discarding the recombinant regions. 
6.2.2 Investigating Content of Recombinant Regions 
Further investigation was carried out to consider the content of recombinant 
regions in ST403CC C. jejuni isolates, and to investigate the presence of shared 
recombinant regions in ST403CC C. jejuni isolates, as well as quantifying 
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recombination in ST403CC C. jejuni compared to non-ST403CC C. jejuni and C. coli 
isolates. 
6.2.2.1 Converting BRATNextGen Output Carried out by Simon Harris at the 
Sanger Centre 
Post-processing was kindly carried out by Simon Harris at the Sanger Centre, 
producing BRAT recombination output file which was readable in Artemis, to allow 
visualisation of the location and content of recombinant regions.   
6.2.2.2 Applying Statistics to Quantified Recombination Results 
The frequency of recombinant events in C. jejuni and C. coli isolates were analysed; 
in order to determine the statistical significance of variation in recombination 
between groups - ST403CC C. jejuni, non-ST403CC C. jejuni, and C. coli using T-test 
to determine whether variation between groups was statistically significant, or 
likely to be due to chance.  Statistical analysis was used to test the Null Hypothesis: 
there will be no significant difference in recombinant frequency between groups.  
Specifically no significant difference in the number of recombination events will be 
observed between ST403CC C. jejuni and non-ST403CC C. jejuni. 
The standard T-test used previously throughout this thesis (section 2.2.7) was not 
appropriate for the recombination frequency data due to the assumption of Normal 
distribution in this method.  The values in the samples (recombination frequency 
per group) do not indicate normal distribution, and do not have distributions of the 
same shape, therefore the Mann-Whitney T-test was selected as an appropriate 
measure, using Log values. 
6.2.2.3 Recombinant Region Content 
Once the Artemis readable file was kindly produced by Simon Harris (Sanger 
Centre), Artemis sequence viewer (Rutherford et al, 2000) was used to investigate 
the recombinant regions of the ST403CC C. jejuni isolates.   The output of the core 
genome alignment was a multiple genome fastA file; from this the feature 
representing the core aligned genome sequence of ST403CC C. jejuni 857 was 
selected and saved as a new fastA file; onto which the complete annotation of C. 
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jejuni 857 was transferred using RATT (Otto et al, 2011), producing an annotated 
core genome region for the isolate; into this was read the recombinant region 
annotation produced by Simon Harris, providing an annotated core genome 
revealing recombinant regions in ST403CC C. jejuni isolate 857.  This was then used 
to investigate regions identified by BRATNextGen analysis which were unique or 
otherwise interesting in ST403CC C. jejuni isolates, and identify coding regions in 
these areas. 
6.2.2.4 Investigating the Function of CDS in Recombinant Regions 
BLAST searching was implemented in order to ascertain potential function and 
relatedness of coding sequences.  As described in Chapter Four, both the built-in 
NCBI BLAST function in Artemis was used to identify related sequences in the global 
database, and local database BLAST searching was applied to investigate sequence 
homology across the specific thirty-four included genomes. 
6.3 Results 
The recombination and genetic admixture of C. jejuni and C. coli isolates was 
assessed, with the aim to reveal the recombinant profile of ST403CC C. jejuni 
isolates; a group of closely related and potentially host adapted strains.  This section 
comprises three sub-sections: the first summarising Hierarchical BAPS and 
BRATNextGen output, followed by the quantification of recombination events, and 
subsequently content analysis of recombination regions. 
6.3.1 Genetic Admixture & Recombination in ST403CC Campylobacter jejuni 
The degree of genetic admixture was determined for thirty-four C. jejuni and C. coli 
isolates, based upon their core genome alignment.  Hierarchical BAPS grouped 
isolates into clusters of related sequences, with dashes representing regions of 
variation between related isolates.  The number and location of recombination 
events were assessed using BRATNextGen for the same group of thirty-four isolates; 
with assessment of the source of the recombinant content.  Figures 6.1 and 6.2 
were produced by Jukka Corander & colleagues at the University of Helsinki, with 
annotation added by the author. 
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Figure 6.1: Admixture of C. jejuni & C. coli Isolates Revealed by Hierarchical BAPS 
Heirarchical BAPS was run by J. Corander & Team at the University of Helsinki, producing this output image.  Annotation was added by L. Morley at the Nottingham Trent 
University 
Each row represents an isolate: isolates are clustered according to level 1 BAPS, separated by black horizontal lines.  (BAPS level 1 = C. coli; level 2 = C. jejuni jejuni 414; level  
3 = C. jejuni jejuni/C. jejuni doylei Hierarchical BAPS produces vertical lines to indicate ‘SNPs’, however, due to the size of the alignment each pixel in fact corresponds to 
numerous SNPs. 
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Figure 6.1 shows hierarchical BAPS output.  Each row represents an isolate and 
isolates are clustered by level 1 BAPS, with clusters separated by black horizontal 
lines.  Hierarchical BAPS analysis grouped all C. coli isolates into one cluster, C. jejuni 
jejuni 414 as a separate cluster of its own, and the remaining C. jejuni jejuni and C. 
jejuni doylei strains, including the ST403CC isolates, as a third cluster.  Hierarchical 
BAPS produces vertical lines to indicate ‘SNPs’, however, due to the size of the 
alignment each pixel in fact corresponds to numerous SNPs. 
High levels of admixture were observed in some C. jejuni isolates, including 11168 
and 1336 in particular.  The overview produced by BAPS analysis also suggests that, 
in fact, lower levels of admixture seem to be observed in ST403CC C. jejuni isolates 
compared to the other included C. jejuni genomes 
Figure 6.2, overleaf, shows visual output from BRATNextGen analysis.  No significant 
recombination events were observed for the included C. coli isolates, or for C. jejuni 
isolate 414 (the highly niche adapted bank vole isolate); although C. jejuni otherwise 
shows recombination events.  ST403CC strains showed a reduced number of 
significant recombination events compared to other C. jejuni isolates, and exhibited 
a distinct ‘recombination profile’ including three recombination events consistent 
across all 7 isolates.  Recombination events which originate from C. coli appear red 
in Figure 6.2, whilst blue segments are from C. jejuni sources, and turquoise are 
predicted to be from other external sources.  It was observed that C. coli sequence 
is incorporated into all recombining C. jejuni isolates, however there was no 
evidence of increased acquisition of C. coli sequence within the ST403CC group
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Figure 6.2: Recombination Events in C. jejuni & C. coli Isolates Revealed by BRATNextGen Analysis  
BRATNextGen was run by J. Corander & Team at the University of Helsinki, producing this output image.  Annotation was added by L. Morley at the Nottingham Trent 
University. 
Each row represents an isolate, as indicated on the right.  Each vertical line represents a recombination event; red lines indicate import from C. coli; blue indicates 
import from C. jejuni.  ST403CC isolates are highlighted with bold text, and enclosed in black box. 
Note: C. jejuni strains are C. jejuni jejuni unless specified otherwise. 
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Figure 6.3 depicts a phylogenetic tree based upon the remaining core genome 
alignment data, following removal of recombinant regions.  This tree is similar in 
appearance to the previously shown phylogenetic trees, the overall population 
structure is not noticably altered. 
Figure 6.3: Phylogenetic Tree of C. jejuni & C. coli Isolates based upon Non-Recombinant Core 
Genome Regions 
Phylogenetic tree based upon core genome alignment following removal of recombinant 
regions, including colour coding relating to BAPS categories.  This tree was produced by J. 
Corander at the University of Helsinki 
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Figure 6.3 was produced by Jukka Corander & colleagues at the University of 
Helsinki. 
Initial assessment of BAPS and BRATNextGen results revealed that ST403CC C. jejuni 
isolates group within other non-ST403CC C. jejuni isolates based upon genetic 
admixture, and confirmed that the ST403CC C. jejuni isolates do not exhibit an 
increase in the uptake of C. coli associated genetic content, as revealed based upon 
coding sequence analysis in Chapter Four.  It was visible that the ST403CC C. jejuni 
isolates contained fewer recombinant regions than their non-ST403CC C. jejuni 
relatives, but more than was observed for the included C. coli isolates.  To draw 
further information from these results, quantification was carried out to reveal the 
differences in recombination in ST403CC and non-ST403CC C. jejuni and C. coli. 
6.3.2 Quantification of Recombination Events 
Results are presented on the size and frequency of recombinant regions in ST403CC 
and non-ST403CC C. jejuni and C. coli isolates.   
The percentage of the core genome made up of recombination fragments was 
calculated as shown in Table 6.1.  The percentage of the core genome made up of 
recombination fragments in non-ST403CC C. jejuni (0.017) was more than double 
that of the ST403CC isolates (0.007).   This means that, generally, each recombinant 
region in the studied ST403CC C. jejuni isolates was shorter in nucleotide length 
(mean 5923 nucleotides) than the recombinant regions observed in non-ST403CC C. 
jejuni (mean 14372 nucleotides) isolates, and as such, represent a smaller 
proportion of the core genome.  The standard deviation observed for non-ST403CC 
C. jejuni isolates was also higher than that of the ST403CC C. jejuni, suggesting that 
the smaller size of recombinant fragments was comparatively consistent in ST403CC 
C. jejuni isolates in contrast to higher degree of variation in length of recombinant 
regions in non-ST403CC C. jejuni genomes.  This may suggest a lesser degree of 
genetic diversity in ST403CC C. jejuni than other C. jejuni isolates, although still 
higher than that observed in C. coli. 
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The percentage of (the total number of) SNPs (across the whole genome) which 
occur within recombinant regions calculated as shown in Table 6.2.  The percentage 
of SNPs across the whole genome which occur within recombination fragments was 
very similar for the ST403CC C. jejuni and non-ST403CC C. jejuni, however, the raw 
values show a considerable reduction of SNP frequency in ST403CC C. jejuni 
compared to non-ST403CC C. jejuni. 
 
Group 
 
Mean Length of 
Recombination 
Standard Deviation 
Length of 
Recombination 
Mean Percentage 
of Recombination 
Standard Deviation 
Percentage of 
Recombination 
C. coli 0 0 0 0 
ST403CC 
C. jejuni 
5923 1639.2 0.007 0.002 
Non-
ST403CC 
C. jejuni 
14372 8860.4 0.017 0.0103 
Group 
Total Number of 
SNPs in 
Recombination 
Fragments (R) 
Total Number of 
SNPs in Non-
Recombinant Core 
Genome (M) 
Percentage of SNPs in 
Core Genome 
contained within 
Recombinant Regions 
C. coli 0 32993 0.00 
ST403CC C. jejuni 1104 6161 17.92 
Non-ST403CC C. jejuni 14421 81633 17.67 
All Strains 19115 162325 11.78 
 
Table 6.1: Percentage of Core Genome Comprised of Recombinant Fragments 
The percentage of the core genome which consisted of recombinant fragments was 
calculated from the mean scores for each group; C. coli, ST403CC C. jejuni and non-ST403CC 
C. jejuni 
Table 6.2: Percentage of SNPs Observed in Recombinant Regions 
The percentage of the SNPs across the core genome which were contained within 
recombinant regions was calculated for C. coli isolates, ST403CC C. jejuni isolates and for 
non-ST403CC C. jejuni isolates, based upon the mean number of SNPs for each group. 
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Range and mean values of recombinant event frequencies are shown in Table 6.3.  
No significant recombination events were observed for any C. coli isolate, or for C. 
jejuni 414.  The non-ST403CC C. jejuni recombination frequency ranged from 0-200 
events (mean 48.5), however, this includes two notable outliers – C. jejuni jejuni 414 
and C. jejuni doylei - with zero and 200 recombination events respectively.  
Discarding these two outlier values, the range for recombination frequencies in 
non-ST403CC C. jejuni was 27-95 (mean 39.1), compared to the range for the 
ST403CC isolates of 4-15 events (mean 9.9). 
 
 
 
 
 
Figure 6.4 provides a visual representation of the values in Table 6.3; using the 
mean values of recombination frequencies as determined by BRATNextGen 
analysis, by category, with standard deviation.   
To confirm the statistical significance of the difference in recombination event 
frequency between groups, the Mann-Whitney T-test was used, with Log values - 
however this cannot be applied to zero values, and was not therefore suitable for 
comparison of the C. coli results, or the outlier C. jejuni isolate 414.  The high 
recombination outlier C. jejuni doylei 269.97 was also excluded from statistical 
analysis as described in Table 6.3.  The Mann-Whitney T-test (two-tailed, unpaired, 
nonparametric means, based upon Log values) confirmed that the difference in 
Group Range Mean Standard Deviation 
C. coli 0 0 0 
Non-ST403CC C. jejuni 0-200 49 50 
Non-ST403CC C.jejuni* 27-95 39 21 
ST403CC C. jejuni 4-15 10 4 
Table 6.3: Quantification of Recombinant Events in C. jejuni & C. coli Genomes 
The range and mean of the number of recombination events observed in each 
group of isolates studied; C. coli, ST403CC C. jejuni and non-ST403CC C. jejuni. 
*Non-ST403CC C. jejuni isolates excluding extraneous strains C. jejuni jejuni 414 
and C. jejuni doylei 269.97 
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recombination event frequency between ST403CC C. jejuni and non-ST403CC C. 
jejuni (excluding outlier values C. jejuni 414 and C. jejuni doylei 269.97) was 
statistically significant (P<0.0001).   
These results indicate that the Null hypothesis can be rejected - significant variation 
was observed between ST403CC C. jejuni and non-ST403CC C. jejuni, with ST403CC 
isolates displaying statistically significantly fewer recombination events 
As stated previously, zero significant recombination events were observed in C. coli.  
As such, this data was unsuitable for analysis based upon Log values, therefore the 
Mann-Whitney T-test was run on the raw values to provide an indication of 
significance.  Significant difference in variation was observed between C. coli and 
ST403CC C. jejuni (P<0.0001), as well as between C. coli and non-ST403CC C. jejuni 
(P <0.0001), however these results were based upon raw values and are therefore 
less dependable; although the difference between these groups was clearly visible 
as shown in Figure 6.4 and Figure 6.2.  
Figure 6.4: Mean Frequences of Recombination Events in C. jejuni & C. coli Isolates  
6.4a shows the mean values and standard deviation for recombination events for C. coli, non-
ST403CC C. jejuni and ST403CC C. jejuni.  Large standard deviation gave rise to big error bars 
due to two ‘unusual’ C. jejuni strains; C. jejuni 414, which showed no significant 
recombination events; and C. jejuni 269.97, which is a different subspecies (C. jejuni doylei) 
and showed a very high rate of recombination. 
6.4b shows the mean values and standard deviation for recombination events for C. coli, non-
ST403CC C. jejuni and ST403CC C. jejuni after discarding the values for the C. jejuni 414 and 
269.97. 
a b 
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6.3.3 Content of Recombinant Regions in ST403CC Campylobacter jejuni 
BRATNextGen analysis led to the recognition of three recombinant regions which 
are common and identical or almost identical across the seven ST403CC C. jejuni 
isolates (Table 6.4). One of which occurs at a site with no neighbouring 
recombination events in non-ST403CC C. jejuni isolates, whilst the other two are 
located nearby to dissimilar recombination events in other C. jejuni isolates.  These 
may represent ‘recombination hotspots’ in the genome, where recombination 
occurs readily, as recombination occurs near this site in the majority of studied C. 
jejuni  isolates, although the recombination event observed in the ST403CC C. jejuni 
isolates is distinct from those taking place in non-ST403CC isolates and is uniform 
across the ST403CC isolate group.   
Proceeding from the beginning of the alignment, the first of the three ST403CC 
common recombination events occurs at 426229-429980bp (426229-429957bp in C. 
jejuni 444 and ATCC33560; 426226-429980 in C. jejuni 623).  A neighbouring 
recombination event exists in C. jejuni isolates 81-176, RM1221 and S3 (426035-
427187bp), however this originates from a different source; origin 1 in these non-
ST403CC isolates, origin 4 in the ST403CC isolates.  Prokka annotation for this region 
indicated the presence of bioA (Adenosylmethionine-8-amino-7-oxononanoate 
aminotransferase) and carB (carbamoyl phosphate synthase large subunit), as 
shown in Figure 6.5.  BLASTx search for this complete 3752bp region confirmed 
similarity with bioA and carB genes.  BLASTx searching also confirmed matches for 
these genes in the non-ST403CC isolates, revealing that this recombination event 
does not signify gain of different coding sequence.  Additionally, local BLASTn 
searches were carried out as described in Chapter Four to confirm sequence 
similarity between the ST403CC C. jejuni isolates.  The UniProt database 
(http://www.uniprot.org/) entry for bioA is made up of 455 amino acids, observed 
lengths in ST403CC isolates 250(304)-436(857) and for carB 1073bp, against 1079 in 
857 and 817 in 304. 
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The second ST403CC common recombination event was located 629005-629206bp 
(629005-629214 in ATCC33560) and only 202-210 base pairs in length.  PROKKA 
(Seemann, 2014) annotation did not reveal any coding sequence within this region, 
Region Start End Origin Isolate 
Region 1 426229 429980 4 304 
 426229 429957 4 444 
 426229 429980 4 484 
 426229 429980 4 5491 
 426226 429980 4 623 
 426229 429980 4 857 
 426229 429957 4 ATCC33560 
Region 2 629005 629206 4 304 
 629005 629206 4 444 
 629005 629206 4 484 
 629005 629206 4 5491 
 629005 629206 4 623 
 629005 629206 4 857 
 629005 629214 4 ATCC33560 
Region 3 788994 789264 1 304 
 788994 789264 1 444 
 788994 789264 1 484 
 789000 789264 1 5491 
 789000 789264 1 623 
 789000 789264 1 857 
 789000 789264 1 ATCC33560 
Table 6.4 
 Recombination Events Common across ST403CC C. jejuni 
 
226 
 
however investigation via Artemis (Figure 6.6) revealed that this region is in fact 
contained within a larger coding sequence (628938-630212c), which was revealed 
by BLASTx search to encode a hydrolase, with database matches in C. jejuni 87459 
and C. coli H8, 1417 and others. 
Local BLASTn searches of the recombination fragment revealed homology in all C. 
coli included in study, and no matches in non-ST403CC C.  jejuni, however the same 
b 
Figure 6.5: Visualisation of the First Recombinant Region Common to the ST403CC C. jejuni Isolates 
  
6.5a: as Annotated for strain 857 
6.5b: as seen in strain 304 
 
a 
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search queried with the full coding sequence (1275bp in C. jejuni 857) revealed 
homology in all included reference genomes. 
The third ST403CC common recombination event (789000-789264; 788994-789264 
in 304, 444, 484), as with the first, is directly neighbouring other recombination 
events in non-ST403CC C. jejuni isolates from different origins, however in this 
instance the ST403CC fragment comes from origin 1 and is neighboured on both 
sides by non-ST403CC recombination events.  The non-ST403CC isolate recombinant 
regions downstream are from origin 4, however the upstream recombinant region, 
Figure 6.6: Visualisation of the Second Recombinant Region Common to theST403CC C. jejuni Isolates 
The blue ‘misc feature’ shown in this image represents the recombinant event in ST403CC C. jejuni, 
whilst on thecomplementary strand at this location is a larger coding sequence. 
Figure 6.7: Visualisation of the Third Recombinant Region Common to the ST403CC C.  jejuni Isolates 
The highlighted grey ‘misc feature’ includes the ST403CC recombination event, but also overlaps with 
a recombination event in 81116 and M1. 
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present in C. jejuni 81116 and M1 are from origin 1.  The 265-271bp recombinant 
region is contained within coding sequence CJ857_01161 (788484-789326; 843bp), 
as identified via Prokka annotation. 
BLASTx search for the recombinant region showed homology with coding sequences 
identified as nucleotidases (in C. coli H56, 1948, 1091), flagellar protein (in C. coli 
LMG 9860) or PseG (pseudominic acid biosynthesis associated protein G in C. coli 
JV20).  Local BLASTn searches revealed that the both recombinant region and the 
full coding sequence CJ857_01161 had homology in all reference genomes. 
6.4 Discussion 
ST403CC C. jejuni isolates have previously been demonstrated to be closely related 
based upon MLST and whole genome sequence alignment.  The six sequenced 
ST403CC isolates were associated with the porcine host, and have been 
demonstrated to be closely related to a historical, geographical and host distinct 
additional ST403CC C. jejuni isolate ATCC33560.  The six studied porcine ST403CC C. 
jejuni isolates have also been demonstrated to be potentially capable of causing 
disease in humans, and have been demonstrated based upon study of the pan 
genome not to have acquired considerable C. coli associated content, despite 
colonising a host typically associated with C. coli.  The work carried out in this 
chapter revealed that ST403CC C. jejuni isolates do not contain increased admixture 
with C. coli within the core genome, but do exhibit a distinct profile of reduced 
recombination compared to non-ST403CC C. jejuni isolates. 
6.4.1 Heirarchical BAPS & BRATNextGen Investigation of Admixture & 
Recombination  
Hierarchical BAPS results confirm that again the ST403CC C. jejuni isolates group 
within the ‘normal’ C. jejuni isolates.  The degree of admixture varies across the six 
isolates, but they appear middle to low in terms of ‘rank’, compared to high 
admixture in NCTC11168, 1336.  Hierarchical BAPS shows a large degree of uniform 
admixture within the C. coli cluster.  This reflects previous work (Kinana et al, 2007; 
Sheppard et al, 2008) as the included C. coli isolates are all either confirmed or 
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suspected Clade 1 C. coli, which are known to share sequence both with C. jejuni 
and C. coli, yet are also a highly clonal population.   
BRATNextGen is conservative in estimating recombination events, so the results 
observed may not represent every recombination event which has taken place (De 
Been et al, 2013) but do provide a useful overview of significant recombination 
events.  Also, although the previously identified restriction/modification system 
associated proteins found in the ST403CC C. jejuni isolates (Chapter Four) were not 
located within identified recombinant regions, it could be that these are part of 
small recombinant regions representing a false negative in BRATNextGen results.  
6.4.2 Recombination Frequency 
Recombination frequency in ST403CC C. jejuni isolates was found to be significantly 
lower than in non-ST403CC C. jejuni, and significantly higher than in C. coli.  The lack 
of significant recombination events observed for C. coli is in line with previous 
research which observed lower levels of recombination in C. coli than C. jejuni (Yu et 
al, 2012; Sheppard et al 2008); Yu et al (2012) observed that recombination gave 
rise to around seven times more SLV generation than does mutation in C. jejuni, 
whereas in C. coli both mutation and recombination play a similar level.  The level of 
recombination observed for non-ST403CC C. jejuni is as could be expected – 
frequent evidence of recombination events, with considerable variation between 
strains.  C. jejuni 414 was unusual in that it showed no evidence of significant 
recombination events, however this is justifiable, as it is a specialist niche isolate 
which survives in an isolated host (Myodes glareolus, the bank vole), it is known to 
have lost regions which are common to more ‘typical’ C. jejuni isolates and although 
it is also described as having gained new genetic information to survive in the bank 
vole host (Hepworth et al, 2011), these will form part of the accessory genome and 
therefore would not be observed in the BRAT analysis. 
6.4.3 Content of Recombinant Regions in ST403CC Campylobacter jejuni 
Although ‘region 1’ showed that both ST403CC and non-ST403CC isolates possessed 
bioA and carB genes, the ST403CC isolates are lacking several other ‘bio’ genes, or 
they are so disparate that they weren’t identified as part of the core genome 
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alignment.  ST403CC isolates contain both bioF and bioA, although whether bioA is 
likely to be functional may be uncertain, as it shows possible frameshift.  carB 
likewise may have a frameshift – annotation using PROKKA identified it as being 
entirely in the second reading frame for 857, despite lots of potential stop codons, 
but examining empty reading frames such as in 304 region 1 suggest it may involve 
a frameshift to frame 1.  It seems possible that the recombination event may not 
have a functional change (although considering the potential frameshift, it may), 
but it may serve as a ‘marker’ as it is consistent across the ST403CC isolates.  It was 
also observed that when searching the public BLAST database the closest matches 
to these genes in the ST403CC C. jejuni were seen in C. coli isolates; suggesting that 
these genes are more like the C. coli bioA and carB genes.   
The second recombinant region common to the ST403CC C. jejuni  isolates was the 
small recombination segment (202-210bp) was confirmed by local database BLAST 
searching as present in these C. jejuni and not in the included non-ST403CC C. jejuni, 
although lower scoring matches were observed in all included C. coli.  The ORF 
which the recombination fragment is revealed to be contained within however 
(length in 857 of 1275bp) has homologues in all 34 isolates.  This suggests that this 
potential hydrolase is present in ‘all’ thermotolerant Campylobacter, but that a 
different ‘fingerprint’ is observed in C. coli and in ST403CC C. jejuni.   
The third recombinant region, similar to the first also appeared to be a distinct 
recombination event in ST403CC C. jejuni isolates which does not appear to have a 
significant effect on the coding sequence. 
6.4.4 Overall Discussion & Conclusions 
ST403CC C. jejuni isolates show a significant reduction in the number of 
recombination events compared to non ST403CC C. jejuni isolates, and have little 
import of C. coli associated DNA.  This is accompanied by the acquisition of four 
restriction/modification enzymes (as described in Chapter Four).  R/M systems 
‘protect’ the strain from the uptake of new genetic information and may, 
theoretically, explain the lack of recombination in the ST403CC C. jejuni isolates. 
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However, it is worth noting that the lack of observed recombination in the C. coli 
isolates appears to be in contradiction with what has been observed in the 
literature.  Sheppard et al (2013) have observed genome wide introgression in C. 
coli isolates from ST828CC; taking up large amounts of C. jejuni DNA.  Lefébure et al 
(2010) observed no recombination or evidence of introgression in C. coli, however 
this was due to their included sample containing only clade one isolates (no non-
agricultural isolates) and their applied method being affected by this bias; as all of 
the included isolates may have contained the same introgression signature, the 
analysis wouldn’t necessarily have been able to ‘filter’ the event and identify it.  It 
may be possible that the included BRATNextGen analysis suffered false negatives in 
not identifying recombination events in the C. coli isolates, however it is more 
probable that the recombination occurring would be part of the accessory genome 
and therefore not included in the analysis based upon the core genome alignment 
used in this technique. 
The observation of significantly reduced recombination in ST403CC C. jejuni isolates 
disproves the initial supposition that these isolates may exhibit increased uptake of 
C. coli content, however this in itself represents a way in which the ST403CC C. 
jejuni isolates emulate the behaviour of C. coli via the reduction in recombination. 
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Chapter Seven: Discussion 
7.1 Summary 
Previous work identified, by MLST, a clonal complex group of C. jejuni isolates which 
were considered a potentially host adapted group of strains (Manning et al, 2003).  
For the purpose of this thesis, a selection of these isolates representing six different 
sequence types within the clonal complex (ST403CC) were studied for evidence of 
this potential host adaptation.   
It was hypothesised that these ST403CC C. jejuni isolates, being associated with the 
porcine host more commonly associated with C. coli, may exhibit increased genetic 
recombination with C. coli, and at an extreme may represent an intermediary group 
or ‘fuzzy species’ within the boundary between C. jejuni and C. coli.  It was also 
suggested that the ST403CC C. jejuni isolates might demonstrate a distinct 
phenotype as a result of adapting to survive the porcine host, such as exhibiting 
differential ability to survive environmental stressors or internalise into human cells 
in cell culture experiments.  As such, the work carried out in this thesis aimed to 
investigate evidence of niche adaptation in these isolates through assessment of 
phenotypic characteristics; whole genome phylogeny; core and pan genome 
content; genetic variation; and genomic recombination. 
The initial ST403CC isolates which inspired this research were recovered by 
Manning et al (2003) and were associated primarily with pigs and with cows to a 
lesser extent; with no ST403CC isolates associated with human infection in the UK 
during that study.  At a similar timepoint, Duim et al (2003) found an association 
with ST403CC C. jejuni and human gastroenteritis in Curaçao.  A recent overview of 
the recorded isolates of ST403CC C. jejuni on the PubMLST database (Jolley & 
Maiden, 2010: http://pubmlst.org/campylobacter/) is shown in Figure 7.1 overleaf: 
the ST403 sequence type, and the ST403CC clonal complex have been isolated from 
food mammals, dogs, and frequently from human cases, but have not been 
recovered from poultry. 
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There exist many STs within the ST403CC which are represented by only one isolate, 
and therefore only one reported source.  Of those with multiple isolates in a 
Sequence Type, some such as ST270 and ST403 represent a variety of source types, 
whilst others seem specific to a single host type or source.  ST933 represents the 
latter with the majority of isolates associated with cattle and beef products, and a 
small number of human gastroenteritis cases.  Others such as ST5408 have only 
1 1 
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Human Gastroenteritis
Human (Other/Unspecified)
Pig/Pork
Unspecified/Other
Figure 7.1a 
Sources of Sequence Type ST403 isolates as reported on PubMLST (total 103 
isolates recorded). 
Figure 7.1b 
Sources of all ST403 Clonal Complex isolates (sharing four or more of seven loci with 
ST403) as reported on PubMLST (Total 296 isolates recorded). 
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been isolated from a single source type (in this case pigs and pork products) and not 
yet linked with human cases. 
The work presented in this thesis demonstrated that the selected ST403CC C. jejuni 
isolates did not display a distinct pattern of phenotypic behaviour when compared 
to other C. jejuni and C. coli isolates, rather giving equivalent results to previously 
characterised C. jejuni; with the typical strain-strain variation observed within these 
species, however it was demonstrated that these isolates were capable of motility 
and host cell invasion in vitro – adhering to and internalising into human colonic 
Caco-2 cells – indicating that these isolates, given the opportunity would potentially 
be capable of causing human illness.  It was also confirmed that the isolates are 
closely related based upon whole genome phylogeny, but do exhibit between strain 
variation in genetic content.  The ST403CC C. jejuni isolates do not exhibit increased 
sharing of CDS with C. coli compared to non-ST403CC C. jejuni isolates, and contain 
also only a small number of CDS shared with none of the included C. jejuni and C. 
coli isolates in the group-pan genome analysis carried out.  The coding sequence 
content of ST403CC C. jejuni isolates was largely ‘normal’ for C. jejuni, however 
some potential prophage content was found which was common to all six included 
ST403CC C. jejuni isolates.  Predicted prophage content was also observed which 
represented part of the variation between isolates in the ST403 Clonal Complex. 
As described in Chapter Six, the ST403CC C. jejuni isolates were demonstrated to 
exhibit a significant reduction in the rate of recombination occurring, compared to 
non-ST403CC C. jejuni isolates, which was accompanied by and possibly explained 
by, the acquisition of four restriction modification enzymes which are not common 
in sequenced C. jejuni - in the local database searches using 34 C. jejuni and C. coli 
genomes, three of the four CDS had homologues only in the seven ST403CC C. jejuni 
isolates, whilst the fourth had an additional homologue in a porcine C. coli isolate - 
and may ‘protect’ the isolates from the uptake of new genetic information.  
Although the ST403CC C. jejuni isolates did not show an increased homology with C. 
coli isolates, the reduced recombination profile observed reflects a genetic 
similarity to C. coli.  C. coli isolates undergo lower recombination frequencies than 
C. jejuni, as demonstrated by BRATNextGen in Chapter Six and also in the literature 
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(Sheppard et al 2008; Yu et al, 2012).  It may be postulated that the ST403CC C. 
jejuni isolates are in fact ‘behaving’ more like C. coli than non-ST403CC C. jejuni 
isolates due to this significant reduction in recombination.   
7.2 Related ST403CC Isolate Campylobacter jejuni ATCC33560 
As described in Chapter Four NCBI blast searching coding regions from the ST403CC 
C. jejuni isolates revealed frequent high scoring matches with a C. jejuni isolate 
ATCC33560 – which was revealed to be a geographically and temporally distinct 
ST403CC isolate (ST403) from a bovine faecal sample.  This isolate was therefore 
included in subsequent analyses, to investigate whether the ‘effects’ of ST403CC 
over-ride the effects of host, time and country.  The additional ST403CC isolate was 
found to be largely similar to the six porcine ST403CC C. jejuni isolates, with the 
exception of its lack of prophage content as revealed in Chapter Five.  It is noted 
however that the lack of prophage content in ATCC33560 does not necessarily 
signify a difference in ability to acquire prophage; it may be that due to the 
different time, location or host of isolation the isolate may not have encountered 
bacteriophage to integrate.  It is also possible that there is some difference in 
ST403CC isolates associated with cattle not encountering or not acquiring phage 
content, however further research would be required on additional isolates in order 
to reveal this.  As shown below (Figure 7.2) C. jejuni ATCC33560 clusters with the 
other ST403CC C. jejuni isolates based upon whole genome phylogeny, but is visibly 
distinct.   
C. jejuni ATCC33560 is the quality control isolate for C. jejuni antimicrobial 
sensitivity testing, and was used to demonstrate the influence of the CmeR 
regulator by Hyytiäinen & Hänninen (2012). 
In addition, as described in Chapter Six, C. jejuni ATCC33560 also fits the reduced 
recombination profile of the ST403CC C. jejuni isolates, suggesting that the unusual 
characteristics of ST403CC isolates are not specific to porcine isolates but related to 
some other linking factor within the clonal complex.   
236 
 
7.3 ST403CC Campylobacter jejuni Isolates in the Literature 
The ST403 clonal complex was primarily associated with pigs, and also with cattle to 
a seemingly lesser extent (Manning et al, 2003) however isolates of this clonal 
complex have increasingly been identified from a range of sources, and have also 
been associated with human clinical infections. 
In an investigation into an increased burden of Campylobacteriosis and GBS in 
Curaçao, Duim et al (2003) identified 41 isolates (21% of the isolates fully 
characterised in the study) within the ST403 clonal complex, which were associated 
with a temporal association with November-February (although this is the wet 
season there and has the hightest levels of Campylobacter infection in general) and 
were all Sequence Type 403.  Duim et al (2003) also noted difficulty in AFLP typing 
ST403CC isolates, possibly linked to four adenine specific methyltransferases known 
to be produced in C. jejuni (11168; Parkhill et al, 2000), as methylation can block 
restriction by HindIII – one of the AFLP enzymes – however there was no 
explanation of whether this was responsible, or why this effect might be particularly 
Figure 7.2  
Whole genome alignment phylogeny tree for 20 C. jejuni isolates, including the additional 
ST403CC C. jejuni isolate ATCC33560 
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pronounced in these isolates.  This may potentially be associated with results 
observed in Chapter Four; additional methyltransferases were identified in the six 
sequenced ST403CC isolates, perhaps these have a role in preventing restriction by 
HindIII – although this is just postulation which has not been demonstrated it 
represents a possible explanation. 
ST403CC isolates were also recovered from dogs during a study by Parsons et al 
(2009) where they demonstrated that a relatively low proportion of domestic dogs 
may carry C. jejuni and may in fact acquire C. jejuni infection from the same sources 
as humans, they still represent a risk for zoonotic C. jejuni infection. 
Additionally, ST403CC C. jejuni isolates have recently been associated with raw bulk 
milk in Italian dairy herds (Bianchini et al, 2014).  Bianchini et al (2014) also 
recorded the presence of ST21CC and ST48CC isolates which are known ‘generalist’ 
C. jejuni lineages (ST21, Gripp et al, 2011; ST48, Sheppard et al, 2009).  ST21CC may 
be described as a ‘true generalist’ C. jejuni lineage.  The research by Gripp et al 
(2011) demonstrated high genomic diversity linked with large scale recombination 
and acquisition of prophage content.  The ST48CC was associated with a range of 
host types in a survey by Sheppard et al (2009). 
Grove-White et al (2011) surveyed cattle and sheep in Lancashire and found some 
association between ST21CC and both cattle (16.7%) and sheep (13.2%), ST48 linked 
with sheep (13.2% and only in 2.9% of cattle isolates) and ST403CC with cattle 
(16.7%, compared to 2.8% in sheep). 
ST403CC isolates were associated with a winter peak in a six year study by Cody et 
al (2012) and were generally ciprofloxacin sensitive. Cody et al (2012) described 
ST403CC isolates as being generally associated with a wide range of hosts and 
typically not with poultry.  The winter peak of ST403CC recovery observed by Cody 
et al (2012) also correlates with the wet season peak observed by Duim et al (2003), 
whilst contradicting the usual summer seasonal peak for C. jejuni in the UK.  It may 
be proposed that there could be an unrevealed link between certain clonal 
complexes of C. jejuni and the wetter seasons, however this may not be linked with 
mammalian hosts, and the cause of the association is not yet clear.  Both the 
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ST403CC and ST353CC had winter (wet) peaks during a 6 year longitudinal study in 
Oxfordshire in the UK; whereas the ST45, ST283 and ST42 Clonal complexes 
exhibited the typical summer peak of C. jejuni in the UK (Cody et al, 2012).  Both the 
ST45CC and ST283CC are chicken associated clonal complexes, however ST42CC is 
commonly associated with ruminants; and although ST403CC is associated with a 
range of hosts excluding poultry, the ST353CC is associated with chicken  - thereby 
there is little suggestion that this link is associated with a difference between 
poultry and non-poultry isolates (Cody et al, 2012).  Interestingly, the ST353CC 
identified as a wet season associated complex by Cody et al (2012), was also one of 
the ten major clonal complexes identified by Duim et al (2003) in Curaçao alongside 
the ST403CC, where it also matched the rainy season peak. 
Sheppard et al (2009) revealed an association with ST403CC and cattle and sheep.  
Also, although they found the majority of clinical isolates included were related to 
chicken associated genotypes, they did observe a small proportion of clinical 
isolates from the ST403CC. 
ST403CC C. jejuni isolates have even been associated with GBS cases (Islam et al, 
2009) during a survey in Bangladesh, representing five of the ten GBS related 
isolates included in their study.  Islam et al (2009) observed an association between 
ST403CC and Penner serotype HS:23 in their study on GBS and enteritis isolates.  Of 
the six sequenced ST403CC isolates used in this research, in previous study, four 
were deemed untypeable, however isolates 484 (PS484) and 444 (PS444) were 
designated HS:23 (Manning et al, 2003; Frost et al 1998).  Across the sixteen porcine 
ST403CC isolates in total included in Manning et al (2003), 9 were untypeable, and a 
total of four serotypes were observed across the remainder (23 (n=4), 35 (n=1), 29 
(n=1), 22 (n=1)).   
It may be that, rather than representing a host adapted isolate as first predicted, 
the ST403 clonal complex may represent a more generalist lineage, with a bias 
towards mammalian hosts.  Works published in the literature also link ST403CC 
isolates with enteric infection and even with GBS so it is revealed that these may 
represent a threat lurking within the meat production industry. 
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7.4 Gene Content of ST403CC Campylobacter jejuni Isolates 
The annotated genomes produced were subsequently used to return to the regions 
of variance identified in Chapter Three (Figure 3.9) which were found to contain 
largely hypothetical proteins, unfortunately investigation of these regions was not 
highly informative.  Although one of the divergent regions in 623 contained flgE, 
dnaA, dnaN, gyrB – however it is difficult to accurately identify exact locations from 
BRIG so this may be directly upstream of the variant region. 
Raphael et al (2005) described the gene cbrR (Campylobacter bile resistance 
regulator) in C. jejuni 11168 (coding region Cj0643).  This gene was shown to 
provide resistance to sodium deoxycholate; mutants were highly sensitive and the 
complemented mutant had restored resistance.  cbrR mutants were also less able 
to colonise in the chick model.  In the thirty four genomes included in analysis, a 
cbrR homologue was identified in all included C. jejuni strains and none of the C. coli 
isolates.  The match for the niche adapted isolate C. jejuni 414 was much lower 
however suggesting the gene may be degraded.  All of the ST403CC C. jejuni 
contained a cbrR homologue, which supports the level of sodium deoxycholate 
sensitivity observed in Chapter Two, as they are seemingly able to respond to and 
survive sodium deoxycholate stress. 
Karlyshev et al (2014) characterised a previously unstudied peptidase in C. jejuni 
11168, Cj0511.  They confirmed that this was a serine peptidase and demonstrated 
that mutants in Cj0511 were poor colonisers in the chicken model.   A BLASTn 
search of the local database containing thirty four C. jejuni and C. coli genomes, as 
described in Chapter Four revealed that a high-scoring Cj0511 homologue was 
present in all included C. jejuni isolates, with approximately 50% similarity to 
homologues also found in each included C. coli isolate.  This supports their 
conclusion that this may play a role in colonisation, as all tested C. jejuni strains 
contained a Cj0511 homologue and were able to invade host cells in cell culture 
experiments.  However this cannot directly be compared as chicken colonisation 
experiments were not done in this work. 
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Champion et al (2005) identified a group of CDS which were seemingly linked with 
livestock strains of C. jejuni (Cj1321-Cj1326 in C. jejuni 11168).  Subsequently, during 
the re-annotation of C. jejuni 11168 (Gundogdu et al, 2007) the CDS Cj1325 and 
Cj1326 were joined to represent a single gene split across two reading frames 
(designated as Cj1325).  Homologues of Cj1321-1323 from C. jejuni 11168 were 
observed in local database BLASTn searching in the two hyper invasive human C. 
jejuni isolates (01/10 and 01/51), the human microbiome isolate C. coli JV20 and 
seven porcine C. coli isolates, whereas Cj1324 and Cj1325 had homologues in the 
same ten previously described as well as in the bank vole adapted C. jejuni isolate 
414, the human blood isolate C. jejuni doylei 269.97, the sheep isolate C. jejuni 
IA3902 and the seven ST403CC C. jejuni isolates.  These results largely fit with those 
observed by Champion et al (2005), as these isolates are mostly livestock 
associated, the notable exceptions being human clinical or commensal isolates; 
these may likely be explained by the fact that the probable source of the infections 
originated from a livestock source.  In the case of C. coli JV20 having been 
associated with the human gut microbiome, this seemingly suggests that this is a 
pathogenic isolate however it could possibly be suggested that this is a potential 
pathogen which had either not reached a high enough dose level to create 
symptoms, or was post-illness and not fully cleared, or represents an example of 
adaptive immunity. 
7.5 Host Adaptation & Host Generalists 
Bronowski, James & Winstanley (2014) describe that C. jejuni must survive oxygen 
stress in different environments - and that Campylobacter uses catalase rather than 
SOD (superoxide dismutase) as in most bacteria.  The katA gene is the major 
catalase in C. jejuni however another has been recently identified - Cj1386 
downstream of katA.  A brief check using local database blast searching revealed 
that a katA homologue was observed in all thirty four included genomes, with 
greater homology in C. jejuni than C. coli.  Homology matches were also observed 
for all thirty four genomes for Cj1386 however scores were much lower (and 
discarded) for all C. coli isolates (approximately 50% homology score, and higher E. 
values). 
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As described in the introductory chapter (1.7 Host Association) in 2005, French et al 
noticed a prevalence of uncA17 allele in ST61CC cattle isolates.  In this study uncA17 
was found in two of the four newly sequenced porcine C. coli isolates.  All six newly 
sequenced porcine ST403CC C. jejuni isolates contained uncA7; this allele is also 
found in some ST61CC isolates. 
Sheppard et al (2014) demonstrated that recombination does not occur in the 
natural host environment between two of the major generalist C. jejuni lineages, 
despite considerable opportunity in common hosts.  Sheppard et al (2014) propose 
that the barrier to recombination between these lineages is not a physical 
prevention - as they can recombine easily in the lab - there may be some unclear 
ecological niche reason preventing recombination between these two lineages. 
In this thesis, it has been attempted to discern evidence of host adaptation within a 
potential niche adapted group of C. jejuni; this has been evidenced in some 
lineages, but is not always a discernable feature (Méric et al, 2014; Sheppard et al, 
2014).  It may be postulated that seemingly generalist lineages simply have not had 
a long enough time period to adapt to a given host, and although this may be the 
case in some examples, this has also been refuted in studies such as that by 
Sheppard et al (2014). 
Méric et al (2014) used a similar method to the approach taken here in Chapter 
Four, of filtering through the pan genome content to identify genes associated with 
species or sub-group of isolates, however Méric et al (2014) have developed a new 
technique to identify these genes.  
Based upon seven C. jejuni and C. coli isolates Méric et al (2014) observed a pan 
genome of 3933 CDS, with a core genome of 1035 and accessory genome of 2792 
CDS.  This aligns with the results observed in this research; the core genome 
determined for thirty three included genomes was 591 CDS with a pan genome 
across the thirty three isolates of 5329 CDS.  The core represented approximately 
11% of the total pan genome, and the accessory genome (calculated simply as the 
size of the pan genome size minus the core genome size) was 4738 CDS.  Whilst for 
the six ST403CC isolates alone, the core genome was 1444 CDS, with a pan genome 
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of 2220 CDS.  The core represented approximately 65% of the pan genome, with an 
accessory genome of 776 CDS. 
Méric et al (2014) used this seven genome reference pan genome to investigate 
genetic variation both between the two species and within specific lineages within 
the species.  They did not identify specific CDS linked with specific lineages (clonal 
complexes) as they tended to also be present in some other smaller lineage.  
However they did observe some ‘generalist’ genes which were associated with the 
multiple host associated ST21CC and ST45CC, plus others which were related to 
host restricted groups (ST353CC and ST61CC).  This falls in line with the results 
observed here also; few CDS were observed which were distinct to ST403CC 
isolates, however this is not surprising due to the close relationship between C. 
jejuni clonal complexes.  Méric et al (2014) also observed gene flow between the 
generalist lineage ST21CC and C. coli clade one isolates, as has been previously 
described (Sheppard et al 2013; Sheppard et al 2008). 
Yahara et al (2014) produced a new approach for identifying ‘hotspots’ of 
recombination in bacterial genomes.  Using this they demonstrated three 
recombinant ‘hotspots’ in C. jejuni which were largely associated with membrane 
associated proteins.  The work presented here supports the findings of Yahara et al 
(2014) in that the regions where the ST403CC C. jejuni isolates tended to vary from 
other C. jejuni were observed to be largely consisting of membrane associated 
proteins.   
7.6 Temperature Effects 
The normal body temperature range of the pig is 38.7-39.8°C, and in cattle 36.7-
39.3°C (beef cattle 36.7-39.1°C; dairy cattle 38.0-39.3°C) compared to 40.6-43°C in 
chickens (as described in the Merck veterinary 
manual; http://www.merckmanuals.com/vet/appendixes/reference_guides/normal
_rectal_temperature_ranges.html ) and 37°C in humans.  In the course of the 
phenotypic experiments carried out it was demonstrated that the ST403CC C. jejuni 
isolates grow successfully at 37°C and 42°C, however no specific experimentation 
was carried out in this region.  It may be of future interest to carry out a 
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temperature growth curve experiment, to ascertain the optimum growth 
temperature of ST403CC C. jejuni isolates and determine whether it reflects the 
42°C optimum typically associated with C. jejuni, and similar to the chicken host, or 
whether perhaps the optimum of these isolates may be closer to the normal body 
temperature of pigs or mammals in general. 
7.7 Benefits & Limitations of Genomic Investigation 
It is important to remember in this era of ever increasing genomic study, that 
genome alone cannot inform us of how the bacteria may be behaving in the 
host/ecosystem/even in the lab.  A simple example that illustrates this is the issue 
of hippurate hydrolysis. As described early on (Chapter Two), hippurate hydrolysis 
was a traditional discriminator between C. jejuni and C. coli - wherein C. coli are 
negative and C. jejuni are positive, however in newer studies it was shown that 
some C. jejuni, including the isolates which provided the basis for this work, are 
phenotypically hippurate negative.  Although as shown in Chapter Four these 
isolates do still maintain the hipO gene - for the isolates included in the analysis 
here it was shown that presence or absence of the hipO gene can separate the two 
species, however it does not inform upon which are able to express the enzyme.  
This is an issue which may be relevant in many genome based studies - it is 
important to remember that it may give us clues and associations but cannot give 
the whole picture. 
7.8 Further Work, Future Perspectives & Conclusions 
The work produced in this thesis has revealed that the potential porcine associated 
ST403CC C. jejuni isolates previously identified (Manning et al, 2003) may represent 
a mammalian niche associated lineage, and that this grouping appears to transcend 
temporal and geographical factors.   
The ST403 Clonal Complex is associated with a significantly reduced rate of genomic 
recombination compared to other C. jejuni isolates from a range of sources and 
clonal complexes.  However the low recombination rate is mirrored in C. coli, which 
undergo less genomic recombination than C. jejuni, and also in the highly niche 
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adapted C. jejuni isolate 414 which did not exhibit recombination; although it may 
be difficult to affirm whether this is due to genetic or environmental barriers.   
If it were a feasible prospect, a future goal would be to acquire sequence data for 
additional ST403CC isolates, including human clinical isolates and a range of 
additional sources, in order to investigate whether the reduced recombination 
profile is common across the remainder of the group or whether it differs between 
human and ‘mammalian’ hosts.  This would also provide a basis to further consider 
the potential role of prophages in this group of isolates.   
The work presented here has provided new information on the effect of host 
adaptation on evolution and recombination in C. jejuni.  It has been demonstrated 
that a group of ST403CC C. jejuni isolates exhibit a profile of reduced recombination 
in isolates from both pigs and cattle and may represent a mammalian associated 
specialist lineage of C. jejuni. 
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Appendix 9.1 Isolate Information Table
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Chapter 2: 
Phenotyping
Chapter 3: 
Phylogeny
Chapter 4: 
Genome 
Content
Chapter 5: 
Prophage
Chapter Six: 
Recombination
C. jejuni jejuni 857 2000 UK Pig N/A 270 403 CJ857     
C. jejuni jejuni 549.1 1999 UK Pig N/A 403 403 CJ857     
C. jejuni jejuni 623 1999 UK Pig N/A 552 403 CJ857     
C. jejuni jejuni 304 1999 UK Pig N/A 551 403 CJ857     
C. jejuni jejuni 484 1999 UK Pig N/A 435 403 CJ857     
C. jejuni jejuni 444 1999 UK Pig N/A 553 403 CJ857     
C. jejuni jejuni ATCC33560 1970 Belgium Cow 380625642 403 403 N/A  
C. jejuni jejuni 81116 1981 UK Human CP000814.1 267 283 C8J_    
C. jejuni jejuni 11168 1977 UK Human AL111168.1 43 21 Cj    
C. jejuni jejuni 1336 - - Water CM000854.1 841* ~ C1336_   
C. jejuni jejuni 414 2000 UK Water Vole CM000855.1 3704 ~ C414_   
C. jejuni jejuni 81-176 1981 USA Milk CP000538.1 604* 42* CJJ81176_   
C. jejuni jejuni S3 1999 UK Sheep CP001960.1 632 42 CJS3_   
C. jejuni jejuni IA3902 2006 USA Sheep CP001876.1 8 21 CJSA_   
C. jejuni jejuni ICDCCJ07001 2007 China Human CP002029.1 2993 362 ICDCCJ07001_   
C. jejuni jejuni M1 1999 UK Human CP001900.1 137 45 CJM1_   
C. jejuni jejuni 01/10 - UK Human - 104* 21* CJ0110_   
C. jejuni jejuni 01/51 - UK Human - 19* 21* CJ0110_   
C. jejuni jejuni RM1221 1997 USA Chicken CP000025.1 354 354 CJE   
C. jejuni doylei 269.97 1997 South Africa Human CP000768.1 1845 ~ JJD26997_   
C. coli RM2228 1998 USA Chicken AAFL00000000 1063 828 CCO   
C. coli JV20 - - Human AEER00000000 860* 828* HMPREF9399_   
C. coli 111-3 2001 USA Pig AIMI00000000 1467* 828* cco1_   
C. coli 132-6 2001 USA Pig AINA00000000 3861* ~ cco5_   
C. coli 151-9 2001 USA Pig AINQ00000000 1102* ~ cco8_   
C. coli 59-2 2000 USA Pig AIND00000000 890* 828* cco6_   
C. coli 67-8 2000 USA Pig AINI00000000 1061* 828* cco7_   
C. coli 7—1 2001 USA Pig AIMZ00000000 3860* ~ cco4_   
C. coli 84-2 2000 USA Pig AIMS00000000 113* 828* cco12_   
C. coli 90-3 2001 USA Pig AIMJ00000000 3862* ~ cco10_   
C. coli 99/321 1999 Denmark Pig N/A 1153* 828* CC03121_     
C. coli 03/121 2003 UK Pig N/A 887* 828* CC03121_     
C. coli 03/103 2003 UK Pig N/A 2732* 828* CC03121_     
C. coli 03/317 2003 UK Pig N/A 1145* 828* CC03121_     
Details of isolates used in this study. - information not available.  MLST/CC determined in silico .  ~Clonal 
Complex not assigned
Included in
ST ST CC  CDS PrefixAccessionSpecies Isolate Date Country Source
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C. jejuni 81116 C. jejuni  11168 C. jejuni  857 C. jejuni  549.1 C. jejuni 623 C. jejuni  304 C. jejuni  484 C. jejuni 444 C. coli  99/321 C. coli  03/121 C. coli 03/103 C. coli  03/317
Minimum 19 21 18 6 3 29 13 9 3 3 6 9
Maximum 19 21 24 6 3 31 15 17 4 3 18 13
Mean 19 21 21.67 6 3 30 14 13 3.333 3 11.67 11
Std. Deviation 0 0 3.215 0 0 1.414 1.414 4 0.5774 0 6.028 2.828
Minimum 0.245 0.229 0.6 0.716 0.7 0.289 0.805 0.567 0.67 0.482 0.648 0.816
Maximum 0.285 0.444 0.667 0.717 0.818 0.496 1.028 0.656 0.731 0.502 0.726 0.993
Mean 0.2607 0.3543 0.643 0.7163 0.7677 0.362 0.896 0.6133 0.7053 0.4887 0.674 0.9157
Std. Deviation 0.02136 0.1118 0.03732 0.0005773 0.06088 0.1162 0.117 0.04461 0.03163 0.01155 0.04503 0.09059
Minimum 2.08 0.3567 1.151 1.1 0.1931 2 1.25 1.152 0.6255 1.333 1.35 2.186
Maximum 2.83 0.7833 1.395 1.166 0.2863 4.667 1.415 1.461 2.498 2.333 2.392 3.098
Mean 2.455 0.57 1.273 1.133 0.2397 3.333 1.333 1.306 1.562 1.833 1.871 2.642
Std. Deviation 0.5303 0.3017 0.1723 0.04667 0.06586 1.886 0.1167 0.2183 1.324 0.7071 0.7366 0.6453
Minimum 0.003415 0.161 0.001304 0.00466 0.00279 0.01333 0.02085 0.002456 0.009363 0.0004113 0.003003 0.02005
Maximum 0.004835 0.2557 0.001364 0.005 0.003721 0.01653 0.0225 0.002535 0.009363 0.0004333 0.003473 0.02552
Mean 0.004125 0.2083 0.001334 0.00483 0.003255 0.01493 0.02168 0.002495 0.009363 0.0004223 0.003238 0.02279
Std. Deviation 0.001004 0.06694 4.24E-05 0.0002404 0.0006585 0.002263 0.001167 5.54E-05 0 1.56E-05 0.0003323 0.003864
Minimum 24 29 25 22 30 15 24 26 28 16 25 20
Maximum 26 35 27 24 34 24 28 28 28 20 28 25
Mean 25 31.67 25.67 23 31.67 20 26.33 27 28 18 26.33 22.67
Std. Deviation 1 3.055 1.155 1 2.082 4.583 2.082 1 0 2 1.528 2.517
Minimum 35 30 30 32 38 29 31 36 30 30 29 35
Maximum 41 36 34 55 50 44 42 40 36 34 43 39
Mean 37.6 32.4 31.8 43.2 43.8 35.6 35.8 37.4 32 32.2 38.4 36.8
Std. Deviation 2.408 2.881 1.789 8.701 5.02 5.771 5.263 1.949 2.55 1.483 5.727 1.483
Minimum 7 8 7 7 8 10 8 6 6 6 5 8
Maximum 8 9 9 8 9 13 10 7 8 7 7 8
Mean 7.667 8.333 7.667 7.667 8.333 12 9 6.667 7 6.667 6 8
Std. Deviation 0.5774 0.5774 1.155 0.5774 0.5774 1.732 1 0.5774 1 0.5774 1 0
Minimum 5 6 7 7 6 7 7 7 6 6 6 6
Maximum 7 8 8 8 7 8 7 10 8 7 8 7
Mean 6.333 7 7.667 7.667 6.667 7.667 7 8 7 6.667 7 6.667
Std. Deviation 1.155 1 0.5774 0.5774 0.5774 0.5774 0 1.732 1 0.5774 1 0.5774
Minimum 6 6 5 6 5 7 6 5 5 6 7 8
Maximum 6 7 6 7 6 8 7 8 6 7 8 10
Mean 6 6.333 5.333 6.333 5.333 7.333 6.667 6.667 5.667 6.333 7.667 9
Std. Deviation 0 0.5774 0.5774 0.5774 0.5774 0.5774 0.5774 1.528 0.5774 0.5774 0.5774 1
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CDS
Cjj 1336 
Wild Bird
Cjj 414 
Water 
Vole
Cjj S3 
Sheep
Cjj 
IA3902 
Sheep
Cjd 
26997 
Human 
Blood
Cjj 81-
176 
Human 
(Milk)
Cjj 
ICDCCJ0
7001 
Human 
GBS 
Stool
Cjj 81116 
Human 
(Water)
Cjj M1 
Human 
(Chicken
)
Cjj 11168 
(Human)
Cjj 0110 
Human
Cjj 0151 
Human
Cc JV20 
Human 
(Microbi
ome)
Cjj 
RM1221 
Chicken
Cc 
RM2228 
Chicken
Cc 111-3 
Pig
Cc 132-6 
Pig
Cc 151-9 
Pig
Cc 59-2 
Pig
Cc 67-8 
Pig
Cc 7--1 
Pig
Cc 84-2 
Pig
Cc 90-3 
Pig
Cc 99321 
Pig
Cc 03121 
Pig
Cc 03103 
Pig
Cc 03317 
Pig
Cjj 857 
Pig
Cjj 5491 
Pig
Cjj 623 
Pig
Cjj 304 
Pig
Cjj 484 
Pig
Cjj 444 
Pig
Cj0672
putative periplasmic 
protein
Cj0246c
putative MCP-domain 
signal transduction 
protein
Cj0344
hypothetical protein 
Cj0344
CJE1384
hypothetical protein
Cj0556
putative 
amidohydrolase 
family protein
Cj0555
putative dicarboxylate 
carrier protein MatC
C8J 0033
hypothetical protein
Cj0417
hypothetical protein 
Cj0417
Cj1158c
small hydrophobic 
protein
C8J 1559
hypothetical protein
HMPREF9399 0599
conserved 
hypothetical protein
HMPREF9399 0256
conserved 
hypothetical protein
CCO1311
hypothetical protein
cco4 04499
hypothetical protein
cco4 04519
hypothetical protein
cco4 04524
hypothetical protein
CCO0280
methyl-accepting 
chemotaxis protein 
(tlpA)
CCO1740
hypothetical protein
CCO1688
hypothetical protein
CCO0184
Hemolysin, putative
cco1 04927
hypothetical protein
CCO1041
conserved 
hypothetical protein
CCO1040
conserved 
hypothetical protein
cco1 08394
hypothetical protein
HMPREF9399 0022
conjugal transfer 
protein TrbD
HMPREF9399 0023
conjugal transfer pilus 
assembly protein TrbC
HMPREF9399 0024
conjugative transfer 
protein TrbB
HMPREF9399 0013
conserved 
hypothetical protein
HMPREF9399 0012
conjugal transfer 
protein TrbI
HMPREF9399 0011
conjugal transfer 
protein
cco5 00320
hypothetical protein
HMPREF9399 0010
single-strand binding 
protein
HMPREF9399 0009
conjugal transfer 
protein
HMPREF9399 0008
DNA primase TraC
HMPREF9399 0007
conjugal transfer 
protein TraG
HMPREF9399 0006
conjugal transfer pilus 
assembly protein TraL
cco1 07549
hypothetical protein
CCO1639
ISCco1, transposase 
orfA
CCO0036
Chain B, Stru
HMPREF9399 0018
P-type conjugative 
transfer protein TrbJ
HMPREF9399 0031
TraJ protein
HMPREF9399 0032
relaxase/mobilization 
nuclease domain 
protein
HMPREF9399 0033
hypothetical protein
HMPREF9399 0034
plasmid partition ParA 
protein
HMPREF9399 0035
conjugal transfer 
protein TraM
HMPREF9399 0036
plasmid transfer 
protein TraF
CCO0533
membrane protein , 
putative
cco4 06586
ferrous iron transport 
protein
cco4 03101
hypothetical protein
HMPREF9399 1768
flagellin
HMPREF9399 1770
motility accessory 
factor
cco1 08991
methyl-accepting 
chemotaxis signal 
transduction protein
CCO1784
hypothetical protein
cco1 08404
hypothetical protein
CCO1173
hypothetical protein
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CDS
Cjj 1336 
Wild Bird
Cjj 414 
Water 
Vole
Cjj S3 
Sheep
Cjj IA3902 
Sheep
Cjd 26997 
Human 
Blood
Cjj 81-176 
Human 
(Milk)
Cjj 
ICDCCJ07
001 
Human 
GBS Stool
Cjj 81116 
Human 
(Water)
Cjj M1 
Human 
(Chicken)
Cjj 11168 
(Human)
Cjj 0110 
Human
Cjj 0151 
Human
Cc JV20 
Human 
(Microbio
me)
Cjj 
RM1221 
Chicken
Cc 
RM2228 
Chicken
Cc 111-3 
Pig
Cc 132-6 
Pig
Cc 151-9 
Pig
Cc 59-2 
Pig
Cc 67-8 
Pig
Cc 7--1 
Pig
Cc 84-2 
Pig
Cc 90-3 
Pig
Cc 99321 
Pig
Cc 03121 
Pig
Cc 03103 
Pig
Cc 03317 
Pig
Cjj 857 
Pig
Cjj 5491 
Pig
Cjj 623 
Pig
Cjj 304 
Pig
Cjj 484 
Pig
Cjj 444 
Pig
CCO1078
hypothetical protein
CCO0104
conserved 
hypothetical protein
CCO0183
Hemolysin  putative
CCOA0046
hypothetical protein
CCO1325
hypothetical protein
CCO0249
conserved 
hypothetical protein
cco1 04747
hypothetical protein
CCO1587
DnaJ-related protein
cco1 04490
hypothetical protein
cco1 04020
DNA adenine 
methylase
cco1 04025
hypothetical protein
cco1 04030
DNA 
methyltransferase
CCO1671
catalase-like protein
cco1 03601
hypothetical protein
CCO0658
conserved 
hypothetical protein
HMPREF9399 0017
conserved 
hypothetical protein
cco1 03616
hypothetical protein
CCO1514
hypothetical protein
CCO1131
hypothetical protein
CCO0037
Chain B, Stru
cco1 00200
hypothetical protein
CCO1307
conserved 
hypothetical protein
HMPREF9399 0038
conserved 
hypothetical protein
CCO0035
Tat (twin-arginine 
translocation) 
pathway signal 
sequence domain 
protein
Cj0860
putative integral 
membrane protein
Cj0818
putative lipoprotein
CCO1339
ISCco1, transposase
C8J 0706
hypothetical protein
CCO1299
hypothetical protein
CCO1281
cobalamin synthesis 
protein/P47K family 
protein
CCO1280
conserved 
hypothetical protein
CCO1279
polysaccharide 
deacetylase family 
protein
CCO1278
hydrolase, carbon-
nitrogen family
Cj1203c
putative integral 
membrane protein
C8J 1076
hypothetical protein
C8J 1077
p
C8J 1078
hypothetical protein
C8J 1080
hypothetical protein
C8J 1082
hypothetical protein
C8J 1084
hypothetical protein
C8J 1090
hypothetical protein
Cj1137c
putative 
glycosyltransferase
CJE0051
hypothetical protein
Cj1051c
restriction 
modification enzyme
Cj0179
biopolymer transport 
protein
Cj0181
TonB transport 
protein
C8J 1459
arsenical-resistance 
protein  putative
C8J 1458
arsenate reductase
cco5 04288
hypothetical protein
CCO0182
hemagglutinin/hemol
ysin-related protein
CCO0137
transcriptional 
regulator, Crp family, 
putative
C8J 0988
hypothetical protein
cco1 08384
CitT protein
cco1 08409
GTP-binding protein 
LepA
CCOA0168
conserved 
hypothetical protein
CCOA0171
conserved 
hypothetical protein
CCOA0027
hypothetical protein
HMPREF9399 0027
conserved 
hypothetical protein
CCOA0048
hypothetical protein
CJE1103
conserved 
hypothetical protein
CJE0389
membrane protein, 
putative
CJE0388
membrane protein, 
putative
CJE0387
membrane protein, 
putative
CCO0413
tricarboxylate 
transport protein 
TctC  putative
CCO0412
tricarboxylate 
transport protein 
TctB  putative
CCO0411
tricarboxylate 
transport protein 
TctA  putative
CJE1127
hypothetical protein
CJE1126
hypothetical protein
CJE1884
lipopolysaccharide 
core biosynthesis 
protien  putative
Cj1723c
putative periplasmic 
protein
Cj1725
putative periplasmic 
protein
Cj1726c
homoserine O-
succinyltransferase
CCO0026
YeeE/YedE family 
protein family
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Appendix 9.3.1 EDGAR ST403CC Absent CDS
 270
CDS
Cjj 1336 
Wild Bird
Cjj 414 
Water 
Vole
Cjj S3 
Sheep
Cjj IA3902 
Sheep
Cjd 26997 
Human 
Blood
Cjj 81-176 
Human 
(Milk)
Cjj 
ICDCCJ07
001 
Human 
GBS Stool
Cjj 81116 
Human 
(Water)
Cjj M1 
Human 
(Chicken)
Cjj 11168 
(Human)
Cjj 0110 
Human
Cjj 0151 
Human
Cc JV20 
Human 
(Microbio
me)
Cjj 
RM1221 
Chicken
Cc 
RM2228 
Chicken
Cc 111-3 
Pig
Cc 132-6 
Pig
Cc 151-9 
Pig
Cc 59-2 
Pig
Cc 67-8 
Pig
Cc 7--1 
Pig
Cc 84-2 
Pig
Cc 90-3 
Pig
Cc 99321 
Pig
Cc 03121 
Pig
Cc 03103 
Pig
Cc 03317 
Pig
Cjj 857 
Pig
Cjj 5491 
Pig
Cjj 623 
Pig
Cjj 304 
Pig
Cjj 484 
Pig
Cjj 444 
Pig
Cj1727c
putative O-
acetylhomoserine 
(thiol)-lyase
CCO0039
sodium:solute 
symporter family 
protein
CCO0040
Protein of unknown 
function, DUF485 
superfamily
Cj0486
putative sugar 
transporter
Cj0488
conserved 
hypothetical protein 
Cj0488
Cj0487
putative 
amidohydrolase
Cj0485
putative 
oxidoreductase
Cj0484
putative MFS (Major 
Facilitator 
Superfamily) transport 
protein
Cj0483
putative altronate 
hydrolase C-terminus
Cj0482
putative altronate 
hydrolase N-terminus
Cj0481
putative 
dihydrodipicolinate 
synthase
Cj0480c
putative 
transcriptional 
regulator
cco5 00550
mannose-1-phosphate 
guanylyltransferase/m
annose-6-phosphate 
isomerase
cco5 00545
GDP-D-mannose 
dehydratase
cco1 04120
WbdK
Cj0122
hypothetical protein 
Cj0122
CJE0140
methyl-accepting 
chemotaxis protein
cco5 04298
helicase, putative
cco5 04303
hypothetical protein
CCO1658
major facilitator 
family transporter  
CJE1429
conserved 
hypothetical protein
CCOA0077
hypothetical protein
CJE0555
hypothetical protein
CJE0554
hypothetical protein
CJE0553
hypothetical protein
CJE0550
site-specific DNA-
methyltransferase, 
putative
Cj1321
putative transferase
Cj1322
hypothetical protein 
Cj1322
Cj1323
hypothetical protein 
Cj1323
CJE0587
hypothetical protein
CJE0588
hypothetical protein
CJE0589
hypothetical protein
CJE1103
conserved 
hypothetical protein
Cj0070c
hypothetical protein 
Cj0070c
Cj1309c
hypothetical protein 
Cj1309c
CJE1445
hypothetical protein
CJE0598
hypothetical protein
CJE0599
hypothetical protein
CJE0600
hypothetical protein
CJE0601
hypothetical protein
Cj0299
putative periplasmic 
beta-lactamase
CJE0732
type III restriction-
modification enzyme
CJE0731
type III 
restriction/modificatio
n enzyme, methylase 
subunit
CJE0574
hypothetical protein
CJE0575
hypothetical protein
CJE0576
conserved domain 
protein
CJE0577
terminase B protein, 
putative
CJE0578
conserved domain 
protein
CJE0579
hypothetical protein
CJE0580
hypothetical protein
CJE0581
hypothetical protein
CJE0582
hypothetical protein
Cj1591
50S ribosomal protein 
L36
CCO1298
sodium/pantothenate 
symporter , putative
Cj1208
putative 5-
formyltetrahydrofolat
e cyclo-ligase family 
protein
CJE1611
GDP-mannose 4,6-
dehydratase
CCOA0206
tetracycline resistance 
protein
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-- - - - - -- -  - - --  - -  -- -
- 
- -
 - - -  - - -
- - - - - -- - -  - - -  - - - -
-
 - - -  - - - -
- - - - - -- -  - - --  - -  -- - - -
- - --  - - - - - -  - -- - - -  -
- -- - - - - - - - -  -
- - -
- - - - - -
- - -
 - - -  - -
- - - - - - - - -  --  - 
-  -  - -- -   - 
- -- - - - - -- - -  - - -  - - 
- - - 
- - -
-  - -  - -
- - - - - -     --  -   
 
- -
    - - - 
- - - - - -    - --     - -
-
- -  -    - -
- - - - - -   - - -       - -
-- - - - - - -  - - --  -   -
- - - -  -- - -  - -
- - - - -
- - - - - - - - -  - - -- -    
-  -              - - - - -
-
 -    - - - -
 - - - - -   -       -     
- -
 -    - - -
  - - - -    - -     - -    
- - -
 -   - - -
   - - -     - -    - - -    -    -
- - - - - -  -             
-
 -   - - - - -
 - - - - -   -       -      -    - - -
- -  - - - -    -      - -    
- - -
 -    - -
   - - -     -     - - -  -  -    -
- - - - -
      - - - -
-  -             
   -     - -
-
 -    - - - -
 - - - - -   
      - -  
 -
- -
- - - -  - - -
  - - - - 
- -  -  
- - - 
- - -
- - - -  - -
  - - - -    
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CDS
Cjj 1336 
Wild Bird
Cjj 414 
Water 
Vole
Cjj S3 
Sheep
Cjj IA3902 
Sheep
Cjd 26997 
Human 
Blood
Cjj 81-176 
Human 
(Milk)
Cjj 
ICDCCJ07
001 
Human 
GBS Stool
Cjj 81116 
Human 
(Water)
Cjj M1 
Human 
(Chicken)
Cjj 11168 
(Human)
Cjj 0110 
Human
Cjj 0151 
Human
Cc JV20 
Human 
(Microbio
me)
Cjj 
RM1221 
Chicken
Cc 
RM2228 
Chicken
Cc 111-3 
Pig
Cc 132-6 
Pig
Cc 151-9 
Pig
Cc 59-2 
Pig
Cc 67-8 
Pig
Cc 7--1 
Pig
Cc 84-2 
Pig
Cc 90-3 
Pig
Cc 99321 
Pig
Cc 03121 
Pig
Cc 03103 
Pig
Cc 03317 
Pig
Cjj 857 
Pig
Cjj 5491 
Pig
Cjj 623 
Pig
Cjj 304 
Pig
Cjj 484 
Pig
Cjj 444 
Pig
Cj1560
putative permease
Cj0490
putative aldehyde 
dehydrogenase C-
terminus
Cj0819
small hydrophobic 
protein
Cj1042c
putative transcriptional 
regulatory protein
Cj0177
putative iron transport 
protein
Cj0178
putative TonB-
denpendent outer 
membrane receptor
CCO1689
hypothetical protein
Cj0748
hypothetical protein 
Cj0748
HMPREF9399 0019
antirepressor
HMPREF9399 0026
conserved hypothetical 
protein
CCOA0078
hypothetical protein
cco4 08036
hypothetical protein
Cj0967
putative periplasmic 
protein
C8J 0987
RlfA
C8J 0986
hypothetical protein
C8J 0985
hypothetical protein
CJM1 1376
NAD-dependent 
epimerase/dehydratase
CJM1 1380
Glucose-1-phosphate 
cytidylyltransferase
Cj0144
putative methyl-accepting 
chemotaxis signal 
transduction protein
C8J 1349
hypothetical protein
CJJ81176 0445
hypothetical protein
CJE0473
hypothetical protein
CJE1101
hypothetical protein
C8J 0528
hypothetical protein
CJE0466
hypothetical protein
Cj0424
putative acidic 
periplasmic protein
Cj0425
putative periplasmic 
protein
CCO1211
glycosyl transferase, 
group 1 family protein
C8J 0644
hypothetical protein
CJE0270
bacteriophage DNA 
transposition protein A, 
putative
CJE0269
bacteriophage DNA 
transposition protein B, 
putative
CJE0268
conserved domain 
protein
CJE0265
host-nuclease inhibitor 
protein Gam, putative
CJE0231
tail fiber protein H, 
putative
CJE0232
phage tail protein, 
putative
CJE0233
baseplate assembly 
protein J  putative
CJE0234
baseplate assembly 
protein W, putative
CJE0236
baseplate assembly 
protein V, putative
CJE0237
conserved hypothetical 
protein
CJE0238
hypothetical protein
CJE0239
lipoprotein, putative
CJE0240
hypothetical protein
CJE0241
conserved hypothetical 
protein
CJE0243
hypothetical protein
CJE0244
Mu-like prophage I 
protein, putative
CJE0245
hypothetical protein
CJE0246
conserved hypothetical 
protein
CJE0247
conserved domain 
protein
CJE0248
hypothetical protein
CJE0249
phage uncharacterized 
protein
CJE0250
hypothetical protein
CJE0251
prophage MuSo1, F 
protein, putative
CJE0252
phage tail protein, 
putative
CJE0253
tail protein X, putative
CJE0254
tail protein D, putative
CJE0258
conserved domain 
protein
CJE0261
hypothetical protein
CJE0229
conserved hypothetical 
protein
CJE0228
hypothetical protein
CJE0227
major tail sheath protein
CJE0226
phage major tail tube 
protein, putative
CJE0220
DNA adenine methylase
C8J 0648
hypothetical protein
C8J 0649
phage repressor protein, 
putative
Cj1341c
motility accessory factor 
(function unknown)
CJE1607
hypothetical protein
CJE1606
haloacid dehalogenase-
like hydrolase 
domain/phosphoribuloki
nase domain protein
CJE1605
capsular polysaccharide 
biosynthesis protein, 
putative
CJE1604
capsular polysaccharide 
biosynthesis protein, 
putative
Cj0262c
putative methyl-accepting 
chemotaxis signal 
transduction protein
Cj0056c
hypothetical protein 
Cj0056c
CJE1136
hypothetical protein
Cj1139c
beta-1,3 
galactosyltransferase
- - - - - -- - -   - - - -
- - - - - -
 -  - - - - - - -  - -   - - -
- - -   - - - -
- - - - - -
 -  - - - - - - -  - -   - - -
- - -  - - - - -
- - - - - -
-
- -  - - - - - -
 -  - - - - - - -  - -   - -
- - - - - -
 -         - - -   - - -
-  - -  - - - -
- - - - - -
-   - - -    -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - - -   -  - -  - - - -
-  - -  - - - -
- - - - - -
- -  - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
- -  - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   -  - - - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-
-  - -  - - - -
-   - - - - - - -  - -  - - -
- - - - - -
-   - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-
-  - -  - - - -
-   - - - - - - -  - -  - - -
- - - - - -
-   - - - - - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - - - - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - - - - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-   - - - - - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-  - - - -  - - -  - -  - - - -
-  - -  - - - -
- - - - - -
-
-  - -  - - - -
-  - - - -  - - -  - -  - - -
- - - - - -
-  - - - - -   - - - -  - - - -
 - - -  - - - -
- - - - - -
  - -  - - - - - - - - -  - - -
 - - - - - - - -
- - - - - -
- - -  - -  - -    - - - - - -
 - - - - - - - -
- - - - - -
- - -  - -  - -    - - - - - -
 - - - - - - - 
- - - - - -
 -  -  -  - - - - -    - - -
- - -     - -
- - - - - -
- - - - -     - - -  - - - - 
- - - - - -  - -
- - - - - -
 - - -  - - - - - - - -   - - 
- - - - - -  - -
- - - - - -
 -  -  - - - - - - - -  - - - 
     - - - -
- - - - - -
- - - -   - - - - - - - - - - - 
 - - - - - - - -
- - - - - -
-  - -  - -   - - - - -  - - 
-  - -  - - - -
- - - - - -
- -  - -      - -   - - - 
   - - - - - -
- - - - - -

-   - - - - - -
 - - - - -  -  - - -  - - - -
- - - - - -
- - - - - -  -  - - -  - - - - 
   - - - - - -
- - - - - -
-  - - - - -   - - -  - - -  -
   - - - - - -
- - - - - -
-  - -  - -   - - -  - - -  -
   - - - - - -
- - - - - -
-  - -  - -   - - -  - - -  -
-  - - -   - 
- - - - - -
- - -  - - - - -  - -  -  -  -
   - - - - - -
- - - - - -
 - - -  - - - - - - - - - - -  -
   - - - - - -
- - - - - -
 - - -  - - - - - - - - -  -  -
-  - -  -  - -
- - - - - -
-  - -  - - - - - - -  - - -  -
-  - -  -  - -
- - - - - -
- - - -  - - - - - - -  - - -  -
 -    - - - -
- - - - - -
- -   - - - - -  - - - -    
       - 
- - - - - -
 - - - - - - - - - - -  -    
       - 
- - - - - -
-
       - 
- -   - -  - -        
- - - - - -
- -   - -  - -         
-  -     - 
- - - - - -
    -            - -
 - -   - - - -
- - - - - -
- - -   - - - -  - -  -   - 
     -  - 
- - - - - -
 -    - - - -         
     -  - --    -  -  -   -      
- -- - - - - -- - - - - -- - - -- -   - -
-
- -     
   - - - - - -   
 
- - - - - - - -- - - - - -
- - -- - - - - -   - - 
  -
- - -- -  - - -
-
- - -  -  - - -
- - - - - -- -  - - -- -
-
- - - -    
- - - - - -- -   - - 
-
- -- - -  - - - -  - - - - - -
- - --   -  -
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CDS
Cjj 
1336 
Water
Cjj 414 
Water 
Vole
Cjj S3 
Sheep
Cjj 
IA3902 
Sheep
Cjj 81-
176 
Milk
Cjd 
26997 
Huma
n 
Blood
Cjj 
ICDCCJ
07001 
Huma
n GBS 
Stool
Cjj 
81116 
Huma
n 
(Water
)
Cjj M1 
Huma
n 
(Chick
en)
Cjj 
11168 
(Huma
n)
Cjj 
0110 
Huma
n
Cjj 
0151 
Huma
n
Cc 
JV20 
Huma
n 
(Micro
biome)
Cjj 
RM122
1 
Chicke
n
Cc 
RM222
8 
Chicke
n
Cc 111-
3 Pig
Cc 132-
6 Pig
Cc 151-
9 Pig
Cc 59-
2 Pig
Cc 67-
8 Pig
Cc 7--1 
Pig
Cc 84-
2 Pig
Cc 90-
3 Pig
Cc 
99321 
Pig
Cc 
03121 
Pig
Cc 
03103 
Pig
Cc 
03317 
Pig
Cjj 857 
Pig
Cjj 
5491 
Pig
Cjj 623 
Pig
Cjj 304 
Pig
Cjj 484 
Pig
Cjj 444 
Pig
CJ857_00074
hypothetical 
protein
CJ857_00075
hypothetical 
protein
CJ857_00839
hypothetical 
protein
CJ857_00896
R.HinP1I 
restriction 
endonuclease
CJ857_00897
Modification 
methylase HhaI
CJ857_01361
hypothetical 
protein
CJ857_01649
hypothetical 
protein
CJ857_01723
hypothetical 
protein
CJ857_01724
R.Pab1 
restriction 
endonuclease
CJ857_01734
hypothetical 
protein
CJ857_01735
recombination 
protein F

    
    

    
    


     
    

     
     
     
    
- - - -
    
- -- - - - -- - - - - - - -
- - - - - - - - -
- - - - -- - -
-
- - -
- - - - -- - - - -
- - - - -
- - - -
- - - - - - - - -
- - -
- - - - -- - - - -
- - - - -- - - - - - - - -- - - - -
- -
- -
- - - - - - - - - - - - - -
- - - - --
- - -
- - - - - - - - - - - - -
- - - - -- - -
- - -
- - - - -- - - - -
- - - - - - - - - -- - - - - - - - -
- - - -
- - - - -
- - - - -- - - - - - - - -- - - - -
- -
- -
- - - - - - - - - - - - - -
- - - - --
- - -
- - - - - - - - - - - - -
- - - - -- - -
- - -
- - - - -- - - - -
- - - - - - - - - -- - - - - - - - -
- - - -
- - - - -
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CDS
Cjj 
1336 
Water
Cjj 414 
Water 
Vole
Cjj S3 
Sheep
Cjj 
IA3902 
Sheep
Cjd 
26997 
Human 
Blood
Cjj 81-
176 
Milk
Cjj 
ICDCCJ
07001 
Human 
GBS 
Stool
Cjj 
81116 
Human 
(Water
)
Cjj M1 
Human 
(Chicke
n)
Cjj 
11168 
(Huma
n)
Cjj 
0110 
Human
Cjj 
0151 
Human
Cc 
JV20 
Human 
(Micro
biome)
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Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value
Typing CDS HipO 2645 0 2645 0 2645 0 2639 0 2645 0 2645 0 2628 0 2678 0 2767 0
kpsC 3109 0 3109 0 3109 0 3109 0 3109 0 3109 0 3109 0 1711 0 3823 0
kpsD 2798 0 2837 0 2837 0 2798 0 2832 0 2832 0 2832 0 3059 0 3064 0
kpsE 1884 0 1879 0 1879 0 1884 0 1879 0 1884 0 1879 0 2067 0 2067 0
kpsF 1483 0 1511 0 1522 0 1483 0 1489 0 1489 0 1489 0 1552 0 1751 0
kpsM 1048 0 1048 0 1003 0 1048 0 1003 0 1048 0 998 0 1447 0 1447 0
kpsS 2015 9 2032 0 2032 0 2032 0 2032 0 2032 0 2037 0 2012 0 2189 0
kpsT 976 0 998 0 1026 0 998 0 1020 0 992 0 1026 0 1225 0 1225 0
cadF 1707 0 1707 0 1707 0 1707 0 1773 0 1707 0 1707 0 1724 0 1773 0
cdtA 1413 0 1413 0 1413 0 1413 0 1413 0 1413 0 1413 0 1469 0 1491 0
cdtB 1240 0 1240 0 1240 0 1240 0 1240 0 1251 0 1240 0 1430 0 1474 0
cdtC 987 0 987 0 987 0 987 0 981 0 987 0 987 0 1026 0 1053 0
ciaB 3253 0 3258 0 3253 0 3314 0 3258 0 3269 0 3258 0 3314 0 3386 0
dnaJ 1953 0 1941 0 1953 0 1941 0 1953 0 1953 0 1941 0 1892 0 2073 0
flaA 636 0 933 0 623 2E-177 769 0 885 0 627 2E-178 881 0 909 0 3175 0
iamB 1901 0 1884 0 1890 0 1884 0 1879 0 1890 0 1890 0 1895 0 2050 0
pldA 1779 0 1729 0 1779 0 1735 0 1790 0 1779 0 1768 0 1735 0 1829 0
racR 1203 0 1203 0 1203 0 1203 0 1203 0 1203 0 1197 0 1125 0 1242 0
virB11 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
wlaN 99 8.00E-20 292 4.00E-78 99 8.00E-20 296 3.00E-79 296 3.00E-79 292 4.00E-78 292 4.00E-78 NM NM 1685 0
CJ857_00074 466 5E-131 466 5E-131 466 5E-131 466 5E-131 466 5E-131 466 5E-131 466 5E-131 NM NM NM NM
CJ857_00075 2438 0 2431 0 2438 0 2431 0 2438 0 2438 0 2416 0 NM NM NM NM
CJ857_00839 455 1E-127 455 1E-127 449 5E-126 449 5E-126 455 1E-127 449 5E-126 394 2E-109 NM NM NM NM
CJ857_00896 1419 0 1419 0 1419 0 1419 0 1419 0 1419 0 1419 0 NM NM NM NM
CJ857_00897 1779 0 1779 0 972 0 1779 0 1779 0 1779 0 1779 0 NM NM NM NM
CJ857_01361 2250 0 2211 0 2204 0 2204 0 2211 0 2204 0 2242 0 NM NM NM NM
CJ857_01649 1591 0 1585 0 1580 0 1585 0 1585 0 1585 0 1580 0 NM NM NM NM
CJ857_01723 1973 0 1973 0 1973 0 1973 0 1973 0 1973 0 1973 0 NM NM NM NM
CJ857_01724 1319 0 1319 0 1319 0 1308 0 1319 0 1314 0 1319 0 NM NM NM NM
CJ857_01734 1037 0 1037 0 1037 0 1037 0 1037 0 1037 0 1037 0 NM NM NM NM
CJ857_01735 1951 0 1951 0 1951 0 1951 0 1951 0 1951 0 1951 0 NM NM NM NM
Species
Isolate
C. jejuni jejuni
857
C. jejuni jejuni
549.1 623
C. jejuni jejuni
304
C. jejuni jejuni
484
C. jejuni jejuni
11168
C. jejuni jejuni
444
C. jejuni jejuni
ATCC33560
C. jejuni jejuni
81116
C. jejuni jejuni
BLAST Results for capsule, virulence, and ST403CC associated CDS.  Grey results were considered 'low scoring matches'.  Results in red were discarded scores due to 
low homology or high error values.  Yellow highlighted scores indicate the 'self-match' of the CDS used to investigate homology
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Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value
Typing CDS HipO 2628 0 2025 0 2617 0 2656 0 2545 0 2628 0 2684 0 2678 0 2579 0
kpsC 3149 0 1517 0 3458 0 3109 0 3086 0 3096 0 1810 0 3452 0 3325 0
kpsD 2771 0 2433 0 2959 0 2942 0 2638 0 2809 0 2798 0 2926 0 2987 0
kpsE 1768 0 1613 0 1912 0 1906 0 1435 0 1978 0 1945 0 1873 0 1884 0
kpsF 1530 0 1352 0 1461 0 1434 0 1428 0 1530 0 1483 0 1485 0 1461 0
kpsM 965 0 1013 0 NM NM NM NM NM NM NM NM 1042 0 1070 0 1064 0
kpsS 2039 0 1683 0 2050 0 2089 0 1786 0 2032 0 2039 0 2150 0 1971 0
kpsT 998 0 1009 0 1003 0 1003 0 815 0 1020 0 987 0 1003 0 1003 0
cadF 1735 0 1480 0 1480 0 1762 0 1618 0 1762 0 1724 0 1773 0 1773 0
cdtA 294 9E-79 NM NM 1485 0 1463 0 NM NM 1463 0 1469 0 1491 0 1483 0
cdtB 492 3E-138 NM NM 1474 0 1458 0 NM NM 1447 0 1430 0 1474 0 1474 0
cdtC 878 0 NM NM 1053 0 1048 0 NM NM 1042 0 1026 0 1053 0 1053 0
ciaB 3153 0 2580 0 3319 0 3330 0 3236 0 3341 0 3308 0 3380 0 3341 0
dnaJ 1853 0 1692 0 1958 0 2039 0 1825 0 2002 0 1892 0 1953 0 2073 0
flaA 809 0 741 0 909 0 2396 0 1762 0 765 0 909 0 942 0 1977 0
iamB 1929 0 1574 0 1945 0 1945 0 1845 0 1945 0 1895 0 2006 0 2050 0
pldA 1424 0 1356 0 1724 0 1773 0 252 7E-66 1718 0 1735 0 1757 0 1731 0
racR 1031 0 1020 0 1242 0 1242 0 1064 0 1230 0 1125 0 1242 0 1242 0
virB11 NM NM NM NM 1762 0 NM NM NM NM NM NM NM NM NM NM NM NM
wlaN NM NM NM NM NM NM 267 2.00E-70 NM NM NM NM NM NM 379 3.00E-104 1677 0
J857_0007 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
J857_0007 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
J857_0083 130 7E-30 NM NM NM NM NM NM 316 5E-86 NM NM NM NM NM NM NM NM
J857_0089 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
J857_0089 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
J857_0136 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM 2239 0
J857_0164 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
J857_0172 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
J857_0172 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
J857_0173 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
J857_0173 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
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BLAST Results for capsule, virulence, and ST403CC associated CDS.  Grey results were considered 'low scoring matches'.  Results in red were discarded scores due to 
low homology or high error values.  Yellow highlighted scores indicate the 'self-match' of the CDS used to investigate homology
ICDCCJ07001 M1 01/1081-176 S3 01/51
C. jejuni jejuniSpecies
Isolate
CDS
C. jejuni jejuni C. jejuni jejuni C. jejuni jejuniC. jejuni jejuni C. jejuni jejuni
IA3902
C. jejuni jejuni
1336
C. jejuni jejuni
414
C. jejuni jejuni
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Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value
Typing CDS HipO 2651 0 2545 0 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
kpsC 3109 0 3086 0 NM NM 603 3.00 E-171 3009 0 NM NM 597 2.00 E-169 1855 0 569 3.00 E-161
kpsD 2942 0 2638 0 1325 0 1297 0 3009 0 1301 0 1314 0 2848 0 1277 0
kpsE 1906 0 1435 0 662 0 656 0 1851 0 684 0 667 0 1940 0 756 0
kpsF 1434 0 1428 0 NM NM 924 0 1417 0 939 0 929 0 1417 0 NM NM
kpsM NM NM NM NM NM NM NM NM 1048 0 592 3 E-168 NM NM NM NM 592 3 E-168
kpsS 2089 0 1786 0 1116 0 1116 0 2100 0 1127 0 1155 0 2111 0 1133 0
kpsT 1003 0 815 0 682 0 682 0 1009 0 693 0 688 0 1020 0 704 0
cadF 1762 0 1618 0 601 6E-171 595 3E-169 601 6E-171 601 6E-171 NM NM 601 6E-171 NM NM
cdtA 1463 0 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
cdtB 1458 0 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
cdtC 1048 0 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
ciaB 3330 0 3236 0 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
dnaJ 2039 0 1825 0 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
flaA 2379 0 1762 0 2361 0 848 0 710 0 837 0 793 0 817 0 499 4E-140
iamB 1945 0 1845 0 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
pldA 1773 0 252 7E-66 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
racR 1242 0 1064 0 782 0 787 0 793 0 793 0 793 0 793 0 793 0
virB11 NM NM NM NM NM NM NM NM NM NM 1219 0 NM NM NM NM NM NM
wlaN 285 6.00E-76 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_00074 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_00075 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_00839 128 3E-29 316 5E-86 NM NM NM NM 128 3E-29 NM NM NM NM 268 2E-71 NM NM
CJ857_00896 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_00897 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_01361 NM NM NM NM 682 0 682 0 NM NM NM NM NM NM NM NM NM NM
CJ857_01649 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_01723 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_01724 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_01734 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_01735 NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
151-9
C. coli
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BLAST Results for capsule, virulence, and ST403CC associated CDS.  Grey results were considered 'low scoring matches'.  Results in red were discarded scores due to 
low homology or high error values.  Yellow highlighted scores indicate the 'self-match' of the CDS used to investigate homology
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Score E value Score E value Score E value Score E value Score E value Score E value Score E value
Typing CDS HipO NM NM NM NM NM NM NM NM NM NM NM NM NM NM
kpsC 575 7.00 E-163 NM NM NM NM NM NM NM NM NM NM NM NM
kpsD 1282 0 1321 0 1319 0 1319 0 1303 0 1330 0 1301 0
kpsE 756 0 673 0 NM NM 667 0 662 0 NM NM 684 0
kpsF NM NM 898 0 NM NM 929 0 933 0 926 0 939 0
kpsM 592 3 E-168 NM NM NM NM NM NM NM NM NM NM NM NM
kpsS 1127 0 1171 0 1133 0 1166 0 1155 0 1122 0 1144 0
kpsT 704 0 643 0 649 0 688 0 671 0 649 0 704 0
cadF 601 6E-171 601 6E-171 601 6E-171 601 6E-171 601 6E-171 601 6E-171 601 6E-171
cdtA NM NM NM NM NM NM NM NM NM NM NM NM NM NM
cdtB NM NM NM NM NM NM NM NM NM NM NM NM NM NM
cdtC NM NM NM NM NM NM NM NM NM NM NM NM NM NM
ciaB NM NM NM NM NM NM NM NM NM NM NM NM NM NM
dnaJ NM NM NM NM NM NM NM NM NM NM NM NM NM NM
flaA 414 1E-114 715 0 893 0 525 6E-148 623 2E-177 893 0 300 4E-80
iamB NM NM NM NM NM NM NM NM NM NM NM NM NM NM
pldA NM NM NM NM NM NM NM NM NM NM NM NM NM NM
racR 793 0 787 0 793 0 793 0 793 0 787 0 787 0
virB11 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
wlaN NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_00074 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_00075 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_00839 265 2E-70 NM NM NM NM NM NM NM NM NM NM 322 1E-87
CJ857_00896 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_00897 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_01361 NM NM 682 0 675 0 675 0 676 0 676 0 NM NM
CJ857_01649 NM NM NM NM NM NM NM NM NM NM NM NM 1555 0
CJ857_01723 NM NM NM NM NM NM NM NM NM NM NM NM 1973 0
CJ857_01724 NM NM NM NM NM NM NM NM NM NM NM NM 1319 0
CJ857_01734 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
CJ857_01735 NM NM NM NM NM NM NM NM NM NM NM NM NM NM
BLAST Results for capsule, virulence, and ST403CC associated CDS.  Grey results were considered 'low scoring matches'.  Results in red were discarded 
scores due to low homology or high error values.  Yellow highlighted scores indicate the 'self-match' of the CDS used to investigate homology
90-3
C. coli
99/321
C. coli
7—1
C. coli
84-2
C. coli
03/103
C. coli
03/317
C. coli
03/121
C. coli
ST
40
3C
C 
As
so
ci
at
ed
 C
DS
Species
Isolate
CDS
Ca
ps
ul
e 
As
so
ci
at
ed
 C
DS
Vi
ru
le
nc
e 
As
so
ci
at
ed
 C
DS
Appendix 9.4.2: Local Database BLAST Results for ST403CC Associated CDS in an Extended C. coli Database
279
Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value
NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
682 0 676 0 689 0 682 0 NM NM 682 0 676 0 682 0 NM NM NM NM NM NM NM NM
NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value
333 7E-91 128 4E-29 NM NM NM NM NM NM NM NM 246 1E-64 248 3E-65 NM NM NM NM 267 7E-71
682 0 671 0 682 0 667 0 682 0 NM NM NM NM NM NM 682 0 671 0 688 0
NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM
Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value Score E value
NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM NM 265 3E-70 NM NM NM NM
671 0 NM NM 660 0 682 0 676 0 671 0 667 0 673 0 671 0 682 0 682 0
NM NM 1973 0 NM NM NM NM NM NM 1973 0 NM NM NM NM NM NM NM NM NM NM
NM NM 1319 0 NM NM NM NM NM NM 1314 0 NM NM NM NM NM NM NM NM NM NM
BLAST Results for capsule, virulence, and ST403CC associated CDS.  Grey results were considered 'low scoring matches'.  Results in red were discarded scores due to low homology or high error values.
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